Skip to main content
The Cochrane Database of Systematic Reviews logoLink to The Cochrane Database of Systematic Reviews
. 2021 Nov 6;2021(11):CD001800. doi: 10.1002/14651858.CD001800.pub4

Exercise‐based cardiac rehabilitation for coronary heart disease

Grace Dibben 1, James Faulkner 2, Neil Oldridge 3, Karen Rees 4, David R Thompson 5, Ann-Dorthe Zwisler 6,7, Rod S Taylor 8,9,
Editor: Cochrane Heart Group
PMCID: PMC8571912  PMID: 34741536

Abstract

Background

Coronary heart disease (CHD) is the most common cause of death globally. However, with falling CHD mortality rates, an increasing number of people living with CHD may need support to manage their symptoms and prognosis. Exercise‐based cardiac rehabilitation (CR) aims to improve the health and outcomes of people with CHD. This is an update of a Cochrane Review previously published in 2016.

Objectives

To assess the clinical effectiveness and cost‐effectiveness of exercise‐based CR (exercise training alone or in combination with psychosocial or educational interventions) compared with 'no exercise' control, on mortality, morbidity and health‐related quality of life (HRQoL) in people with CHD.

Search methods

We updated searches from the previous Cochrane Review, by searching CENTRAL, MEDLINE, Embase, and two other databases in September 2020. We also searched two clinical trials registers in June 2021.

Selection criteria

We included randomised controlled trials (RCTs) of exercise‐based interventions with at least six months’ follow‐up, compared with 'no exercise' control. The study population comprised adult men and women who have had a myocardial infarction (MI), coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI), or have angina pectoris, or coronary artery disease.

Data collection and analysis

We screened all identified references, extracted data and assessed risk of bias according to Cochrane methods. We stratified meta‐analysis by duration of follow‐up: short‐term (6 to 12 months); medium‐term (> 12 to 36 months); and long‐term ( > 3 years), and used meta‐regression to explore potential treatment effect modifiers. We used GRADE for primary outcomes at 6 to 12 months (the most common follow‐up time point). 

Main results

This review included 85 trials which randomised 23,430 people with CHD. This latest update identified 22 new trials (7795 participants). The population included predominantly post‐MI and post‐revascularisation patients, with a mean age ranging from 47 to 77 years.

In the last decade, the median percentage of women with CHD has increased from 11% to 17%, but females still account for a similarly small percentage of participants recruited overall ( < 15%). Twenty‐one of the included trials were performed in low‐ and middle‐income countries (LMICs). Overall trial reporting was poor, although there was evidence of an improvement in quality over the last decade. The median longest follow‐up time was 12 months (range 6 months to 19 years).

At short‐term follow‐up (6 to 12 months), exercise‐based CR likely results in a slight reduction in all‐cause mortality (risk ratio (RR) 0.87, 95% confidence interval (CI) 0.73 to 1.04; 25 trials; moderate certainty evidence), a large reduction in MI (RR 0.72, 95% CI 0.55 to 0.93; 22 trials; number needed to treat for an additional beneficial outcome (NNTB) 75, 95% CI 47 to 298; high certainty evidence), and a large reduction in all‐cause hospitalisation (RR 0.58, 95% CI 0.43 to 0.77; 14 trials;  NNTB 12, 95% CI 9 to 21; moderate certainty evidence). Exercise‐based CR likely results in little to no difference in risk of cardiovascular mortality (RR 0.88, 95% CI 0.68 to 1.14; 15 trials; moderate certainty evidence), CABG (RR 0.99, 95% CI 0.78 to 1.27; 20 trials; high certainty evidence), and PCI (RR 0.86, 95% CI 0.63 to 1.19; 13 trials; moderate certainty evidence) up to 12 months' follow‐up. We are uncertain about the effects of exercise‐based CR on cardiovascular hospitalisation, with a wide confidence interval including considerable benefit as well as harm (RR 0.80, 95% CI 0.41 to 1.59; low certainty evidence). There was evidence of substantial heterogeneity across trials for cardiovascular hospitalisations (I2 = 53%), and of small study bias for all‐cause hospitalisation, but not for all other outcomes.

At medium‐term follow‐up, although there may be little to no difference in all‐cause mortality (RR 0.90, 95% CI 0.80 to 1.02; 15 trials), MI (RR 1.07, 95% CI 0.91 to 1.27; 12 trials), PCI (RR 0.96, 95% CI 0.69 to 1.35; 6 trials), CABG (RR 0.97, 95% CI 0.77 to 1.23; 9 trials), and all‐cause hospitalisation (RR 0.92, 95% CI 0.82 to 1.03; 9 trials), a large reduction in cardiovascular mortality was found (RR 0.77, 95% CI 0.63 to 0.93; 5 trials). Evidence is uncertain for difference in risk of cardiovascular hospitalisation (RR 0.92, 95% CI 0.76 to 1.12; 3 trials).

At long‐term follow‐up, although there may be little to no difference in all‐cause mortality (RR 0.91, 95% CI 0.75 to 1.10), exercise‐based CR may result in a large reduction in cardiovascular mortality (RR 0.58, 95% CI 0.43 to 0.78; 8 trials) and MI (RR 0.67, 95% CI 0.50 to 0.90; 10 trials). Evidence is uncertain for CABG (RR 0.66, 95% CI 0.34 to 1.27; 4 trials), and PCI (RR 0.76, 95% CI 0.48 to 1.20; 3 trials).

Meta‐regression showed benefits in outcomes were independent of CHD case mix, type of CR, exercise dose, follow‐up length, publication year, CR setting, study location, sample size or risk of bias.

There was evidence that exercise‐based CR may slightly increase HRQoL across several subscales (SF‐36 mental component, physical functioning, physical performance, general health, vitality, social functioning and mental health scores) up to 12 months' follow‐up; however, these may not be clinically important differences. The eight trial‐based economic evaluation studies showed exercise‐based CR to be a potentially cost‐effective use of resources in terms of gain in quality‐adjusted life years (QALYs).

Authors' conclusions

This updated Cochrane Review supports the conclusions of the previous version, that exercise‐based CR provides important benefits to people with CHD, including reduced risk of MI, a likely small reduction in all‐cause mortality, and a large reduction in all‐cause hospitalisation, along with associated healthcare costs, and improved HRQoL up to 12 months' follow‐up. Over longer‐term follow‐up, benefits may include reductions in cardiovascular mortality and MI. In the last decade, trials were more likely to include females, and be undertaken in LMICs, increasing the generalisability of findings. Well‐designed, adequately‐reported RCTs of CR in people with CHD more representative of usual clinical practice are still needed. Trials should explicitly report clinical outcomes, including mortality and hospital admissions, and include validated HRQoL outcome measures, especially over longer‐term follow‐up, and assess costs and cost‐effectiveness.

Plain language summary

Exercise‐based rehabilitation for coronary heart disease

Background

Coronary heart disease (CHD) is the single most common cause of death globally. However, with falling CHD mortality rates, an increasing number of people live with CHD and may need support to manage their symptoms (such as angina, shortness of breath with physical activity, and fatigue) and reduce the chances of future problems, such as heart attacks. Exercise‐based cardiac rehabilitation (exercise training alone or in combination with psychological or educational interventions) aims to improve the health and outcomes of people with CHD.

Study characteristics

We searched the scientific literature for randomised controlled trials (experiments that randomly allocate participants to one of two or more treatment groups) looking at the effectiveness of exercise‐based treatments compared with no exercise in people of all ages with CHD. The evidence is current to September 2020.

Key results
This latest update identified an additional 22 trials (7795 participants). We included a total of 85 trials that studied 23,430 people with CHD, predominantly heart attack survivors and those who had undergone heart bypass surgery or angioplasty (a procedure which widens narrowed or obstructed arteries or veins). Thirty‐eight (45%) of the trials involved exercise‐only interventions and 47 (55%) involved interventions with exercise plus other components. The type of exercise most often included was stationary cycling, walking or circuit training. Twenty‐one (25%) of the interventions were delivered in the participants' homes. 

The findings of this update are consistent with the previous (2016) version of this Cochrane Review, and show important benefits of exercise‐based cardiac rehabilitation that include a reduction in the risk of death due to any cause, heart attack, and hospital admission, and improvements in health‐related quality of life, compared with not undertaking exercise. A small body of economic evidence was identified, indicating exercise‐based cardiac rehabilitation to be cost‐effective. Many of the studies identified in this current update were undertaken in low‐ and middle‐income countries, which increases the generalisability of our results to these settings where levels of CHD are high and continue to increase.

Quality of evidence
Although the reporting of methods has improved in recent trials, lack of reporting key methodological aspects made it difficult to assess the overall methodological quality and risk of possible bias of the evidence.

Summary of findings

Summary of findings 1. Exercise‐based cardiac rehabilitation compared to 'no exercise' control for coronary heart disease.

Exercise‐based cardiac rehabilitation compared to 'no exercise' control for coronary heart disease
Patient or population: people with coronary heart disease 
Setting: hospital‐based, community‐based and home‐based settings 
Intervention: exercise‐based cardiac rehabilitation 
Comparison: 'no exercise' control
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) № of participants
(studies) Certainty of the evidence
(GRADE) Comments
Risk with 'no exercise' control Risk with exercise‐based cardiac rehabilitation
All‐cause mortality
Follow‐up: range 6 months to 12 months Study population RR 0.87
(0.73 to 1.04) 8823
(25 RCTs) ⊕⊕⊕⊝
Moderatea Exercise‐based cardiac rehabilitation likely results in a slight reduction in all‐cause mortality up to 12 months' follow‐up. 25 RCTs with 26 comparisons. 14 RCTs reported 0 events in both the intervention and control groups. 
57 per 1000 50 per 1000
(42 to 59)
Cardiovascular mortality
Follow‐up: range 6 months to 12 months Study population RR 0.88
(0.68 to 1.14) 5360
(15 RCTs) ⊕⊕⊕⊝
Moderatea Exercise‐based cardiac rehabilitation likely results in little to no difference in cardiovascular mortality up to 12 months' follow‐up. 5 RCTs reported 0 events in both the intervention and control groups.
45 per 1000 39 per 1000
(30 to 51)
Fatal and/or non‐fatal MI
Follow‐up: range 6 months to 12 months Study population RR 0.72
(0.55 to 0.93) 7423
(22 RCTs) ⊕⊕⊕⊕
High Exercise‐based cardiac rehabilitation results in a large reduction in fatal and/or non‐fatal MI up to 12 months' follow‐up. 24 RCTs with 24 comparisons. 3 RCTs reported 0 events in both the intervention and control groups.
NNTB 75 (95% CI 47 to 298)
48 per 1000 35 per 1000
(27 to 45)
Revascularisation ‐ CABG
Follow‐up: range 6 months to 12 months Study population RR 0.99
(0.78 to 1.27) 4473
(20 RCTs) ⊕⊕⊕⊕
High Exercise‐based CR results in little to no difference in CABG revascularisation up to 12 months' follow‐up. 20 RCTs with 22 comparisons. 2 RCTs reported 0 events in both the intervention and control groups.
56 per 1000 56 per 1000
(44 to 72)
Revascularisation ‐ PCI
Follow‐up: range 6 months to 12 months Study population RR 0.86
(0.63 to 1.19) 3465
(13 RCTs) ⊕⊕⊕⊝
Moderatea Exercise‐based CR likely results in little to no difference in risk of PCI revascularisation up to 12 months' follow‐up. 13 RCTs with 14 comparisons. 3 RCTs reported 0 events in both the intervention and control groups.
60 per 1000 52 per 1000
(38 to 72)
All‐cause hospital admissions
Follow‐up: range 6 months to 12 months Study population RR 0.58
(0.43 to 0.77) 2030
(14 RCTs) ⊕⊕⊕⊝
Moderateb Exercise‐based cardiac rehabilitation likely results in a large reduction in all‐cause hospital admissions up to 12 months' follow‐up. 14 RCTs with 16 comparisons. One RCT reported 0 events in both the intervention and control group.
NNTB 12 (95% CI 9 to 21)
214 per 1000 124 per 1000
(92 to 165)
Cardiovascular hospital admissions
Follow‐up: range 6 months to 12 months Study population RR 0.80
(0.41 to 1.59) 1087
(6 RCTs) ⊕⊕⊝⊝
Lowa,c We are uncertain about the effects of exercise‐based CR on cardiovascular hospitalisation, with a wide confidence interval including considerable benefit as well as harm.
78 per 1000 62 per 1000
(32 to 123)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). 

CI: confidence interval; RR: risk ratio; OR: odds ratio; NNTB/H: number needed to treat for an additional beneficial/harmful outcome
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

a95% CI is wide and overlaps no effect; therefore, downgraded by one level for imprecision.
bP < 0.05 in the Egger test, and funnel plot asymmetry; therefore, downgraded by one level for suspected publication bias.
cEvidence of heterogeneity in the I2 test; therefore, downgraded by one level for substantial heterogeneity.

Background

Description of the condition

Coronary heart disease (CHD, see Glossary in Appendix 1) is the single most common cause of death globally, with 7.46 million deaths in 2016, accounting for one‐third of all deaths (WHO 2018). In the United Kingdom (UK), an estimated 2.3 million people live with CHD – around 1.5 million men and 830,000 women, and the condition accounts for one in seven deaths in men and one in twelve deaths in women (BHF 2020). Although remaining stubbornly constant in low‐ and middle‐income countries, the mortality rate from CHD has been falling in the UK and other high‐income settings. This is due to factors such as declines in cigarette smoking, improvements in hypertension treatment and control, widespread use of statins to lower circulating cholesterol levels, and the development and timely use of thrombolysis and stents in acute coronary syndromes (Mensah 2017). Accordingly, an increasingly large number of people live with CHD and may need support to manage their symptoms and prognosis. 

Description of the intervention

Many definitions of cardiac rehabilitation (CR) have been proposed. The following definition encompasses the key concepts of CR: “The coordinated sum of activities required to influence favourably the underlying cause of cardiovascular disease, as well as to provide the best possible physical, mental and social conditions, so that the patients may, by their own efforts, preserve or resume optimal functioning in their community and through improved health behaviour, slow or reverse progression of disease” (BACPR 2017). CR is a complex intervention that may involve a variety of therapies, including exercise, risk factor education, behaviour change, psychological support, and strategies that are aimed at targeting traditional risk factors for cardiovascular disease. CR is an essential part of contemporary CHD care and is considered a priority in countries with a high prevalence of CHD. Based on evidence ‐ including from the previous version of this Cochrane Review (Anderson 2016) ‐ CR following a cardiac event is a Class I recommendation from the European Society of Cardiology, and the American Heart Association and American College of Cardiology, with exercise therapy consistently identified as a central element (Knuuti 2020; Smith 2011). However, despite these positive recommendations for exercise‐based CR, it continues to be widely underused with overall participation rates in recent decades of about 40% (Kotseva 2018). Service provision, though predominantly hospital‐based, varies markedly, and referral, enrolment and completion are sub‐optimal, especially amongst women and older people (Peters 2017Ruano‐Ravina 2016). Home‐ and technology‐based CR programmes have been advocated to widen access and participation (Dalal 2015), and interventions aimed at improving people's uptake and adherence to CR programmes have been identified (Santiago de Araújo Pio 2019).

Exercise‐based CR appears to be a safe intervention. An observational study of more than 25,000 people undergoing CR reported one cardiac event for 50,000 hours of exercise training, equivalent to 1.3 cardiac arrests per million patient‐hours (Pavy 2006). An earlier study reported one case of ventricular fibrillation per 111,996 patient‐hours of exercise, and one myocardial infarction (MI) per 294,118 patient‐hours (Van Camp 1986). In the context of CR, higher risk CHD populations have been defined as those with severe in‐hospital complications after acute coronary syndrome (ACS), cardiac surgery, or percutaneous coronary intervention (PCI) (Pelliccia 2020; Piepoli 2010).

How the intervention might work

Exercise training has been shown to have direct benefits on the heart and coronary vasculature, including myocardial oxygen demand, endothelial function, autonomic tone, coagulation and clotting factors, inflammatory markers, and the development of coronary collateral vessels (Clausen 1976; Hambrecht 2000). However, findings of the original Cochrane Review of exercise‐based CR for CHD (Jolliffe 2001), supported the hypothesis that reductions in mortality may also be mediated via the indirect effects of exercise through improvements in atherosclerotic risk factors (i.e. lipids, smoking and blood pressure) (Taylor 2006).

Why it is important to do this review

People who have had acute MI and coronary revascularisation (along with heart failure) remain those most frequently recommended for CR referral by healthcare systems across the world (Piepoli 2010Pelliccia 2020). Regular updates to this systematic review of randomised controlled trials (RCTs) of CR for CHD is therefore key to ensuring the contemporary nature of the evidence base in order to continue to inform healthcare policy makers and guideline producers.

The 2016 Cochrane review made the following two key recommendations for future evidence collection and clinical trials (Anderson 2016).

  • The need for further evidence from 'hard to reach' groups, including women, elderly people, and ethnic minorities.

  • The need for more consistent collection and reporting of validated health‐related quality of life (HRQoL) outcomes, costs and cost‐effectiveness.

In addition, the majority of evidence (58/63, 92%) in Anderson 2016 was collected in high‐income countries (HICs), with a need to consider trials from low‐ and middle‐income countries (LMICs) when they become available.

Objectives

To assess the clinical effectiveness and cost‐effectiveness of exercise‐based CR (exercise training alone or in combination with psychosocial or educational interventions) compared with 'no exercise' control, on mortality, morbidity and health‐related quality of life (HRQoL) in people with CHD.

Methods

Criteria for considering studies for this review

Types of studies

We included RCTs (with individual participant or cluster allocation, or cross‐over design) and quasi‐RCTs (RCTs in which treatment allocation was obtained by alternation or other predictable methods) of exercise‐based CR versus 'no exercise' control. In order to present outcome data that are meaningful and relevant for clinical and policy decision‐making, we limited our search to studies with a follow‐up period of at least six months in our 2011 update of this Cochrane Review and subsequent updates. Where a full text was not available, we contacted the study authors and attempted to collect further information. If we received no response, we placed the study into the 'awaiting classification' category.

Types of participants

We included adult (≥ 18 years) men and women, in either hospital‐based and community‐based settings, who have had a myocardial infarction (MI), or who have undergone revascularisation (CABG, PCI) or who have angina pectoris or coronary artery disease defined by angiography. We included trials with mixed indication population as long as more than 50% of the trial participants had a CHD diagnosis.  Please note that the terms CHD and coronary artery disease (CAD) are (or can be) sometimes used interchangeably and terms are presented as described by trialists in the Characteristics of included studies

We excluded studies which only included participants following heart valve surgery, with heart failure, atrial fibrillation or heart transplants, or implanted with either cardiac‐resynchronisation therapy or implantable cardiovertor defibrillators. These indications are the subject of other Cochrane reviews (Anderson 2017Nielsen 2019Risom 2017Sibilitz 2016Long 2019). We also excluded studies of participants who had completed a CR programme prior to randomisation.

Types of interventions

Exercise‐based CR is defined as a supervised or unsupervised inpatient, outpatient, community‐ or home‐based intervention which includes some form of exercise training that is applied to a cardiac patient population. The intervention could be exercise training alone or exercise training in addition to psychosocial or educational interventions, or both (i.e. "comprehensive CR").

All CR interventions were compared to a 'no exercise' control, and both the intervention and control group received usual medical care. Usual care could include standard medical care, such as drug therapy, but without any form of structured exercise training or advice.

Types of outcome measures

Studies should have intended to assess any of the following outcomes in both the CR and the control groups, but these outcomes did not form the basis of our inclusion/exclusion criteria. We collected outcome data at three follow‐up periods: short‐term (6 to 12 months), medium‐term ( > 12 to 36 months), and long‐term ( > than 36 months).

Primary outcomes
  • All‐cause mortality

  • Cardiovascular mortality

  • Fatal MI and/or non‐fatal MI

  • Revascularisation with CABG

  • Revascularisation with PCI

  • All‐cause hospitalisation

  • Cardiovascular hospitalisation

We sought data on the number of trial participants who experienced the above events.

Secondary outcomes
  • HRQoL assessed using validated instruments (e.g. SF‐36 (a 36‐item Short Form Health Survey); or EQ‐5D (a standardised measure developed by the EuroQol Group))

  • Costs and cost‐effectiveness ‐ we sought reports of total healthcare or societal costs, or both. Cost‐effectiveness analyses should have reported incremental difference in cost and outcome between CR and control (e.g. cost per quality‐adjusted life year (QALY) or cost per life year gained (LYG) analysis).

Search methods for identification of studies

Electronic searches

We updated the search from the previously published Cochrane Review (Anderson 2016), by searching the following databases on 1 September 2020.

  • Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library (Issue 9, 2020).

  • Epub Ahead of Print, In‐Process & Other Non‐Indexed Citations, MEDLINE Daily and MEDLINE (Ovid; 1946 to 1 September 2020).

  • Embase (Ovid; 1980 to 2020 week 36).

  • Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus (EBSCOHost; 1937 to 1 September 2020).

  • SCI‐Expanded and CPCI‐S on Web of Science (Clarivate Analytics; 1900 to 1 September 2020).

We designed search strategies with reference to those of the previous systematic review (Anderson 2016). We searched the databases using a strategy combining subject headings and free text terms relating to exercise‐based rehabilitation and coronary heart disease, with filters applied to limit to RCTs. The RCT filter for MEDLINE is the Cochrane sensitivity‐maximising RCT filter, and for Embase, terms as recommended in the Cochrane Handbook for Systematic Reviews of Intervenations have been applied (Lefebvre 2019, hereafter referred to as the Cochrane Handbook). For the other databases, except CENTRAL, we applied an adaptation of the Cochrane RCT filter. 

We applied date limits to the previously used search terms, and we searched for the new terms without date limits. We imposed no language or other limitations. We also gave consideration to variations in terms used and spellings of terms in different countries so that studies were not missed by the search strategy because of such variations. See Appendix 2 for details of the search strategies used.

Searching other resources

We searched the following clinical trial registers on 21 June 2021, for ongoing clinical trials.

  •  World Health Organization (WHO) International Clinical Trials Registry platform (ICTRP) (apps.who.int/trialsearch/). 

  • ClinicalTrials.gov (www.clinicaltrials.gov).

We also handsearched reference lists of retrieved articles and systematic reviews published since the last update, for any studies not identified by the electronic searches, and we sought expert advice. 

Data collection and analysis

Selection of studies

Two review authors (JF, RST) independently examined the titles and abstracts of citations identified by the electronic searches for possible inclusion, and coded them as 'retrieve' (eligible or potentially eligible/unclear) or 'irrelevant’. We retrieved full‐text publications of potentially relevant studies (and had them translated into English where required), and two review authors (JF, GD) then independently determined study eligibility using a standardised inclusion form. We resolved any disagreements about study eligibility through discussion and, if necessary, a third review author (RST) was asked to arbitrate. We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, is the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and 'Characteristics of excluded studies' table (Liberati 2009).

We re‐screened full texts excluded in previous versions of this review, where the reason for exclusion was based on reporting of outcomes. None of these studies were eligible for inclusion; we updated the reasons for exclusion. 

Data extraction and management

Two review authors (GD, JF) independently extracted study characteristics of included RCTs and outcome data using a standardised data collection form which had been piloted on two RCTs included in the review. A third review author (RST) checked all extracted data for accuracy. We resolved disagreements by consensus. If data were presented numerically (in tables or text) and graphically (in figures), we used the numeric data because of possible measurement error when estimating from graphs. A third review author (RST) confirmed all numeric calculations and extractions from graphs or figures. We resolved any discrepancies by consensus. One author (GD) transferred extracted data into Review Manager 5.4.1 (Review Manager 2014), and a second author (RST) spot‐checked data for accuracy against the included study.

The following categories of data were extracted.

  • Methods: study design, total duration of study, length of follow‐up, number of centres, setting, date of study conduct.

  • Participants: number randomised, number lost to follow‐up, number analysed, age, sex, ethnicity, CHD diagnosis, and inclusion and exclusion criteria.

  • Intervention and control: mode of exercise, duration, frequency and intensity, any co‐interventions and description of comparator.

  • Outcome: primary and secondary outcomes.

  • Funding and notable conflicts of interest of authors.

If there were multiple reports of the same study, we assessed the duplicate publications for additional data. We extracted outcome results at all follow‐up points post‐randomisation. We contacted study authors where necessary to provide additional information.

Assessment of risk of bias in included studies

Two review authors (GD, JF) assessed the risk of bias in included studies using the Cochrane Collaboration's risk of bias (RoB) tool, which is a domain‐based critical evaluation of the following core risk of bias items: the quality of random sequence generation and allocation concealment, blinding of outcome assessment, incomplete outcome data, and selective reporting (Higgins 2011).

All risk of bias assessments were checked by a third review author (RST), and we resolved any discrepancies by consensus. Details of the assessments of risk of bias for each included trial are shown in the Characteristics of included studies tables.

Measures of treatment effect

We processed data in accordance with the Cochrane Handbook (Deeks 2011). Dichotomous outcomes for each comparison have been expressed as risk ratios (RR) with 95% confidence intervals (CI). For primary outcomes with an effect excluding no difference, we calculated the number needed to treat for an additional beneficial/harmful outcome (NNTB/NNTH), following methods detailed in the Cochrane Handbook (Schünemann 2021). We used the assumed risk with control from the 'Table 1' table as the 'assumed comparator risk'. 

Continuous HRQoL outcome comparisons were pooled where possible; that is, when there were more than two studies using the same HRQoL measure and reporting results on the same scale using the mean difference (MD). We interpreted these data using published minimal clinically important differences (MCIDs) where available. For the SF‐36 instrument, within‐person MCIDs which vary according to domain, have been published for people with heart disease (Wyrwich 2004; 15 for physical functioning, general health and mental health; 16.7 for emotional performance; 18.75 for physical performance and vitality; 20 for bodily pain; and 25 for social functioning). There are none available for the SF‐36 summary component scores. For the EQ‐5D, an MCID of 0.05 was used for interpretation (Briggs 2017). 

Unit of analysis issues

Some trials contained two arms of CR and a single control group. In these cases, we divided the number randomised to the control group in half to obtain the denominator for data analysis; the means and standard deviation for the control group remained unchanged for both comparisons. For trials with cluster randomisation, approximately correct analyses were attempted where sufficient information (the intracluster correlation coefficient (ICC)) was available. 

Given the variation in trial reporting follow‐up timings, we pooled outcome results separately at three time points; namely, short‐term (6 to 12 months); medium‐term ( > 12 to 36 months); and long‐term ( > 36 months) follow‐up.

Dealing with missing data

We contacted multiple authors to verify key study characteristics (such as randomisation), data queries and obtain missing numerical outcome data.

Assessment of heterogeneity

We explored heterogeneity amongst included studies qualitatively (through visual inspection of forest plots and by comparing the characteristics of included studies), and quantitatively (using the Chi2 test of heterogeneity and the I2 statistic). We considered the magnitude and direction of effects, and strength of evidence for heterogeneity (e.g. P value from Chi2 and number of studies) alongside a threshold of I2 greater than 50% to represent substantial heterogeneity (Deeks 2011).

Assessment of reporting biases

When 10 or more studies were included in meta‐analysis, we used the funnel plot and Egger test to examine small study bias (Egger 1997). We processed data in accordance with the Cochrane Handbook (Deeks 2011). We completed data synthesis and analyses using Review Manager 5.4.1 software (Review Manager 2014) and STATA version 16.1 (StataCorp 2020).

Data synthesis

We performed random‐effects meta‐analyses with 95% CIs where appropriate (i.e. when treatments, participants, and the underlying clinical question were similar enough for pooling to make sense). We used random‐effects meta‐analyses due to the qualitative clinical heterogeneity (types of interventions and CHD population characteristics). Compared with a fixed‐effect model, this model provides a more conservative statistical comparison of the difference between intervention and control by typically providing a wider confidence interval around the effect estimate. If a statistically significant difference was present using the random‐effects model, we also reported the fixed‐effect pooled estimate and 95% CI, because of the tendency of smaller trials ‐ which are more susceptible to publication bias ‐ to be over‐weighted with a random‐effects analysis (Heran 2008a; Heran 2008b).

Subgroup analysis and investigation of heterogeneity

We undertook univariate meta‐regression to explore heterogeneity and examine potential treatment effect modifiers. We tested ten hypotheses that there may be differences in the effect of exercise‐based CR on total mortality, cardiovascular mortality, total MI, revascularisation (CABG and PCI) and all‐cause hospitalisation across the following pre‐defined subgroups.

  • CHD case mix (% participants presenting with MI).

  • 'Dose' of exercise intervention (dose (units) = number of weeks of exercise training x average number of sessions/week x average duration of session in minutes).

  • Type of CR (exercise‐only CR versus comprehensive CR).

  • Length of follow‐up period (where trial reported multiple follow‐up times, the longest follow‐up was used).

  • Year of publication (pre‐1995 versus post‐1995, where 1995 is used as proxy time to represent implementation of what might be regarded as ‘modern CHD usual care’).

  • Overall sample size (N ≤ 150 versus N > 150).

  • Setting (home‐ or centre‐based CR).

  • Risk of bias (low risk of bias in < 3 out of 5 domains).

  • Study location (continent ‐ Europe, North America, Australia/Asia or Other)

  • Studies undertaken in low‐, middle‐ or high‐income countries (according to the World Bank Group) (worldbank.org).

Given the relatively small ratio of trials to covariates, meta‐regression was limited to univariate analysis (Deeks 2011). To account for multiple testing, a Bonferroni correction was used and a P value of less than 0.005 (0.05/10 covariates) was used to define statistical significance.

Sensitivity analysis

We did not undertake sensitivity analyses.

Summary of findings and assessment of the certainty of the evidence

One author (GD) used GRADEProfiler software to assess the certainty of evidence for primary outcomes reported in the review (GRADEpro GDT). We downgraded the evidence from high certainty by one level based on the following factors: indirectness of evidence, unexplained heterogeneity, publication bias, risk of bias due to study design limitations, and imprecision of results (Balshem 2011). A second author (RST) checked the assessment. We applied a GRADE assessment to the primary outcomes at 6 to 12 months (the most commonly reported follow‐up timing across trials).

Results

Description of studies

Details of the studies included in the review are listed in the Characteristics of included studies table. Details of excluded studies are listed in the Characteristics of excluded studies table.

Results of the search

In summary, a total of 85 trials reporting data for a total of 23,430 participants have been included in this review update. This includes 30 trials (55 publications, 9552 participants) from the original Cochrane Review (Jolliffe 2001) (Andersen 1981Bell 1998Bengtsson 1983Bertie 1992Bethell 1990Carlsson 1998Carson 1982DeBusk 1994Engblom 1996Erdman 1986Fletcher 1994Fridlund 1991Haskell 1994Heller 1993Holmbäck 1994Kallio 1979Leizorovicz 1991Lewin 1992Miller 1984Oldridge 1991Ornish 1990Schuler 1992Shaw 1981Sivarajan 1982Specchia 1996Stern 1983Vecchio 1981Vermeulen 1983WHO 1983Wilhelmsen 1975); 17 studies (26 publications, 2211 participants) identified by the second updated search (Heran 2011) (Belardinelli 2001Bäck 2008Dugmore 1999Giallauria 2008Hofman‐Bang 1999Kovoor 2006La Rovere 2002Manchanda 2000Marchionni 2003Seki 2003Seki 2008Ståhle 1999Toobert 2000VHSG 2003Yu 2003Yu 2004Zwisler 2008); an additional 16 trials (20 publications, 3872 participants) from the third updated search (Anderson 2016) (Aronov 2010Bettencourt 2005aBriffa 2005Hambrecht 2004Higgins 2001Houle 2012Maddison 2014Maroto 2005Munk 2009Mutwalli 2012Oerkild 2012Reid 2012Roman 1983Sandström 2005Wang 2012West 2012), as well as one publication (Dorn 1999) which provided further follow‐up data from a study included in the original review (Shaw 1981); and 22 trials (43 publications, 7795 participants) from this 2020 updated search (Aronov 2019Bubnova 2019Bubnova 2020Byrkjeland 2015Campo 2020Chaves 2019Dorje 2019Hassan 2016Hautala 2017He 2020Lear 2015Ma 2020Pal 2013Pomeshkina 2017Pomeshkina 2019Prabhakaran 2020Santaularia 2017Snoek 2020Sun 2016Uddin 2020Xu 2017Zhang 2018). The study selection process is summarised in the PRISMA flow diagram shown in Figure 1 (Liberati 2009).

1.

1

PRISMA flow diagram of study selection process

Included studies

Study design

Seventy‐nine (93%) of the studies were two‐arm parallel RCTs. Three studies compared more than two arms (Bubnova 2020; Pomeshkina 2017; Sivarajan 1982), and one study compared three arms with a waiting‐list control design (Chaves 2019) (only outcome data at six months were used in this review as waiting‐list control participants elected which arm of the study to move into after this point). One study used quasi‐randomisation methods based on week of surgery (Uddin 2020). One study was a cluster‐randomised trial (Heller 1993), with clustered data reported at the individual level, and no report of the ICC; therefore, we were unable to attempt to approximately correct the analyses. Given that the study sample size and number of events were small, the implications are expected to be minimal. 

Setting

The majority of studies (48/85, 56%) were undertaken in Europe as single centre (61/85, 72%) studies. Most trials were relatively small in sample size (median 137, range: 25 to 3959). Three large trials contributed approximately 40% (8956 participants) of all included participants (Prabhakaran 2020; WHO 1983; West 2012). The median duration of trial intervention was 6 months (range 3 weeks to 42 months) with median overall trial follow‐up of 12 months (range 6 to 228 months). Sixteen trials identified in this most recent update were undertaken in low‐ and middle‐income countries (LMICs) (Aronov 2019; Bubnova 2019; Bubnova 2020; Chaves 2019; Dorje 2019; Hassan 2016; He 2020; Ma 2020; Pal 2013; Pomeshkina 2017; Pomeshkina 2019; Prabhakaran 2020; Sun 2016; Uddin 2020; Xu 2017; Zhang 2018), although the majority of trial evidence overall remained from high‐income settings (64/85, 75%).

Participants

People with MI alone were recruited in 40 trials (47%, 17,085 participants), with one trial (He 2020) recruiting people with MI in the absence of obstructive coronary artery disease (MINOCA). The remaining trials recruited people suffering exclusively from angina (5 trials, 6%, 368 participants), post‐CABG patients (7 trials, 8%, 983 participants), post‐PCI patients (7 trials, 8%, 1035 participants) or a mixed population of people with CHD (26 trials, 31%, 3959). Two trials included a mixed indication population, where more than 50% had a CHD diagnosis: one included 4 people (2%) who received valve replacement surgery (Snoek 2020). The inclusion of these people is unlikely to have implications for the findings. Additionally, Zwisler 2008 included people with congestive heart failure (12%), and those at high risk of ischaemic heart disease (30%). However, the authors kindly provided separate outcome data for the ischaemic heart disease population only. The mean age of participants within the trials ranged from 47 to 77 years. Although over half of the trials included women (62 trials, 73%), and in the last decade the median percentage of female participants has increased from 11% to 18%, women accounted for fewer than 15% of the participants recruited overall.

Interventions

Thirty‐eight of the 85 (45%) trials involved exercise‐only interventions, and 47 (55%) trials involved interventions comprised of multiple components. Of the 47 trial interventions that included other elements, 20 (43%) were made up of exercise plus education components; 16 (34%) were made up of exercise, education and psychosocial components; 7 (15%) were made up of exercise plus psychosocial components; and four (9%) were made up of exercise plus other components such as controlled diets or dietary advice, risk factor management, smoking cessation and relaxation. One study randomised participants to receive exercise only, exercise plus education, or usual care (Chaves 2019). One study compared exercise only, or exercise plus education plus psychosocial components, to usual care control (Sivarajan 1982).

The mode of exercise training in CR programmes was most often aerobic in nature and most commonly static cycling, walking or circuit training. Twenty‐two (26%) trials specifically reported the inclusion of resistance training, most commonly in the form of weight training, callisthenics or exercises using elastic bands. The 'dose' of exercise intervention (dose (units) = number of weeks of exercise training x average number of sessions/week x average duration of session in minutes) ranged considerably across trials: overall dose (median 3540, range 450 to 32,760 units); frequency (1 to 7 sessions/week); session length (20 to 90 minutes/session); and intensity (50% to 90% of maximal heart rate, peak heart rate or heart rate reserve; 50% to 95% of maximal oxygen uptake (VO2max); Borg rating of perceived exertion 11 to 16). Due to poor and inconsistent reporting of adherence and fidelity to exercise programmes in the RCTs, we were not able to consider the actual amount of exercise that the participants received or performed in this review.

Twenty‐one studies (25%) were conducted in an exclusively home‐based setting (Bäck 2008Belardinelli 2001Bell 1998DeBusk 1994Dorje 2019Fletcher 1994Haskell 1994Heller 1993Higgins 2001Houle 2012Lear 2015Lewin 1992Ma 2020Maddison 2014Miller 1984Mutwalli 2012Oerkild 2012Reid 2012Snoek 2020Uddin 2020Wang 2012), with four of these studies randomising participants to usual care, or to an electronically‐delivered intervention designed with an element of personally tailored or structured exercise, accessed via a mobile phone or the Internet (Dorje 2019; Lear 2015; Maddison 2014Reid 2012).

Comparators

In general, comparator groups were described as receiving usual or standard care (50/85, 59%). Twenty‐four trials (28%) reported participants in the control groups receiving usual care plus education, guidance or advice about diet, exercise, or physical activity from medical professionals or via information leaflets, but no formal exercise training. Eight trials (9%) reported participants in the control group simply received “no exercise”. One trial compared exercise training to stent angioplasty for participants with stable angina (Hambrecht 2004), while another compared exercise training to an "early return to normal activities group", where participants returned to work two weeks following a myocardial infarction, without a formal CR programme (Kovoor 2006). A third trial provided participants in the control group with blinded pedometers and instructions about how to wear the pedometer correctly during seven consecutive days from morning to bedtime (Houle 2012).

Outcomes

Eighty studies (94%) measured and reported outcomes that were used in at least one quantitative analysis (meta‐analysis or vote‐counting for HRQoL and cost‐effectiveness). One study reported clinical events as part of a composite outcome (Byrkjeland 2015). Two studies indicated that outcomes of interest were measured but did not report the results (Pomeshkina 2017; Pomeshkina 2019); triallists did not respond to our requests for data. 

Funding

Fifty trials (59%) were funded by not‐for‐profit organisations, one trial (1%) was funded by industry, and six trials (7%) were funded by a combination of industry and not‐for‐profit organisations. Twenty‐eight trials (33%) did not report funding sources.

Excluded studies

We excluded 201 publications identified in the current search, for reasons listed in the Characteristics of excluded studies table. The most common reasons for exclusion were associated with study design, which included insufficient follow‐up time, or that the study was not a randomised controlled trial, or the comparator intervention included an exercise component.

We describe 15 ongoing trials which meet the inclusion criteria of this review in the Characteristics of ongoing studies table. Fourteen studies are awaiting classification, pending clarification from the authors regarding study characteristics (see Characteristics of studies awaiting classification).

Risk of bias in included studies

The overall risk of bias was low or unclear (Figure 2). A number of trials failed to give sufficient detail to assess their potential risk of bias, although the quality of reporting has generally improved over the last decade, with the percentage of studies with less than three low risk of bias domains decreased from 80% to 55% over the last decade.

2.

2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study

Allocation

All the trial publications reported that the trial was 'randomised', but many provided insufficient detail to assess whether the method was appropriate. A total of 30/85 (35%) studies reported details of appropriate generation of the random sequence (Andersen 1981Bell 1998Bethell 1990Briffa 2005Bubnova 2020Byrkjeland 2015Campo 2020Chaves 2019Dorje 2019Erdman 1986Hambrecht 2004Haskell 1994He 2020Holmbäck 1994Houle 2012Lear 2015Ma 2020Maddison 2014Munk 2009Oerkild 2012Pal 2013Pomeshkina 2017Prabhakaran 2020Reid 2012Santaularia 2017Snoek 2020Sun 2016Wang 2012Wilhelmsen 1975Zwisler 2008), and 23/85 (27%) studies reported appropriate concealment of allocation (Bell 1998Briffa 2005Bubnova 2020Byrkjeland 2015Campo 2020Chaves 2019Dorje 2019Haskell 1994Holmbäck 1994Kovoor 2006Lear 2015Ma 2020Maddison 2014Munk 2009Oerkild 2012Pal 2013Prabhakaran 2020Reid 2012Schuler 1992Snoek 2020VHSG 2003West 2012Zwisler 2008). One study used quasi‐randomisation methods (Uddin 2020), allocating participants to CR or usual care according to the week of surgery for participants.

Blinding

Given the nature of the exercise‐based CR intervention, it is not possible to blind participants or programme personnel.

Only 24/85 studies (28%) reported adequate details of blinding of outcome assessment (Campo 2020Chaves 2019Dorje 2019Fletcher 1994Giallauria 2008Hambrecht 2004He 2020Holmbäck 1994Lear 2015Lewin 1992Maddison 2014Manchanda 2000Marchionni 2003Munk 2009Ornish 1990Prabhakaran 2020Reid 2012Sandström 2005Santaularia 2017Schuler 1992Snoek 2020West 2012Wilhelmsen 1975Zwisler 2008).

Incomplete outcome data

Although losses to follow‐up and dropout were relatively high in some studies (up to 48% in trials where losses to follow‐up were reported), follow‐up of 80% or more was achieved in 59/85 (69%) studies (Andersen 1981Aronov 2010Aronov 2019Bäck 2008; Belardinelli 2001Bell 1998Bethell 1990Bettencourt 2005aBriffa 2005Campo 2020Carlsson 1998Dorje 2019Dugmore 1999Engblom 1996Giallauria 2008Hambrecht 2004Haskell 1994Hassan 2016He 2020Heller 1993Holmbäck 1994Kallio 1979La Rovere 2002Lear 2015Leizorovicz 1991Lewin 1992Ma 2020Maddison 2014Manchanda 2000Marchionni 2003Maroto 2005Miller 1984Munk 2009Oerkild 2012Oldridge 1991Pomeshkina 2017Pomeshkina 2019Prabhakaran 2020Roman 1983Sandström 2005Schuler 1992Seki 2003Shaw 1981Snoek 2020Specchia 1996Ståhle 1999; Stern 1983Toobert 2000Vermeulen 1983VHSG 2003Wang 2012West 2012Wilhelmsen 1975Yu 2003Zhang 2018Zwisler 2008). However, reasons for loss to follow‐up and dropout were often not reported. We judged only 38/85 (44%) studies to have adequately reported reasons for loss to follow‐up and whether there were systematic differences between groups with respect to missing data, thus having a low risk of bias. We judged 40/85 (47%) studies as having a high risk of bias, and seven studies as having an unclear risk of bias.

Selective reporting

The majority (62/85; 73%) of trials reported all outcomes listed in their methods sections, or that were prespecified in the study protocol or trial registration (Campo 2020Chaves 2019Dorje 2019Fridlund 1991Prabhakaran 2020Santaularia 2017Snoek 2020). Nine trials failed to report all outcomes at all time points collected (Dorje 2019La Rovere 2002Manchanda 2000Oerkild 2012Ornish 1990Pomeshkina 2017Pomeshkina 2019Specchia 1996Toobert 2000), and we judged 11 studies as having an unclear risk of bias as their methods sections did not clearly describe the outcomes to be collected (Aronov 2019Bubnova 2019Bubnova 2020Byrkjeland 2015Hassan 2016Hautala 2017He 2020Ma 2020Pal 2013; Sun 2016Uddin 2020Wilhelmsen 1975Xu 2017Zhang 2018). A number of the included studies were not designed to assess treatment group differences in morbidity and mortality (as these were not the primary outcomes of these trials) and, therefore, may not have fully reported all clinical events that occurred during the follow‐up period.

Other potential sources of bias

We did not find any other potential sources of bias amongst the studies.

Effects of interventions

See: Table 1

Where data were available, we have presented pooled outcomes at three follow‐up timings: short‐term (6 to 12 months); medium‐term ( > 12 to 36 months); and long‐term ( > 36 months).

Primary outcomes

All‐cause mortality

Sixty‐one of the 85 included studies (72%) reported all‐cause mortality (Analysis 1.1). Four trials contributed mortality data at more than one follow‐up period (Shaw 1981West 2012WHO 1983Wilhelmsen 1975). Fourteen trials reported zero events in both the intervention and control groups up to 12 months' follow‐up (Aronov 2019Byrkjeland 2015Chaves 2019Hambrecht 2004Houle 2012Kovoor 2006Maddison 2014Manchanda 2000Munk 2009Pomeshkina 2017Pomeshkina 2019Santaularia 2017Seki 2008Zhang 2018). 

1.1. Analysis.

1.1

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 1: All‐cause mortality

Compared with 'no exercise' control, exercise‐based CR likely results in a slight reduction in all‐cause mortality up to 12 months' follow‐up (RR 0.87, 95% CI 0.73 to 1.04; I= 0%; 25 trials, 26 comparisons, 8823 participants). The certainty of the evidence was moderate due to imprecision, with a wide confidence interval. There was no evidence of publication bias for all‐cause mortality up to 12 months' follow‐up (Figure 3; Egger test: P = 0.50). 

3.

3

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: all‐cause mortality at 6 to 12 months' follow‐up

At medium‐ and long‐term follow‐up, exercise‐based CR may result in little to no difference in all‐cause mortality (medium‐term: RR 0.90, 95% CI 0.80 to 1.02; I= 0%; 16 trials, 11,073 participants; long‐term: RR 0.91, 95% CI 0.75 to 1.10; I= 35%; 11 trials, 3828 participants). There was no evidence of publication bias for all‐cause mortality at medium‐ or long‐term follow‐up (Figure 4; Egger test: P = 0.54; Figure 5; Egger test: P = 0.15, respectively). 

4.

4

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: all‐cause mortality at > 36 months' follow‐up

5.

5

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: all‐cause mortality at > 12 to 36 months' follow‐up

Cardiovascular mortality

Thirty‐three of the 85 trials (39%) reported cardiovascular mortality (Analysis 1.2). One trial reported both short‐ and medium‐term follow‐up (WHO 1983). Up to 12 months' follow‐up, five trials reported zero events in both the intervention and control group (Byrkjeland 2015Chaves 2019Maddison 2014Munk 2009Seki 2008). At medium‐term follow‐up, one trial reported zero events in both the intervention and control groups (Belardinelli 2001).

1.2. Analysis.

1.2

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 2: Cardiovascular mortality

Exercise‐based CR likely results in little to no difference in cardiovascular mortality up to 12 months' follow‐up (RR 0.88, 95% CI 0.68 to 1.14; I= 0%; 15 trials, 5360 participants). This result may be driven by the WHO 1983 trial which carries the majority of the weight. The certainty of the evidence was moderate due to imprecision, with a wide confidence interval. There was no evidence of publication bias for cardiovascular mortality (Figure 6; Egger test: P = 0.76).

6.

6

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.2: cardiovascular mortality at 6 to 12 months' follow‐up

However, at medium‐term follow‐up, evidence suggests exercise‐based CR results in a large reduction in cardiovascular mortality (RR 0.77, 95% CI 0.63 to 0.93; I= 5%; 5 trials, 3614 participants), but again, this result may be driven by the WHO 1983 trial which accounts for the majority of the weight. Similarly, at long‐term follow‐up, evidence suggests a large reduction in cardiovascular mortality (RR 0.58, 95% CI 0.43 to 0.78; I= 0%; 8 trials, 1392 participants).

Fatal or non‐fatal myocardial infarction

Forty‐two of the 85 trials (49%) reported the risk of fatal or non‐fatal MI (Analysis 1.3). Three trials reported zero events in both the intervention and control groups up to 12 months' follow‐up (Maddison 2014Reid 2012Seki 2008). Five studies contributed MI data at multiple follow‐up time points (Hambrecht 2004Haskell 1994Hofman‐Bang 1999West 2012WHO 1983). 

1.3. Analysis.

1.3

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 3: Fatal and/or nonfatal MI

Exercise‐based CR likely results in a large reduction in fatal or non‐fatal MI up to 12 months' follow‐up (RR 0.72, 95% CI 0.55 to 0.93; I= 7%; 22 trials, 24 comparisons, 7423 participants). The NNTB is 75 (95% CI 47 to 298), meaning one additional MI could be prevented up to 12 months for every 75 people participating in exercise‐based CR.  The certainty of the evidence was high, and there was no evidence of publication bias (Figure 7; Egger test: P = 0.12).   

7.

7

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.3: myocardial infarction at 6 to 12 months' follow‐up

The evidence suggests there may be little to no difference for risk of MI with exercise‐based CR at medium‐term follow‐up (RR 1.07, 95% CI 0.91 to 1.27, I2 = 0%; 12 trials, 9565 participants), which may be driven by the WHO 1983 study which carries more weight than other studies included in this analysis. There was no evidence of publication bias at medium‐term follow‐up (Figure 8; Egger test: P = 0.18).

8.

8

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: myocardial infarction at > 12 to 36 months' follow‐up

At long‐term follow‐up, the evidence suggests that exercise‐based CR results in a large reduction in risk of fatal or non‐fatal MI (RR 0.67, 95% CI 0.50 to 0.90; I2 = 0%; 10 trials, 1560 participants). There was no evidence of publication bias at long‐term follow‐up (Figure 9; Egger test: P = 0.19).

9.

9

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: myocardial infarction at > 36 months' follow‐up

Revascularisation ‐ CABG

Thirty‐one of the 85 included trials (36%) reported the risk of CABG (Analysis 1.4). Four studies contributed CABG data at multiple follow‐up time points (Haskell 1994Hofman‐Bang 1999Stahle 1999West 2012). Two studies reported zero events in both the intervention and control groups up to 12 months' follow‐up (Maddison 2014Seki 2008). 

1.4. Analysis.

1.4

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 4: CABG

There was little to no difference between exercise‐based CR and 'no exercise' control for CABG up to 12 months' follow‐up (RR 0.99, 95% CI 0.78 to 1.27; I2 = 0%; 20 trials, 22 comparisons, 4473 participants). The certainty of evidence was high, and there was no evidence of publication bias for CABG at short‐term follow‐up (Figure 10; Egger test: P = 0.10).

10.

10

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: CABG at 6 to 12 months' follow‐up

Similarly, at medium‐term follow‐up, evidence suggests little to no difference between exercise‐based CR and 'no exercise' control in risk of CABG (RR 0.97, 95% CI 0.77 to 1.23; I2 = 0%; 9 trials, 2826 participants), whereas across the small number of studies reporting CABG at long‐term follow‐up, evidence was uncertain about the effect of exercise‐based CR on risk of CABG, with a wide 95% CI including considerable benefit and harm (RR 0.66, 95% CI 0.34 to 1.27; I2 = 18%; 4 trials, 675 participants).

Revascularisation ‐ PCI

Twenty‐one of the 85 included trials (25%) reported the risk of PCI (Analysis 1.5). Four studies contributed PCI data at multiple follow‐up time points (Haskell 1994Hofman‐Bang 1999Stahle 1999West 2012). Three studies reported zero events in both the intervention and control groups up to 12 months' follow‐up (Maddison 2014Reid 2012Seki 2008). 

1.5. Analysis.

1.5

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 5: PCI

Exercise‐based CR likely results in little to no difference in PCI up to 12 months' follow‐up (RR 0.86, 95% CI 0.63 to 1.19; I2 = 7%; 13 trials, 14 comparisons, 3465 participants). The certainty of evidence was moderate due to imprecision, with wide confidence intervals. There was no evidence of publication bias for PCI at short‐term follow‐up (Figure 11; Egger test: P = 0.94).

11.

11

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: PCI at 6 to 12 months' follow‐up

At medium‐term and long‐term follow‐up, the evidence is uncertain whether there is a benefit for risk of PCI with exercise‐based CR as the 95% CI is consistent with possible benefit and possible harm (medium‐term: RR 0.96, 95% CI 0.69 to 1.35; I2 = 26%; 6 trials, 1983 participants; long‐term: RR 0.76, 95% CI 0.48 to 1.20; I2 = 0%; 3 trials, 567 participants).

All‐cause hospitalisation

Twenty‐three of the 85 included studies (27%) reported all‐cause hospital admissions (Analysis 1.6). One study reported follow‐up at both short‐ and medium‐term (Hofman‐Bang 1999). One trial reported zero events in both the intervention and control groups at up to 12 months' follow‐up (Maddison 2014). No trials reported hospitalisation data at long‐term follow‐up. 

1.6. Analysis.

1.6

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 6: All‐cause hospital admissions

Exercise‐based CR probably results in a large reduction in all‐cause hospital admissions up to 12 months' follow‐up (RR 0.58, 95% CI 0.43 to 0.77; I2 = 42%; 14 trials, 16 comparisons, 2030 participants). The NNTB is 12 (95% CI 9 to 21) meaning one additional hospital admission for any cause could be prevented up to 12 months for every 12 people participating in exercise‐based CR. The certainty of evidence was moderate, downgraded because of evidence of publication bias (Figure 12; Egger test: P = 0.003).

12.

12

Funnel plot of comparison: exercise‐based rehabilitation versus usual care, outcome 1.1: all‐cause hospitalisation at 6 to 12 months' follow‐up

At medium‐term follow‐up, evidence suggests exercise‐based CR may result in little to no difference in all‐cause hospitalisation (RR 0.92, 95% CI 0.82 to 1.03; I2 = 0%; 9 trials, 5995 participants).

Cardiovascular hospitalisation

Eight studies reported cardiovascular hospital admissions (Analysis 1.7). One study contributed cardiovascular hospital admission data over two follow‐up time points (Haskell 1994). No trials reported data at long‐term follow‐up. Definitions of cardiovascular hospitalisation differed somewhat between trials (Campo 2020: hospitalisations for a cardiovascular cause (acute coronary syndrome (ACS), cerebrovascular accident, heart failure, chronic coronary syndrome; Hambrecht 2004: hospitalisation and coronary angiography owing to worsening angina; Haskell 1994: cardiac events initiating hospitalisation (death, MI, CABG, percutaneous transluminal coronary angioplasty (PTCA)); Mutwalli 2012: elevated heart rate, deep sternal infection and heart attack; Reid 2012: rehospitalised with chest pain; Snoek 2020: hospitalisation for cardiac reasons (chronic coronary syndrome, ACS, pacemaker, PCI, endocarditis, dyspnoea); VHSG 2003: chest pain without objective evidence of ischaemia; Zwisler 2008: acute first‐time readmissions due to heart disease). 

1.7. Analysis.

1.7

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 7: Cardiovascular hospital admissions

We are uncertain whether exercise‐based CR may result in reduced risk of cardiovascular hospital admissions up to 12 months' follow‐up (RR 0.80, 95% CI 0.41 to 1.59; I2 = 53%; 6 trials, 1087 participants). The certainty of evidence was low due to evidence of substantial heterogeneity and a wide confidence interval including considerable benefit as well as harm. 

Similarly, evidence is uncertain in risk of cardiovascular hospitalisation in the few studies that reported medium‐term follow‐up (RR 0.92, 95% CI 0.76 to 1.12; I2 = 0%; 3 trials, 943 participants). There were insufficient studies to assess publication bias.

Secondary outcomes

Health‐related quality of life

Fifteen trials (18%) measured HRQoL at short‐term follow‐up using the same validated measure and reported outcomes on the same scale, enabling meta‐analyses using MD to be performed. For each of these validated measures, an increase in score indicates improvement in HRQoL. There were not enough data reported across trials at medium‐ and long‐term follow‐up for meta‐analysis to be performed. 

Six studies (1731 participants) reported the SF‐36 summary scores (physical component score (PCS) and mental component score (MCS) at short‐term follow‐up (Analysis 1.8). Exercise‐based CR may slightly increase PCS compared to 'no exercise' control (MD 1.70, 95% CI ‐0.08 to 3.47; P = 0.06; 6 trials) and likely increases MCS (MD 2.14, 95% CI 1.07 to 3.22; 6 trials) up to 12 months' follow‐up. However, it is unclear whether these improvements are clinically meaningful. There was evidence of substantial heterogeneity for PCS (I2 = 73%, P = 0.002), but not for MCS (I2 = 21%).

1.8. Analysis.

1.8

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 8: HRQoL SF‐36 summary scores at 6 to 12 months follow up

Eight studies (2812 participants) reported SF‐36 individual domain scores (physical functioning, physical performance, bodily pain, general health, vitality, social functioning, emotional performance, mental health) at short‐term follow‐up (Analysis 1.9). One study did not report scores for the vitality and emotional performance domains (Belardinelli 2001). Exercise‐based CR may result in an increase in six out of eight domains: physical functioning score (MD 8.47, 95% CI 3.69 to 13.24); physical performance (MD 8.08, 95% CI 2.89 to 13.27); general health (MD 5.66, 95% CI 2.08 to 9.25); vitality (MD 5.78, 95% CI 1.89 to 9.67); social functioning (MD 1.98, 95% CI 0.26 to 3.70; I2 = 20%); and mental health (MD 5.60, 95% CI 1.21 to 9.98). There was no difference in the domains bodily pain (MD ‐0.06, 95% CI ‐8.97 to 8.84) and emotional performance (MD 0.69, 95% CI ‐1.33 to 2.71; I2 = 18%). There was evidence of substantial heterogeneity for the following domains: physical functioning (I2 = 92%, P < 0.001); physical performance (I2 = 87%, P < 0.001); bodily pain (I2 = 97%, P < 0.001); general health (I2 = 84%, P < 0.001); vitality (I2 = 85%, P < 0.001); and mental health (I2 = 93%, P < 0.001). Based on the minimally important clinical differences reported by Wyrwich 2004, the increases in each of the domains are not clinically important. 

1.9. Analysis.

1.9

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 9: HRQoL SF‐36 8 domains at 6 to 12 months follow up

Three studies (476 participants) reported EQ‐5D visual analogue scores at short‐term follow‐up (Analysis 1.10). Exercise‐based CR may increase EQ‐5D scores up to 12 months' follow‐up (MD 0.05, 95% CI ‐0.01 to 0.10; P = 0.08). There was evidence of substantial heterogeneity (I2 = 69%, P = 0.04). The increase in EQ‐5D could potentially be clinically meaningful (Briggs 2017).

1.10. Analysis.

1.10

Comparison 1: Exercise‐based rehabilitation versus control, Outcome 10: HRQoL EQ‐5D at 6 to 12 months follow up

In addition to the meta‐analyses, given both the heterogeneity in HRQoL outcome measures and methods of reporting findings, a vote‐counting method was used to summarise descriptive data and direction of effect for all the studies that reported HRQoL (Table 2Campbell 2020). Thirty‐two of the 85 trials (38%, N = 7680 participants) assessed HRQoL using a range of validated generic (e.g. SF‐36) or disease‐specific (e.g. HeartQoL) outcome measures. Thirty of these trials reported HRQoL data at short‐term follow‐up, three reported HRQoL data at medium‐term follow‐up, and only one trial reported HRQoL data at long‐term follow‐up. Although most trials demonstrated an improvement in HRQL at follow‐up compared to baseline following exercise‐based CR, a within‐group improvement was also often reported in control participants. Twenty trials reported higher levels of HRQoL in one or more subscales with exercise‐based CR compared to control at short‐term follow‐up (Belardinelli 2001Bettencourt 2005aBriffa 2005Bubnova 2019Bubnova 2020Campo 2020Hassan 2016Hautala 2017He 2020Heller 1993Hofman‐Bang 1999Houle 2012Ma 2020Maddison 2014Mutwalli 2012Reid 2012Santaularia 2017Uddin 2020Wang 2012Yu 2003), with three at medium‐term follow‐up (Bell 1998Toobert 2000Yu 2003), and one at long‐term follow‐up (Engblom 1996). In twelve trials, there was evidence of a significantly higher level of quality of life in most (> 50%) of the subscales at short‐term follow‐up only (Belardinelli 2001Bell 1998Bubnova 2019Bubnova 2020Campo 2020Hassan 2016Hautala 2017Ma 2020Mutwalli 2012Reid 2012Uddin 2020Wang 2012).

1. Summary of health‐related quality of life (HRQoL) scores at follow‐up.
Measure of HRQoL Mean (SD) outcome values at follow‐up P value Difference between groups
  Exercise Control    
Aronov 2019
Quality of life questionnaire developed by authors (Aronov 2002) % change of mean score at 6 months
  Δ% Δ%    
  30.4 “no change” NR  
Bell 1998
Nottingham Health Profile at 10.5 months' follow‐up:
Energy 17.6 (27.1) 18.3 (29.8) 0.87** Exercise = Control
Pain 2.8 (8.8) 4.82 (11.9) < 0.05 Exercise > Control
Emotional reactions 6.4 (17.0) 12.2 (19.9) < 0.001 Exercise > Control
Sleep 7.5 (18.4) 20.5 (27.8) < 0.001 Exercise > Control
Social isolation 2.3 (10.6) 4.0 (13.3) 0.37* Exercise = Control
Physical mobility 8.4 (11.1) 8.9 (14.5) 0.82** Exercise = Control
Belardinelli 2001
SF‐36 at 6 months' follow‐up:
Physical functioning 78 (19) 55 (20) 0.001 Exercise > Control
Physical performance 75 (13) 65 (14) 0.01 Exercise > Control
Bodily pain 4 (9) 22 (10) 0.001 Exercise > Control
General health 68 (14) 50 (19) 0.001 Exercise > Control
Vitality NR NR    
Social functioning 66 (10) 69 (12) 0.14* Exercise = Control
Emotional performance NR NR    
Mental health 65 (12) 48 (15) 0.01 Exercise > Control
SF‐36 at 12 months' follow‐up:
Physical functioning 82 (18) 54 (20) 0.001 Exercise > Control
Physical performance 76 (9) 58 (14) 0.01 Exercise > Control
Bodily pain 4 (9) 32 (12) 0.001 Exercise > Control
General health 70 (14) 50 (18) 0.001 Exercise > Control
Vitality NR NR    
Social functioning 68 (11) 68 (12) 1.00* Exercise = Control
Emotional performance NR NR    
Mental health 70 (14) 45 (15) 0.001 Exercise > Control
Bettencourt 2005
SF‐36 at 1 year follow‐up:
Physical functioning 70 62 NS* Exercise = Control
Physical performance 66 57 NS* Exercise = Control
Bodily pain 73 65 NS* Exercise = Control
General health 57 46 < 0.02 Exercise > Control
Vitality 62 47 < 0.02 Exercise > Control
Social functioning 73 66 NS* Exercise = Control
Emotional performance 65 58 NS* Exercise = Control
Mental health 87 75 NS* Exercise = Control
Mental component 71 57 0.02 Exercise > Control
Physical component 63 57 NS* Exercise = Control
Briffa 2005
SF‐36 at 6 months' follow‐up:
  Δ (95% CI) Δ (95% CI)    
Physical functioning 15.9 (‐8 to 23) 7.1 (1 to 13) NS* Exercise = Control
Physical performance 75 (0 to 100) 75 (0 to 100) NS* Exercise = Control
Bodily pain 26.6 (18 to 35) 19.2 (11 to 27) NS* Exercise = Control
General health 0.1 (‐6 to 6) ‐0.6 (‐5 to 4) NS* Exercise = Control
Vitality 7.1 (1 to 13) 3.7 (‐2 to 9) NS* Exercise = Control
Social functioning 19.6 (10 to 29) 14.1 (7 to 21) NS* Exercise = Control
Emotional performance 33.3 (0 to 100) 33.3 (33 to 100) NS* Exercise = Control
Mental health 0.5 (‐4 to 5) 1.4 (‐3 to 5) NS* Exercise = Control
SF‐36 at 1 year follow‐up:
  Δ (95% CI) Δ (95% CI)    
Physical functioning 17.6 (10 to 25) 6.8 (‐1 to 14) 0.04 Exercise > Control
Physical performance 100 (0 to 100) 75 (12 to 30) NS* Exercise = Control
Bodily pain 30.2 (23 to 37) 20.9 (‐2 to 7) NS* Exercise = Control
General health 2.7 (‐3 to 5) 2.2 (‐2 to 7) NS* Exercise = Control
Vitality 11.9 (6 to 18) 6.9 (1 to 12) NS* Exercise = Control
Social functioning 23.6 (14 to 33) 16.4 (9 to 23) NS* Exercise = Control
Emotional performance 33.3 (33 to 100) 33.3 (33 to 100) NS* Exercise = Control
Mental health 3.6 (‐1 to 9) 3.9 (0 to 8) NS* Exercise = Control
Bubnova 2019
Quality of life questionnaire developed by authors (Aronov 2002) mean (SD) score after 12 months:
Low rehabilitation potential subgroup ‐4.9 (4.5) ‐7.8 (3.1) < 0.05 Exercise > Control
Average rehabilitation potential subgroup ‐5 (3.2) ‐7.4 (4.3) < 0.05 Exercise > Control
High rehabilitation potential subgroup ‐4.3 (3.9) ‐5.6 (4.3) < 0.05 Exercise > Control
Bubnova 2020
Quality of life questionnaire developed by authors (Aronov 2002) mean (%) score change at 12 months:
  Δ (%) Δ (%)    
BMI < 30 kg/m2 group 42 (6%) 10 (2%) <0.01 Exercise > Control
BMI ≥ 30 kg/m2 group 27 (5%) 8 (2%) <0.001 Exercise > Control
Campo 2020
EuroQol at 6 months' follow‐up:
  Median (IQR) Median (IQR)    
VAS (visual analogue scale) 80 (70‐90) 70 (50‐80) < 0.001 Exercise > Control
5 domains N (%) N (%)    
Pain/discomfort:
No
Moderate
Extreme 103 (89)
10 (9)
3 (3) 89 (77)
24 (21)
3 (3) 0.03 Exercise > Control
Anxiety/depression:
No
Moderate
Extreme 92 (79)
21 (18)
3 (3) 67 (58)
36 (31)
12 (10) 0.001 Exercise > Control
Mobility:
No problems
Some problems
Confined to bed 104 (90)
12 (10)
0 (0) 80 (70)
34 (30)
1 (1) < 0.001 Exercise > Control
Self‐care:
No problems
Some problems
Unable 114 (98)
2 (2)
0 (0) 87 (76)
25 (22)
1 (1) 0.6 Exercise = Control
Usual activities:
No problems
Some problems
Unable 101 (87)
14 (12)
1 (1) 87 (76)
25 (22)
3 (3) 0.04 Exercise > Control
EuroQol at 12 months' follow‐up:
  Median (IQR) Median (IQR)    
VAS (visual analogue scale) 75 (70‐87) 65 (50‐80) < 0.001 Exercise > Control
5 domains N (%) N (%)    
Pain/discomfort:
No
Moderate
Extreme 86 (77)
24 (21)
2 (2) 72 (65)
29 (26)
9 (8) 0.04 Exercise > Control
Anxiety/depression:
No
Moderate
Extreme 83 (74)
23 (21)
6 (5) 58 (53)
37 (34)
15 (14) 0.03 Exercise > Control
Mobility:
No problems
Some problems
Confined to bed 95 (85)
16 (14)
1 (1) 74 (67)
22 (20)
3 (3) 0.008 Exercise > Control
Self‐care:
No problems
Some problems
Unable 101 (91)
6 (5)
3 (3) 100 (91)
5 (5)
5 (5) 0.8 Exercise = Control
Usual activities:
No problems
Some problems
Unable 99 (88)
11 (10)
2 (1) 80 (73)
24 (22)
6 (5) 0.004 Exercise > Control
Dorje 2019
SF‐12 at 6 months' follow‐up:
Physical health score 46.8 (6.9) 45.2 (6.5) 0.22** Exercise = Control
Mental health score 51.5 (9.3) 50 (8.6) 0.28** Exercise = Control
Engblom 1992
Nottingham Health Profile at 5 years' follow‐up:
Energy 18 25 0.08 Exercise = Control
Pain 12 18 0.07 Exercise = Control
Emotional reactions 14 21 0.27 Exercise = Control
Sleep 24 29 0.42 Exercise = Control
Social isolation 7 9 0.42 Exercise = Control
Physical mobility 6 14 0.005 Exercise > Control
Hassan 2016
SF‐36 8 domains at 12 months' follow‐up
Physical functioning 83.5 (6.5) 76.7 (10.6) 0.01 Exercise > Control
Role limitations physical 62.5 (23.4) 50.8 (20.2) 0.04 Exercise > Control
Role limitations emotional 61.1 (21.6) 49.9 (19.1) 0.04 Exercise > Control
Energy/fatigue 66 (11.1) 57.7 (11.7) 0.01 Exercise > Control
Emotional well being 69.5 (2.6) 61.5 (7.5) 0.000 Exercise > Control
Social functioning 67.5 (19) 56.3 (16.3) 0.02 Exercise > Control
Pain 79.6 (18.4) 67.9 (15.9) 0.01 Exercise > Control
General health 43 (7.9) 38.5 (8.8) 0.04 Exercise > Control
Hautala 2017
15D Quality of life measure at 6 months' follow‐up:
  0.915 (0.07) 0.876 (0.084) 0.0004* Exercise > Control
15D Quality of life measure at 12 months' follow‐up:
  0.922 (0.072) 0.886 (0.088) < 0.0015* Exercise > Control
He 2020
SF‐36 at 12 months:
Physical functioning 85 (22) 74 (19) < 0.01 Exercise > Control
Role‐physical 80 (21) 77 (22) 0.362 Exercise = Control
Bodily pain 71 (32) 68 (30) 0.348 Exercise = Control
General health 79 (23) 72 (19) < 0.01 Exercise > Control
Vitality 81 (17) 73 (25) < 0.01 Exercise > Control
Social functioning 75 (22) 74 (19) 0.902 Exercise = Control
Role‐emotional 65 (34) 65 (33) 0.976 Exercise = Control
Mental health 72 (23) 71 (23) 0.825 Exercise = Control
Physical health score 79 (29) 73 (29) < 0.01 Exercise > Control
Mental health score 73 (28) 71 (27) 0.102 Exercise = Control
Heller 1993
QLMI at 6 months' follow‐up:
Emotional 5.4 (1.1) 5.2 (1.2) 0.04 Exercise > Control
Physical 5.4 (1.2) 5.2 (1.3) 0.17* Exercise = Control
Social 5.9 (1.1) 5.8 (1.1) 0.35* Exercise = Control
Hofman‐Bang 1999
AP‐QLQ at 12 months' follow‐up:
Physical activity 4.9 4.3 < 0.05 Exercise > Control
Somatic symptoms NR NR NS Exercise = Control
Emotional distress NR NR NS Exercise = Control
Life satisfaction NR NR NS Exercise = Control
Houle 2012
Quality of Life Index ‐ cardiac version III at 6 months' follow‐up:
Health and functional score 26 (5.1) 24.5 (5.3) 0.048 Exercise > Control
Psychological/spiritual score 25.6 (5.8) 25.5 (3.8) 0.383 Exercise = Control
Social and economic score 25.7 (3.8) 25.4 (4.7) 0.392 Exercise = Control
Family score 28.1 (2.5) 26.7 (4.3) 0.048 Exercise > Control
Overall 26.2 (4.3) 25.8 (4.1) 0.057 Exercise = Control
Quality of Life Index ‐ cardiac version III at 12 months' follow‐up:
Health and functional score 27.8 (2.0) 25.3 (4.6) 0.036 Exercise > Control
Psychological/spiritual score 27.4 (2.5) 26.2 (4.0) 0.336 Exercise = Control
Social and economic score 27.2 (3.0) 25.9 (5.2) 0.638 Exercise = Control
Family score 28 (2.6) 26.8 (5.0) 0.092 Exercise = Control
Overall 27.7 (2.1) 25.7 (4.2) 0.048 Exercise > Control
Ma 2020
SF‐12 change at 12 months' follow‐up:
  Δ (SD) Δ (SD)    
Physical component 13.3 (6) 9.9 (5.9) < 0.001 Exercise > Control
Mental component 12.4 (5.4) 9 (6.2) < 0.001 Exercise > Control
Maddison 2014
EQ‐5D at 24 weeks' follow‐up:
  0.86 0.83 0.23 Exercise = Control
SF‐36 at 24 weeks' follow‐up:      
Physical functioning 52.9 51.9 0.20 Exercise = Control
Role physical 52.6 50.8 0.08 Exercise = Control
Bodily pain 52.4 51.9 0.71 Exercise = Control
General health 55.3 53.2 0.03 Exercise > Control
Vitality 55.7 55.9 0.79 Exercise = Control
Social Functioning 53.3 52.4 0.42 Exercise = Control
Role emotional 51.4 51.6 0.81 Exercise = Control
Mental health 54.6 54.0 0.61 Exercise = Control
Mutwalli 2012
SF‐36 Health status score at 6 months' follow‐up:
  90.14 (4.83) 60.55 (16.21) 0.000 Exercise > Control
Oerkild 2012
SF‐36 at 12 months' follow‐up:
  Δ (95% CI) Δ (95% CI)    
SF 12 PCS ‐1.1 (‐5.3 to 3.1) ‐1.4 (‐5.2 to 2.3) NS* Exercise = Control
SF 12 MCS ‐1.4 (‐6.1 to 3.3) ‐0.3 (‐4.6 to 4.0) NS* Exercise = Control
Oldridge 1991
QLMI at 4 months' follow‐up:
Limitations 54 54 NS Exercise = Control
Emotions 103 101 NS Exercise = Control
QLMI at 8 months' follow‐up:
Limitations 54 54 NS Exercise = Control
Emotions 103 103 NS Exercise = Control
QLMI at 12 months' follow‐up:
Limitations 54 55 NS Exercise = Control
Emotions 105 102 NS Exercise = Control
Reid 2012
MacNew at 6 months' follow‐up:
Global score 5.8 (0.6) 5.6 (0.8) 0.112 Exercise = Control
Emotional subscale 5.6 (0.6) 5.4 (0.7) 0.038 Exercise > Control
Social subscale 6.3 (0.8) 6.0 (1.0) 0.162 Exercise = Control
Physical subscale 6.0 (0.8) 5.8 (1.0) 0.031 Exercise > Control
Sandstrom 2005
Time Trade Off (TTO) at 12 months' follow‐up:
  0.86 (0.23) 0.85 (0.21) NS* Exercise = Control
EuroQol Part one at 12 months' follow‐up:
  0.87 (0.15) 0.86 (0.16) NS* Exercise = Control
EuroQol Part two at 12 months' follow‐up:    
  7.6 (1.46) 7.43 (1.46) NS* Exercise = Control
Santaularia 2017
EuroQol‐5D at 12 months' follow‐up:
  N (%) N(%)    
Mobility
No problems
Problems 33 (84.6)
6 (15.4) 33 (75)
11 (25) 0.019 Exercise > Control
Self‐care
No problems
Problems 38 (97.4)
1 (2.6) 43 (97.7)
1 (2.3) 0.172 Exercise = Control
Usual activities
No problems
Problems 32 (82)
7 (18) 31 (70.5)
13 (29.5) 0.803 Exercise = Control
Pain/discomfort
No problems
Problems 28 (71.8)
11 (28.2) 26 (59.1)
18 (40.9) 0.528 Exercise = Control
Anxiety/depression
No problems
Problems 22 (56.4)
17 (43.6) 26 (59.1)
18 (40.9) 0.429 Exercise = Control
Snoek 2020
SF‐36 summary scores at 6 months:
Physical 50.2 (7.2) 48.3 (7.5) 0.086* Exercise = Control
Mental 54.0 (8.4) 52.7 (9.1) 0.322* Exercise = Control
SF‐36 summary scores at 12 months:
Physical 50.6 (7.2) 49 (8.2) 0.167* Exercise = Control
Mental 53.2 (8.8) 52.5 (9.2) 0.604* Exercise = Control
Stahle 1999
Karolinska Questionnaire at 12 months' follow‐up:
Chest pain 0.6 (1.2) 0.4 (1.3) NS Exercise = Control
Shortness of breath 0.4 (1.1) 0.2 (1.0) NS Exercise = Control
Dizziness ‐0.1 (1.1) 0.2 (0.9) NS Exercise = Control
Palpitation ‐0.1 (1.0) 0.1 (0.9) NS Exercise = Control
Cognitive ability ‐0.1 (0.6) 0.0 (0.7) NS Exercise = Control
Alertness 0.0 (0.9) 0.1 (0.8) NS Exercise = Control
Quality of sleep 0.0 (0.5) 0.1 (0.5) NS Exercise = Control
Physical ability 0.2 (0.7) 0.1 (0.4) NS Exercise = Control
Daily activity 0.3 (0.5) 0.1 (0.5) NS Exercise = Control
Depression 0.1 (0.3) 0.1 (0.2) NS Exercise = Control
Self‐perceived health 0.5 (1.3) 0.3 (1.0) NS Exercise = Control
"Ladder of Life" present 1.2 (1.2) 0.9 (1.8) NS Exercise = Control
"Ladder of Life" future 0.8 (2.7) 0.4 (2.3) NS Exercise = Control
Fitness 0.6 (1.4) 0.4 (1.0) NS Exercise = Control
Physical ability 0.7 (1.0) 0.4 (1.1) NS Exercise = Control
Toobert 2000
SF‐36 at 24 months' follow‐up:
Physical functioning NR NR NS Exercise = Control
Physical performance NR NR NS Exercise = Control
Bodily pain NR NR NS Exercise = Control
General health NR NR < 0.05 Exercise > Control
Vitality NR NR NS Exercise = Control
Social functioning NR NR < 0.05 Exercise > Control
Emotional performance NR NR NS Exercise = Control
Mental health NR NR NS Exercise = Control
Uddin 2020
WHOQoL‐BREF at 12 months' follow‐up
Overall perception of HRQoL 4.03 (0.49) 3.2 (0.82) < 0.01 Exercise > Control
Overall perception of health 4.06 (0.4) 3.17 (0.38) < 0.01 Exercise > Control
Physical domain 26.9 (2.88) 21.17 (3.35) < 0.01 Exercise > Control
Psychological domain 23.42 (2.84) 17.87 (3.19) < 0.01 Exercise > Control
Social relationship domain 11.83 (1.5) 10.75 (0.89) < 0.01 Exercise > Control
Environmental domain 28.8 (4.24) 21.77 (5.31) 0.03 Exercise > Control
Wang 2012
SF‐36 at 6 months' follow‐up:
Physical functioning 80.8 (13.7) 73.2 (13.0) < 0.001 Exercise > Control
Physical performance 68.2 (17.3) 56.2 (46.8) 0.015 Exercise > Control
Bodily pain 68.2 (17.3) 63.5 (14.6) 0.012 Exercise > Control
General health 57.4 (20.3) 49.0 (16.2) 0.017 Exercise > Control
Vitality 66.3 (17.3) 56.4 (21.7) 0.002 Exercise > Control
Social functioning 71.3 (21.4) 65.8 (18.0) 0.031 Exercise > Control
Emotional performance 80.8 (37.9) 75.9 (39.7) 0.12 Exercise = Control
Mental health 73.5 (17.1) 65.4 (20.7) 0.011 Exercise > Control
MIDAS at 6 months' follow‐up:
Physical Activity 37.7 (11.2) 42.6 (12.3) < 0.001 Exercise > Control
Insecurity 28.7 (9.7) 33.4 (13.8) < 0.001 Exercise > Control
Emotional reaction 30.4 (12.8) 34.8 (14.4) 0.008 Exercise > Control
Dependency 27.6 (9.4) 31.8 (16.6) 0.001 Exercise > Control
Diet 36.8 (15.4) 43.6 (20.7) 0.40 Exercise = Control
Concerns over meds 29.4 (12.6) 37.7 (18.0) <0.001 Exercise > Control
Side Effects 28.2 (11.1) 30.8 (14.3) 0.30 Exercise > Control
West 2012
SF‐36 at 12 months' follow‐up:
Physical function 65 (29) 64 (30) NS* Exercise = Control
Role physical 69 (31) 67 (33) NS* Exercise = Control
Role emotional 85 (23) 85 (25) NS* Exercise = Control
Social function 81 (28) 79 (29) NS* Exercise = Control
Mental health 76 (13) 76 (13) NS* Exercise = Control
Energy /vitality 65 (24) 65 (24) NS* Exercise = Control
Pain 69 (28) 68 (29) NS* Exercise = Control
Health Perception 58 (25) 57 (25) NS* Exercise = Control
Yu 2003
SF‐36 at 8 months' follow‐up:
Physical functioning 88 (12) 82 (17) 0.03* Exercise > Control
Physical performance 75 (33) 66 (35) 0.18* Exercise = Control
Bodily pain 80 (25) 80 (25) 1.00* Exercise = Control
General health 64 (26) 60 (28) 0.45* Exercise = Control
Vitality 79 (18) 65 (17) 0.0001 Exercise > Control
Social functioning 89 (27) 82 (28) 0.15 Exercise = Control
Emotional performance 93 (18) 83 (35) 0.05 Exercise = Control
Mental health 84 (16) 80 (15) 0.2 Exercise = Control
SF‐36 at 24 months' follow‐up:
Physical functioning 88 (13) 87 (9) 0.67* Exercise = Control
Physical performance 80 (32) 79 (30) 0.87* Exercise = Control
Bodily pain 81 (21) 85 (20) 0.33* Exercise = Control
General health 64 (20) 61 (18) 0.43* Exercise = Control
Vitality 73 (21) 73 (17) 1.00* Exercise = Control
Social functioning 79 (30) 90 (18) 0.04* Exercise > Control
Emotional performance 89 (25) 93 (25) 0.42* Exercise = Control
Mental health 85 (14) 85 (12) 1.00* Exercise = Control
Zwisler 2008
SF‐36 at 12 months' follow‐up:
Physical Component Score 45.2 (9.8) 46.4 (9.8) 0.39* Exercise = Control
Mental Component Score 50.6 (10.8) 48.4 (11.5) 0.16* Exercise = Control

AP‐QLQ: Angina Pectoris‐Quality of Life questionnaire
BMI: body mass index
EQ‐5D: five‐dimension EuroQol scale
EuroQoL: European Quality of Life Scale
IQR: interquartile range
MIDAS: Myocardial Infarction Dimensional Assessment Scale
NR: not reported
NS: not significant
QLMI: Quality of Life After Myocardial Infarction questionnaire
SD: standard deviation
SF‐36: Short Form 36‐item questionnaire
WHOQoL‐BREF: World Health Organization Quality of Life abbreviated instrument
* Calculated by authors of this report based on independent two group t test.
** Adjusted for baseline difference between groups.
Exercise = Control: no statistically significant difference (P > 0.05) between exercise and Control groups at follow up
Exercise > Control: statistically significant difference (P < 0.05) between exercise and Control groups at follow up
NS*: The authors of this review have inferred a P value of > 0.05 based either on the 95% CI, or from narrative in the paper, rather than from directly observing the P‐value.

Costs and cost‐effectiveness

Eight of the included studies reported data on costs of CR and overall healthcare costs in both groups (Briffa 2005Hambrecht 2004Hautala 2017Kovoor 2006Maddison 2014Marchionni 2003Oldridge 1991/Oldridge 1993; Yu 2004). These results are summarised in Table 3. While it was not possible to directly compare costs across studies due to differences in currencies and the timing of studies, it is possible to compare the within‐study costs for CR and control groups. Three studies showed no difference in total healthcare costs between groups (Briffa 2005Kovoor 2006Yu 2004); two studies found healthcare costs for CR to be lower (USD 2378 less per participant; EUR 1083 less per participant) compared to control (Hambrecht 2004Hautala 2017); one study reported the healthcare costs for CR to be higher (USD 4839 more per participant) than usual care (Marchionni 2003); while two studies did not report total healthcare costs (Maddison 2014Oldridge 1991/Oldridge 1993).

2. Summary of costs of exercise‐based rehabilitation and usual care.
Author/
year
Briffa 2005 Hambrecht 2004 Hautala 2017 Kovoor 2006/Hall 2002 Maddison 2014 Marchionni 2003 Oldridge 1991/93 Yu 2004
Follow‐up (months) 12 12 12 12 6 14 12 24
Year of costs (currency) 1998 (Australian dollars ‐ AUD) NR (US dollars ‐ USD) NR (euros ‐ EUR) 1999 (Australian dollars ‐ AUD) NR (euros ‐ EUR) 2000 (US dollars ‐ USD) 1991 (US dollars ‐ USD) 2003 (US dollars ‐ USD)
Cost of rehabilitation
Mean cost/patient AUD 694 NR EUR 299 AUD 394 EUR 127 USD 5246 USD 670 NR
Costs considered Details of costed elements not provided NR Estimated according to the average monthly fees in Finnish gyms where individual guidance in exercise training is led by a health care professional staff, assessments, counselling, education, patient travel NR NR space, equipment, staff, literature resources, operating costs, parking, patients costs NR
Total healthcare costs
Rehabilitation mean cost/patient AUD 4937 USD 3708 ± 156 EUR 1944 NR NR USD 17,272 NR USD 15,292
Usual care mean cost/patient AUD 4541 USD 6086 ± 370 EUR 3027 NR NR USD 12,433 NR USD 15,707
Absolute difference in mean cost/patient* AUD 395 USD ‐2378 EUR ‐1083 NR NR USD 4839 USD 480 USD ‐415
P value for cost difference 0.74 P < 0.001 NR P > 0.05 (see below) NR NR NR P > 0.05
Additional healthcare costs considered Hospitalisations, pharmaceuticals, tests, consultations, rehabilitation, patient expenses, ambulance Rehospitalisations, revascularisation, cycle ergometers, training facilities, and supervising staff Primary health care costs, secondary health care costs, occupational health care service costs Phone calls (P = 0.10); hospital admissions (P = 0.11); gated heart pool scan (P = 0.50); exercise stress test (P = 0.72); other diagnostics (P = 0.37); visits to general practitioner (P = 0.61), specialist doctor (P = 0.35), or health‐care professional (P = 0.31) NR NR Service utilisation, physician costs, emergency costs, in‐patient days, allied health, other rehabilitation visits Hospitalisations; revascularisations; private clinic visit; cardiac clinic visits; public non‐cardiac visits; casualty visits; drugs
Cost‐effectiveness
Rehabilitation mean health care benefits Utility‐based quality of life –
heart questionnaire: 0.026 (95% CI 0.013 to 0.039) NR Average change in 15D utility: 0.013 NR NR NR NR NR
Usual care mean health care benefit Utility 0.010 (95% CI ‐0.001 to 0.022) NR Average change in 15D utility: ‐0.012 NR NR NR NR NR
Incremental mean health care benefit Utility 0.013 (95% CI, NR) P = 0.38; +0.009 QALYs NR 0.045 QALYs (0.023‐0.077) NR NR NR 0.052 QALYs (95% CI, 0.007 to 0.1) 0.06 QALYs
Incremental cost effectiveness ratio/patient AUD +42,535 per QALY. Extensive sensitivity analyses reported. NR EUR ‐24,511 per QALY NR EUR +15,247 per QALY NR USD +9200 per QALY USD ‐650 per QALY

NR: not reported
QALY: quality‐adjusted life year

* The currency for Hambrecht 2004 is not reported, but healthcare costs are reported within the paper with $

Five studies also reported cost‐effectiveness using a cost utility approach (i.e. cost per quality‐adjusted life year (QALY)) (Briffa 2005Hautala 2017Oldridge 1991/Oldridge 1993; Maddison 2014Yu 2004). Two studies showed CR (compared to control) to be economically dominant; that is, associated with more QALYs and less overall costs (Hautala 2017Yu 2004). In the remaining three studies, the incremental cost ratio compared to control was USD 42,535 per QALY (Briffa 2005), EUR 15,247 per QALY (Maddison 2014), and USD 9200 per QALY (Oldridge 1991/Oldridge 1993). Based on these analyses, authors consistently concluded CR to be a cost‐effective use of healthcare resources compared to usual care.

Meta‐regression

We examined predictors of total mortality, cardiovascular mortality, recurrent MI, revascularisation (CABG and PCI) and all‐cause hospitalisation across the longest follow‐up of each individual study, using univariate meta‐regression. We did not perform meta‐regression where there were fewer than 10 studies included in the analysis. No statistically significant associations were seen in any of the analyses (Table 4Table 5Table 6Table 7Table 8Table 9).

3. Results for univariate meta‐regression for all‐cause mortality.
Explanatory variable (n trials) Exp (slope)* 95% confidence interval,P value Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 46) RR = 1.00 1.00 to 1.00, P = 0.15 56.1% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 33) RR = 1.00 1.00 to 1.00, P = 0.11  
 
100%
No evidence that risk ratio is associated with type of CR
Duration of follow‐up (months) (n = 47) RR = 1.00 1.00 to 1.00, P = 0.07 100% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 47) RR = 1.04 0.84 to 1.31, P = 0.70 ‐27.1% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 47) RR = 0.84 0.70 to 0.99, P = 0.04 100% No evidence that risk ratio is associated with publication year
CR setting (n = 47) RR = 0.95 0.82 to 1.24, P = 0.95 ‐11.3% No evidence that risk ratio is associated with type of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 47) RR = 1.02 0.94 to 1.09, P = 0.67 ‐68.55% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 47) RR = 1.01 0.86 to 1.19, P = 0.93 ‐41.24% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high‐income country (n = 47) RR = 1.02 0.70 to 1.48, P = 0.93 ‐45.10% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 47) RR = 1.19 0.73 to 1.93, P = 0.47 16.07% No evidence that risk ratio is associated with study sample size
4. Results of univariate meta‐regression analysis for cardiovascular mortality.
Explanatory variable (n trials) Exp (slope)* 95% confidence interval,Pvalue Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 27) RR = 1.00 0.99 to 1.01, P = 0.76 ‐8.74% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 22) RR = 1.00 1.00 to 1.00, P = 0.62 0% No evidence that risk ratio is associated with dose of exercise
Duration of follow‐up (months) (n = 28) RR = 0.99 0.99 to 1.00, P = 0.05 90.36% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 28) RR = 0.83 0.62 to 1.10, P = 0.18 75.69% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 28) RR = 1.37 0.89 to 2.13, P = 0.15 63.31% No evidence that risk ratio is associated with publication year
Setting (centre vs home) (n = 28) RR = 1.05 0.88 to 1.24, P = 0.61 ‐29.66% No evidence that risk ratio is associated with setting of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 28) RR = 0.90 0.73 to 1.11, P = 0.30 85.73% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 28) RR = 1.02 0.75 to 1.39, P = 0.89 ‐41.75% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high‐income country (n = 28) RR = 0.69 0.22 to 2.19, P = 0.52 9.36% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 28) RR = 1.28 0.69 to 2.37, P = 0.42 28.43% No evidence that risk ratio is associated with study sample size
5. Results of univariate meta‐regression analysis for fatal and/or non‐fatal MI.
Explanatory variable (n trials) Exp (slope)* 95% confidence interval,Pvalue Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 41) RR = 1.00 0.99 to 1.01, P = 0.93 ‐4.57% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 33) RR = 1.00 1.00 to 1.00, P = 0.68 0% No evidence that risk ratio is associated with dose of exercise
Duration of follow‐up (months) (n = 41) RR = 1.00 0.99 to 1.01, P = 0.97 ‐12.45% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 41) RR = 0.85 0.58 to 1.25, P = 0.39 9.68% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 41) RR = 1.36 0.94 to 1.97, P = 0.11 25.40% No evidence that risk ratio is associated with publication year
Setting (centre vs home) (n = 39) RR = 0.80 0.67 to 0.95, P = 0.01 67.62% No evidence that risk ratio is associated with setting of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 41) RR=1.39 0.85 to 2.26, P = 0.18 ‐16.70% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 41) RR = 0.71 0.49 to 1.05, P = 0.09 12.94% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high income country (n = 41) RR = 0.65 0.33 to 1.61, P = 0.20 0.86% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 41) RR = 1.69 1.05 to 2.72, P = 0.03 54.95% No evidence that risk ratio is associated with study sample size
6. Results of univariate meta‐regression analysis for CABG.
Explanatory variable (n trials) Exp (slope)* 95% confidence interval,P value Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 31) RR = 1.01 1.00 to 1.02, P = 0.05 0% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 25) RR = 1.00 1.00 to 1.00, P = 0.78 0% No evidence that risk ratio is associated with dose of exercise
Duration of follow‐up (months) (n = 31) RR = 1.00 0.99 to 1.01, P = 0.75 0% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 31) RR = 1.04 0.67 to 1.61, P = 0.86 0% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 31) RR = 0.88 0.56 to 1.41, P = 0.59 0% No evidence that risk ratio is associated with publication year
Setting (centre vs home) (n = 31) RR = 1.07 0.87 to 1.33, P = 0.51 0% No evidence that risk ratio is associated with setting of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 31) RR = 0.94 0.64 to 1.38, P = 0.73 0% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 31) RR = 1.19 0.83 to 1.71, P = 0.34 0% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high income country (n = 31) RR = 0.51 0.08 to 3.18, P = 0.46 0% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 31) RR = 1.31 0.82 to 2.09, P = 0.25 0% No evidence that risk ratio is associated with study sample size
7. Results of univariate meta‐regression for PCI.
Explanatory variable (n trials) Exp (slope)* 95% confidence interval,
P value Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 18) RR = 1.00 1.00 to 1.01, P = 0.50 0% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 16) RR = 1.00 1.00 to 1.00, P = 0.50 0% No evidence that risk ratio is associated with dose of exercise
Duration of follow‐up (months) (n = 18) RR = 1.00 0.99 to 1.01, P = 0.82 0% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 18) RR = 0.78 0.38 to 1.59, P = 0.47 0% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 18) RR = 0.95 0.46 to 1.95, P = 0.87 0% No evidence that risk ratio is associated with publication year
Setting (centre vs home) (n = 18) RR = 0.91 0.72 to 1.15, P = 0.41 0% No evidence that risk ratio is associated with setting of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 18) RR = 1.09 0.72 to 1.66, P = 0.67 0% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 18) RR = 0.81 0.53 to 1.23, P = 0.30 0% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high income country (n = 18) RR = 0.29 0.05 to 1.63, P = 0.15 0% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 18) RR = 1.19 0.70 to 2.01, P = 0.49 0% No evidence that risk ratio is associated with study sample size
8. Results of univariate meta‐regression for all‐cause hospitalisation.
Explanatory variable (n trials) Exp (slope)* 95% confidence interval,P value Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 23) RR = 1.00 1.00 to 1.01, P = 0.71 ‐20.91% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 19) RR = 1.00 1.00 to 1.00, P = 0.44 ‐69.78% No evidence that risk ratio is associated with dose of exercise
Duration of follow‐up (months) (n = 23) RR = 1.01 1.00 to 1.01, P = 0.07 56.52% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 23) RR = 0.93 0.65 to 1.33, P = 0.70 ‐50.20% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 23) RR = 1.12 0.80 to 1.57, P = 0.48 ‐32.69% No evidence that risk ratio is associated with publication year
Setting (centre vs home) (n = 23) RR = 0.94 0.83 to 1.06, P = 0.28 ‐36.70% No evidence that risk ratio is associated with setting of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 23) RR = 1.00 0.71 to 1.40, P = 0.99 ‐44.14% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 23) RR = 0.86 0.69 to 1.08, P = 0.18 ‐137.18% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high income country (n = 23) RR = 1.06 0.72 to 1.55, P = 0.76 ‐49.12% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 19) RR = 1.45 1.08 to 1.96, P = 0.02 100% No evidence that risk ratio is associated with study sample size

Discussion

Summary of main results

Exercise‐based CR provides important benefits up to 12 months' follow‐up, including a large reduction in fatal or non‐fatal MI, and likely reductions in all‐cause mortality and all‐cause hospital admissions. There was evidence that exercise‐based CR results in little to no difference in CABG, and likely results in little to no difference in cardiovascular mortality and PCI. Evidence was uncertain whether exercise‐based CR may result in reduced risk of cardiovascular hospital admissions. Imprecision (wide 95% CI), publication bias and statistical heterogeneity led to downgrading the certainty of these outcomes up to 12 months' follow‐up.

At medium‐term follow‐up ( > 12 to 36 months), although there may be little to no difference in all‐cause mortality, MI, PCI, CABG and all‐cause hospitalisation with exercise‐based CR, a large reduction in cardiovascular mortality was found. The evidence was uncertain for difference in risk of cardiovascular hospitalisation.  

At long‐term follow‐up ( > 3 years), evidence suggests that exercise‐based CR may result in little to no difference in all‐cause mortality, but may result in a large reduction in risks of cardiovascular mortality and MI. The evidence was uncertain for difference in risk of CABG and PCI.

Univariate meta‐regression analysis showed that the impact of exercise‐based CR on clinical events appears to be largely consistent across trials, irrespective of case mix (% of post‐MI participants), type of rehabilitation (exercise‐only versus comprehensive), dose of exercise training (number of weeks of exercise training x average number of sessions/week x average minutes/session), duration of follow‐up (months), study location (continent ‐ Europe, North America, Australia/Asia or other, or LMIC versus HIC setting), year of publication (pre‐1995 versus post‐1995), risk of bias (low risk in ≤ 3 items versus > 3 items) or sample size ( ≤ 150 vs > 150).

We did not undertake meta‐analysis for all HRQoL outcomes, due to the range of outcome measures and methods of reporting. However, where meta‐analysis was possible, there was evidence of some small increases in HRQoL with exercise‐based CR compared with 'no exercise' control, across several SF‐36 subscales (mental component, physical functioning, physical performance, general health, vitality, social functioning and mental health scores). However, these may not be clinically important differences. These findings were supported by a vote‐counting approach to summarise HRQoL results across all studies reporting HRQoL, in which 23/32 (72%) trials reported higher levels of HRQoL in one or more subscales with exercise‐based CR compared to control at follow‐up. Whilst this method of synthesis without meta‐analysis has significant limitations, such as not taking account of the differential weights given to each trial, we believe it to be the best available method to concisely and transparently summarise the results (Campbell 2020). 

The five trial‐based economic evaluation studies showed exercise‐based CR to be a potentially cost‐effective use of resources in terms of gain in QALYs.

Overall completeness and applicability of evidence

The generalisability of early versions of this review was limited, as most included studies recruited predominantly male participants (Jolliffe 2001: 9% female; current version: 16% female), following MI (Jolliffe 2001: 80% trials with MI only participants; current version: 47% trials with MI only participants). However, with the inclusion of more women in trials conducted in the last decade and with further data on the outcomes of hospitalisation and HRQoL, the findings of this updated review potentially have greater external validity. An additional 16 new studies identified and included in this current update have been undertaken in low‐ and middle‐income countries, increasing the generalisability of our results to these countries where prevalence of CHD is high and continues to increase (Prabhakaran 2018).

Quality of the evidence

In previous versions of this review, the general lack of adequate reporting of randomisation and blinding methods in the included RCT reports made it difficult to assess their methodological quality. However, the quality of reporting in studies has increased over the last decade, and reassuringly, meta‐regression showed no significant association between the effect of CR compared to control and the level of risk of bias across trials.

GRADE demonstrated that the certainty of the evidence ranged from low to high across the primary outcomes. We downgraded the certainty of the evidence for all‐cause mortality, cardiovascular mortality, PCI and cardiovascular hospitalisations by one level for imprecision, due to wide confidence intervals that overlapped the boundary for no effect (i.e. 95% CI crossed 1). We downgraded the certainty of the evidence for MI and all‐cause hospitalisations by one level due to evidence of publication bias (Egger test: P < 0.05). We downgraded the certainty of the evidence for cardiovascular hospitalisations by one level due to evidence of substantial heterogeneity (Chi2 test: P < 0.05, or I2 test for heterogeneity > 50%, or both).

Potential biases in the review process

We believe this is the most comprehensive systematic review to date of RCT‐based evidence for the impact of exercise‐based CR for people with CHD. However, it is important that we contextualise our review findings in light of some limitations.

Details of random allocation sequence generation and concealment, and blinding of outcome assessment were poorly reported (33% trials adequately reported allocation sequence generation and 29% trials adequately reported blinding of outcome assessment), and therefore may be subject to bias. Funnel plot asymmetry for the risk of MI and all‐cause hospital admission is indicative of small‐study bias and possible publication bias. There was also evidence of statistical heterogeneity for all‐cause and cardiovascular hospitalisations, and all HRQoL subscales, except SF‐12 MCS.

The number of trials reporting medium‐term ( > 12 to 36 month follow‐up) and long‐term data ( > 36 months' follow‐up) has decreased from 47% (27/57 trials) to 21% (7/33 trials) over the last decade, while sample sizes have remained relatively small over the same period (median sample size increased from 125 to 142). As a result, the number of deaths and other clinical events, including hospitalisations, reported by many trials is small, or in some cases, zero. Indeed, in many studies, we located event data in the participant flow diagrams and descriptions of losses to follow‐up and exclusions, rather than as prespecified outcomes measured, reported, or analysed within trials. In addition, cause of death was often not reported. Furthermore, in recent studies, clinical events have often been reported as a composite endpoint (e.g. major adverse cardiac events) rather than as individual events. These data reporting and evidence syntheses issues may have resulted in some of the apparently paradoxical findings of this review, such as reduced all‐cause mortality but not cardiovascular mortality in the short term. 

All included studies involved a 'no formal exercise training' intervention comparator. However, a wide range of comparators were seen across the trials, including education, psychological intervention or usual medical care alone. Due to poor and inconsistent reporting of adherence and fidelity to exercise programmes in the RCTs, we were not able to consider the actual amount of exercise that participants received or performed in this review.

Agreements and disagreements with other studies or reviews

The findings of this updated review are largely in accord with the previous version of this review. Although there was a trend towards a slight reduction in all‐cause mortality with exercise‐based CR compared to 'no exercise' control, this reduction failed to reach statistical significance. This is likely explained by the inclusion of more recent trials conducted in the era of optimal medical therapy. Given the proven survival advantage of contemporary medical treatments, and the limited opportunity for mortality gain in this patient cohort, any incremental mortality benefit with exercise is likely to be small. This theory is supported by Powell and colleagues' meta‐analysis of contemporary trials (Powell 2018), demonstrating no improvement in all‐cause mortality across 19 trials (risk difference (RD) 0.00, 95% CI ‐0.02 to 0.01; P = 0.38), or 9 trials reporting cardiovascular mortality (RD ‐0.01, 95% CI ‐0.02 to 0.01; P = 0.25), published between 2000 and 2017. Our meta‐regression analysis showed a potential trend (RR 0.84, 95% CI 0.70 to 0.99; P = 0.04) suggesting all‐cause mortality could be somewhat associated with publication year. However, due to multiple testing, we cannot rule out that this finding was by chance, and did not meet the criteria for statistical significance once the Bonferroni correction was applied.

Our results are also somewhat consistent with the findings of a recently published comprehensive network meta‐analysis (Huang 2021). In this study, the authors found that comprehensive exercise‐based CR reduces the risk of all‐cause mortality, yet unlike our results, risks of PCI and CABG revascularisation were also reduced. Exercise‐only CR was found to reduce the risks of non‐fatal MI, cardiovascular mortality, and all‐cause and cardiovascular hospitalisation, but not the risk of all‐cause mortality or revascularisations compared to standard care. The authors also similarly found no strong evidence to differentiate the relative benefits of exercise‐based CR, whether delivered as an exercise‐only intervention or a comprehensive intervention.

McGregor and colleagues performed a meta‐analysis of exercise‐based CR based on HRQoL outcomes of people with CHD, including 15 short‐term (i.e. 1 to 6 months) and 9 medium‐term (i.e. 8 to 12 months) trials (McGregor 2020). Pooled HRQoL results were consistent with the present review, showing improvement with CR across a number HRQoL domain scores.

The recently updated meta‐analysis of the Cardiac Rehabilitation Outcome Study (CROSII), which included RCTs and prospective and retrospective cohort studies, reported a mortality benefit of CR in people with acute coronary syndrome and revascularisation, with an index event in 1995 or later (Salzwedel 2020). However, with inclusion of observational evidence, the prognostic benefit reported by the CROSII study is subject to selection bias and confounding.

Authors' conclusions

Implications for practice.

This review shows that exercise‐based cardiac rehabilitation (CR) provides important benefits by likely reducing risks of all‐cause mortality, myocardial infarction (MI), all‐cause hospitalisation and associated healthcare costs, and improving health‐related quality of life (HRQoL) in people with coronary heart disease (CHD). There was an increase in the proportion of female participants in more recent trials. However, the application of this evidence base to more poorly‐represented groups, particularly people with angina pectoris and higher‐risk CHD, and those with major comorbidities, remains a question of clinical judgement. There appears to be little to choose between exercise‐only CR or exercise in combination with psychosocial or educational CR interventions. In the absence of definitive cost‐effectiveness conclusions comparing psychosocial or educational approaches to exercise‐based CR, it would be rational to use cost considerations to determine practice. Finally, this update included a further 16 randomised controlled trials (RCTs) undertaken in low‐ and middle‐income countries (LMICs), increasing the generalisability of our findings to these settings.

Implications for research.

In spite of incorporation of recent trial evidence including more women, the population of people with CHD studied in this review remains predominately low‐risk, middle‐aged males following MI or revascularisation. Therefore, well‐designed, and adequately‐reported RCTs of CR in groups of people with CHD more representative of usual clinical practice are still needed. These trials need to explicitly report clinical events, including mortality and hospital admission; should include validated HRQoL outcome measures, especially over longer‐term follow‐up; and should assess costs and cost‐effectiveness. Further details of the presentation and diagnoses of people with CHD, and interventions offered and received, should be reported in trials, so that results of future reviews can better stratify outcomes according to the range of CHD populations or types of CR interventions.

What's new

Date Event Description
13 April 2021 New citation required but conclusions have not changed 22 newly included studies in this update, with 85 included in total. No substantive change in review conclusions.
11 January 2021 New search has been performed New search has been performed (1/9/2020)

History

Protocol first published: Issue 3, 1999
Review first published: Issue 4, 2000

Date Event Description
3 September 2015 New citation required but conclusions have not changed No substantive change in review conclusions
3 September 2015 New search has been performed No substantive change in review conclusions
24 February 2015 Amended New Author (Ann‐Dorthe Zwisler) added
24 February 2015 Amended New Author (Nicole Martin) added
24 February 2015 Amended New Author (Lindsey Anderson) added
24 February 2015 Amended Author (David Thompson) details updated
7 June 2011 New citation required and conclusions have changed The inclusion criteria have been revised for this update. Five out of the 35 formerly included studies (in the review) have therefore been excluded.
The conclusions have changed based on the analysis of 47 included studies and have focused more on the impact of exercise‐based cardiac rehabilitation on clinical events and HRQL outcomes.
7 June 2011 New search has been performed The searches were updated and re‐run in December 2009, identifying an additional 17 studies for inclusion. Fourty‐seven trials in total have been included.
1 November 2000 New citation required and conclusions have changed Substantive amendment

Acknowledgements

We would like to thank Olga Utkina‐Macaskill, Houra Haghpanahan and Lili Wei (Institute of Health and Wellbeing, University of Glasgow) for their translation services. We would also like to thank all the authors who provided additional information about their trials. Finally, we would like to acknowledge the support of co‐authors on the three previous versions of this review, and peer reviewers Philippa Davies (University of Bristol) and Gordon McGregor (UHCW NHS Trust/Coventry University/University of Warwick), as well as consumer reviewer Stewart Witt.

The background and methods section of this review is based on a standard template provided by Cochrane Heart.

Appendices

Appendix 1. Glossary of terms used in this review 

Angina pectoris: commonly known as angina, is the sensation of chest pain, pressure, or squeezing, often due to ischaemia of the heart muscle from obstruction or spasm of the coronary arteries.

Angioplasty: a treatment to expand a narrowed artery.

Arrhythmia: an abnormal heart rhythm.

Atheroma: the fatty material that can build up within the walls of your arteries.

Atherosclerosis: the build‐up of fatty materials within the walls of your arteries, causing them to narrow.

Cardiovascular: to do with the heart and blood vessels.

Coronary artery bypass surgery: also known as coronary artery bypass graft (CABG) surgery, and colloquially as heart bypass or bypass surgery, is a surgical procedure to improve the blood supply to the heart.

Coronary heart disease (CHD): also known as coronary artery disease (CAD), ischaemic heart disease (IHD), or atherosclerotic heart disease, is a group of diseases that includes: stable angina, unstable angina, myocardial infarction and sudden coronary death. It is caused when the walls of your coronary arteries become narrowed by a gradual build‐up of atheroma, allowing too little blood flow to the heart from the coronary arteries.

Echocardiogram: often referred to as a cardiac echo or simply an echo, is a sonogram of the heart. Echocardiography uses standard two‐dimensional, three‐dimensional, and Doppler ultrasound to create images of the heart.

Electrocardiogram (ECG): is a test that checks for problems with the electrical activity of your heart. An ECG shows the heart's electrical activity as line tracings on paper. The spikes and dips in the tracings are called waves. The heart is a muscular pump made up of four chambers.

Heart attack: myocardial infarction (MI) or acute myocardial infarction (AMI), occurs when blood flow stops to a part of the heart, starving it of oxygen and causing damage to the heart muscle.

Heart failure (HF): often referred to as congestive heart failure (CHF), occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the needs of your body.

Heart rate: The number of times your heart beats in a minute.

Implantable cardiovertor defibrillator (ICD): a device implanted within your chest wall to monitor your heart's rhythm. If there is a dangerous, abnormal rhythm, the ICD can treat it by giving your heart an electric shock.

Intermittent claudication: A cramp‐like pain, mostly in your calf and leg muscles, which is caused by a lack of oxygen in the blood. It is often brought on by walking and relieved by rest.

Ischaemia: a restriction in blood supply to tissues, causing a shortage of the oxygen and glucose needed.

Ischaemic heart disease (IHD): see coronary heart disease (CHD).

Myocardial infarction (MI) or acute myocardial infarction (AMI): commonly known as a heart attack, occurs when blood flow stops to a part of the heart, causing damage to the heart muscle.

Percutaneous coronary intervention (PCI): commonly known as coronary angioplasty, is a non‐surgical procedure used to treat the stenotic (narrowed) coronary arteries of the heart found in coronary heart disease.

Revascularisation: a procedure that either opens up the existing blood vessels or bypasses the blockage of the coronary arteries.

Risk factor for coronary heart disease: something that can increase your risk of getting coronary heart disease. Risk factors include smoking, high blood pressure, raised cholesterol, physical inactivity, obesity, diabetes, your sex, your ethnic background, your age and whether you have a family history of heart disease.

ST segment: is the flat, isoelectric section of the ECG trace, between the end of the S wave (the J point) and the beginning of the T wave.

Appendix 2. Search strategies

CENTRAL

#1 MeSH descriptor: [Myocardial Ischemia] explode all trees

#2 (myocard* near isch*mi*):ti,ab,kw

#3 isch*mi* near heart:ti,ab,kw

#4 MeSH descriptor: [Coronary Artery Bypass] explode all trees

#5 myocard* near infarct*:ti,ab,kw

#6 heart near infarct*:ti,ab,kw

#7 angina:ti,ab,kw

#8 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw

#9 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees

#10 (percutaneous next coronary near/2 (interven* or revascular*))

#11 MeSH descriptor: [Angioplasty] explode all trees

#12 angioplast*

#13 ((coronary or arterial) near/4 dilat*)

#14 endoluminal next repair*

#15 MeSH descriptor: [Stents] explode all trees

#16 stent*

#17 pci or ptca

#18 MeSH descriptor: [Atherectomy] explode all trees

#19 atherectom*

#20 acute next coronary next syndrom*

#21 (NSTEMI or STEMI)

#22 ACS

#23 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20

#24 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22

#25 MeSH descriptor: [Exercise Therapy] explode all trees

#26 MeSH descriptor: [Sports] explode all trees

#27 MeSH descriptor: [Physical Exertion] explode all trees

#28 rehabilitat*:ti,ab,kw

#29 (physical* near (fit* or train* or therap* or activit*)):ti,ab,kw

#30 MeSH descriptor: [Exercise] explode all trees

#31 (train*) near (strength* or aerobic* or exercise*):ti,ab,kw

#32 ((exercise* or fitness) near/3 (treatment or intervent* or program*)):ti,ab,kw

#33 MeSH descriptor: [Rehabilitation] explode all trees

#34 kinesiotherap*:ti,ab,kw

#35 MeSH descriptor: [Physical Education and Training] explode all trees

#36 MeSH descriptor: [Patient Education as Topic] this term only

#37 (patient* near/5 educat*)

#38 ((lifestyle or life‐style) near/5 (interven* or program* or treatment*))

#39 MeSH descriptor: [Self Care] this term only

#40 (self near/5 (manag* or care or motivate*))

#41 MeSH descriptor: [Psychotherapy] explode all trees

#42 psychotherap*

#43 (psycholog* near/5 intervent*)

#44 MeSH descriptor: [Counseling] this term only

#45 (counselling or counseling)

#46 ((behavior* or behaviour*) near/5 (modify or modificat* or therap* or change))

#47 (psycho‐educat* or psychoeducat*)

#48 (motivat* near/5 (intervention or interv*))

#49 MeSH descriptor: [Health Education] this term only

#50 (health near/5 educat*)

#51 (psychosocial or psycho‐social)

#52 (cognitive near/2 behav*)

#53 #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52

#54 #23 and #53 in Trials

#55 #24 and #53 in Trials

#56 #55 not #54 in Trials

#57 #23 and #53 with Publication Year from 2014 to 2020, in Trials

#58 #56 or #57

MEDLINE OVID

1 exp Myocardial Ischemia/

2 (myocard* adj5 (ischaemia or ischemia)).tw.

3 (isch?emi* adj5 heart).tw.

4 exp Coronary Artery Bypass/

5 (myocard* adj5 infarct*).tw.

6 (heart adj5 infarct*).tw.

7 angina.tw.

8 (coronary adj5 (disease* or bypass or thrombo* or angioplast*)).tw.

9 exp Percutaneous Coronary Intervention/

10 (percutaneous coronary adj2 (interven* or revascular*)).tw.

11 exp Angioplasty/

12 angioplast*.tw.

13 ((coronary or arterial) adj4 dilat*).tw.

14 endoluminal repair*.tw.

15 exp Stents/

16 stent*.tw.

17 (pci or ptca).tw.

18 exp Atherectomy/

19 atherectom*.tw.

20 acute coronary syndrom*.tw.

21 (NSTEMI or STEMI).tw.

22 ACS.tw.

23 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20

24 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22

25 exp Exercise Therapy/

26 Sports/

27 Physical Exertion/

28 rehabilitat*.mp.

29 (physical* adj5 (fit* or train* or therap* or activit*)).mp.

30 exp Exercise/

31 (train* adj5 (strength* or aerobic* or exercise*)).tw.

32 ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.

33 exp Rehabilitation/

34 kinesiotherap*.tw.

35 "Physical Education and Training"/

36 Patient Education as Topic/

37 (patient* adj5 educat*).tw.

38 ((lifestyle or life‐style) adj5 (interven* or program* or treatment*)).tw.

39 Self Care/

40 (self adj5 (manag* or care or motivate*)).tw.

41 exp Psychotherapy/

42 psychotherap*.tw.

43 (psycholog* adj5 intervent*).tw.

44 Counseling/

45 (counselling or counseling).tw.

46 ((behavior* or behaviour*) adj5 (modify or modificat* or therap* or change)).tw.

47 (psycho‐educat* or psychoeducat*).tw.

48 (motivat* adj5 (intervention or interv*)).tw.

49 Health Education/

50 (health adj5 educat*).tw.

51 (psychosocial or psycho‐social).tw.

52 (cognitive adj2 behav*).tw.

53 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52

54 randomized controlled trial.pt.

55 controlled clinical trial.pt.

56 randomized.ab.

57 placebo.ab.

58 drug therapy.fs.

59 randomly.ab.

60 trial.ab.

61 groups.ab.

62 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61

63 exp animals/ not humans.sh.

64 62 not 63

65 23 and 53 and 64

66 24 and 53 and 64

67 limit 65 to ed=20140702‐20200901

68 66 not 65

69 67 or 68

Embase OVID

1 exp Heart Muscle Ischemia/

2 (myocard* adj5 (ischaemia or ischemia)).tw.

3 (isch?emi* adj5 heart).tw.

4 exp Coronary Artery Bypass Graft/

5 (myocard* adj5 infarct*).tw.

6 (heart adj5 infarct*).tw.

7 angina.tw.

8 (coronary adj5 (disease* or bypass or thrombo* or angioplast*)).tw.

9 exp percutaneous coronary intervention/

10 (percutaneous coronary adj2 (interven* or revascular*)).tw.

11 exp angioplasty/

12 angioplast*.tw.

13 ((coronary or arterial) adj4 dilat*).tw.

14 endoluminal repair*.tw.

15 exp stent/

16 stent*.tw.

17 (pci or ptca).tw.

18 exp atherectomy/

19 atherectom*.tw.

20 acute coronary syndrom*.tw.

21 (NSTEMI or STEMI).tw.

22 ACS.tw.

23 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20

24 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22

25 exp Kinesiotherapy/

26 Sport/

27 rehabilitat*.mp.

28 (physical* adj5 (fit* or train* or therap* or activit*)).mp.

29 exp Exercise/

30 (train* adj5 (strength* or aerobic* or exercise*)).tw.

31 ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.

32 exp Rehabilitation/

33 kinesiotherap*.tw.

34 Physical Education/

35 patient education/

36 (patient* adj5 educat*).tw.

37 ((lifestyle or life‐style) adj5 (interven* or program* or treatment*)).tw.

38 self care/

39 (self adj5 (manag* or care or motivate*)).tw.

40 exp psychotherapy/

41 psychotherap*.tw.

42 (psycholog* adj5 intervent*).tw.

43 counseling/

44 (counselling or counseling).tw.

45 ((behavior* or behaviour*) adj5 (modify or modificat* or therap* or change)).tw.

46 (psycho‐educat* or psychoeducat*).tw.

47 (motivat* adj5 (intervention or interv*)).tw.

48 health education/

49 (health adj5 educat*).tw.

50 (psychosocial or psycho‐social).tw.

51 (cognitive adj2 behav*).tw.

52 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51

53 random$.tw.

54 factorial$.tw.

55 crossover$.tw.

56 cross over$.tw.

57 cross‐over$.tw.

58 placebo$.tw.

59 (doubl$ adj blind$).tw.

60 (singl$ adj blind$).tw.

61 assign$.tw.

62 allocat$.tw.

63 volunteer$.tw.

64 crossover procedure/

65 double blind procedure/

66 randomized controlled trial/

67 single blind procedure/

68 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67

69 (animal/ or nonhuman/) not human/

70 68 not 69

71 23 and 52 and 70

72 24 and 52 and 70

73 limit 71 to dd=20140702‐20200901

74 72 not 71

75 73 or 74

76 limit 75 to embase

CINAHL

S75 S73 OR S74

S74 S22 AND S52 AND S70 Limiters ‐ Published Date: 20140701‐20200831

S73 S72 NOT S71

S72 S23 AND S52 AND S70

S71 S22 AND S52 AND S70

S70 S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69

S69 TX cross‐over*

S68 TX crossover*

S67 TX volunteer*

S66 (MH "Crossover Design")

S65 TX allocat*

S64 TX control*

S63 TX assign*

S62 TX placebo*

S61 (MH "Placebos")

S60 TX random*

S59 TX (doubl* N1 mask*)

S58 TX (singl* N1 mask*)

S57 TX (doubl* N1 blind*)

S56 TX (singl* N1 blind*)

S55 TX (clinic* N1 trial?)

S54 PT clinical trial

S53 (MH "Clinical Trials+")

S52 S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51

S51 (cognitive N2 behav*)

S50 (psychosocial or psycho‐social)

S49 (health N5 educat*)

S48 (MH "Health Education")

S47 (motivat* N5 (intervention or interv*))

S46 (psycho‐educat* or psychoeducat*)

S45 ((behavior* or behaviour*) N5 (modify or modificat* or therap* or change))

S44 (counselling or counseling)

S43 (MH "Counseling")

S42 (psycholog* N5 intervent*)

S41 psychotherap*

S40 (MH "Psychotherapy+")

S39 (self N5 (manag* or care or motivate*))

S38 (MH "Self Care")

S37 ((lifestyle or life‐style) N5 (interven* or program* or treatment*))

S36 (patient* N5 educat*)

S35 (MH "Patient Education")

S34 (MH "Physical Education and Training")

S33 kinesiotherap*

S32 (MH "Rehabilitation+")

S31 ((exercise* or fitness) N3 (treatment or intervent* or program*))

S30 (train* N5 (strength* or aerobic* or exercise*))

S29 (MH "Exercise+")

S28 (physical* N5 (fit* or train* or therap* or activit*))

S27 rehabilitat*

S26 (MH "Physical Activity")

S25 (MH "Sports")

S24 (MH "Therapeutic Exercise+")

S23 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22

S22 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19

S21 ACS

S20 (NSTEMI or STEMI)

S19 "acute coronary syndrom*"

S18 atherectom*

S17 (MH "Atherectomy+")

S16 pci or ptca

S15 stent*

S14 (MH "Stents+")

S13 "endoluminal repair*"

S12 ((coronary or arterial) N4 dilat*)

S11 angioplast*

S10 (MH "Angioplasty+")

S9 (percutaneous coronary N2 (interven* or revascular*))

S8 (coronary N5 (disease* or bypass or thrombo* or angioplast*))

S7 angina

S6 (heart N5 infarct*)

S5 (myocard* N5 infarct*)

S4 (MH "Coronary Artery Bypass+")

S3 (isch?emi* N5 heart)

S2 (myocard* N5 (ischaemia or ischemia))

S1 (MH "Myocardial Ischemia+")

Web of Science

#16 #15 OR #14

#15 #11 AND #10 AND #8 Indexes=SCI‐EXPANDED, CPCI‐S Timespan=2014‐2020

#14 #13 NOT #12

#13 #11 AND #10 AND #9

#12 #11 AND #10 AND #8

#11 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross‐over*)

#10 TS=((rehab* or educat*))

#9 #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1

#8 #5 OR #4 OR #3 OR #2 OR #1

#7 TS=ACS

#6 TS=(NSTEMI or STEMI)

#5 TS=(PCI or percutaneous or angioplast* or "endoluminal repair*" or stent* or atherectom* or "acute coronary syndrom*")

#4 TS=((angina or cardiac* or PTCA or CABG))

#3 TS=(((heart) SAME (infarct* or isch?emia or failure or attack)))

#2 TS=(((coronary* or heart*) SAME (by?pass or disease*)))

#1 TS=(((myocard*) SAME (isch?emia or infarct* or revasculari?*)))

ClinicalTrials.gov

Condition or disease: Coronary Heart Disease

Intervention/treatment: Cardiac Rehabilitation

Study type: Interventional studies (Clinical Trials)

WHO ICTRP

Condition: Coronary Heart Disease

Intervention: Exercise OR Cardiac rehabilitation

Data and analyses

Comparison 1. Exercise‐based rehabilitation versus control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 All‐cause mortality 47   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.1.1 Follow‐up of 6 to 12 months 25 8823 Risk Ratio (M‐H, Random, 95% CI) 0.87 [0.73, 1.04]
1.1.2 Follow‐up of > 12 to 36 months 16 11073 Risk Ratio (M‐H, Random, 95% CI) 0.90 [0.80, 1.02]
1.1.3 Follow‐up longer than 3 years 11 3828 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.75, 1.10]
1.2 Cardiovascular mortality 26   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.2.1 Follow‐up of 6 to 12 months 15 5360 Risk Ratio (M‐H, Random, 95% CI) 0.88 [0.68, 1.14]
1.2.2 Follow‐up of > 12 months to 36 months 5 3614 Risk Ratio (M‐H, Random, 95% CI) 0.77 [0.63, 0.93]
1.2.3 Follow‐up of longer than 3 years 8 1392 Risk Ratio (M‐H, Random, 95% CI) 0.58 [0.43, 0.78]
1.3 Fatal and/or nonfatal MI 39   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.3.1 Follow‐up of 6 to 12 months 22 7423 Risk Ratio (M‐H, Random, 95% CI) 0.72 [0.55, 0.93]
1.3.2 Follow‐up of > 12 to 36 months 12 9565 Risk Ratio (M‐H, Random, 95% CI) 1.07 [0.91, 1.27]
1.3.3 Follow‐up of longer than 3 years 10 1560 Risk Ratio (M‐H, Random, 95% CI) 0.67 [0.50, 0.90]
1.4 CABG 29   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.4.1 Follow‐up of 6 to 12 months 20 4473 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.78, 1.27]
1.4.2 Follow‐up of > 12 to 36 months 9 2826 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.77, 1.23]
1.4.3 Follow‐up of longer than 3 years 4 675 Risk Ratio (M‐H, Random, 95% CI) 0.66 [0.34, 1.27]
1.5 PCI 18   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.5.1 Follow‐up of 6 to 12 months 13 3465 Risk Ratio (M‐H, Random, 95% CI) 0.86 [0.63, 1.19]
1.5.2 Follow‐up of > 12 to 36 months 6 1983 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.69, 1.35]
1.5.3 Follow‐up of longer than 3 years 3 567 Risk Ratio (M‐H, Random, 95% CI) 0.76 [0.48, 1.20]
1.6 All‐cause hospital admissions 22   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.6.1 Follow‐up of 6 to 12 months 14 2030 Risk Ratio (M‐H, Random, 95% CI) 0.58 [0.43, 0.77]
1.6.2 Follow‐up of > 12 to 36 months 9 5995 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.82, 1.03]
1.7 Cardiovascular hospital admissions 8   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.7.1 Follow‐up of 6 to 12 months 6 1087 Risk Ratio (M‐H, Random, 95% CI) 0.80 [0.41, 1.59]
1.7.2 Follow up of >12 to 36 months 3 943 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.76, 1.12]
1.8 HRQoL SF‐36 summary scores at 6 to 12 months follow up 6   Mean Difference (IV, Random, 95% CI) Subtotals only
1.8.1 Physical component score 6 1741 Mean Difference (IV, Random, 95% CI) 1.70 [‐0.08, 3.47]
1.8.2 Mental component score 6 1741 Mean Difference (IV, Random, 95% CI) 2.14 [1.07, 3.22]
1.9 HRQoL SF‐36 8 domains at 6 to 12 months follow up 8   Mean Difference (IV, Random, 95% CI) Subtotals only
1.9.1 Physical functioning 8 2756 Mean Difference (IV, Random, 95% CI) 8.47 [3.69, 13.24]
1.9.2 Physical performance 8 2756 Mean Difference (IV, Random, 95% CI) 8.08 [2.89, 13.27]
1.9.3 Bodily pain 8 2756 Mean Difference (IV, Random, 95% CI) ‐0.06 [‐8.97, 8.84]
1.9.4 General health 8 2756 Mean Difference (IV, Random, 95% CI) 5.66 [2.08, 9.25]
1.9.5 Vitality 7 2638 Mean Difference (IV, Random, 95% CI) 5.78 [1.89, 9.67]
1.9.6 Social functioning 8 2756 Mean Difference (IV, Random, 95% CI) 1.98 [0.26, 3.70]
1.9.7 Emotional performance 7 2638 Mean Difference (IV, Random, 95% CI) 0.69 [‐1.33, 2.71]
1.9.8 Mental health 8 2756 Mean Difference (IV, Random, 95% CI) 5.60 [1.21, 9.98]
1.10 HRQoL EQ‐5D at 6 to 12 months follow up 3 476 Mean Difference (IV, Random, 95% CI) 0.05 [‐0.01, 0.10]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Andersen 1981.

Study characteristics
Methods Study design: RCT
Country: Denmark
Dates participants recruited: NR
Maximum follow‐up: 37 months
Post MI randomised four weeks after discharge.
Participants Inclusion criteria: < 66 yrs with 1st MI
Exclusion criteria: participants without motivation and participants with impairment of the motorial apparatus that excluded training
N randomised: total: 75; intervention: 38; comparator: 37
Diagnosis (% of participants): post MI: 100%
Age (mean ±SD): intervention: 52.2 ± 7.5; comparator: 55.6 ± 6.3
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: aerobic activity e.g. running, cycling, skipping + weights for 1 hour x 2 weekly for 2 months, then x 1 week for 10 months. Then continue at home.
Components: exercise only
Setting: centre‐based initially, followed by home
Exercise programme modality: e.g. running, cycling, skipping
Length of session: 1 hour
Frequency: twice a week for two months, and then weekly for 10 months
Intensity: initial load of 150 kpm/min (24.5 W). increased with 150 kpm/min every 6 mins
Resistance training included? yes ‐ weights
Total duration: 12 months
Co‐interventions: none described
Comparator: non‐trained group (although some participants trained on own initiative)
Co‐interventions: none described
Outcomes Total and CHD mortality
Non‐fatal MI
Outcomes measured at 1, 13, 25 and 37 months post‐discharge
Source of funding NR
Conflicts of interest NR
Notes 88 participants were randomised, but 13 failed to follow up. Therefore, 75 took part in the study.
Several participants in control group trained on own initiative, but were analysed as intention‐to‐treat.
Triallists concluded that physical training after MI appears to reduce consequences and to improve PWC, but PWC declines once participant is on their own.
Physical training had no effect on period of convalescence or return to work, but age and previous occupation were of significance.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "random numbers"
Allocation concealment (selection bias) Unclear risk Allocation concealment not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 15% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points

Aronov 2010.

Study characteristics
Methods Study design: multicentre RCT (20 cities)
Country: Russia
Dates participants recruited: NR
Maximum follow‐up: 1 year
Participants Inclusion criteria: people 3 to 8 weeks after MI, unstable angina or reconstructive coronary arteries intervention. In some cases (at discretion of the researchers), people with stable angina after hospital treatment with unconfirmed diagnosis of MI or unstable angina were included in the study.
Exclusion criteria: none reported
N Randomised: total: 392; intervention: 197; comparator: 195
Diagnosis (% of participants):
Stable angina: intervention: 62.7; comparator: 77.7
Post MI: intervention: 78.4; comparator: 77.3
Unstable angina: intervention: 5.0; comparator: 10.9
(not mutually exclusive)
Age (mean ± SD): intervention: 51.9 ± 7.2; comparator: 51.9 ± 7
Percentage male: intervention: 95.5; comparator: 91.7
Ethnicity: NR
Interventions Intervention: participants of the main group received moderate‐intensity PT (50% to 60% of the performed capacity by bicycle ergometry (BE) test) 3 times per week with duration of exercises from 45 minutes to 1 hour for 1 year
Components: exercise only
Setting: NR
Exercise programme modality: cycling
Length of session: 45‐60 mins
Frequency: 3 times a week
Intensity: 50% to 60% of the performed capacity by bicycle ergometry test
Resistance training included? No
Total duration: 1 year
Co‐interventions: participants received standard medical therapy described below.
Comparator: participants received standard medical therapy which included beta‐blocker, acetylsalicylic acid or other antithrombotic drug, as well as nitrate, and ACE inhibitor. Some participants took lipid‐lowering drugs.
Co‐interventions: none described
Outcomes Mortality and MI
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of randomisation not described….“patients were randomised into 2 groups….”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding of assessments not described
Incomplete outcome data (attrition bias)
All outcomes Low risk Withdrawals were similar for both groups.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Aronov 2019.

Study characteristics
Methods Study design: single‐centre RCT
Country: Russia
Dates participants recruited: NR
Maximum follow‐up: 12 months
Participants Inclusion criteria: male participants with coronary artery disease that underwent CABG 3 to 8 weeks before enrolment
Exclusion criteria: early post‐surgery stenocardia, pericarditis (diagnosed by echocardiography), pericardial effusion with a volume of pericardial fluid exceeding 200 mL, separation of the pericardial layers in diastole more than 1 cm, or moderate pericardial effusion with signs of inflammation), sternal diastasis and other post‐surgery complications (impaired wound healing, suture sinuses or pain), cardiac arrhythmia, heart failure, maximal power output in cycle ergometer test < 50 W, hypertension ( ≥ 180/100 mmHg), history of stroke or transient ischaemia, carotid artery narrowing by ≥ 50%, intermittent claudication syndrome, relapsing thromboembolism complications, severe diabetes mellitus, morbid obesity, pulmonary disorders, concurrent diseases that impede physical training.
N randomised: total: 36; intervention: 18; comparator: 18
Diagnosis (% of participants): intervention: received CABG 17 (94%), history of MI 13 (72.2%), history of angina 13 (72.2%); comparator: received CABG 17 (94%), history of MI 10 (55.6%), history of angina 15 (83.3%).
Age (mean ±SD): intervention: 58.6 ± 7.0; comparator 55.9 ± 7.0
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: “School for coronary bypass patients” ‐ an integrated cardiac rehabilitation program. Weekly group information sessions (60 to 80 min) under guidance by a cardiologist. Sessions focused on most common topics related to rehabilitation after CABG: cardiac diseases, cardiovascular risk factors, smoking cessation, stress management, anxiety and depression, and “hearthealthy” diet and cooking. Supervised physical training 3 times per week for 4 months. 60‐minute sessions including breathing exercise, physical drill complexes and cycling on a stationary bicycle at moderate intensity (50% to 60% max. power assessed by graded cycle ergometer test). After 4 months centre‐based CR, participants continued home‐based exercise for 6 months. Participants provided with written instructions and a video with recommendations to follow the programme for a year. Participants instructed to perform self‐assessment of their physical well being at home. Exercises included breathing, physical drill and walking.
Components: exercise plus education plus individual counselling sessions upon request
Setting: centre‐ and then home‐based
Exercise programme modality: breathing exercises, physical drills, centre‐based stationary cycling, and home‐based walking
Length of session: 1 hour
Frequency: three sessions per week
Intensity: 50% to 60% maximal power
Resistance training included? No
Total duration: 10 months
Co‐interventions: none described
Comparator: control group participants attended the same educational sessions as intervention group. Participants received a recommendation to follow physical training at home on their own.
Co‐interventions: none described
Outcomes Total mortality, revascularisations, hospitalisations, HRQoL
Source of funding NR
Conflicts of interest None declared
Notes Authors contacted for further clinical outcomes and QoL data but no response received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information provided regarding methods used to generate allocation sequence
Allocation concealment (selection bias) Unclear risk No information provided regarding methods used to conceal allocation sequence
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided regarding blinding of outcome assessment for any of the main outcomes of interest
Incomplete outcome data (attrition bias)
All outcomes Low risk Only 1 participant in control group reported as withdrawn for non‐medical reasons
Selective reporting (reporting bias) Unclear risk No protocol paper or clinical trials registration available

Bäck 2008.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: 2004 to 2006
Maximum follow‐up: 8 months (6 months following PCI)
Participants Inclusion criteria: coronary artery stenosis documented by angiography or previous coronary artery bypass grafting, classes I‐III angina pectoris, classified according to Canadian Cardiovascular Society.
Exclusion criteria: disabling disease that hindered regular exercise, or if the individual has already engaged in exercise more than 3 days/week
N randomised: total: 37; intervention: 21; comparator: 16
Diagnosis (% of participants): stable CAD: 100%
Age (years): 63.6 years; intervention: 61.5 (59.8 to 65.5); comparator: 64 (58.5 to 71.0)
Percentage male: 86.5%; intervention: 81.0%; comparator: 93.8%
Ethnicity: NR
Interventions Intervention: participants were asked to exercise at home on a bicycle ergometer for 30 min (including a 10‐minute warm‐up and a 5‐minute cool‐down), 5 days a week for 8 months. The training programme was initiated 2 months before the PCI. Twice a week the training participants were allowed to exchange cycling for an equivalent exercise such as jogging or swimming.
Components: exercise and education
Setting: home
Exercise programme modality: bicycle ergometer
Length of session: 30 min
Frequency: 5 times a week.
Intensity: 70% of V02max.
Resistance training included? Resistance exercise with elastic bands, 3 times a week
Total duration: 8 months
Co‐interventions: participants in both groups were invited to participate in the CR care consisting of group‐based lifestyle education and aerobic as well as resistance exercise twice a week during months 4 to 6.
Comparator: usual care
Co‐interventions: as above
Outcomes PCI at 2 months before PCI and 6 months after PCI
Source of funding The Swedish Heart Association, the Research and Development Council for Southern Gothenberg and Bohuslan, and Rene Eanders Foundation
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomised"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 8.1% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points (although absolute values not always given)

Belardinelli 2001.

Study characteristics
Methods Study design: single‐centre RCT
Country: Italy
Dates participants recruited: NR
Maximum follow‐up: 33 (SD 7) months
Participants Inclusion criteria: successful procedure of coronary angioplasty in 1 or 2 native epicardial coronary arteries and ability to exercise
Exclusion criteria: previous coronary artery procedures, cardiogenic shock, unsuccessful angioplasty (defined as residual stenosis > 30% of initial value), complex ventricular arrhythmias, uncontrolled hypertension and diabetes mellitus, creatinine > 2.5 mg/dL, orthopedic or neurological limitations to exercise or unstable angina after procedure and before enrolment
N randomised: total:118; intervention: 59; comparator: 59
Diagnosis (% of participants):
Myocardial infarction: intervention: 51; comparator: 47
Hypercholesterolemia: intervention: 61; comparator: 54
Diabetes: intervention: 17; comparator: 20
Hypertension: intervention: 42; comparator: 47
LVEF (%): intervention: 52 (SD 16); comparator: 50 (SD 14)
Age (mean ± SD): intervention: 53 ± 11; comparator: 59 ± 10
Percentage male: intervention: 83.1%; comparator: 84.8%
Percentage white: NR
Interventions Intervention: exercise sessions were performed at the hospital gym and were supervised by a cardiologist. After a 15‐min phase of stretching and callisthenics, participants pedaled on an electronically‐braked cycle ergometer at the target work rate for 30 min. This working phase was preceded by a 5‐min loadless warm‐up and followed by 3 min of unloaded cool‐down pedaling.
Components: exercise only
Setting: supervised in hospital gym
Exercise programme modality: electronically‐braked cycle ergometer
Length of session: 53 min.
Frequency: 3 sessions/week
Intensity: 60% of peak oxygen uptake (VO2)
Resistance training included? Yes ‐ callisthenics
Total duration: six months
Co‐interventions: none described
Comparator: control participants were recommended to perform basic daily mild physical activities but to avoid any physical training. A list of acceptable physical activities was provided, together with a diary to report daily activities.
Co‐interventions: none described
Outcomes Cardiac mortality; myocardial infarction; coronary angioplasty (percutaneous transluminal coronary angioplasty, coronary stent); coronary artery bypass graft; health‐related quality of life: MOS Short‐Form General Health Survey
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk Cardiac events of 12 participants who were excluded not accounted for
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Bell 1998.

Study characteristics
Methods Study design: multicentre RCT (5 sites), participants randomised 4 to 6 days post‐event.
Two independent 2‐way evaluations: conventional CR versus the Heart Manual (HM) and HM versus usual care
Country: UK
Dates participants recruited: NR
Maximum follow‐up: 1 year
Participants Inclusion criteria: post MI < 65 years
Exclusion criteria: physical infirmity which precludes exercise, inability to speak or read English, dementia or psychosis, age over 75 years, residency more than 20 miles from the coronary care unit (CCU), serious persisting complications which had not been stabilised at time of proposed randomisation including: continuing post‐infarct ischaemia, clinically significant heart failure, important cardiac arrhythmias, conduction disturbances (LBBB > mobitz type 1, 2nd degree AV block), concurrent illnesses (e.g. severe respiratory disease, renal insufficiency, etc.), any other condition which, in the consultant's opinion, would interfere with the individual's successful participation in the programme, or previous participation in the rehabilitation programme
N randomised: total: 353; intervention: 251; comparator: 102
Diagnosis (% of participants): MI: 100%
Age (mean ±SD): for women: 60.7 ± 7.2 to 64.3 ± 7.3; for men: 57.8 ± 8.9 to 59.4 ± 9.4
Percentage male: 78%
Ethnicity: NR
Interventions Intervention:
Heart Manual group: the Heart Manual is a comprehensive home‐based programme which includes an exercise regimen, relaxation and stress management techniques, specific self‐help treatments for psychological problems commonly experienced by MI patients and advice on coronary risk‐related behaviours.
Components: exercise, education and psychological
Setting: home
Exercise programme modality: walking
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: up to 6 weeks
Co‐interventions: relaxation and stress management techniques, specific self‐help treatments for psychological problems commonly experienced by MI patients and advice on coronary risk‐related behaviours
Conventional CR group: 1 to 2 group classes per week, walking etc., other days for 8 to 12 weeks with multidisciplinary team
Comparator: usual care
Co‐interventions: none described
Outcomes Total mortality, health‐related quality of life: Nottingham Health Profile
Source of funding British Heart Foundation
Conflicts of interest NR
Notes Hospital readmissions significantly reduced in Heart Manual group compared with conventional CR and control in initial six‐month period
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomisation was achieved by providing each hospital with a series of sealed envelopes containing cards evenly distributed between conditions. The envelopes were taken sequentially and, before opening the envelope, the patient's surname was written diagonally across the sealed flap, in such a way that when the envelope was opened the name was 'torn in two'. Opened envelopes were retained and returned to the trial coordinator. The importance of remaining neutral when advising the patients of the outcome of randomisation was emphasised in the written protocol and was reinforced during the sessions which were held to familiarise facilitators with the protocol."
Allocation concealment (selection bias) Low risk "Randomisation was achieved by providing each hospital with a series of sealed envelopes containing cards evenly distributed between conditions. The envelopes were taken sequentially and, before opening the envelope, the patient's surname was written diagonally across the sealed flap, in such a way that when the envelope was opened the name was 'torn in two'. Opened envelopes were retained and returned to the trial coordinator. The importance of remaining neutral when advising the patients of the outcome of randomisation was emphasised in the written protocol and was reinforced during the sessions which were held to familiarise facilitators with the protocol."
Comment: participants were informed of outcome of randomisation.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk 1.5% lost to follow‐up and reported description of withdrawals and/or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Bengtsson 1983.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: October 1973 to January 1975
Maximum follow‐up: 14 months
Participants Inclusion criteria: participants > 65 years with MI
Exclusion criteria: severe cardiac failure, post myocardial infarction (PMI)‐syndrome, aortic regurgitation, cerebral infarct hemiparesis, disease of hip, status post‐poliomyelitis, amputation of lower extremity, diabetes with retinopathy, hyper/hypo thyroidism, hyperparathyroidism, mental illness
N randomised: total: 87; intervention: 44; comparator: 43
Diagnosis (% of participants): AMI: 100%
Age (years ± SD): intervention: 55.3 ± 6.6; comparator: 57.1 ± 6.6
Percentage male: 85%
Ethnicity: NR
Interventions Intervention: physical training under the supervision of a specially‐trained physiotherapist attached to the cardiological unit. Exercises consisted of interval training of large muscle groups on a mechanically‐braked ergometer bicycle, callisthenics and jogging for 30 minutes twice weekly over a period of 3 months. The intensity of the exercises was graded individually on the basis of the findings at the exercise tolerance test, and a maximum heart rate at exercise was prescribed.
Components: exercise, counselling and social measures
Setting: supervised at the cardiological unit
Exercise programme modality: ergometer cycling
Length of session: 30 min.
Frequency: twice per week
Intensity: 90% of the max heart rate at the exercise tolerance test
Resistance training included? Interval training of large muscle groups, callisthenics
Total duration: 3 months
Co‐interventions: Counselling was given, supplying practical information on avoiding weight gain, to stop smoking, to keep on with the physical exercise and to resume leisure activities as much as possible.
Comparator: conventional care
Co‐interventions: none described
Outcomes Total mortality, CHD mortality, non‐fatal MI up to average 14 months
Source of funding NR
Conflicts of interest NR
Notes Most emphasis on social/ psychological aspects.
171 participants were randomised and at discharge, the cardiologist decided whether the participant was fit to take part in the rehabilitation programme ‐ 45 participants were excluded at this point. Seven people in the intervention group declined to take part, but six of these were seen at follow‐up and included in the analysis because "control group probably had a comparable number who would have declined further treatment."
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "allocated at random"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk Description of withdrawals and dropouts: intervention group 29%; control group 33% lost to follow‐up from 126 who took part. 171 were randomised and then 45 excluded by cardiologist.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Bertie 1992.

Study characteristics
Methods Study design: single‐centre RCT; participants were randomised on day of discharge after MI
Country: UK
Dates participants recruited: NR
Maximum follow‐up: 24 months
Participants Inclusion criteria: men and women with AMI
Exclusion criteria: uncontrolled heart failure; serious rhythm disturbances which persisted and required treatment at time of discharge; another disabling disease
N randomised: total: 110; intervention: 57; comparator: 53
Diagnosis (% of participants): AMI: 100%
Age (mean ± SD): intervention: 52.1 ± 1.3; comparator: 52.7 ± 1.3
Percentage male: NR
Ethnicity: NR
Interventions Exercise: a formal rehabilitation programme at the hospital started 3 weeks post‐discharge. The programme concentrated mainly on standard pulse‐monitored group exercise, supervised by a physiotherapist. Participants completed a circuit of 12 exercises, and after a five‐minute interval, they repeated the circuit, up to a maximum of four circuits.
Components: exercise
Setting: supervised group sessions in the hospital gymnasium
Exercise programme modality: "group exercises"
Length of session: NR
Frequency: twice per week
Intensity: NR
Total duration: 4 weeks
Co‐interventions: health, smoking and dietary advice and a relaxation technique
Comparator: standard hospital care
Co‐interventions: all participants were asked to stop smoking and given dietary advice either for weight reduction or because of elevated serum cholesterol. To boost confidence, each participant was asked to walk up two flights of stairs under supervision and was given advice on mobilisation on discharge.
Outcomes Total mortality, non‐fatal MI, revascularisation; assessments at day of discharge, 3rd week after discharge; after rehabilitation (for intervention group); four months after infarct and 12 to 24 months after infarct)
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomised"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 24% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Bethell 1990.

Study characteristics
Methods Study design: single‐centre RCT
Country: UK
Dates participants recruited: 1 December 1979 to March 1984
Maximum follow‐up: 5 years
Participants Inclusion criteria: < 65 years post MI; history of chest pain typical of MI, progressive ECG changes, rise and fall in aspartate transaminase concentrations with at least one reading above 40 units/mL
Exclusion criteria: medical or orthopaedic problems that precluded their taking part in the exercise course; insulin‐dependent diabetes mellitus; atrial fibrillation; on investigator's personal general practice list
N randomised: total: 200; intervention: 99; comparator: 101
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 54.2 ± 7.2; comparator: 54.2 ± 7.2
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: treatment participants entered a three‐month course of three times a week circuit training.
Components: exercise only
Setting: centre
Exercise programme modality: 8 stage circuit aerobic training
Length of session: NR
Frequency: 3 times a week
Intensity: 70% to 85% predicted HR max.
Resistance training included? Yes ‐ weight training
Total duration: 3 months
Co‐interventions: NR
Comparator: participants were given a short talk on the sort of exercise that they might safely take unsupervised
Co‐interventions: NR
Outcomes Total mortality, CHD mortality, non‐fatal MI
(11 year follow‐up published in 1999. Five‐year follow‐up data from unpublished material used for meta analysis.)
Source of funding British Heart Foundation and Wessex Regional Health Authority
Conflicts of interest NR
Notes 229 participants were randomised; 14 in the intervention group and 15 in control dropped out before the first exercise test due to death, refusal or other problems. Therefore 200 took part in the study.
Cardiac mortality of 3% per annum, once participants survived to be in the trial. Suggests more severely affected participants were not included.
Significant predictors of cardiac death were pulmonary oedema on admission, complications during admission, one or more previous infarcts, increasing age and low initial fitness.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random letter sequence
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 16% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Bettencourt 2005a.

Study characteristics
Methods Study design: single‐centre RCT (1:3 randomisation)
Country: Portugal
Dates participants recruited: 1 September 2001 to 31 December 2002
Maximum follow‐up: 1 year
Participants Inclusion criteria: participants without previous cardiological follow‐up, with > 4 years’ education, following hospitalisation for acute coronary syndrome (ACS)
Exclusion criteria: none stated
N randomised: total: 126; intervention: 31; comparator: 95
Diagnosis (% of participants):
Unstable angina: intervention 20; comparator: 27
Non‐Q wave MI: intervention 33; comparator: 31
Anterior MI: intervention 23; comparator: 20
Inferior MI: intervention 24; comparator: 21
MI of undetermined location: intervention 10; comparator 11
Age (years): intervention: 56 (range: 31‐80); comparator: 58 (range: 33‐86)
Percentage male: intervention: 84 %; comparator 83%
Ethnicity: NR
Interventions Intervention: the sessions took place in the hospital’s gymnasium under qualified supervision. They consisted of a warm‐up period at the beginning of each session, 20 to 30 minutes on a treadmill or ergometric bicycle and a recovery period with low intensity activities. The exercise programme was initially based on the maximum heart rate reached on the exercise test prior to beginning the programme (performed on average five weeks after the ACS).
Components: exercise only
Setting: aerobic exercise in supervised group sessions
Exercise programme modality: treadmill and bicycle
Length of session: 60 minutes
Frequency: 3 times/week
Intensity: NR
Resistance training included? No
Total duration: 12 weeks, followed by one session a month for the remainder of the year
Co‐interventions: none described
Comparator: standard follow‐up consisting of a mean of 3.5 consultations per year following the first event
Co‐interventions: none described
Outcomes HRQoL
Source of funding The Commission to Foster Health Care Research
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "...the patients were randomly allocated to our hospital’s cardiac rehabilitation program or standard cardiological follow‐up."
Allocation concealment (selection bias) High risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes High risk “nature of the intervention being assessed did not permit blinding”
Incomplete outcome data (attrition bias)
All outcomes Low risk There was no loss to follow‐up.
Selective reporting (reporting bias) Low risk All outcomes described in the methods were reported in the results section for both time points.

Briffa 2005.

Study characteristics
Methods Study design: multicentre open RCT (2 sites)
Country: Australia
Dates participants recruited: 2‐year period. No dates given.
Maximum follow‐up: 1 year
Participants Inclusion criteria: uncomplicated acute myocardial infarction (AMI) or recovery from unstable angina aged under 75 years, self‐caring, adequately literate in the English language, residing in the geographical area of the health service
Exclusion criteria: presentation with uncompensated heart failure, uncontrolled arrhythmias, severe and symptomatic aortic stenosis, or other conditions precluding physical activity
N randomised: total: 113; intervention: 57; comparator: 56
Diagnosis (% of participants):
AMI: intervention 36.8; comparator 48.2
Unstable angina: intervention 63.2; comparator 51.8
Thrombolytic therapy: intervention 14.0; comparator 25.0
PCI/CAGS: intervention 59.6; comparator 46.4
Prior AMI, PCI, CAGS: intervention 36.8; comparator 50.0
Age (Mean ± SD): intervention: 60.8 ± 8.7; comparator: 61.9 ± 9.4
Percentage male: intervention 72%; comparator 75%
Ethnicity: NR
Interventions Intervention: comprehensive exercise‐based outpatient cardiac rehabilitation
Components: exercise plus education plus psychosocial counselling
Setting: hospital‐based, supervised exercise
Exercise programme modality: aerobic circuit training interspaced with resistance training
Length of session: 60 to 90 minutes
Frequency: 3 times per week
Intensity: NR
Resistance training included? Yes
Total duration: 6 weeks
Co‐interventions: 45 minutes of education (12 occasions) and 45 minutes of psychosocial counselling (6 occasions). If necessary, additional one‐on‐one counselling was provided.
Comparator: conventional care: participants from both groups received individualised medical treatment including non‐invasive and invasive cardiological procedures, surgical revascularisation, pharmacotherapy, and lifestyle counselling, as determined by their usual doctors.
Co‐interventions: none described ("Access to community cardiac rehabilitation programs was limited for the conventional management group")
Outcomes Costs, HRQoL
Source of funding University of Sydney, the Cardiac Society of Australia and New Zealand, and the National Heart Foundation of Australia; NHMRC; Department of Cardiology, Royal Prince Alfred Hospital
Conflicts of interest "None identified"
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "...randomisation using dynamic balancing was performed"
Allocation concealment (selection bias) Low risk “Central randomisation of participants was performed at the National Health and Medical Research Council Clinical Trials Centre”
Blinding of outcome assessment (detection bias)
All outcomes High risk “Open” trial so we assume that outcomes were not blinded
Incomplete outcome data (attrition bias)
All outcomes Low risk One person was lost to follow‐up and 5 participants changed groups; 2 participants were excluded from each group i.e. 4/113 (4%)
Selective reporting (reporting bias) Low risk All outcomes described in the methods section are reported in results.

Bubnova 2019.

Study characteristics
Methods Study design: single‐centre RCT
Country: Russia
Dates participants recruited: NR
Maximum follow‐up: 12 months.
Participants Inclusion criteria: male and female participants of working age (male < 60 years, female < 55 years) with acute MI (3 to 8 weeks prior), signed informed consent to participate, absence of generally accepted contraindications to performing exercise training
Exclusion criteria: left ventricular aneurysm with thrombosis, stroke, serious disturbances in the rhythm and conduction of the heart, uncontrolled arterial hypertension with blood pressure ≥ 180/100 mmHg, NYHA class III‐IV heart failure, thromboemboli, aortic aneurysm, history of syncope, thrombophlebitis, phlebothrombosis, musculoskeletal disorders, moderate to severe diabetes, severe concomitant diseases, chronic respiratory, hepatic or renal failure
N randomised: total: 300; intervention: 155; comparator: 145. Groups then split into 3 subgroups according to rehabilitation potential (intervention: low n = 32, average n = 55, high n = 68; control: low n = 22, average n = 64, high n = 59)
Diagnosis (% of participants): 100% acute MI (68% STEMI)
Age (mean ±SD): intervention: 49.9 ± 7.2; comparator 50.9 ± 6.1
Percentage male: intervention: 93.5%, comparator: 92.4%
Ethnicity: NR
Interventions Intervention: physical rehabilitation classes consisting of gymnastics exercises carried out for 60 minutes in groups under supervision of a cardiologist 3 times per week for 1 year.
Components: exercise only
Setting: centre‐based
Exercise programme modality: gymnastic exercises
Length of session: 1 hour
Frequency: three sessions per week
Intensity: not reported
Resistance training included? No
Total duration: 1 year
Co‐interventions: none described
Comparator: no exercise training
Co‐interventions: none described
Outcomes HRQoL, mortality, MI
Source of funding Not reported
Conflicts of interest None declared
Notes Paper translated from Russian
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Patients were randomized using the envelope method"; no further detail reported
Allocation concealment (selection bias) Unclear risk "Patients were randomized using the envelope method"; no further detail reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No detail regarding outcome assessment blinding was reported
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No PRISMA flow diagram provided, no N in tables and text unclear about attrition, appears that there was no loss to follow‐up
Selective reporting (reporting bias) Unclear risk No published protocol, outcomes described in methods appear to be reported in the results. Cardiovascular complications unclear

Bubnova 2020.

Study characteristics
Methods Study design: single‐centre RCT (4 arms)
Country: Russia
Dates participants recruited: NR
Maximum follow‐up: 12 months
Participants Inclusion criteria: patients after AMI ( > 3 weeks) and percutaneous coronary interventions (PCI) at the age of < 60 years for men and < 55 years for women
Exclusion criteria: inadequately controlled hypertension, aortic or left ventricular (LV) aneurysm with thrombosis, serious arrhythmias, NYHA class III‐IV HF, BMI ≥ 40 kg/m2, moderate/severe diabetes and other severe comorbidities
N randomised: total: 312; intervention 1 (BMI < 30 kg/m2) = 78; intervention 2 (BMI ≥ 30 kg/m2) = 78; comparator 1 (BMI < 30 kg/m2) = 78; comparator 2 (BMI ≥ 30 kg/m2) = 78
Diagnosis (% of participants): 100% post MI with PCI
Age (mean ±SD): intervention 1 (BMI < 30 kg/m2) = 51.9±7.9; intervention 2 (BMI ≥ 30 kg/m2) = 51.7±6.8; comparator 1 (BMI < 30 kg/m2) = 52.2±7.2; comparator 2 (BMI ≥ 30 kg/m2) = 52.6±6.7
Percentage male: intervention 1 (BMI < 30 kg/m2) = 93.6%; intervention 2 (BMI ≥ 30 kg/m2) = 96.2%; comparator 1 (BMI < 30 kg/m2) = 94.9%; comparator 2 (BMI ≥ 30 kg/m2) = 93.6%
Ethnicity: NR
Interventions Intervention: physical rehabilitation programme included group exercise classes lasting 60 minutes 3 times/week involving a set of gymnastic exercises of moderate intensity
Components: exercise only
Setting: centre‐based
Exercise programme modality: gymnastic exercises
Length of session: 1 hour
Frequency: three sessions per week
Intensity: 60% of the threshold value according to cycle ergometer test
Resistance training included? No
Total duration: 1 year
Co‐interventions: none described
Comparator: control participants did not use exercise training programme
Co‐interventions: none described
Outcomes Mortality, MI, HRQoL
Source of funding Not reported
Conflicts of interest None declared
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Patients were randomised into four groups depending on BMI”. Authors provided further information: "randomly assigned to the physical training or to the control group using a computer programme".
Allocation concealment (selection bias) Low risk Authors provided further information: "The allocation sequence was concealed from enrolling researcher".
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided regarding blinding
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No PRISMA flow diagram or description of attrition
Selective reporting (reporting bias) Unclear risk No published protocol available, but outcomes described in methods appear to be reported.

Byrkjeland 2015.

Study characteristics
Methods Study design: single‐centre RCT
Country: Norway
Dates participants recruited: August 2010 to March 2012
Maximum follow‐up: 12 months
Participants Inclusion criteria: type 2 diabetes and verified CAD by angiography
Exclusion criteria: presence of proliferative retinopathy, end‐stage renal disease, cancer, stroke or acute MI within the last 3 months, unstable angina, uncompensated heart failure, serious arrhythmia, severe valvular disease, severe rheumatologic disease, chronic obstructive pulmonary disease (COPD) stadium Global Initiative for Chronic Obstructive Lung Disease (GOLD) IV, thromboembolic disease, ongoing infections, severe musculoskeletal disorders and other disabilities limiting the ability for physical activity
N randomised: total: 137; intervention: 69; comparator: 68
Diagnosis (% of participants): stable angina 51 (37%); previous MI 62 (45%).
Age (mean ±SD): intervention: 64.6 ± 7.9; comparator: 63.2 ± 7.2
Percentage male: intervention: 45 (87%); comparator: 50 (81%)
Ethnicity: NR
Interventions Intervention: 12‐month combined aerobic and resistance training programme
Components: exercise only
Setting: both centre‐ and home‐based
Exercise programme modality: circuits containing aerobic and resistance exercises, interval uphill walking/running training, interval step training, spinning on a bike
Length of session: 1 hour
Frequency: three sessions per week (2 supervised centre‐based, 1 home‐based)
Intensity: rating of perceived exertion (RPE) 12 to 14 or ≥ 15 for high‐intensity interval training
Resistance training included? Yes, as part of circuit training and separate resistance training included
Total duration: 12 months
Co‐interventions: none described
Comparator: continuation of normal follow‐up with general practitioner
Co‐interventions: none described
Outcomes Serious cardiovascular events (composite outcome ‐ worsening of stable angina pectoris and chronic heart failure, unstable angina pectoris, AMI, stroke, sudden cardiac arrest)
Source of funding "no specific grant from any funding agency in the public, commercial or not‐for‐profit sectors"
Conflicts of interest None declared
Notes Authors contacted to request clinical outcome data, but no response received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomisation was performed by use of consecutively numbered...in a 1:1 ratio according to tables of random numbers, arranged by the Unit of Epidemiology and Biostatistics."
Allocation concealment (selection bias) Low risk "Consecutively numbered, non‐translucent envelopes"
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk “The ventilatory threshold (VT) was calculated by the ventilatory equivalent method and was determined by two blinded, independent investigators.” Presume other outcomes were not blinded
Incomplete outcome data (attrition bias)
All outcomes High risk 17/69 (24%) participants in the intervention group lost to follow‐up or excluded from analysis due to < 40% adherence to exercise intervention (9/69, 13%)
Selective reporting (reporting bias) Unclear risk Published protocol paper not available, clinical trials.gov registration gives very vague information about proposed outcomes

Campo 2020.

Study characteristics
Methods Study design: multicentre RCT (3 sites)
Country: Italy
Dates participants recruited: January 2017 to April 2018
Maximum follow‐up: 12 months
Participants Inclusion criteria: age ≥ 70 years, hospital admission for ACS, short physical performance battery (SPPB) score from 4 to 9 at the inclusion visit (30 ± 5 days after discharge)
Exclusion criteria: participants with SPPB score ≥ 10 or ≤ 3. Multivessel disease with indication for surgical revascularisation or staged PCI, inability to be discharged to home, congestive HF, LVEF < 30%, severe valvular disease
N randomised: total: 235; intervention: 118; comparator: 117
Diagnosis (% of participants): intervention: STEMI 33 (28%), NSTEMI 75 (65%), unstable angina 10 (7%); comparator: STEMI 31 (26%), NSTEMI 77 (66%), unstable angina 9 (8%)
Age (median, range): intervention: 76, 72 to 80; comparator: 77, 73 to 80
Percentage male: intervention: 92 (78%); comparator: 89 (76%)
Ethnicity (White, %): NR
Interventions Intervention: 4 supervised sessions (1, 2, 3, 4 months after discharge) combined with an individualised home‐based exercise programme. Centre‐based sessions supervised by sports physician and nurse, and included moderate treadmill walk, strength and balance exercises (30 to 40 min). Participants received a walking programme to perform at home along with a selection of callisthenic exercises based on the Otago Exercise Programme. Participants encouraged to perform exercises 2 times per week for approx 20 mins. After the 4 month supervised session, a long‐term home‐based exercise programme was designed by the sports physician.
Components: exercise only
Setting: 4 centre‐based sessions, home‐based afterwards
Exercise programme modality: walking, callisthenics, strength and balance
Length of session: 30 to 60 minutes
Frequency: at least 3 to 4 times per week
Intensity: RPE 11 to 13
Resistance training included? No
Total duration: 6 months
Co‐interventions: health education
Comparator: standard of care
Co‐interventions: health education – 15 minute visit with study doctor, who explained the importance of aerobic physical activity (30 to 60 min/day, moderate intensity, e.g. brisk walking for at least 3 days/week). A detailed brochure explaining the benefits of physical exercise provided to all participants.
Outcomes Total and cardiovascular mortality, ACS, hospitalisations, HRQoL
Source of funding "Investigator‐driven clinical trial conducted by the University of Ferrara"
Conflicts of interest None declared
Notes None
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Randomization is performed….via a dedicated website and stratified according the following three variables: sex, clinical presentation (ST‐segment elevation ACS vs. non ST‐segment elevation ACS) and SPPB score at the inclusion (4–6 vs. 7–9). A dedicated website assigns a unique treatment code"
Allocation concealment (selection bias) Low risk “Randomization is performed….via a dedicated website and stratified according the following three variables: sex, clinical presentation (ST‐segment elevation ACS vs. non ST‐segment elevation ACS) and SPPB score at the inclusion (4–6 vs. 7–9). A dedicated website assigns a unique treatment code"
Blinding of outcome assessment (detection bias)
All outcomes Low risk “The assessment staff was blinded to the intervention. Participants were asked not to disclose their assigned group and not to talk about their interventions during the assessment. All events were centrally adjudicated by the clinical events committee whose members were unaware of patient randomisation assignment.”
Incomplete outcome data (attrition bias)
All outcomes Low risk Low numbers of participants missing from 1 year follow‐up (6 and 7 from each group, < 20%), numbers balanced and reasons provided.
Selective reporting (reporting bias) Low risk Published protocol paper available, all outcomes listed in protocol paper are reported at 1 year.

Carlsson 1998.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: NR
Maximum follow‐up: 1 year
Participants Inclusion criteria: AMI; CABG < 2 weeks prior; PCI < 2 weeks prior
Exclusion criteria: signs of unstable angina; signs of ST‐depression at exercise test of more than 3 mm in 2 chest leads or more than 2 mm in two limb leads at four weeks post‐discharge from hospital, signs of CHF, severe, non‐cardiac disease; drinking problems, not a Swedish speaker
N randomised: total: 235; intervention: 118; comparator: 117
Diagnosis (% of participants): CABG: 25%; AMI: 75%
Age (mean ±SD):
AMI patients: intervention: 62.2 ± 5.8; comparator: 61.7 ± 6
CABG patients: intervention: 62.7 ± 4.8; comparator: 59.8 ± 4.8
Percentage male: NR
Ethnicity: NR
Interventions Intervention: continuous physical exercise programme 2 to 3 times weekly for 2 to 3 months. The exercise sessions lasted one hour and were comprised of the following parts: 10 minutes of warm‐up; 40 minutes of interval walking or jogging; 10 minute cool‐down period (consisting of relaxation and light stretching exercises). Individual exercise schedules were provided in order to maintain the effects of the exercise programme beyond the discharge from the hospital training centre.
Components: exercise plus education
Setting: centre and then home
Exercise programme modality: walking or jogging
Length of session: 60 minutes
Frequency: 2 to 3 times/week
Intensity: NR
Resistance training included? No
Total duration: 2 to 3 months
Co‐interventions: 9 hours of nurse counselling in individual and group sessions over 1 year; smoking cessation 1.5 hours, dietary management 5.5 hours
Comparator: usual care, which included two or three visits to their general practitioners during the first year
Co‐interventions: all participants were informed about CAD risk factors and the effect of lifestyle changes on the prognosis.
Outcomes Mortality
Source of funding NR
Conflicts of interest NR
Notes Groups of 20 participants randomly allocated to intervention and control groups (usual care). Randomised 4 weeks post discharge.
In first 3 weeks post discharge, all participants had 2 visits by nurse & 1 by cardiologist, plus all participants invited to join regular exercise group x 1 per week for 30 mins information and 30 mins easy interval training.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk < 20% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Carson 1982.

Study characteristics
Methods Study design: single‐centre RCT; participants randomised 6 weeks post‐admission
Country: UK
Dates participants recruited: NR (recruited over a 3.5 year period)
Maximum follow‐up: 3 years
Participants Inclusion criteria: MI; diagnosis based on ECG changes and/or elevation of serum glutamic oxaloacetic transaminase or lactic dehydrogenase taken on three consecutive days.
Exclusion criteria: > 70 years; heart failure at follow‐up clinic; cardio‐thoracic ratio exceeding 59%; severe chronic obstructive lung disease; hypertension requiring treatment; diabetes requiring insulin; disabling angina during convalescence; orthopaedic or medical disorders likely to impede progress in the gym, personality disorders likely to render participant unsuitable for the course.
N randomised: total: 303; intervention: 151; comparator: 152
Diagnosis (% of participants): MI: 100%
Age (mean ± SE): intervention: 50.3 ± 0.65; comparator: 52.8 ± 0.67
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: participants attended the hospital gym twice weekly for 12 weeks. They were supervised by a doctor and physical educationalist and full resuscitative equipment was available. The exercises were arranged on a circuit basis and pure isometric exercise was avoided.
Components: exercise only
Setting: centre
Exercise programme modality: exercises arranged on a circuit basis
Length of session: NR
Frequency: twice per week
Intensity: NR
Resistance training included? No
Total duration: 12 weeks
Co‐interventions: none described
Comparator: did not attend gym
Co‐interventions: none described
Outcomes Total mortality, non‐fatal MI at 5 months, 1 year, 2 years and 3 years after MI (mean follow‐up 2.1 years)
Source of funding Department for Health and Social Security Grant
Conflicts of interest NR
Notes There appears to be a reduction in mortality in exercise participants with inferior MI.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly allocated"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 21% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points described in the methods.

Chaves 2019.

Study characteristics
Methods Study design: superiority RCT with waiting‐list control (single centre)
Country: Brazil
Dates participants recruited: March 2015 to April 2017
Maximum follow‐up: 12 months ‐ 6 months waiting‐list control
Participants Inclusion criteria: participants aged > 18 years and living in the Belo Horizonte area, with coronary artery disease: post myocardial infarction undergone percutaneous coronary intervention or coronary artery bypass graft surgery and had been referred to CR
Exclusion criteria: cardiac conditions associated with some risk during high‐intensity exercise (e.g. heart failure with EF < 45%, complex ventricular dysrhythmia), any comorbid physical condition (e.g. leg amputation, advanced cancer, disabling stroke, Parkinson’s disease), or serious mental illness that would interfere with the ability to exercise, according to CR clinical practice guidelines, or any visual or cognitive condition that would preclude the participant from completing the questionnaires
N randomised: total: 115; intervention 1 (exercise only): 39; intervention 2 (comprehensive CR): 37; comparator: 39
Diagnosis (% of participants): participants with CAD after MI or those undergoing PCI/CABG. MI 107 (93%), angina 69 (60%), PCI 68 (59.1%), CABG 29 (25.5%).
Age (mean): intervention 1: 59 ± 9.9; intervention 2: 60.7 ± 8.8; comparator: no CR (n = 16) 55.9± 6.7, exercise only (n = 12) 60.7 ± 13.3, comprehensive CR (n = 11) 60.6 ± 8.4
Percentage male: intervention 1: 28 (71.8%); intervention 2: 27 (73%); comparator: no CR (n = 16) 11 (68.8%), exercise only (n = 12) 12 (100%), comprehensive CR (n = 11) 4 (36.4%)
Ethnicity (white, %): NR
Interventions Intervention: CR program led by a physician and staffed by physiotherapists. Exercise programme 6 months, consisting of 36 1‐hour supervised sessions descending in frequency. Participants provided individualised exercise prescription based on exercise test. Participants requested to exercise in their communities on non‐centre‐based exercise days to accumulated ≥ 30 minutes of MVPA on ≥ 5 days per week.
Comprehensive CR participants were offered an additional 24, weekly 30‐minute education sessions, delivered in groups by a health educator, and received a validated education workbook to accompany the sessions.
Components: exercise only (group 1); exercise plus education (group 2)
Setting: centre‐based (with request to complete home‐based exercise in addition)
Exercise programme modality: treadmill/bike/walking
Length of session: 1 hour
Frequency: 3 times per week for 4 weeks, 2 times per week for 4 weeks, once per week for 16 weeks.
Intensity: 50% to 80% heart rate reserve
Resistance training included? NR
Total duration: 6 months
Co‐interventions: education sessions provided for comprehensive CR group (group 2). Educational curriculum included: information about the CR program, their aerobic exercise prescription and safety, managing angina, irregular heartbeats, diabetes, exercising in cold and hot weather, the heart (anatomy, pathophysiology, diagnoses, and treatment) and cardiac medications risk factor profile, goal setting and action planning, resistance training, nutrition (fats, fibre, reading food labels, sodium), psychosocial risk, and sexual intimacy, how much physical activity is good, aerobic and resistance training progression, relapse planning, and graduation.
Comparator: waiting‐list control – all participants received follow‐up appointments with their physician as deemed medically important. Participants in the control arm received CR after 6‐month mortality ascertained. Participants elected whether they wanted to have exercise only or comprehensive CR, or no CR.
Co‐interventions: none
Outcomes Cardiovascular mortality, MI, revascularisations, hospitalisations
Source of funding Professor Britto was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq no. 305786/2014‐8), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG no. PPM‐00869‐15 and CS00290‐16) and Coordination for the Improvement of Higher Education Personnel (CAPES)
Conflicts of interest None declared
Notes Outcomes at 6 months only used for this review, as waiting‐list control participants elected which arm of the study to go into after this point.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “The randomisation sequence was generated by a professor not involved in the study using the randomization.com website in random blocks of four, with a 1:1:1 allocation ratio.”
Allocation concealment (selection bias) Low risk “To ensure allocation concealment, the principal investigator (RB) had the allocation sequence in a password‐protected file, and only provided randomisation information to the PhD student once it was confirmed the participant was eligible.”
Blinding of outcome assessment (detection bias)
All outcomes Low risk “A master’s student blinded to random allocation was responsible for post‐test assessments, outcome ascertainment and data entry.”
Incomplete outcome data (attrition bias)
All outcomes High risk Loss to follow‐up: control 9/39 (23%), comprehensive CR 5/37 (14%), exercise‐only CR 8/39 (20%)
Selective reporting (reporting bias) Low risk Outcomes reported in protocol are reported in main paper in addition to event and rate.

DeBusk 1994.

Study characteristics
Methods Study design: multicentre RCT (5 sites); participants were randomised 3rd day post MI
Country: USA
Dates participants recruited: NR
Maximum follow‐up: 12 months
Participants Inclusion criteria: men and women aged 70 years or younger who were hospitalised for AMI.
Exclusion criteria: none described
N randomised: total: 585; intervention: 293; comparator: 292
Diagnosis (% of participants): MI: 100%
Age (mean): intervention: 57 ± 8; comparator: 57 ± 8
Percentage male: intervention: 78.5%; comparator: 79.1%
Ethnicity (white, %): intervention: 78.0%; comparator: 75.9%
Interventions Intervention: the exercise prescription was based on a heart rate range corresponding to 60% to 85% of the peak heart rate achieved during treadmill testing. Participants were instructed to exercise at the prescribed heart rate for 30 minutes per day 5 days per week. Participants walked briskly, jogged, rode a bicycle, or swam. After 4 weeks, the ceiling of the heart‐rate training range was raised to 100% of the peak treadmill exercise heart rate or 85% of the age‐predicted max HR.
Components: exercise plus education
Setting: nurse‐managed, home‐based
Exercise programme modality: walking, jogging, cycling or swimming
Length of session: 30 minutes per day
Frequency: 5 days per week
Intensity: 60% to 85% of the peak heart rate achieved during treadmill testing, then raised to 100%
Resistance training included? No
Total duration: 12 months
Co‐interventions: all medically eligible participants received exercise training; all smokers received the smoking cessation intervention; and all participants received dietary counselling and, if needed, lipid‐lowering drug therapy
Comparator: usual care including physician counselling on smoking cessation, nutritionist counselling on dietary change during hospitalisation, and physician‐managed, lipid‐lowering drug therapy after hospital discharge
Co‐interventions: group outpatient smoking cessation programmes were available for a $50 fee. Group exercise rehabilitation, not generally provided, was available to participants at various community facilities at an average cost of $1800 to $2700 for 3 months' participation.
Outcomes Total mortality
Source of funding Grant support: By HL38874 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland and a Shannon Award from the National Institutes of Health, Bethesda, Maryland. Dr. Thomas participated as a Clinical Scholar of the Robert Wood Johnson Foundation.
Conflicts of interest NR
Notes Levels of psychological distress dropped significantly for both groups by 12 months.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly allocated"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 33% lost to follow‐up; no description of withdrawals and dropouts
Selective reporting (reporting bias) Low risk All outcomes reported for all time points described.

Dorje 2019.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: November 2016 to March 2017
Maximum follow‐up: 12 months.
Participants Inclusion criteria: participants aged 18 or older with documented coronary heart disease (including MI and unstable or stable angina) who were treated with PCI during their index admission. Participants were required to own an operational smartphone, have an active WeChat account or be willing to create one and have sufficient Chinese language proficiency to enable communication with the cardiac rehabilitation and secondary prevention coach via WeChat.
Exclusion criteria: contraindications to exercise rehabilitation, an inability to operate a smartphone for the purpose of the trial (e.g. vision, hearing, and cognitive or dexterity impairment), no internet access at their place of residence, or pre‐existing comorbid disease with a life expectancy less than 1 year.
N randomised: total: 312; intervention: 156; comparator: 156
Diagnosis (% of participants): post PCI (100%)
Age (mean): intervention: 61.9 ± 8.7; comparator: 59.1 ± 9.4
Percentage male: intervention: 126 (81%); comparator: 128 (82%)
Ethnicity (white, %): NR
Interventions Intervention: smartphone‐based home cardiac rehabilitation delivered via WeChat platform. Included a simplified and culturally sensitive WeChat based education programme addressing coronary heart disease knowledge and awareness.
Exercise component: individualised walking programme based on baseline 6MWT, with time and intensity of walking increased gradually over the first 8 weeks.
Physical activity monitored using WeChat’s inbuilt pedometer function to monitor step counts, along with a WeChat interfaced blood pressure and heart rate monitor.
Support provided for medication adherence and risk factor modification (dietary change, lipid control, smoking cessation) provided as required by participants.
Data readings automatically transmitted to a secure data portal and reviewed by cardiac rehabilitation coach on a regular basis and provided individualised feedback.
Components: exercise plus education
Setting: Home‐based
Exercise programme modality: walking
Length of session: NR
Frequency: at least 5 times per week
Intensity: NR
Resistance training included? No
Total duration: 6 months
Co‐interventions: none described
Comparator: standard care as provided by their community doctors and cardiologists. Typically involves brief inpatient health education provided by a ward nurse, medication management and ad‐hoc follow‐up visits to a cardiologist or health care provider according to the participant’s self‐assessment of their own cardiovascular health
Co‐interventions: none described
Outcomes HRQoL, adverse cardiac events
Source of funding Curtin University
Conflicts of interest None declared
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "The randomisation sequence was computer‐generated by permuted block randomisation (block size of 10), by staff from the study coordinating centre at Curtin University who were not involved with the recruitment of study participants."
Allocation concealment (selection bias) Low risk "The randomisation sequence was computer generated by staff from the study coordinating centre at Curtin university who were not involved with the recruitment of study participants."
Blinding of outcome assessment (detection bias)
All outcomes Low risk “To maintain blinding of research personnel involved in follow‐up assessments to group allocation, participants received a WeChat message before each follow‐up visit, to remind them not to reveal their allocation to study personnel. Study personnel who helped participants to set up the SMART‐CR/SP system on their smartphone or provided technology training before the commencement of the trial were not involved in assessments.”
Incomplete outcome data (attrition bias)
All outcomes Low risk Missing participants balanced across the two groups (intervention: 22/156 (14%); control: 25/156 (16%)) with similar reasons, and maximum‐likelihood estimation methods used in models to account for missing data.
Selective reporting (reporting bias) High risk Protocol paper (table 1) states that quality of life assessments would be carried out at 12 month follow‐up, but these data have not been reported. All‐cause mortality data not formally reported, just states that no adverse cardiac events occurred – unclear whether this is at 6 or 12 months.

Dugmore 1999.

Study characteristics
Methods Study design: single‐centre RCT
Country: UK
Dates participants recruited: between 1984 and 1988
Maximum follow‐up: 5 years
Participants Inclusion criteria: MI according to conventional WHO cardiac enzyme and ECG criteria of MI
Exclusion criteria: NR
N randomised: total: 124; intervention: 62; comparator: 62
Diagnosis (% of participants): MI: 100%
Age (years): intervention: 54.8; comparator: 55.7
Percentage male: 98% intervention: NR; comparator: NR
Ethnicity: NR
Interventions Intervention: participants received regular aerobic and local muscular endurance training three times a week for 12 months. This consisted of warm‐up and cool‐down exercises, sit ups, wall bar/bench step ups, cycle ergometry, and a major component centred on the training of aerobic capacity, using walking and jogging. Training programmes were individually designed and based on the results of regular exercise tests and trial exercise prescriptions.
Components: exercise only
Setting: centre
Exercise programme modality: walking, jogging and cycle ergometry
Length of session: individually designed
Frequency: 3 times a week
Intensity: varied between approx 50% to 65% of measured peak oxygen uptake (VO2) in the poor prognosis participants and 65% to 80% of peak VO2 in those with a good prognosis
Resistance training included? Yes ‐ local muscular endurance training
Total duration: 12 months
Co‐interventions: none described.
Comparator: received no formal exercise training throughout the same 12‐month period
Co‐interventions: none described
Outcomes CV mortality; non‐fatal MI; HRQL at 4, 8, 12 months
Source of funding NR
Conflicts of interest NR
Notes The population was subdivided into groups with good and bad prognoses. There were 36 participants with a good prognosis and 26 with a poor prognosis. Each group were matched with control participants.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly allocated"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk All participants accounted for
Selective reporting (reporting bias) Low risk All outcomes reported for all time points described.

Engblom 1996.

Study characteristics
Methods Study design: single‐centre open RCT
Country: Finland
Dates participants recruited: February 1986 to December 1987
Maximum follow‐up: 5 years
Participants Inclusion criteria: participants who underwent elective CABG
Exclusion criteria: any other serious disease; > 65 years of age
N randomised: total: 228; intervention: 119; comparator: 109
Diagnosis (% of participants):
Previous unstable angina: intervention: 29; comparator: 31
Previous MI: intervention: 42; comparator: 46
Hypertension: intervention: 31; comparator: 23
LVEF: intervention: 70.3; comparator: 71.4
Age (mean ± SD): intervention: 54.1 ± 5.9; comparator: 54.3 ± 6.2
Percentage male: 88%
Ethnicity: NR
Interventions Intervention: 6 to 8 weeks after the CABG, participants followed a 3‐week general CR program, mainly based on exercises, including 24 hours of supervised activities consisting of ergometer cycle training, ball games, outdoor activities, gymnastics and swimming. The participants were also advised to increase their physical activity in leisure time.
Components: exercise and education
Setting: supervised group sessions at centre
Exercise programme modality: ergometer cycle training, ball games, outdoor activities, gymnastics and swimming
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 3 weeks (plus an additional 5 days over a 30‐month period)
Co‐interventions: participants participated in a 4‐stage CR programme over 30 months, including dietary counselling and advice about the importance of healthy nutrition and economical cooking.
Comparator: all of the participants in both groups received standard postoperative care which consisted of visits to the cardiac outpatient clinic 2, 6, 12, 24, 36 and 60 months after the CABG
Co‐interventions: none described
Outcomes Mortality, CABG, HRQoL: Nottingham Health Profile
Source of funding Grants from the Sauli Viikari Fund within the Cultural Foundation of Varsinais‐Suomi, Turku, Finland
Conflicts of interest NR
Notes Five years after CABG, only 20% of participants were working, despite 90% of participants being in functional classes 1‐2. Almost half of participants had retired pre‐CABG. Many other factors affect return to work post‐CABG ‐ age, education, physical requirements of the job, type of occupation, self‐employed status, non‐work income, personality type, self‐perception of working capacity and mostly length of absence from work pre‐CABG.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 13% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported for all time points described.

Erdman 1986.

Study characteristics
Methods Study design: single‐centre RCT
Country: the Netherlands
Dates participants recruited: September 1976 to March 1978
Maximum follow‐up: 5 years
Participants Inclusion criteria: first MI within 6 months before the first psychological investigation; < 65 years; meet three psychological inclusion criteria ‐ one or more symptoms of the anxiety reaction, diminished self‐esteem, positive motivation to take part in the programme
Exclusion criteria: severe cardiomyopathy, severe valvular disorders, inadequate performance on exercise, unstable angina pectoris
N randomised: total: 80; intervention: 40; comparator: 40
Diagnosis (% of participants): MI: 100 %
Age (years): 51 years (range 35 to 60 years); intervention: NR; comparator: NR
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: two 1½ hour sessions of fitness training a week in a conventional gymnasium, supervised by a cardiologist. Each session consisted of a 15‐min warm‐up, gymnastics and jogging (both 15 min); sport such as volleyball, soccer and hockey (30 min), and relation exercises (15 min).
Components: exercise and education
Setting: supervised group sessions in centre
Exercise programme modality: gymnastics, jogging and team sports
Length of session: 90 min
Frequency: twice a week.
Intensity: NR
Resistance training included? No
Total duration: 6 months
Co‐interventions: in cases of severe psychopathology, a psychologist or a psychiatrist was consulted.
Comparator: home rehabilitation ‐ participants received an educational brochure with guidelines and advice about physical fitness training and jogging.
Co‐interventions: treatment with either beta blockers or anticoagulants was given upon indication only and not as a prophylactic measure.
Outcomes Mortality, non‐fatal MI at 5 years
Source of funding Dutch Heart Foundation
Conflicts of interest NR
Notes Complex presentation of results.
Authors conclude that participants who will benefit from rehabilitation can be detected on psychological grounds. Those who have engaged in habitual exercise, but feel seriously disabled, yet do not feel inhibited in a group, will benefit from rehab.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "randomly allocated by means of a table for random numbers"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 29% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Fletcher 1994.

Study characteristics
Methods Study design: single‐centre RCT
Country: USA
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: ≤ 73 years; CAD and physical disability. CAD documented by history of MI, coronary artery bypass surgery, PCI or angiographically demonstrated CAD; have the functional use of more than 2 extremities, 1 being an arm, in order to perform the exercise test and training protocols.
Exclusion criteria: uncontrolled hypertension or diabetes mellitus, clinically significant cardiac dysrhythmias, unstable angina pectoris, cognitive deficits, or other problems that would interfere with compliance to the prescribed exercise and diet protocol.
N randomised: total: 88; intervention: 41; comparator: 47
Diagnosis (% of participants): CAD and a physical disability
Age (mean ±SD): intervention: 62 ± 8; comparator: 63 ± 7
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: participants were provided with a wheelchair ramp with rollers and a telephone electrocardiographic recording device. They were instructed to exercise using the ramp which essentially transformed their wheelchair into a stationary wheelchair ergometer. Specific instructions were to exercise 5 days/week for 20 minutes a day for a total of 100 minutes each week.
Components: exercise plus education
Setting: home
Exercise programme modality: stationary wheelchair ergometer
Length of session: 20 min
Frequency: 5 days/week
Intensity: 85% of predicted maximal heart rate
Resistance training included? No
Total duration: 6 months
Co‐interventions: both groups received didactic and written dietary instruction from a registered dietitian on the American Heart Association Step I low‐cholesterol, low‐saturated fat diet.
Comparator: usual care
Co‐interventions: participants in the control group received dietary instruction and were instructed to follow activity guidelines provided by their primary physician and health care team.
Outcomes Total mortality, non‐fatal MI at 6 months
Source of funding United States Department of Education
Conflicts of interest NR
Notes The treatment programme decreased myocardial oxygen demand.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Low risk "The same experienced cardiologist interpreted all echocardiograms and was unaware of randomization procedures"
Incomplete outcome data (attrition bias)
All outcomes High risk 32% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported for all time points.

Fridlund 1991.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: September 1985 to March 1988
Maximum follow‐up: 5 years
Participants Inclusion criteria: 65 years or younger at the time of MI; independent living in the Health Care District after discharge from hospital; meaningful communication and rehabilitation that was not hindered by the MI or other serious illness
Exclusion criteria: cerebral or cardiac disorders or serious alcohol abuse
N randomised: total: 178; intervention: 87; comparator: 91
Diagnosis (% of participants):
MI: 100%
Angina: intervention: 32.1%; comparator: 33.3%
Age (years): intervention: 55; comparator: 57.6
Percentage male: 87% intervention: 86.8%; comparator: 87.3%
Ethnicity: NR
Interventions Intervention: participants and their spouses visited the hospital for a 2‐hour group session each week for 6 months. These group sessions consisted of a physical and a psychosocial part and were carried out together with a support team consisting of a physiotherapist, a physician and a rehabilitation nurse. The physical part consisted of both exercise and relaxation.
Components: exercise plus psychosocial support
Setting: centre
Exercise programme modality: NR
Length of session: 2 hrs
Frequency: once a week
Intensity: NR
Resistance training included? NR
Total duration: 6 months
Co‐interventions: the psychosocial part contained eleven themes concerning lifestyle and risks after MI, and psychosocial consequences of MI
Comparator: routine cardiac follow‐up
Co‐interventions: none described
Outcomes Total mortality, non‐fatal MI, revascularisations
Source of funding Swedish Heart Lung Foundation, National Association for Heart and Lung Patients, Sweden, and the County Council, Halland, Sweden
Conflicts of interest NR
Notes Positive long‐term effects on physical condition, life habits, cardiac health knowledge. No effects found for cardiac events or psychological condition.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly subdivided"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 32% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points (although absolute values not always given).

Giallauria 2008.

Study characteristics
Methods Study design: single‐centre RCT
Country: Italy
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: acute ST elevation MI
Exclusion criteria: residual myocardial ischaemia, severe ventricular arrhythmias, AV block, valvular disease requiring surgery, pericarditis, severe renal dysfunction (creatinine > 2.5 mg/dL)
N randomised: total: 61; intervention: 30; comparator: 31
Diagnosis (% of participants): MI: 100%
Age (mean ±SD): intervention: 55.9 ± 3.1; comparator: 55.1 ± 3.7
Percentage male: intervention: 73%; comparator: 71%
Ethnicity: NR
Interventions Intervention: training sessions were supervised under continuous electrocardiography monitoring. Each session was preceded by a 5‐min warm‐up and followed by a 5‐min cool‐down. Exercise was performed for 30 min on a bicycle ergometer with the target of 60% to 70% of VO2 peak achieved at the initial symptom‐limited cardiopulmonary exercise test. Exercise workload was gradually increased until the achievement of the predefined target.
Components: exercise only
Setting: supervised in centre
Exercise programme modality: bicycle ergometer
Length of session: 40 min
Frequency: 3 times a week
Intensity: target of 60% to 70% of VO2 peak achieved at the initial symptom‐limited cardiopulmonary exercise test
Resistance training included? No
Total duration: 6 months
Co‐interventions: none described
Comparator: discharged with generic instructions on maintaining physical activity and a correct lifestyle
Co‐interventions: none described
Outcomes Fatal/non‐fatal MI (6 month follow‐up)
Source of funding "None"
Conflicts of interest "None"
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Low risk "The physician performing all Doppler‐echocardioraphy studies was....blinded to the patient allocation into the study protocol."
Incomplete outcome data (attrition bias)
All outcomes Low risk All participants were accounted for.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Hambrecht 2004.

Study characteristics
Methods Study design: single‐centre RCT
Country: Germany
Dates participants recruited: March 1997 to March 2001
Maximum follow‐up: 1 year
Participants Inclusion criteria: angina pectoris according to Canadian Cardiovascular Society class I–III, with documented myocardial ischaemia during stress‐electrocardiogram and/or 99mTc scintigraphy and amenable to PCI. Only participants living within a 25 km radius of the host institution were recruited.
Exclusion criteria: acute coronary syndromes or recent myocardial infarction ( < 2 months); left main coronary artery stenosis > 25%; reduced left ventricular function (ejection fraction < 40%); significant valvular heart disease; insulin‐dependent diabetes mellitus; previous coronary artery bypass graft or PCI; and conditions excluding regular exercise
N randomised: total: 101; intervention: 51; comparator: 50
Diagnosis (% of participants):
Stable CAD: 100%
(class I to III angina pectoris)
Age (years ± SEM): intervention: 62 ± 1; comparator: 60 ± 1
Percentage male: 100 %
Ethnicity: NR
Interventions Intervention: during the first 2 weeks, participants exercised in the hospital 6 times/day for 10 min on a bicycle ergometer at 70% of the symptom‐limited max HR. Before discharge, a maximal symptom‐limited ergospirometry was performed to calculate the target heart rate for home training, which was defined as 70% of the maximal heart rate during symptom‐limited exercise. Participants were asked to exercise on their bicycle ergometer close to the target heart rate for 20 min per day and to participate in one 60 min group training session of aerobic exercise/week.
Components: exercise only
Setting: supervised exercise in hospital, followed by unsupervised at home plus weekly group training
Exercise programme modality: bicycle ergometer
Length of session: 10 minutes
Frequency: 6 times a day.
Intensity: 70% of symptom‐limited max heart rate
Resistance training included? No
Total duration: 2 weeks, followed by 20 min per day unsupervised at 70% plus 60 min aerobic group training per week
Co‐interventions: all participants were recommended to receive acetylsalicyl acid, β‐blockers, angiotensin‐converting enzyme inhibitors and statins according to common guidelines.
Comparator: stent angioplasty: “the target lesion was treated with PCI after a bolus of 10,000 IU of heparin with a 6F guiding catheter.”
Co‐interventions: all participants were given acetylsalicylic acid 100 mg/d and clopidogrel 300 mg/d on the day before the procedure.
Outcomes Clinical symptoms, angina‐free exercise capacity, myocardial perfusion, cost‐effectiveness, and frequency of a combined clinical end point (death of cardiac cause, stroke, CABG, angioplasty, acute myocardial infarction, and worsening angina with objective evidence resulting in hospitalisation)
Source of funding “This study was supported by an unconditional scientific grant from Aventis Germany".
Conflicts of interest NR
Notes 2 year results of this study are reported by Walther 2008.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Patients were randomly assigned to either stent angioplasty or exercise training by drawing an envelope with the treatment assignment enclosed.”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Low risk “Initially and after 12 months the angina pectoris status of all patients was classified according to CCS class by a physician blinded for patient assignment.”
Incomplete outcome data (attrition bias)
All outcomes Low risk Discontinued study, n: intervention 2/51; comparator 2/50
Disabling stroke, n: intervention 1/51; comparator 1/50
Refused angiography, n: intervention 1/51; comparator 0/50
Selective reporting (reporting bias) Low risk All outcomes reported.

Haskell 1994.

Study characteristics
Methods Study design: multicentre RCT (4 sites)
Country: USA
Dates participants recruited: February 1984 to March 1987
Maximum follow‐up: 4 years
Participants Inclusion criteria: men and women < 75 years of age with clinically‐indicated coronary arteriography who lived within a 5‐hour drive of Stanford University and considered capable of following the study protocol. After arteriography, participants received PCI or CABG and remained eligible if at least one major coronary artery had a segment with lumen narrowing between 5% and 69% that was unaffected by revascularisation procedures.
Exclusion criteria: severe congestive heart failure, pulmonary disease, intermittent claudication, or non‐cardiac life‐threatening illnesses; no qualifying segments, medical complication occurred during angiography, left ventricular ejection fraction of less than 20%, or participant was in another research study
N randomised: total: 300; intervention: 145; comparator: 155
Diagnosis (% of participants): CHD: 100%
Age (mean ± SD): intervention: 58.3 ± 9.2; comparator: 56.2 ± 8.2
Percentage male: 86%
Ethnicity: NR
Interventions Intervention: a physical activity programme consisting of an increase in daily activities such as walking, climbing stairs and household chores, and a specific endurance exercise training programme* with the exercise intensity based on the subject's treadmill exercise test performance.
Components: exercise plus education
Setting: home
Exercise programme modality: stationary cycling or walking
Length of session: 30 min
Frequency: 5 days a week.
Intensity: 70% to 85% of the peak heart rate attained on exercise testing at 3 weeks, an average of 96 to 121 beats/min
Resistance training included? No
Total duration: NR
Co‐interventions: each risk‐reduction participant met with a nurse to design an individualised risk‐reduction programme based on the participant's risk profile, his or her motivation, and resources for making specific changes. Participants were instructed by a dietitian in a low‐fat, low‐cholesterol, and high‐carbohydrate diet with a goal of < 20% of energy intake from fat, < 6% from saturated fat, and < 75 mg of cholesterol per day. Current or recent ex‐smokers were provided with an individualised stop‐smoking or relapse‐prevention programme by a staff psychologist.
Comparator: usual care
Co‐interventions: none described
Outcomes Total and CHD mortality, non‐fatal MI, revascularisation at year 1, 2, 3 and 4
Source of funding National Heart, Lung, and Blood Institute and a gift from the Claude R. Lambe Charitable Foundation. Lipid drugs for participants in the risk reduction group provided by the Upjohn Company, Merck & Company, and Parke‐Davis, Inc.
Conflicts of interest NR
Notes *This exercise programme followed guidelines developed previously for home‐based exercise training of cardiac patients (Miller 1984).
The rate of change in the minimal coronary artery diameter was 47% less in intervention than comparator. This was still significant when adjusted for age and baseline segment diameter (P = 0.03).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomization was performed using a random‐numbers table."
Allocation concealment (selection bias) Low risk "....sequentially numbered, sealed opaque envelopes for each stratification category that were provided by the biostatistician".
Blinding of outcome assessment (detection bias)
All outcomes High risk "The staff collecting data in the clinic were not blinded to group assignment of subjects".
Incomplete outcome data (attrition bias)
All outcomes High risk 18% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Hassan 2016.

Study characteristics
Methods Study design: single‐centre RCT
Country: Egypt
Dates participants recruited: NR
Maximum follow‐up: 12 months
Participants Inclusion criteria: age 40 to 60, within the first year after PCI, mean BMI ≤ 35 kg/m2
Exclusion criteria: people with renal failure, chronic liver disease; people with arrhythmia, chest disease and those who could not fulfil the questionnaire or cooperate through the performed procedures
N randomised: total: 60; intervention: 30; comparator: 30
Diagnosis (% of participants): post PCI
Age (mean ±SD): intervention: 52.6 ± 5; comparator: 53.8 ± 5
Percentage male: intervention: 70%; comparator: 67%
Ethnicity: NR
Interventions Intervention: participants received mild to moderate exercise training and educational program of secondary prevention. Participants in the CR program were requested to attend their exercise program 3 times per week for 6 months.
Components: exercise plus education
Setting: centre‐based
Exercise programme modality: bicycle ergometer
Length of session: 40 to 50 min
Frequency: 3 days/week.
Intensity: RPE 11‐14
Resistance training included? No
Total duration: 6 months
Co‐interventions: none described
Comparator: participants received instructions about risk factors after PCI once, and were followed up one year later.
Co‐interventions: none described
Outcomes HRQoL
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “Patients...were selected and assigned to two equal groups in number.” No further information
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes Low risk All participants completed all follow‐up assessments.
Selective reporting (reporting bias) Unclear risk Study protocol and trial registration unavailable

Hautala 2017.

Study characteristics
Methods Study design: single‐centre RCT
Country: Finland
Dates participants recruited: February 2011 to May 2014
Maximum follow‐up: 12 months
Participants Inclusion criteria: CAD patients who suffered from acute coronary syndrome, with coronary angiography to confirm the CAD.
Exclusion criteria: NYHA class ≥ III, scheduled or emergency procedure for bypass surgery, unstable angina pectoris, severe peripheral atherosclerosis, diabetic retinopathy or neuropathy, or inability to perform regular home‐based exercises, for example, due to severe musculo‐skeletal problems
N randomised: total: 204; intervention: 109; comparator: 95
Diagnosis (% of participants): intervention: NSTEMI 47 (48%); STEMI 44(45%); comparator: NSTEMI 45 (58%); STEMI 28 (36%)
Age (mean): intervention: 60 ± 11; comparator: 62 ± 9
Percentage male: intervention: 80 (73%); comparator: 67 (71%)
Ethnicity (white, %): NR
Interventions Intervention: the 1‐year exercise training intervention consisted of home‐based aerobic (30 to 40 min) and gym‐based strength exercises (30 to 40 min).
On the first two visits to the gym, participants were provided instruction on use of the gym, a home‐base exercise training program for the first month, how to fill in the exercise training diary, use of the RPE scale to evaluate the average intensity of a single exercise session, a schedule for gym visits, and use of an accelerometer. Thereafter, the participants exercised in the gym once per week for 6 months in groups of no more than eight participants.
A wrist‐worn accelerometer was provided to improve motivation and adherence. Participants instructed to continuously wear the accelerometer and monitor their own daily PA.
After 6 months, home‐based exercise continued and checkpoint visits to monitor progression of exercise training were scheduled at 9 and 12 months.
Components: exercise plus other components such as dietary counselling or check‐up by a medical doctor when appropriate.
Setting: both centre and home (1 centre‐based resistance training session per week for 6 months).
Exercise programme modality: walking, running, cycling or cross‐country skiing
Length of session: 30 to 40 minutes
Frequency: 4 to 5 per week
Intensity: RPE 12‐15 (aerobic), RPE 13 (resistance)
Resistance training included? Yes ‐ strength exercise circuit targeted at major muscle groups at moderate intensity (2‐3 X 7 sets, ≥ 10 repetitions/set) RPE 13.
Total duration: 1 year
Co‐interventions: None described
Comparator: usual care – participants did not receive any individually‐tailored exercise prescriptions.
Co‐interventions: none described
Outcomes Mortality, hospitalisations, HRQoL, cost effectiveness
Source of funding NR
Conflicts of interest JMA is a partner of ESiOR Oy, which provides health economic and outcome research services to pharmaceutical and medical device companies. The other authors report no conflicts of interest.
Notes Authors provided further data relating to clinical outcomes and HRQoL.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information provided regarding method used to generate allocation sequence
Allocation concealment (selection bias) Unclear risk No information provided regarding method used to conceal the allocation sequence
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided regarding blinding of outcome assessors
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Missing data balanced in numbers (intervention 28%, control 26%); missing data were imputed using appropriate methods, but reasons for loss to follow‐up not reported.
Selective reporting (reporting bias) Unclear risk No published protocol available, clinical trial registry available, but outcome information is limited

He 2020.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: August 2014 to October 2016
Maximum follow‐up: 3 years
Participants Inclusion criteria: (1) fulfilling Third Universal Definition of Myocardial Infarction criteria; (2) a coronary angiography that show no artery stenosis ≥ 50% in any infarct‐related artery; (3) no other clinically overt cause or account for the acute presentation
Exclusion criteria: (1) sepsis, cardiac contusion, pulmonary embolism, overlooked obstructive coronary artery disease (CAD), coronary emboli or thrombus, Takotsubo syndrome, and myocarditis; (2) limited exercise tolerance (ejection fraction <35%, chronic obstructive pulmonary disease with FEV1 <50%, severe anaemia); (3) age ≥ 75 years old; (4) physical disability or mental confusion; (5) individuals refused to participate in the trial
N randomised: total: 524; intervention: 262; comparator: 262
Diagnosis (% of participants): 100% MI with PCI
Age (mean ±SD): intervention: 60.6 ± 12.7; comparator 60.9 ± 12.9
Percentage male: intervention: 45.8%, comparator: 47.7%
Ethnicity: NR
Interventions Intervention: participants exercised 3x per week in the hospital for 20 to 30 min on a treadmill or bicycle at 65% to 75% of symptom limited maximal heart rate. After discharge, moderate continuous training was performed – cycling or treadmill running continuously at a moderate intensity (65% to 75% max HR) for 47 mins 3x per week. Participants used MI electronic band to monitor heart rate and physicians used WeChat software to instruct and supervise individuals each month during the follow‐up period. The home‐based program consisted of 52 exercise sessions (3x per week) each year.
Components: exercise only
Setting: centre‐ and home‐based
Exercise programme modality: treadmill walking/running or cycling
Length of session: 20 to 30 minutes increasing to 47 minutes
Frequency: three sessions per week
Intensity: 65% to 75% of the symptom limited heart rate max
Resistance training included? No
Total duration: 3 years
Co‐interventions: none described
Comparator: control participants did not receive CR
Co‐interventions: none described
Outcomes MACE at 3 years, HRQoL at 1 year
Source of funding Supported by Zhejiang Provincial Science Foundation of China under Grant No. LY20H020006 and Zhejiang Provincial Basic Public Welfare Research Program of China under Grant No. LGF19H020007
Conflicts of interest None declared
Notes Authors emailed to request further data (mortality, MI, hospitalisation) but no response
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “randomly allocated either to an exercise‐based cardiac rehabilitation group (CR+ group) or a control group (CR− group) on a 1:1 base by drawing an envelope with the assignment enclosed.”
Allocation concealment (selection bias) Unclear risk “drawing an envelope with the assignment enclosed”
Blinding of outcome assessment (detection bias)
All outcomes Low risk “Only the members of The Safety and Monitoring Committee knew the group allocation. Data collectors and researchers were blind to the study group assignment.”
Incomplete outcome data (attrition bias)
All outcomes Low risk Loss to follow‐up balanced across groups and reasons provided.
1 year (SF‐36) intervention: 30/262 = 11%, control: 26/262 = 10%
"10.7% dropout reported over the 3 year study period."
Selective reporting (reporting bias) Unclear risk Protocol paper and trial registration unavailable

Heller 1993.

Study characteristics
Methods Study design: cluster‐randomised multicentre RCT
Country: Australia
Dates participants recruited: 18 September 1990 to 5 December 1991
Maximum follow‐up: 6 months
Participants Inclusion criteria: < 70 years with a suspected heart attack registered by the Newcastle collaborating centre of the WHO MONICA Project and discharged alive from hospital
Exclusion criteria: renal failure or other special dietary requirements and those considered by their physicians to have 'endstage' heart disease
N randomised: total: 450; intervention: 213; comparator: 237
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 59 ± 8; comparator: 58 ± 8
Percentage male: 71%
Ethnicity: NR
Interventions Intervention: a mail‐out programme designed to help participants reduce dietary fat, obtain regular exercise by walking and to quit smoking.
  • 1st package: Step 1 "Facts on fat" kit, together with walking programme information, encouragement to walk in the form of a magnetic reminder sticker, and "Quit for Life" programme for smokers.

  • 2nd package: Steps 2‐3 "Facts on fat" kit; exercise log.

  • 3rd package: Steps 4‐5 "Facts on fat" kit, together with information regarding local "Walking for Pleasure" groups.


Components: exercise plus education
Setting: home
Exercise programme modality: walking
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 6 months.
Co‐interventions: supplementary telephone contact was also used and a letter was sent to the family doctor regarding the benefit of aspirin and β blockers for secondary prevention.
Comparator: usual care
Co‐interventions: none described
Outcomes Total mortality, HRQL
Study outcomes assessed at 6 months
Source of funding National Health and Medical Research Council of Australia
Conflicts of interest NR
Notes Low use of preventative services (dietary, anti smoking) by both groups
10% of participants received CR ‐ mostly having had CABG
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Cluster‐randomisation by GP. "All general practices were randomly allocated to intervention or usual care within those strata." Method of randomisation not described.
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 17% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Higgins 2001.

Study characteristics
Methods Study design: single‐centre RCT
Country: Australia
Dates participants recruited: June 1995 to January 1997
Maximum follow‐up: Mean = 51 weeks; range = 36 to 56 weeks post PCI
Participants Inclusion criteria: participants scheduled for PCI
Exclusion criteria: major co‐morbidity such as malignancy, a history of cerebrovascular accident, or other severe, chronic debilitating disease; previous CABG or peri‐PCI complications; unemployment in previous year; MI within 1 month pre‐procedure; surgical management at home time during the 1 year duration of study.
N randomised: total: 105; intervention: 54; comparator: 51
Diagnosis (% of participants):
Previous MI: intervention: 52%; comparator: 51%
Previous PCI: intervention: 10%; comparator: 16%
Age (years): intervention: 48 (range 31 to 63); comparator: 47 (range 26 to 63)
Percentage male: intervention: 83 %; comparator: 96 %
Ethnicity: NR
Interventions Intervention: individualised comprehensive CR programme based on the principles of social cognitive theory involved a moderate‐intensity walking programme with a graded increase in the frequency and duration of exercise. In the 2 months post‐PCI, the clinician made 3 home visits to each participant and went walking with them as part of this visit. In addition, during home visits, participants were taught to monitor their rate of perceived exertion (RPE) during their walking programme and to document the frequency, duration and RPE of those sessions in an exercise log.
Components: exercise plus psychological plus education
Setting: home
Exercise programme modality: walking
Length of session: not specified – goal setting was based on personalised risk‐factor profiles
Frequency: NR
Intensity: NR
Resistance training included? No
Total duration: not specified
Co‐interventions: the intervention group received the same education sessions as the control group as well as an individualised, comprehensive CR program based on the principles of social cognitive theory. Strategies used to modify risk factors included (1) goal setting, (2) self‐monitoring and feedback, (3) skills training, (4) reinforcement of target behaviours, and (5) the provision of social support by the clinician. Vocational counselling included specific recommendations regarding return to work. The clinician also made monthly calls when she provided counselling and guidance.
Comparator: whilst hospitalised, control participants received two, one‐to‐one bedside education sessions; one 45 min session pre‐PCI and one 60 min session post‐PCI. Teaching media included videotapes of the procedure, photographs of coronary anatomy during the procedure, and equipment. Post‐PCI education included providing information about the pathology and risk factors for CHD and instruction on wound and medication management.
Co‐interventions: the clinician made 3 monthly post‐discharge CHD information‐focused telephone calls to each control participant.
Outcomes Mortality
Source of funding “Prince Charles Hospital Private Practice Fund supported the research”
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "Patients ……were randomly assigned to either control or intervention.”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes High risk Assessments do not appear to be blinded.
Incomplete outcome data (attrition bias)
All outcomes High risk Although all withdrawals and exclusions were clearly described and the number of withdrawals were similar in the intervention (5) and control (4) groups, 11 (20%) and 5 (10%) participants were lost from the intervention and control groups, respectively.
Selective reporting (reporting bias) Low risk All outcomes have been reported at all time points.

Hofman‐Bang 1999.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: February 1993 to December 1995
Maximum follow‐up: 2 years
Participants Inclusion criteria: (a) at least one significant stenosis suitable for PTCA and at least one additional ‐ although clinically non‐significant ‐ stenosis or plaque, measurable with quantitative computerised angiography (QCA); (b) age < 65 years; (c) employed; (d) absence of other diseases of importance for the programme or with poor prognosis; and (e) able to perform a bicycle ergometer test with a minimum exercise capacity of 70 watts.
Exclusion criteria: none described
N randomised: total: 87; intervention: 46; comparator: 41
Diagnosis (% of participants): treated with percutaneous transluminal angioplasty
Age (mean): intervention: 53; comparator: 53
Percentage male: 83.9%
Ethnicity: NR
Interventions Intervention: started with a 4‐week residential stay at the intervention unit. The programme included intense health education and activities promoting behavioural changes ‐ stress management, diet, exercise and smoking habits. Each subject was assigned a daily individual task including self‐observation, Type A behavioural drills, relaxation training and exercise. Followed by 11‐month structured maintenance programme.
Components: exercise plus psychological plus education
Setting: centre followed by home
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 12 months
Co‐interventions: maintenance programme consisted of continuous self‐observation and self‐recording of important everyday lifestyle behaviours, feedback of behaviour changes, and of regular follow‐up contacts between the participant and his/her personal coach for verbal feedback, problem‐solving, and replanning discussions when needed.
Comparator: standard care
Co‐interventions: none described
Outcomes Cardiovascular mortality, MI, CABG, PTCA, hospitalisations, health‐related quality of life: Angina Pectoris Quality of Life Questionnaire (APQLQ) recorded during the 2 years' follow‐up.
Source of funding AMF Insurance Co., the SPP Insurance Co., and The Swedish Heart and Lung Foundation
Conflicts of interest NR
Notes 93 participants were randomly assigned to an intervention group or a control group, respectively. Six subjects (two in the intervention group and four in the control group) refused further participation in close connection to randomisation.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly assigned"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 21.8% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Holmbäck 1994.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: "during a 2‐year period"
Maximum follow‐up: 1 year
Participants Inclusion criteria: acute MI patients under 65 years of age
Exclusion criteria: not stated, but individuals have been excluded for being incapable of performing strenuous training due to poor left ventricular function or arrhythmias, orthopaedic disorders, other incapacitating somatic diseases or mental disorders.
N randomised: total: 69; intervention: 34; comparator: 35
Diagnosis (% of participants): post‐MI: 100%
Age (mean years [range]): intervention: 55 (38 to 65); comparator: 55 (43 to 63)
Percentage male: 97%
Ethnicity: NR
Interventions Intervention: started 8 weeks post‐MI and participants trained over a 12‐week period for at least 45 minutes (effective time) twice a week with interval training involving large muscle groups: bicycling (10 min), callisthenics (10 min), jogging (15 min) ending with relaxation (10 min).
Components: exercise only
Setting: not described, but assumed in a centre
Exercise programme modality: bicycling 10 mins, callisthenics 10 min, jogging
Length of session: at least 45 mins
Frequency: twice per week.
Intensity: 70% to 85% of peak heart at the bicycle test for initial session and workload individually adjusted to obtain the desired maximum heart rate if possible
Resistance training included? Yes ‐ callisthenics
Total duration: 12 weeks
Co‐interventions: none described
Comparator: received regular medical care with no emphasis on exercise
Co‐interventions: none described
Outcomes Total mortality, non‐fatal MI & revascularisation
Health‐related quality of life: self‐report questionnaire
Evaluations at 6 weeks and 1 year post‐MI
Source of funding Research support was given by Malmöhus County Council
Conflicts of interest NR
Notes Study authors found no benefit from exercise training. Outcomes were related to self‐rated levels of physical and psychological well being.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomization was performed according to random numbers in sealed envelopes".
Allocation concealment (selection bias) Low risk "Randomization was performed according to random numbers in sealed envelopes".
Blinding of outcome assessment (detection bias)
All outcomes Low risk Evaluations were "supervised by independent investigators".
Incomplete outcome data (attrition bias)
All outcomes High risk 14.5% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported for all time points (although absolute values not always given).

Houle 2012.

Study characteristics
Methods Study design: multicentre RCT (2 sites)
Country: Canada
Dates participants recruited: April 2007 to April 2008
Maximum follow‐up: 12 months
Participants Inclusion criteria: participants hospitalised for an ACS (unstable angina, non‐ST–elevation or ST elevation myocardial infarction) and willing to travel to the CR centre every 3 months to meet the clinical nurse specialist and able to read and speak French
Exclusion criteria: inability to perform activities of daily living (such as feeding themselves, bathing, dressing, grooming, work, homemaking and leisure); enrolment in another research project or in a heart failure clinic where serial follow‐up creates a bias and contraindication to exercise testing; medical diagnosis of debilitating chronic illness (such as cancer without remission), musculoskeletal or neurological disorder (such as multiple sclerosis, Parkinson's disease, etc.); people with a previous history of stroke could be included if they had no residual effects related to their stroke); serious and unstable mental incapacities or major depression
N randomised: total: 65; intervention: 32; comparator: 33
Diagnosis (% of participants):
Unstable angina: intervention: 50%; comparator: 52%
STeMI: intervention: 28%; comparator: 27%
Non STeMI: intervention:22%; comparator: 21%
Age (mean ± SD): intervention: 58 ± 8; comparator: 59 ± 9
Percentage male: total: 78%; intervention: 81%; comparator: 76%
Ethnicity: NR
Interventions Intervention: participants received a pedometer‐based programme concomitantly with a socio‐cognitive intervention led by a clinical nurse specialist. Participants used 1 pedometer blinded and used a second one to monitor their daily steps since discharge.
Components: exercise plus education plus socio‐cognitive intervention
Setting: home
Exercise programme modality: walking
Length of session: not specified
Frequency: not specified
Intensity: not specified
Resistance training included? No
Total duration: 12 months
Co‐interventions: participants received a socio‐cognitive intervention led by a clinical nurse specialist, and a blinded pedometer with instructions about how to wear the pedometer correctly during 7 consecutive days from morning to bedtime.
Comparator: participants received the usual advice by the nurse or the physician, or both, at discharge regarding physical activity, diet and medication. They had no restriction to go to a centre‐based cardiac rehabilitation programme or to consult a health care professional such as a nutritionist, an exercise specialist or a psychologist. Participants in both groups received usual medical follow‐up by their own physicians (cardiologist and family physician).
Co‐interventions: participants received a blinded pedometer and instructions about how to wear the pedometer correctly during 7 consecutive days from morning to bedtime.
Outcomes HRQoL
Source of funding Heart and Stroke Foundation of Canada, Research centre of Institut Universitaire de Cardiologie et Pneumologie de Québec, and Pfizer Canada
Conflicts of interest "Authors had no conflict of interest to declare".
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "They were randomly allocated to the experimental group or to the usual care group using a randomization table".
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Physical activity recorded by a blinded pedometer. However, blinding of assessors of other tests and measurements not described.
Incomplete outcome data (attrition bias)
All outcomes High risk Loss to follow‐up was high in both groups: 9/32 (28%) and 11/33 (33%) were lost to follow‐up from the intervention and control groups.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points described either in the paper or in the supplementary material online.

Kallio 1979.

Study characteristics
Methods Study design: multicentre RCT (2 sites)
Country: Finland
Dates participants recruited: May 1973 to October 1975
Maximum follow‐up: 3 years
Participants Inclusion criteria: participants treated in hospital for acute myocardial infarction based on WHO criteria
Exclusion criteria: NR
N randomised: total: 375; intervention: 188; comparator: 187
Diagnosis (% of participants): AMI: 100%
Age (mean): intervention: 54.4; comparator: 54.1
Percentage male: 80.3%
Ethnicity: NR
Interventions Intervention: the programme was started two weeks after discharge from hospital and consisted of medical examinations by an internist at least monthly for the first six months after AMI, then when necessary or at least 3‐monthly. A physical exercise programme, tailored to the individual’s working capacity determined in a bicycle ergometer test, was recommended, and for most participants, it was done under supervision. The rehabilitation programme was most intensive during the first three months after myocardial infarction.
Components: exercise, education and psychological
Setting: supervised in a centre
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: NR
Co‐interventions: besides the internist, the team included a social worker, a psychologist, a dietitian, and a physiotherapist. Health education consisted of anti‐smoking and dietary advice, and discussions on psychosocial problems.
Comparator: usual care
Co‐interventions: none described
Outcomes Total mortality; cardiovascular mortality (follow‐up 3 years).
Source of funding Social Insurance Institution
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly allocated"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk 1% lost to follow‐up
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Kovoor 2006.

Study characteristics
Methods Study design: multicentre RCT (2 sites)
Country: Australia
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: AMI; < 75 years of age; no angina; < 2 mm ST‐segment depression with exercise and if they attained > 7‐METS workload; left ventricular ejection fraction > 40% or no inducible ventricular tachycardia
Exclusion criteria: participants were excluded if there was 2 mm ST‐segment depression with exercise or if 7‐METS workload was attained.
N randomised: total: 142; intervention: 70; comparator: 72
Diagnosis (% of participants): AMI: 100%
Age (mean): intervention: 56.2; comparator: 55.8
Percentage male: intervention: 89%; comparator: 86%
Ethnicity: NR
Interventions Intervention: exercise (conventional treatment group): 5 week rehabilitation program consisted of exercise, education and counselling sessions that were held 2 to 4 times per week, including work at 6 weeks after AMI.
Components: exercise, education and psychological
Setting: NR
Exercise programme modality: NR
Length of session: NR
Frequency: 2 to 4 times per week
Intensity: NR
Resistance training included? NR
Total duration: 5 weeks
Co‐interventions: the 2 groups of participants were encouraged to exercise at home on a regular basis. Participants were given the telephone numbers of the cardiologist and the nurse co‐ordinator so they could be contacted in case of problems.
Comparator: control group (ERNA ‐ early return to normal activities group): return to work at 2 weeks after AMI without a formal CR programme.
Co‐interventions: this group of participants was contacted over the telephone by the nurse co‐ordinator once per week for 5 weeks. The 2 groups were encouraged to exercise at home on a regular basis. Participants were given the telephone numbers of the cardiologist and the nurse co‐ordinator so they could be contacted in case of problems.
Outcomes Total mortality; fatal/non‐fatal mortality; CABG; PCI; HRQoL. Costs reported in Hall 2002.
Assessment at 6 weeks and at 6 months
Source of funding National Health and Medical Research Council, Sydney, Australia
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of randomisation not described
Allocation concealment (selection bias) Low risk "Randomization schedules were generated by an independent investigator and were kept in opaque sealed envelopes."
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk "GHPS .... scans being analyzed in a blinded fashion by an independent nuclear medicine specialist." Blinding of other outcome assessments not described
Incomplete outcome data (attrition bias)
All outcomes High risk 20.4% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points

La Rovere 2002.

Study characteristics
Methods Study design: single‐centre RCT
Country: Italy
Dates participants recruited: 1984 to 1985
Maximum follow‐up: 10 years
Participants Inclusion criteria: post‐MI patients admitted at Centro Medico di Montescano in 1984 to 1985
Exclusion criteria: atrial fibrillation or abnormal sinus node function, insulin‐dependent diabetes, exercise‐induced myocardial ischaemia, and arterial BP > 160/90
N randomised: total: 95; intervention: 49; comparator: 46
Diagnosis (% of participants): uncomplicated MI: 100%
Age (mean): intervention: 51; comparator: 52
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: the exercise sessions (30 minutes, 5 times a week) consisted of callisthenics and stationary bicycle ergometry
Components: exercise, education and psychological
Setting: supervised in a centre
Exercise programme modality: stationary bicycle ergometry
Length of session: 30 minutes
Frequency: 5 times a week
Intensity: 75% of heart rate at peak V02, rising to 85% in the second and third weeks and 95% in the final week
Resistance training included? Yes ‐ callisthenics
Total duration: 4 weeks
Co‐interventions: sessions were held by cardiologists and psychologists, dealing with secondary prevention of cardiovascular disease and stressing dietary changes and smoking cessation.
Comparator: no training
Co‐interventions: all participants attended sessions, held by a cardiologist and a psychologist, dealing with secondary prevention of cardiovascular disease and stressing dietary changes and smoking cessation.
Outcomes Cardiac mortality; non‐fatal MI; CABG at 3 to 4 month intervals from the time of entry into the study for the first 3 years and contacted periodically by telephone thereafter.
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk All participants accounted for
Selective reporting (reporting bias) High risk Results not reported for all time points collected

Lear 2015.

Study characteristics
Methods Study design: multicentre RCT (2 sites)
Country: Canada
Dates participants recruited: February 2009 to April 2011
Maximum follow‐up: 16 months
Participants Inclusion criteria: participants residing in either the region serviced by the Northern Health Authority of British Columbia, or the Coast Garibaldi region, which is inaccessible by road, and residents must travel by either air or ferry to reach the Vancouver area. Participants must have been admitted for either acute coronary syndrome or revascularisation procedure, be at low or moderate risk based on the American Association of Cardiovascular and Pulmonary Rehabilitation guidelines at the time, had regular Internet access (home, work, or other environment), no physical limitations to regular physical activity, and be fluent in English.
Exclusion criteria: people with previous experience with cardiac rehabilitation, depression, uncontrolled diabetes mellitus, and other significant comorbidities that may interfere with effective cardiovascular management, pregnant women and those who the attending physician thought were unsuitable for participation.
N randomised: total: 78; intervention: 38; comparator: 40
Diagnosis (% of participants): intervention: NSTEMI 47 (48%) STEMI 44(45%); comparator: NSTEMI 45 (58%) STEMI 28 (36%).
Age (median, IQR): intervention: 61.7, 51.3‐65.2; comparator: 58.4 (52.8‐64.7).
Percentage male: intervention: 34 (90%); comparator: 32 (80%)
Ethnicity (white, %): NR
Interventions Intervention: web‐based virtual cardiac rehabilitation program.
30‐minute in‐person training session on the use of the virtual CR program. Participants supplied with heart rate monitor and blood pressure monitor.
Virtual CR program included online intake forms (medical, risk factor and lifestyle), scheduled one on one chat sessions with the program nurse or case manager, exercise specialist and dietician (3 times each during 12 weeks), weekly education sessions with interactive slide presentations, data capture for exercise stress test and blood test results, progress notes and monthly 'ask an expert' group chat sessions.
The home‐page displayed the tasks that needed to be completed for each week. Participants were asked to wear heart rate monitor whilst exercising and upload exercise data at least twice per week into the system.
Components: exercise plus education
Setting: home‐based
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 16 weeks
Co‐interventions: none described
Comparator: usual care (care from primary care physician); participants were given simple guidelines for safe exercising and healthy eating habits and a list of internet‐based resources.
Co‐interventions: none described
Outcomes Cardiovascular‐related emergency room and major events
Source of funding Heart and Stroke Foundation of BC and Yukon and in part by Canada Health Infoway. Dr Lear holds the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Prevention Research at St. Paul’s Hospital.
Conflicts of interest None declared
Notes Authors contacted for specific clinical outcomes, but no response received.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “The random allocation was computer generated by a statistician unassociated with the trial who was the only one to have access to the list during the study.”
Allocation concealment (selection bias) Low risk “The list was incorporated into a telephone randomization system to which the randomization research coordinator called for treatment allocation. The randomization research coordinator informed the participants of their group assignment.”
Blinding of outcome assessment (detection bias)
All outcomes Low risk Outcome assessment reported to be blind – stress test technicians blinded, medical records were adjudicated by the study cardiologist (A.I.) blinded to the participant group assignment and categorized into emergency room visit events only and major cardiovascular events (revascularization, unstable angina requiring hospitalization, stroke, and death of any kind).”
“The vCRP was evaluated in a 16‐month randomized controlled trial with blinded outcome assessment”.
Incomplete outcome data (attrition bias)
All outcomes Low risk Low numbers of missing data in both groups, for similar reasons (intervention 12%, control 8%).
Selective reporting (reporting bias) Low risk No published protocol, but outcomes listed in trial registration appear to be reported.

Leizorovicz 1991.

Study characteristics
Methods Study design: multicentre RCT (4 sites)
Country: France
Dates participants recruited: February 1981 to May 1984
Maximum follow‐up: 2 years
Participants Inclusion criteria: admitted to participating coronary care units with suspected MI; < 65 years old with typical MI, no major irreversible complication or disability
Exclusion criteria: contraindication to exercise testing; i.e. recent stroke, disability of lower limbs, uncontrolled heart failure, severe rhythm disturbances, SBP > 180 mmHg, severe angina pectoris, or abnormalities triggered by baseline exercise test.
N randomised: total: 182; intervention: 61; comparator (usual care): 60 counselling programme: 61 (no data analysed in this review)
Diagnosis (% of participants): MI: 100%
Age (mean): intervention: 51; comparator: 49
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: the programme started within a few days of randomisation and included three training sessions a week on a cycloergometer, walking and gymnastics.
Components: exercise and education
Setting: centre
Exercise programme modality: cycloergometer, walking and gymnastics
Length of session: 25 min
Frequency: 3 times per week
Intensity: 80% of max HR and then decreased progressively over 2 min (increased as the sessions progressed)
Resistance training included? No
Total duration: 6 weeks
Co‐interventions: also included respiratory physiotherapy, relaxation, recommendations on control of cardiovascular risk factors (smoking habits, diet); recommendations to continue regular physical training at the end of the 6‐week programme.
Comparator: participants in the usual care group were referred to their usual private practitioner or cardiologist or both.
Co‐interventions: None described
Outcomes Non‐fatal MI, angina, surgery
Source of funding Institut National de la Same et de la Recherche Medicale, by the Hospices Civils de Lyon and by the Association pour la Promotion et la Realisation d'Essais Therapeutiques
Conflicts of interest NR
Notes Only 14% of all MI patients admitted to the participating hospitals were randomised to the trial. Exclusion of women and patients > 65 accounted for 60% of exclusions.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk No losses to follow‐up
Selective reporting (reporting bias) Low risk All outcomes reported for all time points (although absolute values not always given).

Lewin 1992.

Study characteristics
Methods Study design: single‐centre RCT
Country: Scotland, UK
Dates participants recruited: March 1988 to March 1991
Maximum follow‐up: 1 year
Participants Inclusion criteria: confirmed MI (WHO criteria); age less than 80 years; able to speak and read English; resident in the hospital catchment area
Exclusion criteria: known history of major psychiatric illness; current psychotic symptoms; evidence of dementia or continuing uncontrolled arrhythmias or heart failure
N randomised: total: 176; intervention: 88; comparator: 88
Diagnosis (% of participants): MI: 100%
Age (mean ±SD): intervention: 55.3 ± 10.7; comparator: 56.3 ± 10.5
Percentage male: intervention: 70.0%; comparator: 72.7%
Ethnicity: NR
Interventions Intervention: heart manual consisted of six weekly sections that included education, a home‐based exercise programme, and a tape‐based relaxation and stress management programme.
Components: exercise, education and psychological
Setting: home
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 6 weeks.
Co‐interventions: specific self‐help treatments were provided for psychological problems commonly experienced by post‐MI patients. Before the participant was discharged from hospital, spouses were given an audiotape that provided information and advice. After discharge, the facilitator made contact with both groups of participants at 1, 3 and 6 weeks, by telephone, at a hospital clinic, or, when neither of these was possible, by brief home visits.
Comparator: the control group received an equal amount of the facilitator’s time (approximately 10 min).
Co‐interventions: participants were given an extensive package of leaflets from various sources, intended to cover the same information as that presented in the manual.
Outcomes HRQoL, Hospital Anxiety and Depression Scale (HAD), General Health Questionnaire (GHQ)
Source of funding This research was supported by a grant from the Chief Scientist Office of the Scottish Home and Health Department. The British Heart Foundation donated additional computer equipment.
Conflicts of interest NR
Notes Study terminated (due to expiry of funding) before all participants reached 6‐month or 12‐month stage.
Anxiety scores showed significant treatment effect at 6 weeks and 1 year, depression at 6 weeks.
Pre‐hospital discharge, 52% of all participants had HAD scores indicating clinically significant anxiety or depression (8+). Control group were significantly more anxious and depressed at all follow‐ups.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "allocated to the experimental or control group by use of a written pre‐determined randomisation protocol". Method of randomisation not described
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Questionnaires were scored and the data entered into the statistical analysis programme by a clerical assistant based at a separate hospital who was blind both to the experimental design and to the patients."
Incomplete outcome data (attrition bias)
All outcomes High risk 17% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported at all time points

Ma 2020.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: January 2014 to December 2015
Maximum follow‐up: 36 months (12 month intervention plus 24 month follow‐up)
Participants Inclusion criteria: angiographically diagnosed as unprotected left main coronary artery disease (ULMCAD), and the ‘unprotected’ in this context was defined that no perfusion distal to the left main stenosis was supplied by either a patent bypass graft or a collateral vessel; underwent CABG for the first time; age ≥ 18 years; able to independently fulfil the assessment questionnaires used in the study; likely to be followed up regularly, which was evaluated by the investigators.
Exclusion criteria: cardiogenic shock; cerebrovascular accident with a persistent neurological deficit before enrolment; complicated with malignancies; pregnant or lactating women.
N randomised: total: 300; intervention: 150; comparator: 150.
Diagnosis (% of participants): CABG (100%).
Age (mean, SD): intervention: 63.1 ± 9.7; comparator: 62.8 ± 10.7.
Percentage male: intervention: 121 (80.7%); comparator: 115 (76.7%).
Ethnicity (white, %): NR
Interventions Intervention:
Comprehensive rehabilitation and intensive education (CRIE) program consisting of 4 components:
1. CAD‐related health education (1/wk for 2 months) – lectures covering basic knowledge of disease, primary therapeutic strategies, risk factors, antiplatelet and anticoagulant therapy, BP management, lipid, glucose, and uric acid, prevention of upper GI mucosal injury, rehabilitation management about exercise, diet and nutrition, psychological care and good lifestyle formation.
2. Exercise guidance and formation (1/month for 10 months) – formulating an individualised exercise plan covering exercise mode: low intensity walking, moderate intensity aerobics (e.g. jogging, gymnastics, tai chi, bicycling), and moderate to high resistance training (e.g. mountain climbing, mid‐distance sprint); duration 60 to 90 mins each time; frequency 3 to 5 times per week; intensity: RPE 11 to 13. Monthly supervision and guidance by motivational interviewing.
3. Risk factor control (1/month for 10 months): diet control, alcohol and cigarette cessation, management of blood pressure, lipid, glucose and uric acid. Monthly supervision and guidance by motivational interviewing.
4. Psychological nursing (1/month for 10 months): making a holistic assessment of each participants' physical, functional, psychological, social and spiritual status; identifying potential issues in psychological aspects; eliminating negative emotions and improving compliance; providing music therapy.
Components: exercise plus education and psychological nursing
Setting: centre‐based lectures, with home‐based exercise
Exercise programme modality: low‐intensity walking, moderate‐intensity aerobics
Length of session: 60 to 90 minutes
Frequency: 3 to 5 sessions per week
Intensity: RPE 11 to 13
Resistance training included? Yes: moderate‐high intensity resistance training described as mountain climbing or mid‐distance sprinting
Total duration: 12 months
Co‐interventions: none described
Comparator: participants provided discharging guidance and a CAD‐related health education manual (same as distributed to intervention group). Provided rehabilitation recommendations and medication consultation through telephone calls or clinic visits according to need.
Co‐interventions: None described
Outcomes Major adverse cardiac and cerebrovascular events (composite outcome), HRQoL
Source of funding Supported by National Clinical Key Speciality Construction Project
Conflicts of interest None declared
Notes We contacted authors, requesting specific clinical outcome data, but received no response.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "The randomisation sequence was computer‐generated using SAS 9.1"
Allocation concealment (selection bias) Low risk "The assignment of patients was performed by an independent nurse with the use of sealed envelopes"
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided regarding blinding of outcome assessment.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Number of participants lost to follow‐up provided ( < 20%) and appear balanced across groups, but no reasons provided
Selective reporting (reporting bias) Unclear risk No published protocol paper or trial registration

Maddison 2014.

Study characteristics
Methods Study design: single‐blind multicentre RCT (2 sites)
Country: New Zealand
Dates participants recruited: 2010 to 2012
Maximum follow‐up: 24 weeks
Participants Inclusion criteria: aged 18 years or more, with a diagnosis of IHD, defined as angina, myocardial infarction, revascularisation, including angioplasty, stent or coronary artery bypass graft within the previous 3 to 24 months. All participants were clinically stable as outpatients, able to perform exercise, able to understand and write English, and had access to the Internet (e.g. at home, work, library or through friends or relatives).
Exclusion criteria: participants were excluded if they had been admitted to hospital with heart disease within the previous 6 weeks; had terminal cancer, or had significant exercise limitations other than IHD
N randomised: total: 171; intervention: 85; comparator: 86
Diagnosis (% of participants):
IHD: 100%
MI: 74%
Angina: 50%
Age (mean ±SD): total: 60.2 ± 9.3; intervention: 61.4 ± 8.9; comparator: 59.0 ± 9.5
Percentage male: total: 81%; intervention: 81%; comparator: 81%
Ethnicity:
NZ Maori: total: 8%; intervention: 7%; comparator: 8%
Pacific: total: 6%; intervention: 6%; comparator: 6%
Asian: total: 10%; intervention: 9%; comparator: 10%
NZ European/other: total: 76%; intervention: 78%; comparator: 76%
Interventions Intervention: the HEART programme is a personalised, automated package of text messages via mobile phones aimed at increasing exercise behaviour over 24 weeks. Participants received six messages per week for the first 12 weeks, five messages per week for 6 weeks, and then four messages per week for the remaining 6 weeks.
Components: exercise
Setting: home
Exercise programme modality: moderate to vigorous aerobic‐based exercise (e.g. walking and household chores)
Length of session: minimum of 30 minutes
Frequency: at least 5 days/week.
Intensity: NR
Resistance training included? No
Total duration: 24 weeks
Co‐interventions: focus on altering the key mediators of behaviour change, including self‐efficacy, social support and motivation.
Comparator: usual care, with encouragement to be physically active and attend a cardiac club.
Co‐interventions: all participants were free to participate in any other CR service or support that they wished to use (e.g. participating in community‐based CR education sessions on modifying CVD risk factors and psychological support), as well as encouragement to be physically active.
Outcomes HRQoL, costs
Source of funding Health Research Council of New Zealand and the Heart Foundation. Dr Maddison was supported by a Heart Foundation Research Fellowship and a Health Research Council Sir Charles Hercus Research Fellowship.
Conflicts of interest None declared
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "....were randomly allocated..... by means of a central computerized service. Randomization was conducted using the minimization method, stratifying by sex (male and female), ethnicity (Maori – indigenous – and non‐Maori), and exercise history"
Allocation concealment (selection bias) Low risk "Allocation concealment was maintained up to the point of randomization"
Blinding of outcome assessment (detection bias)
All outcomes Low risk "This was a single‐blind trial, where outcome assessors were blinded to treatment allocation"
Incomplete outcome data (attrition bias)
All outcomes Low risk Loss to follow‐up was well reported and was similar in both groups. 10/85 (12%) and 8/86 (9%) were lost to follow‐up from the intervention and control groups, respectively.
Selective reporting (reporting bias) Low risk All outcomes described in the methods section are reported in results.

Manchanda 2000.

Study characteristics
Methods Study design: single‐centre RCT
Country: India
Dates participants recruited: NR
Maximum follow‐up: 1 year
Participants Inclusion criteria: chronic stable angina and angiographically proven CAD
Exclusion criteria: recent (within last six months) MI or unstable angina
N randomised: total: 42; intervention: 21; comparator: 21
Diagnosis (% of participants): chronic stable angina and angiographically proven CAD
Age (years): intervention: 51; comparator: 52
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: participants and their spouses spent four days at a yoga residential centre where they underwent training in various yogic lifestyle techniques. Subsequently they carried out the yogic exercises at home for an average of 90 min daily. The programme included health rejuvenating exercises, breathing exercises, relaxation, meditation, reflection, stress management, dietary control and moderate aerobic exercises.
Components: exercise, education and psychosocial support
Setting: centre followed by home
Exercise programme modality: yoga and "moderate aerobic exercises"
Length of session: 90 min
Frequency: daily
Intensity: NR
Resistance training included? No
Total duration: 1 year
Co‐interventions: relaxation, reflection, stress management, dietary control
Comparator: managed by conventional methods i.e. risk factor control and American Heart Association step I diet.
Co‐interventions: none described
Outcomes total mortality; CABG; PCI
Assessments are baseline and 1 year
Source of funding This study was supported in part by a grant from the Central Research Institute of Yoga, Ministry of Health, Government of India.
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Two independent observers who were blinded to group allocation analysed all arteriograms."
Incomplete outcome data (attrition bias)
All outcomes Low risk All participants accounted for
Selective reporting (reporting bias) High risk While participants were given a clinical exam and clinical investigations every month, only the results at 1 year are presented.

Marchionni 2003.

Study characteristics
Methods Study design: single‐centre RCT
Country: Italy
Dates participants recruited: NR (48‐month period)
Maximum follow‐up: 14 months
Participants Inclusion criteria: > 56 years; referred to unit for functional evaluation 4 to 6 weeks after MI
Exclusion criteria: severe cognitive impairment or physical disability, left ventricular EF < 35%, contraindications to vigorous physical exercise, eligibility for myocardial revascularisation because of low‐effort myocardial ischaemia, refusal, or living too far from the unit
N randomised: total: 270; intervention: 90; home: 90; comparator: 90
Diagnosis (% of participants): MI: 100%
Age (mean [range]): 69 years [46 to 86]
Percentage male: 67.8%
Ethnicity: NR
Interventions Partcipants were randomised to outpatient, hospital‐based CR (Hosp‐CR), home‐based CR (Home‐CR), or no CR within 3 predefined age groups.
Intervention:
Hospital‐CR: programme consisted of 40 exercise sessions: 24 sessions (3/wk) of endurance training on cycle ergometer (5‐min warm‐up, 20‐min training at constant workload, 5‐min cool‐down, 5‐min post‐exercise monitoring) plus 16 (2/wk) 1‐hr sessions of stretching and flexibility exercises.
Home‐CR: 4 to 8 supervised instruction sessions in CR unit, where taught how to perform training at home; then participants received exercise prescription similar to Hosp‐CR group.
Setting: centre or home
Components:  
Hospital‐CR: exercise plus psychosocial support
Home‐CR: exercise plus psychosocial support
Exercise programme modality: cycle ergometer
Length of session: 35 min endurance training; 1 hour stretching and flexibility exercises
Frequency: 3 per week of endurance training; 2 per week of stretching and flexibility exercises
Intensity: 70% to 85% of heart rate
Resistance training included? No
Total duration: 8 weeks
Co‐interventions: participants received cardiovascular risk factor management counselling twice per week and were invited to join a monthly support group together with family members.
Comparator: participants randomised to no CR were referred back to their family physicians.
Co‐interventions: participants received asingle structured education session on cardiovascular risk factor management.
Outcomes HRQoL at month 2, 8 and 14
Costs over study duration
Source of funding National Research Council (CNR), the University of Florence, and the Regional Government of Tuscany, Italy
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Testing personnel were blinded to patient assignment."
Incomplete outcome data (attrition bias)
All outcomes High risk 38 (14.1%) dropped out; clinical event data for these participants not reported per treatment group
Selective reporting (reporting bias) Low risk Changes in all outcomes reported for all time points (although absolute values not given)

Maroto 2005.

Study characteristics
Methods Study design: single‐centre RCT
Country: Spain
Dates participants recruited: NR (2‐year enrolment period)
Maximum follow‐up: 10 years
Participants Inclusion criteria: male participants diagnosed with AMI and admitted to the coronary care unit; age < 65 years; low risk (hospital course without complications, absence of signs of myocardial ischaemia, functional capacity > 7 metabolic equivalent time (MET), ejection fraction > 50%, and absence of severe ventricular arrhythmias)
Exclusion criteria: none described
N randomised: total: 180; intervention: 90; comparator: 90
Diagnosis (% of participants):
AMI: 100%
Anterior: intervention: 40.0%; comparator: 48.3%
Inferior/posterior: intervention: 48.3%; comparator: 46.3%
Non‐Q wave: intervention: 11.6%; comparator: 5.3%
Age (mean ± SD): intervention: 50.3 ± 6; comparator: 52.6 ± 9
Percentage male: 100%
Ethnicity: NR
Interventions Intervention:
Multidisciplinary CR programme, consisting of:
  • three months supervised, individualised physical training;

  • psychological programme including behavior modification techniques, group therapy, and relaxation sessions;

  • educational programme on modifying lifestyle and controlling coronary risk factors;

  • return to work counselling.


Supervised training was complemented by progressively increasing daily walks of 1 hour in duration, when participants tried to maintain the heart rate achieved during training. Walks were undertaken by participants individually and were unsupervised.
Components: exercise plus psychological plus education plus return to work counselling
Setting: individualised supervised programme in hospital gym
Exercise programme modality: physiotherapy and aerobic training on mats or an exercise bicycle
Length of session: 1‐hour sessions
Frequency: 3 times per week
Intensity: 75% to 85% max HR.
Resistance training included? No
Total duration: 3 months
Co‐interventions: participants received a psychological programme including behaviour modification techniques, group therapy, and relaxation sessions, an educational programme on modifying lifestyle and controlling coronary risk factors, and return to work counselling.
Comparator: participants received conventional treatment
Co‐interventions: none described
Outcomes Mortality, MI
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "The 180 patients were randomized into 2 groups”.
Allocation concealment (selection bias) Unclear risk Allocation concealment is not described.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk 7/90 lost to sample in intervention group and 4/90 lost to sample in control group.
Selective reporting (reporting bias) Low risk All outcomes described in methods section are reported at all time points.

Miller 1984.

Study characteristics
Methods Study design: RCT; participants randomised 3 weeks post‐MI
Country: USA
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: men < 70 years with MI documented by the combination of characteristic elevation of serum creatine kinase or oxaloacetic transaminase, a history of prolonged chest pain consistent with myocardial infarction, and the appearance of new Q waves or evolutionary ST segment changes.
Exclusion criteria: conditions that precluded symptom‐limited treadmill testing 3 weeks after infarction. e.g. congestive heart failure, unstable angina pectoris, valvular heart disease, atrial fibrillation, bundle branch block, stroke, limiting orthopedic abnormalities, peripheral vascular disease, chronic obstructive pulmonary disease and obesity, a history of coronary artery bypass graft (CABG) surgery, reinfarction before testing, and intercurrent noncardiac illness.
N randomised: total: 198; group 1: 66; group 2: 61; group 3: 34; comparator: 37
Diagnosis (% of participants): MI: 100%
Age (mean ±SD): 52 ± 9
Percentage male: 100%
Ethnicity: NR
Interventions Participants were randomly assigned to one of four exercise protocols:
  • group 1: 8 to 26 weeks of training at home;

  • group 2: training in a group programme;

  • group 3: treadmill testing at 3 weeks without subsequent training;

  • control: treadmill testing for the first time at 26 weeks.


Regimens of home and group exercise training were designed to provide a similar intensity and duration of exercise training.
Intervention: home training
Components: exercise only
Setting: home
Exercise programme modality: stationary cycling or walking
Length of session: 30 min
Frequency: 5 days a week
Intensity: weeks 3 to 11: 70% to 85% of the peak heart rate at week 3; weeks 11 to 26: 70% to 85% of the peak heart rate at week 11.
Resistance training included? No
Total duration: 8 weeks or 26 weeks.
Co‐interventions: none described
Intervention: group training
Components: exercise
Setting: supervised in centre
Exercise programme modality: walking or jogging
Length of session: 1 hour
Frequency: 3 times a week
Intensity: participants regulated their training intensity by palpation of the radial or carotid pulse during the first 10 sec after brief cessation of walking or jogging.
Resistance training included? No
Total duration: 8 weeks or 26 weeks
Co‐interventions: none described
Comparator: usual care (treadmill testing for the first time at 26 weeks)
Co‐interventions: none described
Outcomes CHD mortality, non‐fatal MI and revascularisation
Source of funding Supported by grant from the NHLBI, Bethesda, and by a grant from the PepsiCo Foundation, Purchase, NY
Conflicts of interest NR
Notes Low rate of cardiac events reflects identification of low risk population
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 5% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes reported for all time points

Munk 2009.

Study characteristics
Methods Study design: single‐centre RCT
Country: Norway
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: successful PCI, defined as a residual diameter stenosis after stent implantation of < 20% of the reference diameter
Exclusion criteria: history of myocardial infarction (MI) or CABG; significant valvular heart disease; > 80 years; inability to give informed consent; inability to participate in regular training due to residency, work situation or comorbidity; any known chronic inflammatory disease other than atherosclerosis, or planned surgery within the next 6 months.
N randomised: total: 40; intervention: 20; comparator: 20
Diagnosis (% of participants):
Stable angina, post PCI: intervention: 85%; comparator: 95%
Unstable angina, post PCI: intervention: 15%; comparator: 5%
Age (mean ± SD): intervention: 57 ±14; comparator: 61 ± 10
Percentage male: Total: 21%; intervention: 18%; comparator: 25%
Ethnicity: NR
Interventions Intervention: starting 11 ± 4 days after PCI, the training model included 10 min warm‐up at 60% to 70% of max HR, followed by 4 min intervals at 80% to 90% of max HR, when participants were riding an ergometric bicycle or were running. Intervals were interrupted by 3 minutes of active recovery at 60% to 70% of maximal heart rate. Afterwards, there was a 5‐min cool‐down, 10 min of abdominal and spine resistance exercises, and 5 min of stretching and relaxing. The training sessions were monitored with individual pulse watches allowing the participant to achieve the target heart rate.
Components: exercise only
Setting: centre‐based supervised training in groups of 10
Exercise programme modality: ergometric bicycle or running
Length of session: 1 hour
Frequency: 3 times a week
Intensity: 60% to 70% max HR
Resistance training included? Spine & abdominal resistance exercises
Total duration: 6 months
Co‐interventions: none described
Comparator: participants received usual care (not described), including drug therapy of clopidogrel, aspirin and statins
Co‐interventions: none described
Outcomes Mortality, MI, and revascularisations
Source of funding Norwegian Health Association, Oslo, Norway, and Stavanger University Hospital
Conflicts of interest NR in this paper, but none declared in Munk 2011
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “The order of treatments within the block was randomly permuted by a computer‐generated sequence.”
Allocation concealment (selection bias) Low risk “The investigator, who recruited patients into the trial, was unaware of the group to which a participant was allocated.”
Blinding of outcome assessment (detection bias)
All outcomes Low risk “All scans were analysed twice with EchoPACtm (GE Vingmed Ultrasound) by two blinded investigators. Two experienced cardiologists independently interpreted the images in a blinded manner.” However, not clear if blinded for clinical events and exercise capacity.
Incomplete outcome data (attrition bias)
All outcomes Low risk “No patient was lost to follow up.”
Selective reporting (reporting bias) Low risk All outcomes described in methods were reported at all time points.

Mutwalli 2012.

Study characteristics
Methods Study design: single‐centre RCT
Country: Kingdom of Saudi Arabia
Dates participants recruited: 8 June 2008 to 3 January 2010
Maximum follow‐up: 6 months
Participants Inclusion criteria: participants admitted for coronary artery bypass graft (CABG) surgery
Exclusion criteria: history of ejection fraction less than 30%, poor mobility leading to difficulty in walking, chronic atrial fibrillation, repeat CABG or implantable pacemaker were excluded from the study.
N randomised: total: 49; intervention: 28; comparator: 21
Diagnosis (% of participants): post‐CABG: 100%
Age (years): intervention: 56.75 (range 53.6 to 59.8); comparator: 57.22 (range 54.4 to 60.2)
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: whilst in the cardiac ward, the participants walked daily for 30 minutes. Additionally, before discharge, the participants climbed one flight of stairs and were then asked to walk unaided at a comfortable pace 30 minutes per day until they completed the 6‐month home‐based CR programme.
Components: exercise plus education
Setting: at home, unsupervised with telephone support
Exercise programme modality: walking
Length of session: 30 minutes
Frequency: daily
Intensity: NR
Resistance training included? No
Total duration: 6 months
Co‐interventions: participants received pre‐CABG, immediately post‐CABG, and home‐based CR program, including education, food management education and a one‐hour group workshop which included advice on modifiable and non‐modifiable risk factors, change of lifestyle, active life, stress, and then discussed participant’s problems and feelings during the past 2 months. This group workshop was repeated 4 months and 6 months after hospital discharge.
Comparator: the control group received standard hospital care, including regular advice from doctors and followed usual hospital instructions. This did not include a rehabilitation programme or telephone calls by the study authors.
Co‐interventions: None described
Outcomes Mortality, MI, hospitalisation and HRQoL
Source of funding "Work was not supported or funded by any drug company.”
Conflicts of interest “Authors have no conflict of interests.”
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “Patients who consented to participate in the study, were randomly assigned....”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 7/50 participants (14%) lost to follow‐up: one from control group died (1/22, 5%) and 6 from the intervention group (6/28, 21%) could not complete the study requirements.
Selective reporting (reporting bias) Low risk All outcomes described in methods are reported at all time points.

Oerkild 2012.

Study characteristics
Methods Study design: single‐centre RCT
Country: Denmark
Dates participants recruited: January 2007 to July 2008
Maximum follow‐up: 12 months; mortality data after 5.5 years (mean follow‐up 4½ years)
Participants Inclusion criteria: participants ≥ 65 years with a recent coronary event defined as acute myocardial infarction (MI), percutaneous transluminal coronary intervention (PCI) or coronary artery bypass graft (CABG) and who declined participation in centre‐based CR
Exclusion criteria: mental disorders (dementia), social disorders (severe alcoholism and drug abuse), living in a nursing home, language barriers or use of wheelchair
N randomised: total: 40; intervention: 19; comparator: 21
Diagnosis (% of participants):
Previous MI: intervention: 31.7; comparator: 38.1
Previous PCI: intervention: 21.1; comparator: 23.8
Previous CABG: intervention: 0; comparator: 9.5
Heart failure LVEF ≤ 45%: intervention: 50.0; comparator: 42.9
Event prior to entry into the study:
Post‐MI without invasive procedure: intervention: 0; comparator: 19.1
Post‐PCI: intervention: 84.2; comparator: 66.7
Post‐CABG: intervention: 15.8; comparator: 14.3
Age (mean ± SD): intervention: 77.3 ± 6.0; comparator: 76.5 ± 7.7
Percentage male: intervention: 63.2%; comparator: 52.3%
Ethnicity: NR
Interventions Intervention: individualised exercise programmes followed the international recommendations with 30 min exercise/day including 5‐ to 10‐min warm‐up (e.g. slow walking) and 10‐min cool‐down at a frequency of 6 days/week at an intensity of 11 to 13 on the Borg scale. For very disabled participants, the exercise programmes were of shorter duration but then repeated several times a day. At 4 and 5 months, a telephone call was made by the cardiologist to encourage continuous exercising and to answer any medical questions.
Components: exercise plus risk factor management
Setting: unsupervised individualised programme at home, with telephone support
Exercise programme modality: individualised
Length of session: 30 min
Frequency: 6 days a week
Intensity: 11 to 13 on the Borg scale
Resistance training included? No
Total duration: 12 months
Co‐interventions: the participants consulted a cardiologist at baseline and after 3, 6 and 12 months, regarding risk factor intervention and medical adjustment. All participants were offered dietary counselling and, if required, smoking cessation.
Comparator: participants received usual care. They received consultation with a cardiologist, and telephone calls at 4 and 5 months. They were not offered exercise education or dietary counselling.
Co‐interventions: participants were offered risk factor intervention and medical adjustment by a cardiologist at baseline and after 3, 6 and 12 months.
Outcomes Mortality, HRQoL
Source of funding Velux Foundations
Conflicts of interest None
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Patients were randomised in alternated block sizes of 4–6 using computer‐generated randomly permuted blocks”.
Allocation concealment (selection bias) Low risk “An impartial person, not related to the study, randomised the patients”.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk “Because of the nature of the intervention, concealment of randomisation was not feasible with regard to both patients and researcher”. It is not clear if outcome measures are blinded.
Incomplete outcome data (attrition bias)
All outcomes Low risk “A total of nine patients died during a mean follow‐up of 4.5 years (usual care group n=5 and home group n=4). There was no loss to follow‐up.”
Selective reporting (reporting bias) High risk Although the methods state that outcomes were measured at 3, 6 and 12 months, only exercise capacity is reported at 6 months.

Oldridge 1991.

Study characteristics
Methods Study design: multicentre RCT (6 sites)
Country: Canada
Dates participants recruited: NR
Maximum follow‐up: 1 year
Participants Inclusion criteria: diagnosis of AMI and scoring > 5 on the short form of the Beck Depression Inventory or > 43 on the Spielberger State Anxiety Inventory or > 42 on the Spielberger Trait Anxiety Inventory while still in hospital
Exclusion criteria: residence > 30 miles from the Health Sciences Centre; inability to exercise due to
uncontrolled dysrhythmias, heart failure or unstable angina; neurologic, orthopedic, peripheral vascular or respiratory disease; and inability to complete the quality of life questionnaires due to cognitive or language problems
N randomised: total: 201; intervention: 99; comparator: 102
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 52.9 ± 9.5; comparator: 52.7 ± 9.5
Percentage male: intervention: 88%; comparator: 90%
Ethnicity: NR
Interventions Intervention: participants attended 50‐min exercise sessions twice a week for 8 consecutive weeks. These sessions were held in a hospital gymnasium under the direct supervision of a cardiologist and qualified exercise specialists. There was a I0‐min group warm‐up at the beginning of each session; stationary cycle ergometry, treadmill walking and arm ergometry followed for 20 to 30 minutes. A cool‐down, involving low‐intensity activities, concluded the exercise session.
Components: exercise and behavioural counselling
Setting: centre
Exercise programme modality: stationary cycle ergometry, treadmill walking and arm ergometry
Length of session: 50 min
Frequency: twice a week
Intensity: initially on 65% of the maximal heart rate
Resistance training included? No
Total duration: 8 weeks
Co‐interventions: the cognitive behavioural group intervention, facilitated by group leaders without formal training in counselling, consisted of 8 sessions of 90 minutes complemented by progressive relaxation training at the end of the session. Both participant and spouse were invited to attend the group sessions.
Comparator: conventional care
Co‐interventions: none described
Outcomes Mortality. Health‐related quality of life: QOLMI time trade‐off. Cost data reported in Oldridge 1993
Source of funding This work was supported by the National Health Research and Development Programme, Health and Welfare, Canada
Conflicts of interest NR
Notes Both groups improved over 12 months, with the biggest changes occurring in the first 8 weeks.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes High risk "the investigators were not blinded to allocation"
Incomplete outcome data (attrition bias)
All outcomes High risk For the primary outcome ‐ HRQL ‐ 9% lost to follow‐up; no description of withdrawals or dropouts
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Ornish 1990.

Study characteristics
Methods Study design: multicentre RCT (2 sites)
Country: USA
Dates participants recruited: NR
Maximum follow‐up: 5 years
Participants Inclusion criteria: age 35 to 75 years, male or female; residence in the greater San Francisco area; one, two, or three vessel CAD (defined as any measurable coronary atherosclerosis in a non‐dilated or non‐bypassed coronary artery); LVEF > 25%
Exclusion criteria: other life‐threatening illnesses; MI during the preceding 6 weeks, history of receiving streptokinase or alteplase; currently receiving lipid‐lowering drugs; scheduled to receive CABG
N randomised: total: 48; intervention: 28; comparator: 20
Diagnosis (% of participants): moderate to severe CAD: 100%
Age (mean ±SD): Intervention: 56.1 ± 7.5; Comparator: 59.8 ± 9.1
Percentage male: Intervention: 95%; Comparator: 79%
Ethnicity: NR
Interventions Intervention: the intervention began with a week‐long residential retreat at a hotel to teach the lifestyle intervention to the experimental‐group participants. Participants then attended regular group support meetings (4 h twice a week). Participants were individually prescribed exercise levels (typically walking) according to their baseline treadmill test results. Participants were asked to exercise for a minimum of 3 h per week and to spend a minimum of 30 min per session exercising within their target heart rates.
Components: exercise plus psychosocial and diet
Setting: centre
Exercise programme modality: typically walking
Length of session: minimum of 30 min
Frequency: up to 6 times a week
Intensity: heart rate of 50‐80%
Resistance training included? No
Total duration: 1 year
Co‐interventions: stress management, low fat vegetarian diet, group psychosocial support
Comparator: usual care
Co‐interventions: none described
Outcomes CHD mortality, non‐fatal MI, revascularisation
Assessment at baseline and after 1 year and 5 years
Source of funding National Heart, Lung, and Blood Institute of the National Institutes of Health, the Department of Health Services of the State of California, Gerald D. Hines Interests, Houston Endowment Inc, the Henry J. Kaiser Family Foundation. the John E. Fetzer Institute, Continental Airlines, the Enron Foundation, the Nathan Cummings Foundation, the Pritzker Foundation, the First Boston Corporation, Quaker Oats Co., Texas Commerce Bank, Corrine and David Gould, Pacific Presbyterian Medical Center Foundation, General Growth Companies, Arthur Andersen and Co.
Conflicts of interest NR
Notes Intervention group had 91% reduction in reported frequency of angina after 1 year and 72% after 5 years; comparator group had 186% increase in reported frequency of angina after 1 year and 36% decrease after 5 years.
Intervention group had 7.9% relative improvement in coronary artery diameter at 5 years, comparator group had 27.7% relative worsening at 5 years.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly assigned"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Investigators carrying out all medical tests remained unaware of both patient group assignment and the order of the tests".
Incomplete outcome data (attrition bias)
All outcomes High risk 45/93 (48%) of randomised participants did not participate; no description of withdrawals or dropouts
Selective reporting (reporting bias) High risk Outcomes are only presented for 1 year, although blood tests were also taken at 6 months.

Pal 2013.

Study characteristics
Methods Study design: single‐centre RCT
Country: India
Dates participants recruited: February 2007 to July 2010
Maximum follow‐up: 18 months
Participants Inclusion criteria: “Patients with proven CAD were recruited. Disease was diagnosed by history of electrocardiograms, echocardiography and treadmill testing. Their willingness to complete the entire span of the project (18 months) was assured.”
Exclusion criteria: “Patients who had other co‐morbid conditions (e.g. malignant hypertension, diabetes mellitus, chronic obstructive pulmonary disease, asthma, diseases of the nervous system, endocrinal disorders, congenital heart disease) and patients with known complications of CAD, those on pacemakers, and those who had undergone bypass surgery were excluded from the study”
N randomised: total: 258; intervention: 129; comparator: 129
Diagnosis (% of participants): participants with proven CAD (100%)
Age (mean ±SD): Intervention: 59.1 ± 9.9; Comparator: 56.4 ± 10.9
Percentage male: intervention: 80%; comparator: 81%
Ethnicity: NR
Interventions Intervention: yogic intervention plus medication performed in the Department of Physiology at Chhatrapati Sahuji Maharah Medical University under the guidance and supervision of yoga experts. 35 to 40 minutes per day, for 5 days per week over 18 months. 
Components: exercise only
Setting: centre
Exercise programme modality: yoga
Length of session: 35 to 40 minutes
Frequency: 5 times a week
Intensity: NR
Resistance training included? No
Total duration: 18 months
Co‐interventions: none described
Comparator: medication only
Co‐interventions: none described
Outcomes All‐cause mortality reported in study flow diagram
Source of funding Department of AYUSH, Ministry of Health and Family Welfare, Government of India
Conflicts of interest None declared
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Using a random number generator... A professional not associated with this study generated the randomization scheme.” 
Allocation concealment (selection bias) Low risk “A professional not associated with this study generated the randomization scheme.”
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding of yoga instructors, study personnel and outcome assessors was not described 
Incomplete outcome data (attrition bias)
All outcomes High risk 19% in the intervention group and 20% in the control group lost to follow‐up. Reasons were described and "Patients who dropped out of the study did not differ significantly in terms of age and sex".
Selective reporting (reporting bias) Unclear risk No published protocol or trial registration available. Triallists state that this study is part of “a larger study conducted under the Extra Mural Research Project of the Department of Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), at the Indian Ministry of Health and Family Welfare”  but no reference provided. 

Pomeshkina 2017.

Study characteristics
Methods Study design: single‐centre RCT with 3 arms (supervised cycling vs home‐based walking vs control)
Country: Russia
Dates participants recruited: NR
Maximum follow‐up: 12 months
Participants Inclusion criteria: male with coronary artery disease, planned myocardial revascularisation surgery (cardiopulmonary bypass)
Exclusion criteria: age over 65 years, unstable angina pectoris, recent MI (less than 30 days), changes in ECG making it difficult to interpret the QRS complex and ST segment, atrial fibrillation and other serious cardiac arrhythmias, decreased LVEF ( < 40%), pulmonary hypertension, respiratory and renal failure, metabolic (obesity, decompensated diabetes mellitus) and concomitant diseases that prevent exercise
N randomised: total: 114; intervention 1 (cycling): 36; intervention 2 (walking): 36; comparator: 42
Diagnosis (% of participants): CABG (100%)
Age (median, IQR): intervention 1 (cycling): 57, 51‐59; intervention: 56, 51‐57; comparator: 56 (51‐57)
Percentage male: 100%
Ethnicity (white %): NR
Interventions Intervention:
Group 1: controlled aerobic exercise carried out on a stationary bike
Group 2: independent dosed walking at home, with training pace controlled by pedometer
Components: Exercise only
Setting: group 1 ‐ hospital‐based; group 2 ‐ home‐based
Exercise programme modality: group 1 ‐ cycling; group 2 ‐ walking
Length of session: 30 minutes
Frequency: group 1: 3 sessions per week; group 2: at least 3 times per week
Intensity: group 1: 50% to 75% peak heart rate; group 2: walking pace determined by calculation using cycle ergometry test, target heart rate 50% to 75% peak
Resistance training included? No
Total duration: 3 months
Co‐interventions: None described
Comparator: Medication plus monthly telephone follow‐up
Co‐interventions: None described
Outcomes HRQoL (results not reported)
Source of funding Not reported
Conflicts of interest None declared
Notes Paper translated from Russian. Authors contacted to request HRQoL data, but no response received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk By simple randomisation using a table of random numbers
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes Low risk Number randomised and reported in final outcomes the same, appears to be no dropouts
Selective reporting (reporting bias) High risk Methods state that at each time point, participants underwent clinical examination, echocardiography, quality of life assessment and determination of exercise tolerance, but these results are not reported.

Pomeshkina 2019.

Study characteristics
Methods Study design: single‐centre RCT
Country: Russia
Dates participants recruited: January 2015 ‐ December 2016
Maximum follow‐up: 12 months
Participants Inclusion criteria: participants with coronary artery disease who underwent CABG with the presence of arterial erectile dysfunction
Exclusion criteria: confirmed endocrine causes of erectile dysfunction, acquired primary hypogonadism, anatomical deformities of the external genital organs, drug‐related decrease in secretion testosterone, cancer, history of stroke, radical interventions on the pelvic organs, decompensated somatic diseases, low (< 50 W) exercise tolerance (TFN), arterial hypertension with diastolic blood pressure above 100 mmHg, recent myocardial infarction (< 28 days), complex rhythm and conduction disturbances (paroxysmal tachycardia, atrial fibrillation, polytopic and group ventricular extrasystoles, atrioventricular blockade (II‐III degree), chronic heart failure (class III, IV), subacute course of chronic non‐specific lung diseases, postoperative thrombophlebitis of the lower extremities, diabetes mellitus, a variety of neurological disorders that could interfere with cycling.
N randomised: total: 114; intervention: 53; comparator: 61
Diagnosis (% of participants): CABG (100%)
Age (mean, SD): intervention: 56.9 ± 4.7; comparator: 57.1 ± 4.8
Percentage male: 100%
Ethnicity (white %): NR
Interventions Intervention: controlled physical training in the form of cycling training
Components: exercise only
Setting: centre‐based
Exercise programme modality: cycling
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? No
Total duration: NR
Co‐interventions: none described
Comparator: no physical training
Co‐interventions: none described
Outcomes Methods states: myocardial infarction (MI), episodes of unstable angina pectoris, ischaemic stroke, lethal outcomes. But these are not reported in the results.
Source of funding Not reported
Conflicts of interest None declared
Notes Paper translated from Russian. Authors contacted to request clinical outcome data, but no response received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information about methods used to generate allocation sequence
Allocation concealment (selection bias) Unclear risk No information about methods used to conceal allocation sequence
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided about blinding of outcome assessors
Incomplete outcome data (attrition bias)
All outcomes Low risk Appears to be no missing outcome data
Selective reporting (reporting bias) High risk Methods report collection of myocardial infarction (MI), episodes of unstable angina pectoris, ischaemic stroke, lethal outcome data, but these are not reported in results section

Prabhakaran 2020.

Study characteristics
Methods Study design: multicentre RCT (24 sites)
Country: India
Dates participants recruited: August 2014 ‐ March 2018
Maximum follow‐up: median follow‐up 21.6 months
Participants Inclusion criteria: participants aged 18 to 80 years with acute myocardial infarction within the past 14 days were eligible if they were willing and able to complete the hospital‐based CR programme. Acute MI confirmed by the WHO definition (presence of symptoms of ischaemia and changes in ECG) or the Third Universal definition of MI (elevation of a cardiac biomarker along with the presence of other symptoms of MI or changes in ECG).
Exclusion criteria: participants who practised yoga regularly (i.e. > 3hr per week) or were participating in other clinical trials. Those with diseases that limited their life span to < 1 year or considered unlikely to complete the study by the local investigator.
N randomised: total: 3959; intervention: 1970; comparator: 1989
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 53.4 ± 11; comparator: 53.4 ± 10.8
Percentage male: intervention: 86.2%; comparator: 85.9%
Ethnicity: NR
Interventions Intervention: Yoga‐care program. 13 direct contact sessions over 12 weeks. First two sessions delivered individually and the remainder in groups at the hospital. Group sessions lasted ~75 minutes and involved a combination of exercises related to general physical conditioning, stress and relaxation (health rejuvenating exercises ‐ around 10 min, yoga poses ‐ 25 min, breathing exercises ‐ 15 min, meditation and relaxation practices ‐ 15 min; and moderated discussion ‐ 10 min), and some exercises believed to be of particular cardio‐protective benefit in yogic texts. The lifestyle and other educational components were informed by yogic ideas but moderated by established scientific evidence. Sessions led by yoga teachers trained in delivery of yoga‐care program. Participants were also encouraged to practice daily at home following the instructions provided in a DVD and booklet.
Components: exercise and education
Setting: centre‐based
Exercise programme modality: yoga
Length of session: 75 min
Frequency: at least once a week
Intensity: not reported
Resistance training included? No
Total duration: 12 weeks
Co‐interventions: None described
Comparator: Enhanced standard care in the form of educational advice leaflets (once before discharge, at 5 and 12 weeks) along with standard medical care as elsewhere in India but does not include rehabilitation.
Co‐interventions: none described
Outcomes Mortality, MI, hospitalisations, HRQoL (only at 12 weeks), cost effectiveness
Source of funding Indian Council of Medical Research and the Medical Research Council, United Kingdom
Conflicts of interest Dr. Chathurvedi has served as a member of the Data Safety and Monitoring Committee for AstraZeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Block randomization, stratified by centers, age (<60 or $60 years), and sex, was carried out by a central computer program”
Allocation concealment (selection bias) Low risk "...central computer program using an interactive Web response system"
Blinding of outcome assessment (detection bias)
All outcomes Low risk “Events were adjudicated by an independent committee unaware of trial‐group assignments, using standard definitions specified in the protocol.”
Patient‐reported outcomes/quality of life not blinded.
Incomplete outcome data (attrition bias)
All outcomes Low risk Intervention 61/1979 (3%), Control 49/1989 (2%) participants lost to follow‐up are low in number and < 20%, similar across groups and for similar reasons. Protocol paper states that sensitivity analyses and multiple imputation would be performed, but these are not reported in the main publication.
Selective reporting (reporting bias) Low risk Protocol paper available. Prespecified economic analyses are not reported in the main report – authors confirmed this will be a separate publication. QoL data at later follow‐up time points also to be included in a later publication.

Reid 2012.

Study characteristics
Methods Study design: multicentre RCT (2 sites)
Country: Canada
Dates participants recruited: December 2004 to December 2007
Maximum follow‐up: 12 months
Participants Inclusion criteria: Admitted for acute coronary syndromes who: underwent successful percutaneous coronary revascularisation; were not planning on enrolling in CR; had Internet access at home or work; and were 20 to 80 years of age.
Exclusion criteria: CABG; implantable cardioverter‐defibrillator; NYHA Class III or IV heart failure; inability to speak and read English.
N randomised: total: 223 ; intervention: 115; comparator: 108
Diagnosis (% of participants):
AMI this admission: 29.1%
PCI this admission: 98.2%
First cardiac event: 64.6%
Previous AMI: 18.8%
Previous PCI: 27.4%
Previous CABG: 9.0%
Age (mean ±SD): intervention: 56.7 ± 9.0; comparator: 56.0 ± 9.0
Percentage male: intervention: 82.6%; comparator: 86.1%
Ethnicity: NR
Interventions Intervention: Participants were visited in hospital by an exercise specialist, who presented a personally tailored physical activity plan and instructions on how to access the CardioFit website. Following discharge, participants were asked to log their daily activity on the CardioFit website and complete a series of five online tutorials (at weeks 2, 4, 8, 14, and 20). Following each tutorial, a new physical activity plan was developed. Between tutorials, participants received emails from the exercise specialist providing motivational feedback on their progress.
Components: exercise plus psychological support
Setting: home
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 20 weeks
Co‐interventions: the CardioFit website and tutorials were designed to foster behavioural capability, self‐efficacy, social support, and realistic outcome expectations. Tutorials were organised to engage self‐control processes including exercise planning, goal setting, monitoring and self‐regulation, and relapse prevention.
Comparator: physical activity guidance from their attending cardiologist and an education booklet.
Co‐interventions: none described
Outcomes HRQoL
Source of funding Heart and Stroke Foundation of Ontario. Dr Reid was supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. Dr Blanchard is supported by the Canada Research Chairs programme.
Conflicts of interest "The authors declare that there is no conflict of interests"
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Participants were randomized ... using a random sequence that was computer generated by a statistical consultant in blocks of 4, 8, and 10."
Allocation concealment (selection bias) Low risk "Sequences were generated for Ottawa and London and placed in sealed, numbered envelopes to ensure that treatment allocation was concealed until after baseline data collection. Research coordinators allocated the next available number on study entry (while the participant was still hospitalized)"
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Research assistants, blinded to the participants’ treatment allocation, conducted follow‐up assessments"
Incomplete outcome data (attrition bias)
All outcomes High risk Loss to follow‐up was well reported but was high in both groups 36/115 [31%] and 33/108 [31%] were lost to follow‐up from the intervention and control groups.
Selective reporting (reporting bias) Low risk All outcomes described in the methods section are reported in results.

Roman 1983.

Study characteristics
Methods Study design: single‐centre RCT
Country: Chile
Dates participants recruited: June 1973 to June 1981
Maximum follow‐up: 9 years
Participants Inclusion criteria: participants with transmural AMI
Exclusion criteria: severe arrhythmias persisting after the acute phase of AMI (frequent ventricular premature beats, grade iii‐iv of the Lown classification, atrial flutter, partial or complete AV block); great left‐ventricular enlargement; left ventricular aneurysm; persistent cardiac failure; severe diastolic hypertension post‐myocardial infarction angina.
N randomised: total: 193; intervention: 93; comparator: 100
Diagnosis (% of participants):
Transmural AMI: 100%
Anterior wall infarction: 55%
Posteroinferior infarction: 45%
Age (mean ± SD): intervention: 56.2 ± 10.3; comparator: 59.1 ± 8.8
Percentage male: intervention: 93.6%; comparator: 87%
Ethnicity: NR
Interventions Intervention: Supervised physical training programme according to the guidelines reported by Zohman and Tobias. It was started with combined ergometric, callisthenic and walk‐jogging exercise lasting 30 min, three times a week. The intensity of the training was graded according to the target heart rate threshold, defined as 70% of maximal heart rate achieved by the participant in the former ergometric work test.
Components: exercise only
Setting: centre
Exercise programme modality: combined ergometric and walk‐jogging exercise
Length of session: 30 min
Frequency: three times a week
Intensity: 70% of maximal heart rate
Resistance training included? Callisthenics
Total duration: average 42 months (range 6 to 108 months)
Co‐interventions: none described
Comparator: Control participants were medically treated according to the guidelines commonly used; namely, short‐ and long‐lasting nitrites, ß‐ blockers or Ca antagonists (nifedipine).
Co‐interventions: A small number (8 participants) were also treated with oral anticoagulants.
Outcomes Mortality, MI and revascularisations
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “Patients were randomly allocated…”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes Low risk 18/93 (19.4%) and 18/100 (18%) withdrew or dropped out from intervention and control groups over the 9‐year period.
Selective reporting (reporting bias) Low risk Mortality, morbidity and complications were recorded over the duration of the study and are presented as rates.

Sandström 2005.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: NR (recruited over a period of 2½ years)
Maximum follow‐up: 12 months
Participants Inclusion criteria: participants > 65 years admitted following an acute coronary event. Participants had to perform a pre‐discharge exercise test with a workload of ≥ 70 watts in men and ≥ 50 watts in women.
Exclusion criteria: participants with neurological sequelae, memory dysfunction such as dementia, orthopaedic disability, inability to speak or understand Swedish, or both, and a planned coronary intervention within 3 months.
N randomised: total: 101; intervention: 50; comparator: 51
Diagnosis (% of participants):
Angina pectoris: intervention: 20%; comparator: 21%
Previous AMI: intervention: 18%; comparator: 11%
Acute coronary event: intervention: 50%; comparator: 51%
Previous PCI: intervention: 7%; comparator: 5%
Previous CABG: intervention: 9%; comparator: 9%
(Not mutually exclusive numbers.)
Age (median): total: 71 years (range 64‐84); intervention: 71 years (range 64‐84); comparator: 71 years (range 65‐83)
Percentage male: total 80.2%; intervention: 82%; comparator: 78.4%
Ethnicity: NR
Interventions Intervention: 50 min aerobic group training programme three times a week for 3 months, with a voluntary 50 min step‐down period once a week for another 3 months. The complete programme was supported by music, which guided the intensity of the performance during the session. The training sessions were followed by 10 min of relaxation, also supported by music.
Components: exercise only
Setting: centre‐based supervised group sessions
Exercise programme modality: aerobic exercises to music
Length of session: 50 min with a voluntary 50 min step‐down period once a week for another 3 months
Frequency: 3 times a week
Intensity: NR
Resistance training included? No
Total duration: 3 months
Co‐interventions: none described
Comparator: participants were recommended to take a daily walk at a comfortable speed, and to gradually increase the time, length and speed, and were encouraged to restart their prior physical activity as soon as they felt fit enough for this.
Co‐interventions: none described
Outcomes HRQoL and revascularisation
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "….were randomly allocated into one of two groups:”
Allocation concealment (selection bias) Unclear risk Allocation concealment was not described.
Blinding of outcome assessment (detection bias)
All outcomes Low risk “patients were evaluated ….. by an independent, blinded to group allocation, researcher.”
Incomplete outcome data (attrition bias)
All outcomes Low risk There was no attrition ‐ data were reported for all participants randomised.
Selective reporting (reporting bias) Low risk All outcomes mentioned in methods were reported at all time points.

Santaularia 2017.

Study characteristics
Methods Study design: single‐centre RCT
Country: Spain
Dates participants recruited: June 2010 ‐ June 2012
Maximum follow‐up: 12 months
Participants Inclusion criteria: Age over 18 years, diagnosis of myocardial ischaemia (MI pre‐infarct angina, angina pectoris, other specific forms of chronic ischaemic heart disease or unspecified ischaemic heart disease) during the current admission, residence in the catchment area of the hospital, absence of cognitive deficit (Pfeiffer test: 0‐2 mistakes), sufficient functional capacity to follow the CRP (Barthel index > 60), and willingness to participate in the study and provide signed informed consent.
Exclusion criteria: Symptoms of right heart failure producing pulmonary hypertension or dyspnoea caused by severe pulmonary pathology, additional comorbidities affecting the prognosis of cardiac disease, major comorbidities or limitations that could interfere with the exercise training programme.
N randomised: total: 86; intervention: 42; comparator: 44
Diagnosis (% of participants): intervention: myocardial ischaemia (85.4%), pre‐infarct angina (4.9%), cardiac angina (9.8%); comparator: myocardial ischaemia (72.7%), pre‐infarct angina (13.6%), cardiac angina (11.4%), other specific forms of chronic ischaemic heart disease (2.3%).
Age (mean ± SD): intervention: 59.4 ± 12; comparator: 59.7 ± 10.4
Percentage male: intervention: 93%; comparator: 77%
Ethnicity: NR
Interventions Intervention: Supervised outpatient exercise training programme based on the results of the exercise stress test and mindful of comorbid conditions and physical limitations. Intervention started within 3 days of exercise test which was performed within 1 month of discharge. Hospital‐based programme of physiotherapist‐supervised exercise (3 hours/week spread over 3 days), for 10 weeks. Classes consisted of 10 minutes of warm‐up and muscle stretching, 30 minutes of aerobic exercises on a cycle ergometer, 15 minutes of isotonic exercises for the upper and lower limbs and 5 minutes of cool‐down. Aerobic exercise intensity was between 75% and 90% of the maximum heart rate obtained in the previous exercise stress test and progressed according to the perceived exertion rate score of 11–15. Resistance training was performed with 10–15 repetitions for three sets, maintaining a perceived exertion rate score of 11–14.
Components: exercise only
Setting: centre‐based
Exercise programme modality: cycle ergometry
Length of session: 1 hour
Frequency: 3 sessions per week
Intensity: 75‐90% peak heart rate, RPE 11‐15
Resistance training included? Yes – upper and lower limb isotonic exercises, 10‐15 repetitions, 3 sets, RPE 11‐14
Total duration: 10 weeks
Co‐interventions: None described
Comparator: Standard care, given oral and written information about cardiovascular risk factors during hospitalisation. Participants instructed to do exercises to regain mobility and maintain muscle tone and peripheral circulation and taught breathing exercises. Participants provided guidance on how to return to physical activity. Scheduled for follow‐up visits at 3, 6 and 12 months post discharge to control risk factors, reinforce education measures and review adherence to cardiac medication.
Co‐interventions: none described
Outcomes Mortality, hospitalisations, HRQoL
Source of funding Supported by a grant from the Collegi de Fisioterapeutes de Catalunya (no.: R01/08‐09)
Conflicts of interest None declared
Notes Authors contacted to obtain appendices as they were not available online
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "A randomisation list in blocks of 10 was created by a computer random number generator."
Allocation concealment (selection bias) Unclear risk "The randomisation list and allocation of patients to each group were independently controlled by the Clinical Research Unit"
Blinding of outcome assessment (detection bias)
All outcomes Low risk "The endpoint committee who assessed the primary outcomes was blinded regarding group assignment."
Appears that HRQoL assessment was not blinded.
Incomplete outcome data (attrition bias)
All outcomes Low risk < 20% missing outcome data and reasons provided
Selective reporting (reporting bias) Low risk Published protocol paper available; all outcomes reported

Schuler 1992.

Study characteristics
Methods Study design: single‐centre RCT. Participants randomised after routine angiography for angina.
Country: Germany
Dates participants recruited: NR
Maximum follow‐up: 6 years
Participants Inclusion criteria: Male, stable symptoms, willingness to participate in the study for at least 12 months, coronary artery stenoses well documented by angiography, and permanent residence within 25 km of the training facilities at Heidelberg.
Exclusion criteria: Unstable angina pectoris, left main coronary artery stenosis > 25% luminal diameter reduction, severely depressed left ventricular function (ejection fraction < 35%), significant valvular heart disease, insulin‐dependent diabetes mellitus, primary hypercholesterolaemia (type II hyperlipoproteinaemia, low density lipoprotein [LDL] > 210 mg/dL), and occupational, orthopedic, and other conditions precluding regular participation in exercise sessions.
N randomised: total: 113; intervention: 56; comparator: 57
Diagnosis (% of participants): AMI: 66%
Age (mean ± SD): intervention: 52.8 ± 5.8; comparator: 54.2 ± 7.7
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: participants stayed on a metabolic ward during the initial 3 weeks, during which they were instructed how to lower the fat content of their regular diet. Participants were asked to exercise daily at home on a cycle ergometer for a minimum of 30 minutes close to their target heart rates, which were determined as 75% of the maximal heart rate during symptom‐limited exercise. In addition, they were expected to participate in at least two group training sessions of 60 minutes each week.
Components: exercise and education.
Setting: centre (group session) and unsupervised at home.
Exercise programme modality: cycle ergometer.
Length of session: 30 min at home and 60 min group session.
Frequency: daily at home; twice a week at centre.
Intensity: 75% maximal HR.
Resistance training included? No.
Total duration: 12 months.
Co‐interventions: participants were on their regular antianginal medication, including β‐blocking agents.
Comparator: participants spent 1 week on the metabolic ward, where they received identical instructions about the necessity of regular physical exercise and how to lower fat consumption. "Usual care" was rendered by their private physicians.
Co‐interventions: They were asked not to take lipid‐lowering medications.
Outcomes Total and CHD mortality, non‐fatal MI, revascularisation.
Source of funding Bundesministerium für Forschung und Technologie, Bonn, FRG.
Conflicts of interest NR
Notes Exercise adherence in the first year was 68% (39% to 92%), over the next 5 years 33% (3% to 89%).
Participants with regression of coronary atheroma attended exercise sessions significantly more often (54 +/‐ 24%) than participants with no change (20 +/‐ 24%) or progression 31 +/‐ 20%).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Low risk "sealed envelopes"
Blinding of outcome assessment (detection bias)
All outcomes Low risk "Evaluation of coronary angiograms was performed by two technicians blinded to the sequence of films and the patient's identity or group assignment."
Incomplete outcome data (attrition bias)
All outcomes High risk 20% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Seki 2003.

Study characteristics
Methods Study design: single‐centre RCT
Country: Japan
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: Male participants; > 65 years of age; with chronic CAD; referred at least 6 months after a major coronary event, including acute MI, coronary artery bypass grafting or percutaneous balloon angioplasty for acute coronary syndrome.
Exclusion criteria: none described.
N randomised: total: 38; intervention: 20; comparator: 18
Diagnosis (% of participants):
Chronic CAD: 100%
MI: 55%
PCI: 39%
CABG: 39%
Age (mean ± SD): intervention: 69.3±2.9 ; comparator: 70.1±3.7
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: participants participated in an outpatient phase III CR program for 6 months. The weekly supervised exercise session at the clinic consisted of approximately 20 min of warm‐up exercises including stretching and callisthenics, followed by 20–30 min of continuous upright aerobic and dynamic exercise (various combinations of walking, bicycling, jogging, and other activities) and light isometric exercise, such as hand weights, and approximately 20 min of cool‐down stretching and callisthenics. The intensity of exercise was prescribed individually at the anaerobic threshold level measured by a symptom‐limited treadmill exercise test at baseline. In addition to the supervised exercise session, participants were encouraged to exercise twice a week outside of the clinic. Each participant’s exercise prescription was also periodically adjusted on the basis of repeated treadmill exercise test to encourage a gradual increase in overall exercise performance.
Components: exercise and education.
Setting: supervised in a centre and independent at home.
Exercise programme modality: e.g. walking, bicycling, jogging.
Length of session: 60‐70 min.
Frequency: weekly at centre plus twice a week at home.
Intensity: prescribed individually.
Resistance training included? Callisthenics.
Total duration: 6 months.
Co‐interventions: participants were encouraged and interviewed at the supervised exercise session by physicians, dietitians, nurses, and exercise physiologists to comply with both the exercise and dietary education of the programme throughout its duration.
Comparator: participants were followed by an individual physician as a usual outpatient.
Co‐interventions: none described.
Outcomes Health‐related quality of life at 6 months.
Source of funding Health Sciences Research Grants from Ministry of Health and Welfare (Comprehensive Research on Aging and Health).
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly assigned..by envelope method"
Allocation concealment (selection bias) Unclear risk "randomly assigned..by envelope method"
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes Low risk All 38 participants accounted for.
Selective reporting (reporting bias) Low risk All outcomes are reported for all time points.

Seki 2008.

Study characteristics
Methods Study design: single‐centre RCT
Country: Japan
Dates participants recruited: NR
Maximum follow‐up: 6 months
Participants Inclusion criteria: > 65 years old with stable CAD
Exclusion criteria: Ongoing congestive heart failure, liver dysfunction, renal dysfunction, or systemic diseases, including malignancy and collagen disease.
N randomised: total: 39; intervention: 20; comparator: 19
Diagnosis (% of participants):
stable CAD: 100%
MI: 46%
PCI: 31%
CABG: 36%
Age (mean ± SD): intervention: 69±3 ; comparator:70±4
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: Weekly outpatient phase III cardiac rehabilitation programme that included an exercise session, exercise prescription, dietary instruction and an educational programme for 6 months. Supervised exercise sessions at the clinic consisted of approximately 15 min of warm‐up exercises including stretching, followed by 20 to 60 min of continuous upright aerobic exercise and light isotonic exercise such as sit‐ups and squatting using the participant's own body weight, followed by approximately 15 min of cool‐down stretching and callisthenics. The intensity of exercise was prescribed individually at the anaerobic threshold (AT) level as measured by a treadmill exercise test using expiratory gas analysis or a rating of 12 to 13 on the standard Borg perceived exertion scale. In addition to the weekly supervised exercise sessions, participants were encouraged to perform aerobic exercise twice weekly (≥ 30 min) at home at an intensity of heart rate of AT or a rating of 12 to 13 on the Borg scale.
Components: exercise and education.
Setting: centre and home.
Exercise programme modality: e.g. walking, bicycling, jogging.
Length of session: 50 to 110 min at the centre; ≥ 30 min at home.
Frequency: weekly at the centre plus twice a week at home.
Intensity: 12 to 13 on the standard Borg scale.
Resistance training included? Callisthenics.
Total duration: 6 months.
Co‐interventions: participants were instructed about the phase II diet of the American Heart Association at the beginning and every 2 months of the study. An educational programme was also given to each subject by physicians and nurses regarding ischaemic heart disease and risk factors at baseline. Subjects were frequently encouraged by physicians, dietician, nurses, and exercise physiologists to comply with both exercise and dietary instructions throughout the programme. Standard medical care was provided for both groups. Lipid‐lowering drugs and other medications that may affect lipid levels were given at stable doses for at least 4 weeks before entry, and the doses of these medications were not altered during the study period.
Comparator: usual outpatient care.
Co‐interventions: none described.
Outcomes Total mortality; non‐fatal/fatal mortality.
Source of funding Health Sciences Research Grants from Ministry of Health, Labour and Welfare (Comprehensive Research on
Aging and Health).
Conflicts of interest NR
Notes "No subject in either group showed any worsening of symptoms or had clinical events during this study."
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomly assigned"
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No information reported.
Selective reporting (reporting bias) Low risk All outcomes were reported for all time points.

Shaw 1981.

Study characteristics
Methods Study design: Multicentre RCT (5 sites)
Country: USA
Dates participants recruited: 1976
Maximum follow‐up: 5 years
Participants were randomised after completion of a 6‐week, low‐level exercise programme run‐in period.
Participants Inclusion criteria: documented MI ≥ 8 weeks but ≤ 3 years before being enrolled. Other eligibility criteria included the ability to exercise at an intensity level ≥ 3 metabolic equivalents (METs) and a supine resting diastolic blood pressure < 100 mmHg.
Exclusion criteria: participants were considered ineligible if they had any other significant coexisting CVD or other disease likely to be fatal in the near future, uncontrolled diabetes mellitus, complete heart block with or without ventricular pacemaker, or emotional or physical impairments that would make participation and adherence difficult, or if they were already participants in a formal exercise programme.
N randomised: total:651; intervention: 323; comparator: 328
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 51.5 ± 7.4; comparator: 52.1 ± 7.2
Percentage male: 100%
Ethnicity % white: intervention: 93.3%; comparator: 94.4%
Interventions Intervention: An exercise prescription was developed on the basis of each participant’s multistage graded exercise test (MSET) results. An exercise target heart rate guided the prescription and was determined as 85% of the peak heart rate achieved on the test. This group performed brisk physical activity in the laboratory for 8 weeks, exercising 1 hour per day, 3 days per week. The participants were supervised and underwent continuous ECG monitoring. Each individual exercised for 4 minutes on each of 6 stationary machines with a 2‐minute rest interval between machines. Attainment of the target heart rate was the goal for every 4‐minute exercise period.
After 8 weeks, participants exercised in a gymnasium or swimming pool without ECG monitoring, although exercise heart rates were periodically checked. Activities consisted of 15 minutes of continuous jogging, cycling, or swimming, followed by 25 minutes of recreational games. The activities were performed at an intensity level enabling each participant to reach his individually prescribed target heart rate. The men were encouraged to attend 3 sessions per week but in some situations were allowed to exercise on their own.
Components: exercise only.
Setting: group sessions in centre (“but in some situations were allowed to exercise on their own”).
Exercise programme modality: “brisk physical activity” on “stationary machines”.
Length of session: 40 min.
Frequency: 3 days per week.
Intensity: 85% of the peak heart rate.
Resistance training included? No
Total duration: 8 weeks in the laboratory, followed by regular jogging, cycling, or swimming and recreational games.
Co‐interventions: none described.
Comparator: Participants in the non‐exercising control group were encouraged to maintain normal routines but not to participate in any regular exercise programme.
Co‐interventions: none described.
Outcomes Total & CHD mortality, non‐fatal MI.
Source of funding National Heart, Lung, and Blood Institute.
Conflicts of interest NR
Notes 90% of ET attended 90% of 24 scheduled sessions post‐randomisation, only 48% attending > 50% of sessions at 18 months.
30% of control alleged exercising regularly, on own initiative.
At 19 years any protective effect from the programme had decreased over time, but an increase with PWC from the beginning to the end of the trial was associated with a consistent reduction in mortality throughout the 19 years of follow‐up.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Sequence generation not described…."the men were randomly assigned.”
Allocation concealment (selection bias) Unclear risk Allocation concealment not described.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk 6.5% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes reported for all time points.

Sivarajan 1982.

Study characteristics
Methods Study design: Multicentre RCT (7 sites)
Country: USA
Dates participants recruited: 1 September 1977 to 2 December 1979
Maximum follow‐up: 6 months
Random allocation of individuals to two intervention groups (exercise only (Intervention B1) or exercise plus teaching and counselling (Intervention B2)) and a control group (usual care).
Participants Inclusion criteria: Previous MI, age < 70 years, living < 50 miles of centre.
Exclusion criteria: prolonged complications, physical limitations, noncardiac or cardiac diseases, communication problems, other issues e.g. massive obesity, psychological problems, etc.
N randomised: total: 258; Intervention B1: 88; Intervention B2: 86; comparator: 84
Diagnosis (% of participants): AMI: 100%
Age (mean ±SD): Intervention B1: 55.6 ± 9.3; Intervention B2: 56.3 ± 8.3; comparator = 57.1 +/‐ 7.3
Percentage male: > 80%
Ethnicity: > 80% white
Interventions Intervention: The outpatient exercise programme was identical for the participants in groups Bl and B2. It consisted of a gradually progressive callisthenic and walking programme prescribed at weekly 30‐minute clinic visits and performed by the participant at home. Participants were instructed to exercise twice a day until they returned to work and once a day thereafter. If the participant was symptom free, the prescription was gradually increased to add callisthenics of increasing intensity and the distance and time (or rate) of walking were gradually advanced.
Components: exercise only or exercise plus education and counselling.
Setting: centre and home.
Exercise programme modality: walking.
Length of session: NR
Frequency: twice a day until return to work and once a day thereafter.
Intensity: NR
Resistance training included? callisthenics.
Total duration: NR
Co‐interventions: participants in group B2, in addition to receiving exercise prescriptions as described above, attended a series of eight 1‐hour group sessions during weekly clinic visits. The sessions emphasised the practical aspects of anatomy and physiology of the heart, coronary artery disease, myocardial infarction and medications; risk factors, including smoking, hypercholesterolaemia, hypertension, stress and sedentary living; nutritional
aspects of fats, cholesterol, salt and alcohol; activities and exercises; emotional reactions to myocardial infarction
in participants and their families; resumption of sexual activity; and issues concerning return to work or, if retired, to an alternative, meaningful lifestyle.
Comparator: conventional medical and nursing management throughout all phases of hospitalisation and convalescence at home.
Co‐interventions: none described.
Outcomes Total mortality; health‐related quality of life: Sickness Impact Profile.
Source of funding Bureau of Health Professions, Division of Nursing, Department of Health and Human Services.
Conflicts of interest NR
Notes Several reports of the same trial all with various bits of information. Study authors conclude that multiple intervention trial of this short duration did not change participants' behaviour. MI itself acts as a strong stimulus to alter behaviour with respect to risk factors.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk 24% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Snoek 2020.

Study characteristics
Methods Study design: Multicentre RCT (6 sites across 5 countries)
Country: Europe (the Netherlands, Denmark, Spain, Switzerland, France)
Dates participants recruited: November 2015 ‐ January 2018
Maximum follow‐up: 12 months
Participants Inclusion criteria:
Participants of 65 years or older who are a candidate for CR and non‐voluntary to participate in the regular CR programme
Signed written informed consent
One of the following criteria:
  • participants with an acute coronary syndrome, including myocardial infarction (MI) and/or revascularisation within 3 months prior to the start of the CR program

  • participants that underwent a percutaneous coronary intervention (PCI) within 3 months prior to the start of the CR programme

  • participants that received coronary artery bypass grafting (CABG) within 3 months prior to the start of the CR programme

  • participants who were treated surgically or percutaneously for valvular heart disease (including TAVI) within 3 months prior to the start of the CR programme

  • participants with a stable angina with documented significant CAD (defined by standard non‐invasive or invasive methods


Exclusion criteria:
  • Contraindication to CR

  • Mental impairment leading to inability to cooperate

  • Severe impaired ability to exercise

  • Signs of severe cardiac ischaemia and/or a positive exercise testing on severe cardiac ischaemia

  • Insufficient knowledge of the native language

  • No access, availability or insufficient knowledge of a computer with internet

  • Implanted cardiac device (pacemaker, ICD)


N randomised: total: 179; intervention: 89; comparator: 90.
Diagnosis (% of participants):
PCI: intervention 63 (71%); control 65 (72%)
CABG: intervention 11 (12%); control 8 (9%)
Valve replacement: intervention 1 (1%); control 3 (3%)
None: intervention 14 (16%); control 14 (16%)
Age (mean ±SD): intervention: 72.4 ± 5.4; comparator 73.6 ± 5.5
Percentage male: intervention: 78%, comparator: 84%
Ethnicity: intervention: 99%, comparator: 99% white
Interventions Intervention: 6‐month home‐based CR program equipped with a smartphone and heart rate belt. Participants instructed to exercise at moderate intensity for at least 30 minutes per day, 5 days per week. Motivational interviewing was applied by telephone weekly in the first month, every other week in the second month, and monthly until completion of the program at 6 months
Setting: Home‐based
Exercise programme modality: Self‐chosen type of activity
Length of session: > 30 minutes
Frequency: five sessions per week.
Intensity: self‐selected level of intensity (guided by RPE and heart rate zones)
Resistance training included? NR
Total duration: 6 months.
Co‐interventions: none described
Comparator: participants in the control group did not receive any form of cardiac rehabilitation but received locally defined standard of care.
Co‐interventions: none described.
Outcomes Mortality, MI, PCI, cardiovascular hospitalisation, HRQoL
Source of funding Study was supported by grant 634439 from the European Union’s Horizon 2020 Research and Innovation Programme and contract 15.0139 from the Swiss State Secretariat for Education, Research and Innovation
Conflicts of interest Mr Snoek reported receiving grants from European Union’s Horizon 2020 Research and Innovation Programme during the conduct of the study. Dr van der Velde reported receiving grants from the European Union during the conduct of the study. Dr Eijsvogels reported receiving a personal grant from the Dutch Heart Foundation. Dr Prins reported receiving grants from the European Commission during the conduct of the study and outside the submitted work. Dr Bruins reported receiving grants from Isala Heart Centre during the conduct of the study. Dr Meindersma reported receiving grants from the European Commission during the conduct of the study. Dr Peña‐Gil reported receiving grants from European Commission during the conduct of the study. Dr González‐Salvado reported receiving grants from the European Union during the conduct of the study. Dr Iliou reported receiving personal fees and non‐financial support from Servier Laboratories, non‐financial support from Novartis International AG and Sanofi SA, and personal fees from AstraZeneca outside the submitted work. Dr Marcin reported receiving grants from the Swiss National Fond during the conduct of the study. Dr Van’t Hof reported receiving grants from the European Union during the conduct of the study and grants from Medtronic plc, AstraZeneca, and Abbott Laboratories outside the submitted work. Dr de Kluiver reported receiving grants from the European Union during the conduct of the study and having an indirect interest in HC@home/Mobihealth, which provided the hardware and software for this study, outside the submitted work. No other disclosures were reported.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Randomization was performed in fixed blocks of 4, stratified by center, with a 1:1 ratio to the intervention group (MCR) or a control group without cardiac rehabilitation using a centralized computerized allocation system.”
Allocation concealment (selection bias) Low risk “Randomization was performed in fixed blocks of 4, stratified by center, with a 1:1 ratio to the intervention group (MCR) or a control group without cardiac rehabilitation using a centralized computerized allocation system.”
Blinding of outcome assessment (detection bias)
All outcomes Low risk “Researchers assessing primary outcomes were blinded for group assignment.”
Incomplete outcome data (attrition bias)
All outcomes Low risk Intervention group: 16/89 (18%) lost to follow‐up
Control group: 12/90 (13%) lost to follow‐up
Selective reporting (reporting bias) Low risk Trial protocol provided as supplementary file in main publication; outcomes reported in protocol are reported at 6 and 12 months in the results. Costs mentioned in the protocol but likely to be in a future publication.

Specchia 1996.

Study characteristics
Methods Study design: single‐centre RCT
Country: Italy
Dates participants recruited: NR (40‐month period)
Maximum follow‐up: mean 34.5 months
Participants Inclusion criteria: participants < 65 years of age who had not had previous MI, admitted due to chest pain lasting > 30 minutes and because they had a diagnosis of AMI based on evolutionary ECG changes and serum kinase elevation.
Exclusion criteria: complicated in‐hospital clinical course e.g. post‐infarction angina requiring urgent revascularisation; evidence of congestive HF; chronic concomitant illnesses or musculoskeletal handicaps that would prevent them from finishing the exercise training period.
N randomised: total: 256; intervention: 125; comparator: 131
Diagnosis (% of participants):
MI: 100%
Prior angina: 42%
Age (Mean ± SD): intervention: 51.5 ± 7; comparator: 54.3 ± 8
Percentage male: 91% intervention: 91%; comparator: 91%
Ethnicity: NR
Interventions Intervention: participants underwent a 4‐week physical training period consisting of supervised training sessions of 30 minutes of bicycle ergometry five times a week combined with callisthenics. Training intensity was graded according to 75% of maximal work capacity reached in the previous exercise test. At the end of the 4‐week training period, a second symptom‐limited exercise test was performed. Participants were then discharged with the instructions to continue the callisthenics daily and to walk for ≥ 30 minutes every 2 days.
Components: exercise, education and psychology.
Setting: centre and then home.
Exercise programme modality: bicycle ergometry in centre followed by callisthenics and walking at home.
Length of session: ≥ 30 minutes.
Frequency: five times a week in centre followed by daily callisthenics and walking every other day.
Intensity: 75% of maximal work capacity.
Resistance training included? Callisthenics.
Total duration: 4 weeks supervised and then continued at home.
Co‐interventions: All participants went to the Rehabilitation Center for 3 weeks and underwent a symptom‐limited exercise test (28 ± 2 days after myocardial infarction), 24‐hour Holter monitoring, and coronary arteriography (31 ± 3 days after the acute episode). All participants attended colloquial sessions, held by a cardiologist and a psychologist, dealing with secondary prevention of cardiovascular diseases and stressing dietary changes and smoking cessation.
Comparator: Discharged after rehab centre and clinically re‐examined 1 month later when they underwent a second symptom‐limited exercise test.
Co‐interventions: as above
Outcomes CHD mortality, revascularisations
Source of funding NR
Conflicts of interest NR
Notes Ejection fraction (EF) was the only prognostic factor.
Among 51 participants with EF < 41%, relative risk for the 27 untrained participants was 8.63 times higher than for 24 trained ones. (P = 0.04)
If EF > 40%, estimated risk for untrained participant was 1.07 times higher than for trained.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes Low risk No losses to follow‐up.
Selective reporting (reporting bias) High risk While survival data is provided, detailed clinical information was obtained from all participants at 3‐ to 4‐month intervals and these data are not reported.

Ståhle 1999.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: October 1994 to June 1997
Maximum follow‐up: 1 year
Participants Inclusion criteria: participants ≥ 65 years admitted because of an acute coronary event. To be included, the participants had to perform a pre‐discharge exercise test at a workload ≥ 70 W in men and ≥ 50 W in women. For the group with unstable angina pectoris, a ST60 depression of > 1 mm in ≥ two adjacent leads had to be documented at the exercise test.
Exclusion criteria: neurological sequelae, memory dysfunction, orthopaedic disability, inability to understand Swedish, coronary intervention planned within 3 months or other complicating diseases.
N randomised: total: 109; intervention: 56; comparator: 53
Diagnosis (% of participants):
Congestive heart failure: 6%
Previous AMI: 27%
Angina pectoris: 38%
Previous PCI: 11%
Previous CABG: 17%
Age years, (range): intervention: 71 (64‐84); comparator: 68 (65‐83)
Percentage male: intervention: 73%; comparator: 75%
Ethnicity: NR
Interventions Intervention: 50 min aerobic outpatient group‐training programme (including warm‐up and cool‐down) 3 times a week for 3 months. Complete programme was supervised by specialised physiotherapist and supported by music which guided intensity of performance during session. Training followed by 10 min of music‐supported relaxation. After 3 months, participants had possibility of participating in programme once a week for another 3 months.
Components: exercise.
Setting: supervised centre‐based group sessions.
Exercise programme modality: NR
Length of session: 50 min plus 10 min relaxation.
Frequency: 3 times a week.
Intensity: NR
Resistance training included? NR
Total duration: 3 months followed by opportunity to continue once a week for another 3 months.
Co‐interventions: none described
Comparator: usual care ‐ encouraged to re‐start usual/prior physical activity as soon as they felt fit.
Co‐interventions: none described
Outcomes Total mortality, CABG, PCI, health‐related quality of life; Karolinska Questionnaire at 12‐months.
Source of funding National Association for Heart and Lung Patients, the Swedish Heart and Lung Foundation, the Swedish Foundation of Health Care Sciences and Allergy Research, and the King Gustaf V and Queen Victoria Foundation.
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk Clinical event data for 8 (7%) who withdrew before 3 months were not accounted for at 1 yr.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Stern 1983.

Study characteristics
Methods Study design: single‐centre RCT
Country: USA
Dates participants recruited: NR
Maximum follow‐up: 1 year.
Randomised by blocks of 6 into one of three groups: exercise, group counselling & control.
Participants Inclusion criteria: Aged 30 to 69 years with documented MI not less than six weeks nor more than one year prior to admission to the study. Work capacity level < 7 MET (men) or < 6 MET (women) or a Taylor Manifest Anxiety Scale raw score of 19 + or Zung Self‐rating Depression Scale raw score of 40 +, or any or all of these.
Exclusion criteria: Presence of unstable cardiovascular condition i.e. congestive heart failure, or requirement of treatment for any physical/psychological reason.
N randomised: total: 106; intervention: 42; comparator (usual care): 29; group counselling: 35 (no data analysed in this review)
Diagnosis (% of participants): MI: 100%
Age (mean): 54
Percentage male: intervention: 90%; comparator: 76%
Ethnicity: 85% white
Interventions Intervention: Three one‐hour sessions per week over a 12‐week period. All exercises were dynamic, involving rhythmic movements against resistance. Half were upper limb (rowing machine, arm wheel, and arm ergometer) and half were lower limb (treadmill, cycle, and step ergometer). Participants exercised upper and lower limbs alternately for four minutes with two minutes of rest in between. The intensity of exercise was determined by heart‐rate response, the target level being 85% of the peak exercise heart rate achieved in the first evaluation. If the heart rate was consistently above or below target, the work load was increased or decreased.
Components: exercise.
Setting: supervised in a centre.
Exercise programme modality: e.g. rowing, treadmill, cycle or step ergometer.
Length of session: 1 hour.
Frequency: 3 times a week.
Intensity: Target HR 85% of HR max at exercise tolerance test.
Resistance training included? No.
Total duration: 12 weeks.
Co‐interventions: none described.
Comparator: followed up by their physicians and given routine post‐MI medical care. Participants were requested to not join a supervised exercise or a formal counselling programme.
Co‐interventions: none described.
Outcomes Mortality, non‐fatal MI.
Source of funding National Institute of Handicapped Research, Department of Education, Washington, DC.
Conflicts of interest Not reported
Notes Minimal differences between groups at one year.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk 7.7% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes reported for all time points.

Sun 2016.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: NR
Maximum follow‐up: 12 months
Participants Inclusion criteria:
1) 60 to 75 years old
2) Stable coronary heart disease patients
3) Participants with low or medium risk of coronary heart disease (according to the risk stratification standard)
Exclusion criteria:
1) Uncontrolled hypertension; that is, resting systolic blood pressure > 160mm Hg or resting diastolic blood pressure > 100mm Hg
2) Moderate to severe heart valve stenosis
3) Severe left aortic stenosis (stenosis degree ≥ 70%)
4) Osteoarthrosis or vascular disease of the lower extremity
5) Malignant neoplasm
N randomised: total: 70; intervention: 35; comparator: 35
Diagnosis (% of participants): intervention: stable angina pectoris (57.1%), asymptomatic post MI (20%), old MI (28.6%), post PCI (25.7%); comparator: stable angina pectoris (51.4%), asymptomatic post MI (5.7%), old MI (22.9%), post PCI (42.9%), post CABG 5.7%.
Age (mean, range): intervention: 65, range 61‐72; comparator: 65, range 60‐70.
Percentage male: intervention: 54%; comparator: 69%
Ethnicity: NR
Interventions Intervention:
1) Exercise mode: Walk or jog on the exercise board (T2100 exercise board equipped with 12 leads ECG and blood pressure monitoring)
2) Exercise intensity: The heart rate reserve method was used combining self‐perceived fatigue of the participant to reach 50% to 80% of the maximum exercise intensity or Borg rate of perceived exertion at 12 to 16
3) Exercise time: 30 ‐ 60 mins, including 5 ‐ 10 mins warm‐up and relaxation exercises
4) After discharge, participants can choose one or more kinds of aerobic exercise rehabilitation from walking, jogging, walking on the treadmill, cycling, swimming, and playing badminton etc. for 3 to 5 times a week.
Components: exercise plus education.
Setting: centre‐based (3 months), home‐based (9 months)
Exercise programme modality: walking, jogging, walking on the treadmill, cycling, swimming, and playing badminton etc.
Length of session: 30‐60 minutes.
Frequency: 3 sessions per week.
Intensity: 50‐80% heart rate reserve or RPE 12‐16.
Resistance training included? NR
Total duration: 12 months.
Co‐interventions: None described
Comparator: “conventional treatment” including “health education and standard medication”
Co‐interventions: none described.
Outcomes No relevant outcomes reported
Source of funding Military Medicine and Geriatrics of the Headquarters of the General Staff (ZCWS14C25)
Conflicts of interest Not reported
Notes Study reports outcomes of BMI, BP, lipids, smoking, and no CONSORT flow diagram reported.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "random number table used"
Allocation concealment (selection bias) Unclear risk No details reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No details of blinding reported
Incomplete outcome data (attrition bias)
All outcomes Low risk Reasons for lost to follow‐up provided, and equal across groups
Selective reporting (reporting bias) Unclear risk Protocol paper not available

Toobert 2000.

Study characteristics
Methods Study design: single‐centre RCT
Country: USA
Dates participants recruited: NR
Maximum follow‐up: 24 months
Participants Inclusion criteria: Postmenopausal women with coronary heart disease, defined as atherosclerosis, MI, percutaneous transluminal coronary angioplasty, and/or coronary bypass graft surgery.
Exclusion criteria: Other life‐threatening illnesses, infarction during the preceding 6 weeks, receiving streptokinase or alteplase, or being scheduled for bypass surgery.
N randomised: total: 25; intervention: 14; comparator: 11
Diagnosis (% of participants):
CHD: 100%
Previous AMI: 52%
PCI: 36%
CABG: 28%
Age (mean ±SD): intervention: 64 ± 10; comparator: 63 ± 11
Percentage male: 0%
Ethnicity: 92% white
Interventions Intervention: Daily group physical activity sessions included warm‐up, walking or aerobics, and a cool‐down. Participants were individually prescribed exercise intensity based on their treadmill exercise test performance. Following the retreat, the intervention exercise programme required participants to engage in a 1‐hour session per day at least 3 days each week.
Components: exercise, education and psychological support.
Setting: supervised sessions in a centre followed by home.
Exercise programme modality: walking or aerobics.
Length of session: 1 hour.
Frequency: daily and then at least 3 days a week.
Intensity: individually prescribed.
Resistance training included? no.
Total duration: 24 months.
Co‐interventions:. Participants randomised to the PrimeTime programme began the intervention with a 7‐day retreat. Women were encouraged to bring their partner. As well as physical activity, the daily schedule included cooking classes, instruction in stress‐management techniques including Hatha Yoga stretches, progressive deep relaxation, deep breathing, meditation, group support, smoking cessation and directed or receptive imagery.Twice‐weekly 4‐hour meetings followed the retreat with each meeting following a sequence similar to the retreat schedule.
Comparator: usual care.
Co‐interventions: none described.
Outcomes Health‐related quality of life: SF‐36 at 24 months
Source of funding National Heart, Lung, and Blood Institute
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described
Incomplete outcome data (attrition bias)
All outcomes High risk 3/28 (10.7%) participants lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) High risk While most outcomes are reported at all time points, the SF‐36 is poorly reported and it is not stated for which follow‐up the results are reported

Uddin 2020.

Study characteristics
Methods Study design: Quasi‐RCT (single centre)
Country: Bangladesh
Dates participants recruited: July 2012 ‐ July 2013
Maximum follow‐up: 12 months
Participants Inclusion criteria: participants admitted for elective CABG surgery, aged between 25‐65 years and understood Bangla.
Exclusion criteria:
Admission for emergency CABG surgery or revision CABG surgery, any neurological problems or severe comorbidities, or they were not planning to stay in Bangladesh for ≥ 1 year after CABG surgery.
N randomised: total: 142; intervention: 71; comparator: 71
Diagnosis (% of participants): post‐CABG (100%).
Age (mean ± SD): intervention: 54 ± 6; comparator: 55 ± 6
Percentage male: intervention: 66 (93%); comparator: 63 (89%)
Ethnicity: NR
Interventions Intervention: participants participated in a 45‐min CR class (groups of 6‐10, 7‐8 days after surgery) in the hospital and were provided with an educational booklet in Bangla. In the class, participants were encouraged to comply with and have knowledge about medical advice, given information about the home exercise program, stress management, smoking cessation, alcohol intake and diet, encouraged to resume everyday activities and social interaction.
The booklet described a home exercise training program including upper‐ and lower‐limb exercises, breathing exercises, chest movements and aerobic exercise (walking program). Educational information provided about safe levels of activity, details of personal risk factors, useful telephone numbers, when to seek medical advice, and how to manage recurrent breathlessness or chest pain.
Participants received a monthly telephone call for 12 months from a qualified physiotherapist trained by the research team regarding the CR advice booklet and exercise program. The physiotherapist answered any participant questions and reminded them to follow the CR program, and attend their next hospital appointment.
Components: exercise plus education.
Setting: home‐based (with one initial centre‐based session)
Exercise programme modality: Upper and lower limb exercises, breathing and chest exercises, walking.
Length of session: 30 minutes.
Frequency: 4 sessions per week.
Intensity: RPE 11‐13.
Resistance training included? Not clear.
Total duration: 12 months.
Co‐interventions: None described
Comparator: Usual care – conventional hospital discharge care including drug treatment, post‐surgical information (precautions i.e. do not lift, pull or push heavy objects or weight > 5kg, lie in a supine position in bed), dietary advice from a dietician and routine follow‐up hospital visits.
Co‐interventions: none described.
Outcomes HRQoL
Source of funding Not reported
Conflicts of interest None declared
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk “A quasi‐random method was used to allocate patients to either a home‐based CR program in addition to UC or UC alone. Allocation was done according to the week of surgery for patients, with every other week allocating patients to either the CR group or the UC group. Allocation was done by the research team and was not influenced by the preferences of the research team, patients, or relatives.”
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information provided about blinding of outcome assessment
Incomplete outcome data (attrition bias)
All outcomes High risk Intervention 10/71 (14%) Control 31/71 (44%). Missing participant numbers high and uneven across groups, and reasons for loss to follow‐up not provided. Imputation not performed. Demographic characteristics of participants lost to follow‐up were similar to participants with complete data at 12 months.
Selective reporting (reporting bias) Unclear risk Neither a study protocol nor trial registration available.

Vecchio 1981.

Study characteristics
Methods Study design: RCT
Country: Italy
Dates participants recruited: NR
Maximum follow‐up: 1 year
Randomised after exercise tolerance test, 30 days after MI.
Participants Inclusion criteria: participants aged 40 to 60 years with MI
Exclusion criteria: more than one previous MI
N randomised: total: 50; intervention: 25; comparator: 25
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 50.1 ± 5.5; comparator: 50.1 ± 6.3
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: 100% Italians
Interventions Intervention: 6 weeks physical activity programme
Components: exercise
Setting: NR
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 6 weeks
Co‐interventions: NR
Comparator: after discharge a simple plan of daily exercises (intensity ≤ 3 METs ) to perform at home
Co‐interventions: NR
Outcomes CV mortality
Source of funding  
Conflicts of interest  
Notes Trained participants showed a better mid‐term prognosis than controls, but this could not be explained by the physical training procedure.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk 24% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Vermeulen 1983.

Study characteristics
Methods Study design: single‐centre RCT
Country: Netherlands
Dates participants recruited: NR
Maximum follow‐up: 5 years
Randomised 4 to 6 weeks post‐MI after exercise tolerance test.
Participants Inclusion criteria: Men (aged 40 to 55 years) who were hospitalised within 6 hours after onset of complaints of first myocardial infarction.
Exclusion criteria: Combination of bundle branch block and anterior myocardial infarction
N randomised: total: 98; intervention: 47; comparator: 51
Diagnosis (% of participants): MI: 100%
Age (mean ± SD): intervention: 49.4 ± 3.7; comparator: 49.1 ± 4.5
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: The rehabilitation consisted of multidisciplinary intervention (physical, social, psychological).
Components: exercise, psychological support.
Setting: Centre
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 6 ‐ 8 weeks.
Co‐interventions: none described.
Comparator: usual care.
Co‐interventions: none described.
Outcomes Mortality, non‐fatal MI.
Source of funding Prevention Fund, the Hague.
Conflicts of interest NR
Notes Study authors conclude that cardiac rehab benefits participants after MI due to direct effect on myocardial perfusion and to lowering of cholesterol levels.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes Low risk No losses to follow‐up.
Selective reporting (reporting bias) Low risk All outcomes reported at all time points (although absolute values not always given).

VHSG 2003.

Study characteristics
Methods Study design: Multicentre RCT (3 sites)
Country: Norway
Dates participants recruited: NR
Maximum follow‐up: 2 years
Participants Inclusion criteria: participants admitted to hospital for acute MI, unstable angina pectoris or after coronary artery bypass grafting.
Exclusion criteria: none described.
N randomised: total: 197; intervention: 98; comparator: 99
Diagnosis (% of participants):
AMI: 37%
UAP stabilised: 2%
PCI: 20%
CABG: 25%
Age (mean ± SD): intervention: 54 ± 8; comparator: 55 ± 8
Percentage male: intervention: 91%; comparator: 84%
Ethnicity: NR
Interventions Intervention: The first phase lasted for 6 weeks with supervised physical exercise in addition to a regular group meeting twice a week. Each training session started with 15 min of warm up followed by 20 min of dynamic endurance training, 10 min of active cool‐down activities and finally 10 min of stretching and relaxation. Large muscle groups in the arms and legs were used simultaneously to achieve higher exercise intensity (11‐13 on the Borg scale). No weight lifting took place. This was followed by 9 weeks of supervised physical exercise twice weekly. The intensity level was increased to achieve an exertion rate equal to jogging (13‐15 on the Borg scale). Participants were then encouraged to perform regular training at home.
Components: exercise, education and psychological support.
Setting: supervised, group sessions in a centre.
Exercise programme modality: "dynamic endurance training".
Length of session: 55 min.
Frequency: twice a week.
Intensity: RPE 11‐13 on the Borg Scale, increased to 13‐15 after 6 weeks.
Resistance training included? No.
Total duration: 15 weeks.
Co‐interventions: The multidisciplinary CR of "Heart School" comprised dietary advice, smoking cessation, physical activity counselling, risk factor management, psychosocial management and health education.
Comparator: Usual care: participants received usual standardised nurse‐based information on CHD in general and lifestyle measures.
Co‐interventions: none described.
Outcomes Total mortality.
Source of funding The Norwegian Government Directory for Health and Bristol Myers Squib, Norway.
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomised"
Allocation concealment (selection bias) Low risk "[Randomization] was performed with pre‐prepared sealed opaque envelopes containing details on group allocation. The patients opened the envelopes themselves so that their allocation to IP or UC was revealed to them without the prior knowledge of the study investigators".
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk 17.8% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Wang 2012.

Study characteristics
Methods Study design: Multicentre RCT (2 sites)
Country: China
Dates participants recruited: Oct 2005 to April 2007
Maximum follow‐up: 6 months
Participants Inclusion criteria: Inclusion criteria comprised a documented diagnosis of acute MI, the ability to speak and read Chinese, a return to living at home after hospital discharge, availability for telephone follow‐up, and availability for meetings after hospital discharge.
Exclusion criteria: Exclusion criteria comprised a known history of major psychiatric illness, pre‐existing mobility problems, unstable angina, severe complications such as uncontrolled arrhythmias or heart failure, and other conditions that could be aggravated by exercise, such as a resting systolic blood pressure (BP) > 200 mmHg or a resting diastolic BP > 110 mmHg.
N randomised: total: 160; intervention: 80; comparator: 80
Diagnosis (% of participants): AMI: 100%
Age (mean± SD): intervention: 57.3 (± 8.6); comparator: 58.3 (± 10.4)
Percentage male: intervention: 85.3%; comparator: 81.5%
Ethnicity: NR
Interventions Intervention: A 6‐week, home‐based rehabilitation programme using a self‐help heart manual given to the rehab participants just before discharge from hospital. The manual was similar to the UK Heart Manual but incorporated appropriate sociocultural components such as tai chi, qi gong, and Chinese diet.
Section 1 consists of 6 weekly topics on health education.
Section 2 answers commonly asked questions about medication, PCI, anxiety and depression etc.
Section 3 presents information on normal values of cardiac physiological risk parameters.
The rehabilitation group received the manual and the introductory session in addition to usual care.
The exercise component of the manual is not described in this paper, and there is no reference to its description elsewhere.
Components: exercise plus education.
Setting: home.
Exercise programme modality: not described.
Length of session: not described.
Frequency: not described.
Intensity: not described.
Resistance training included? not described.
Total duration: not described.
Co‐interventions: participants in both groups were telephoned by the principal researcher 3 weeks after discharge. For the rehabilitation group, the researcher checked the participants' progress, encouraged adherence to exercise, and helped solve problems that had arisen using the manual. This consultation lasted approximately 30 minutes, with contact designed to promote participant confidence and self‐management, and minimise dependency and the possibility that the nurse could influence outcomes.
Comparator: The usual care group received instructions on taking medications, information leaflets about cardiac risk factors, a healthy diet, and smoking cessation, and a follow‐up appointment.
Co‐interventions: The researcher devoted an equal amount of time to telephone contact with the control group, giving general advice on any problems encountered and encouraging and supporting appropriate actions.
Outcomes Mortality, HRQoL
Source of funding NR
Conflicts of interest NR
Notes Baseline characteristics only reported for those followed up until 6 months i.e. 68 in intervention group and 65 in usual care group.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk “Patients …….were enrolled and assigned to either the experimental or the control group, using a computer‐generated random number”.
Allocation concealment (selection bias) Unclear risk Allocation concealment was not described.
Blinding of outcome assessment (detection bias)
All outcomes High risk “the absence of a blinded condition may threaten its internal validity. In addition, the principal researcher played the role of both intervener and outcome assessor, which may have influenced participants to provide desired answers, and so interviewer bias cannot be excluded”
Incomplete outcome data (attrition bias)
All outcomes Low risk 12/80 (15%) lost from intervention group.
15/80 (18.8%) lost from the control group.
Numbers and reasons were given and were similar for both groups.
Selective reporting (reporting bias) Low risk All outcomes described were reported for all time points.

West 2012.

Study characteristics
Methods Study design: Multicentre RCT (14 sites)
Country: England and Wales, UK
Dates participants recruited: August 1997 to April 2000
Maximum follow‐up: 7 to 9 years
Participants Inclusion criteria: Admission to hospital with a principal primary diagnosis of acute MI (two of the three standard criteria ‘typical history’, electrocardiographic features and cardiac enzymes), discharged home within 28 days, local resident and able to give informed consent with no age or gender restrictions.
Exclusion criteria: Physical frailty, mental confusion, serious co‐existing disease, communication difficulty, previous cardiac rehabilitation and discharged to hospice or another hospital.
N randomised: total: 1813; intervention: 903; comparator: 910
Diagnosis (% of participants): Acute MI: 100%
Age (mean± SD): intervention: 64.2 ± 11.2; comparator: 64.7 ± 10.9
Percentage male: intervention: 72.6%; comparator: 74.4%
Ethnicity: NR
Interventions Intervention: Exercise training was the largest component, typically occupying half of the available time including warm up and cool down, and used exercise equipment in physiotherapy gyms. Relaxation was primarily physical following ‘cooling down’ from exercise with little or no ‘stress management’ training.
Components: exercise plus education plus psych.
Setting: centre‐based supervised programmes which varied by centre.
Exercise programme modality: varied by centre.
Length of session: averaged 20 hours over 6‐8 weeks.
Frequency: weekly or bi‐weekly.
Intensity: NR
Resistance training included? NR
Total duration: 6‐8 weeks.
Co‐interventions: The programmes comprised exercise training, health education about heart, heart disease, risk factors and treatment, counselling for recovery and advice for long‐term secondary prevention. All involved at least one other discipline (exercise physiologist, dietician, pharmacist, health promotion specialist, psychologist, counsellor, social worker, physician and/or cardiologist).
Comparator: All participants in the trial (and in the ‘elective hospitals’ comparison) had similar care in all respects other than referral to cardiac rehabilitation, receiving available explanatory booklets, being advised to see their general practitioner (GP) and attend routine outpatient follow‐up, with referral for further cardiac investigations or interventions as appropriate.
Co‐interventions: none described.
Outcomes Mortality, MI, revascularisations, hospitalisation, HRQoL.
Source of funding NHS Research and Development Programme (northern region) and the Heart Research Fund for Wales.
Conflicts of interest None declared.
Notes An additional 331 participants were entered in two matched pairs of ‘elective rehabilitation’ and ‘elective control’ hospitals; 197 to rehabilitation and 134 to control. These participants did not contribute any data used in the systematic review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “Patients were randomised centrally” – it does not state how.
Allocation concealment (selection bias) Low risk “Patients were randomised centrally on a preset protocol, daily and blind as to entry characteristics and baseline measures, …..The names of those randomised to rehabilitation were passed to the local programme coordinator”.
Blinding of outcome assessment (detection bias)
All outcomes Low risk Secondary outcomes were assessed at 1 year….blind to rehabilitation status”.
Incomplete outcome data (attrition bias)
All outcomes Low risk 5% lost to follow‐up from each group (2 year interviews); “follow‐up interviews were completed in 95% of surviving patients in both groups”
Selective reporting (reporting bias) Low risk All outcomes reported for all time points.

WHO 1983.

Study characteristics
Methods Study design: Multicentre RCT (24 sites; 12 centres accepted for meta analysis.)
Country: Multiple European countries
Dates participants recruited: 1972 to 1974
Maximum follow‐up: 3 years
Participants randomised on discharge from hospital.
Participants Inclusion criteria: Men < 65 years with first or consecutive MI.
Exclusion criteria: NR
N randomised: total: 3184; intervention: 1655; comparator: 1529
Diagnosis (% of participants): MI: 100%
Age (years): intervention: 52.3; comparator:53.5
Percentage male: intervention: 100%; comparator: 100%
Ethnicity: NR
Interventions Intervention: Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly recommended.
Components: exercise, education and psychosocial support.
Setting: centre.
Exercise programme modality: NR
Length of session: NR
Frequency: NR
Intensity: NR
Resistance training included? NR
Total duration: 6 weeks.
Co‐interventions: The intervention had to be at the highest possible level available locally. It had to be comprehensive, with the aim of improving health and reducing IHD risk. It comprised treatment of heath failure, arterial hypertension etc, risk factor modification, weight loss and improving physical working capacity.
Comparator: usual care.
Co‐interventions: none described.
Outcomes Total mortality, CVD, CHD & sudden death. Fatal & non‐fatal re‐infarction.
Source of funding WHO Regional Office for Europe and the Ministries of Health of the participating member states.
Conflicts of interest  
Notes Methodological problems with the execution of the study allowed only death and re‐infarction to be successfully used as end points.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk "Patients were randomised at admission.....by means of random number tables".
However, only "12 centres out of the 24 seemed to have achieved proper randomisation in their groups of R and C patients”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No description of withdrawals or dropouts. Varied greatly from site to site.
Selective reporting (reporting bias) Low risk All clinical endpoints were reported for 12, 24 and 36 month follow‐ups.

Wilhelmsen 1975.

Study characteristics
Methods Study design: single‐centre RCT
Country: Sweden
Dates participants recruited: 1968‐1970
Maximum follow‐up: 5 years
Participants randomised on discharge.
Participants Inclusion criteria: All participants born in 1913 or later who suffered a MI during the period 1968‐1970 and were discharged alive from the hospital.
Exclusion criteria: none described.
N randomised: total: 315; intervention: 158; comparator: 157
Diagnosis (% of participants): MI: 100%
Age (years): intervention: 50.6; comparator: 50.6
Percentage male: intervention: 87%; comparator: 90%
Ethnicity: NR
Interventions Intervention: The training programme started 3 months after the MI. The programme at the hospital consisted of three supervised half‐hour training sessions a week. It included dynamic work, such as callisthenics, cycling, and running in an interval programme with individualised intensity. If a participant found it difficult to attend the hospital for training, then individualised programmes were developed for training at home or in the workplace.
Components: exercise.
Setting: supervised in a centre.
Exercise programme modality: e.g. cycling, running.
Length of session: 1/2 hour.
Frequency: three times a week.
Intensity: 144 ± 18 beats/min; 80% of their heart rate increasing capacity (if no sign of cardiac limitation); 136 ± 19 beats/min in mean highest training heart rate (if limited by angina pectoris).
Resistance training included? Callisthenics.
Total duration: NR ‐ see notes below.
Co‐interventions: At discharge from hospital, all participants were given general recommendations about gradually increasing physical activity during the convalescence period.
Comparator: usual care.
Co‐interventions: as above.
Outcomes Mortality, re‐infarction.
Source of funding NR
Conflicts of interest NR
Notes 1 year post‐MI, only 39% of those who started training were training at the hospital. A further 21% trained at home or at work.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "By the use of a random number table the patients were allocated..."
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Low risk "The exercise test 1 yr after the MI followed the same protocol but was conducted by another physician, who did not know if the patients belonged to the experimental or the control group".
Incomplete outcome data (attrition bias)
All outcomes Low risk No losses to follow‐up for clinical events.
Selective reporting (reporting bias) Unclear risk Outcomes to be collected were not clearly described in the methods.

Xu 2017.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: January 2014 ‐ September 2015
Maximum follow‐up: 6 months
Participants Inclusion criteria:
1) Meet the diagnostic criteria of the coronary heart disease, referring to the 13th edition of the Practice Internal Medicine (a Chinese medical textbook)
2) From 39 to 70 years old
3) Participants who are easy to communicate with
4) Long‐term resident in the local area and completed the informed consent
5) Hemodynamics were stable after PCI
Exclusion criteria:
1) People with serious arrhythmia (such as atrioventricular block, atrial fibrillation, ventricular tachycardia, etc.), myocarditis, cardiomyopathy, and the installation of a pacemaker
2) People with serious cardiac insufficiency (NYHA class IV), left ventricular ejection fraction < 30%
3) People with severe cerebrovascular diseases (such as cerebral infarction and cerebral haemorrhage)
4) People with serious pulmonary diseases (such as chronic obstructive pulmonary disease, emphysema, pulmonary heart disease, etc.)
5) People with rheumatoid arthritis, osteoarthritis, muscles and other diseases that seriously affect physical activity
6) People with serious organic diseases and abnormal liver and kidney function
N randomised: total: 130; intervention: 65; comparator: 65
Diagnosis (% of participants): post‐PCI patients with unstable angina (100%).
Age (mean ± SD): intervention: 56.4 ± 8.1; comparator: 58.6 ± 8
Percentage male: intervention: 46 (79%); comparator: 47 (78%)
Ethnicity: NR
Interventions Intervention:
There are 2 stages. The first stage is after patients had PCI until they were discharged, the second is from when they were discharged to the third month after PCI.
The first stage:
1) The first day after PCI, advise patients to walk for 200 meters per time for 5 times a day.
2) The second day after PCI, advise patients to walk for 300 meters per time for 5 times a day.
3) The third day after PCI, advise patients to walk for 500 meters per time for 5 times a day. They can also go up and down a flight of stairs depending on their own conditions.
The second stage:
1) After the patients discharged in the first month after PCI:
Walking 30 to 40 mins with the speed of 65‐75 m/min for 3 times a week; or, walking for 10 to 15 mins 3 times a day with a 5‐min break among them for 3 times a week; or, walking for 15 to 20 mins twice a day with a 5‐min break between them for 3 times a week. After each time of walking, guide patients to do some chest enlargement, slow leg lift and upper limb extension exercise, so that the patients’ heart rate, blood pressure can be back to normal levels before walking.
2) 1 to 2 months after PCI:
The exercise mode was repeated in alternations of walking and brisk walking. Walk for 90 seconds, followed by brisk walking for 45 s. Repeat above. The walking speed is at 65‐75 m/min, and the brisk walking speed is at 85‐95 m/min. This exercise was 30~40 min each time for 3 times a week. After each time, patients would have relaxation exercise for 10 to 15 mins.
3) 2 to 3 months after PCI:
A set of exercise rehabilitation, includes a combination of upper limb and lower limb exercise, combined with resistance training of elastic band and balance training on yoga mat. The whole process can be divided into the pre‐activity stage (8‐10 min), the exercise march stage (30‐40 min) and the recovery stage (10‐15 min).
Components: exercise only.
Setting: centre‐based
Exercise programme modality: Mostly walking, some upper and lower limb exercise, resistance training and balance exercises.
Length of session: around 30‐40 mins up to 1 hour (length increases over time).
Frequency: 3 times per week (stage 2).
Intensity: walking speed 65‐75 m/min up to 85‐95 m/min (brisk walking).
Resistance training included? Yes, stage 2 included resistance training with elastic bands.
Total duration: 3 months.
Co‐interventions: None described
Comparator: “All patients received conventional drug therapy and post‐PCI knowledge education”
Co‐interventions: none described.
Outcomes No outcomes reported of relevance, no CONSORT flow diagram
Source of funding Not reported
Conflicts of interest Not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk “…used random sampling method to divide patients into intervention and control….”
Allocation concealment (selection bias) Unclear risk No details reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No details reported
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Reasons for participants lost to follow‐up not reported
Selective reporting (reporting bias) Unclear risk No published protocol available

Yu 2003.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: NR
Maximum follow‐up: 2 years
Participants Inclusion criteria: Obese participants with CHD who had either recent AMI or had undergone elective PCI in last 6 weeks.
Exclusion criteria: Post‐infarction angina without revascularisation procedures, significant valvular stenosis, active pericarditis or myocarditis, severe uncontrolled hypertension, physical problems that precluded exercise training, cognitive impairment, malignancies that limited life span to 1 year.
N randomised: total: 112; intervention: 72; comparator: 40
Diagnosis (% of participants):
AMI: 64%
PCI: 36%
Age (mean ±SD): intervention: 62.3 ± 11.2; comparator: 61.2 ± 10.2
Percentage male: intervention: 82%; comparator: 75%
Ethnicity: NR
Interventions Intervention:
Phase 1 was an inpatient ambulatory programme that lasted 7 to 14 days.
Phase 2 was a 16‐session, twice weekly, outpatient exercise and education programme lasting for 8 weeks. Each session included 1 hour of education class followed by 2 hours of exercise training. The first hour of training focused on aerobic CV training with a target intensity of 65% to 85% of maximal aerobic capacity. This included treadmill, ergometry, rowing, stepper, arm ergometry, and dumbbell and weight training.The next hour was conducted by an occupational therapist in which domiciliary or vocational environment‐focused training was performed.
Phase 3 was a community‐based home exercise programme for another 6 months.
Components: exercise and education.
Setting: centre followed by home.
Exercise programme modality: treadmill, ergometry, rowing, stepper, arm ergometry, and dumbbell.
Length of session: 2 hours (for 8 weeks) then unspecified at home.
Frequency: twice a week (for 8 weeks) then unspecified at home.
Intensity: 65% to 85% of maximal aerobic capacity.
Resistance training included? Weight training.
Total duration: 8 1/2 months.
Co‐interventions: Phase 4 was a long‐term follow‐up programme until the end of 2 years, which included half‐yearly monitoring of lipid profiles, and again stressed the importance of regular exercise and risk factor modification.
Comparator: conventional medical therapy.
Co‐interventions: The control group attended a 2‐hour talk that explained CHD, the importance of risk factor modification, and potential benefits of physical activity, but without undergoing an outpatient exercise training programme.
Outcomes HRQoL: 3F‐36 at 8 & 24 months.
Source of funding NR
Conflicts of interest NR
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes Low risk All participants accounted for.
Selective reporting (reporting bias) Low risk All outcomes were reported at all time points.

Yu 2004.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: NR
Maximum follow‐up: 2 years
Participants Inclusion criteria: participants with recent AMI or after elective PCI.
Exclusion criteria: Coronary heart disease without revascularisation procedures, significant mitral stenosis (defined as a mitral valve area of 1 cm2) or aortic stenosis (defined as an aortic valve gradient of 50 mmHg), active pericarditis or myocarditis, severe uncontrolled hypertension (systolic blood pressure 200 mmHg and/or diastolic blood pressure 100 mmHg), physical problems that precluded exercise, cognitive impairment or unwillingness to join the programme, malignancies that limited life span to less than 1 year.
N randomised: total: 269; intervention: 181; comparator: 88
Diagnosis (% of participants):
AMI: 72%
PCI: 28%
Age (mean ±SD): intervention: 64 ± 11; comparator: 64 ± 11
Percentage male: intervention: 76%; comparator: 75%
Ethnicity: NR
Interventions Intervention:
Phase 1 was an inpatient ambulatory programme that lasted 7 to 14 days.
Phase 2 was a 16‐session, twice weekly, outpatient exercise and education programme lasting for 8 weeks. Each session included 1 hour of education class followed by 2 hours of exercise training. The first hour of training focused on aerobic CV training with a target intensity of 65% to 85% of maximal aerobic capacity. This included treadmill, ergometry, rowing, stepper, arm ergometry, and dumbbell and weight training. The next hour was conducted by an occupational therapist in which domiciliary or vocational environment‐focused training was performed.
Phase 3 was a community‐based home exercise programme for another 6 months.
Components: exercise and education.
Setting: centre followed by home.
Exercise programme modality: treadmill, ergometry, rowing, stepper, arm ergometry, and dumbbell.
Length of session: 2 hours (for 8 weeks) then unspecified at home.
Frequency: twice a week (for 8 weeks) then unspecified at home.
Intensity: 65% to 85% of maximal aerobic capacity.
Resistance training included? Weight training.
Total duration: 8 1/2 months.
Co‐interventions: Phase 4 was a long‐term follow‐up programme until the end of 2 years, which included half‐yearly monitoring of lipid profiles, and again stressed the importance of regular exercise and risk factor modification.
Comparator: conventional medical therapy.
Co‐interventions: The control group attended a 2‐hour talk that explained CHD, the importance of risk factor modification, and potential benefits of physical activity, but without undergoing an outpatient exercise training programme.
Outcomes Total mortality, HRQoL, costs.
Source of funding Health Care & Promotion Fund Committee of Hong Kong.
Conflicts of interest "No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors(s) or upon any organization with which the author(s) is/are associated."
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk "randomized"
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding not described.
Incomplete outcome data (attrition bias)
All outcomes High risk 24% lost to follow‐up; no description of withdrawals or dropouts.
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

Zhang 2018.

Study characteristics
Methods Study design: single‐centre RCT
Country: China
Dates participants recruited: January 2010 ‐ December 2012
Maximum follow‐up: 6 months
Participants Inclusion criteria: participants admitted to the outpatient clinic after successful PCI for ST‐segment elevated MI between January 2010 and December 2012.
Exclusion criteria: A large area of myocardial infarction, heart failure, acute systemic illness, systolic BP > 180 mmHg at rest, diastolic BP > 110 mmHg at rest, acute metabolic disorders, uncontrolled malignant arrhythmia, and skeletal vascular disease.
N randomised: total: 130; intervention: 65; comparator: 65
Diagnosis (% of participants): post‐PCI for STEMI (100%).
Age (mean ± SD): intervention: 70.3 ± 10.7; comparator: 69.8 ± 10.4
Percentage male: intervention: 59 (90.8%); comparator: 54 (83.1%)
Ethnicity: NR
Interventions Intervention: GP formulated individual aerobic exercise program that could be performed in the participants' homes or at specialised rehabilitation facilities in the community. Phase II CR optimally initiated within 2 weeks of discharge (lasting 6‐8 weeks). Most available form of exercise was walking, but other forms of aerobic exercise were acceptable. HR < 130 bpm or resting HR plus 30 bpm, or RPE 11‐15. Participants exercised 2‐3 times per week, interval or continuous training for 15‐30 minutes. Phase III started from month 3 to 1 year. Target HR 60‐75% max HR, RPE 12‐16, 30‐45 minutes per session, no less than 3‐5 times per week.
Components: exercise only.
Setting: home‐ or centre‐based (community), participant choice
Exercise programme modality: walking.
Length of session: 15‐30 minutes, increasing to 30‐45 minutes.
Frequency: 2‐3 sessions per week, increasing to 3‐5.
Intensity: < 130 bpm or RPE 11‐13, increasing to 60‐75% max HR or RPE 12‐16.
Resistance training included? No.
Total duration: 12 months.
Co‐interventions: None described
Comparator: Usual care and conventional drug therapy post‐PCI
Co‐interventions: none described.
Outcomes Mortality, MI hospitalisations
Source of funding Supported by Research Project for practice Development of National TCM Clinical Research Bases (JDZX2015133)
Conflicts of interest None declared
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information reported
Allocation concealment (selection bias) Unclear risk No information reported
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk No information reported
Incomplete outcome data (attrition bias)
All outcomes Low risk No participants reported missing for outcomes of interest, all participants completed the study
Selective reporting (reporting bias) Unclear risk No published protocol paper or trial registration, very little description in the methods section about outcome assessment

Zwisler 2008.

Study characteristics
Methods Study design: single‐centre RCT
Country: Denmark
Dates participants recruited: January 2000 to March 2003
Maximum follow‐up: 1 year
Participants Inclusion criteria: Participants with congestive heart failure (12%), *ischaemic heart disease (58%) or high risk of ischaemic heart disease (30%).
Exclusion criteria: Mental or social problems, severe illness, living in nursing home, unable to speak Danish
*Total Randomised (with IHD): total: 446; intervention: 227; comparator: 219
Diagnosis (% of participants): *Ischemic heart disease: 100%
Age (years): intervention: 67; comparator: 67
Percentage male: intervention: 64%; comparator: 63%
Ethnicity: NR
Interventions Intervention: A 6‐week intensive CR programme including 12 exercise training sessions.
Components: exercise, education and psychosocial support.
Setting: centre.
Exercise programme modality: NR
Length of session: NR
Frequency: twice a week.
Intensity: NR
Resistance training included? NR
Total duration: 6 weeks.
Co‐interventions: Standardised CR programme which was individually tailored and carried out by a multidisciplinary team, included participant education, dietary counselling, smoking cessation, psychosocial support, risk factor management, and clinical assessment.
Comparator: usual care.
Co‐interventions: none described.
Outcomes Total mortality, MI, CABG, PCI, health‐related quality of life: SF‐36 at 1‐yr follow‐up.
Source of funding Copenhagen Hospital Corporation Research Council, Danish Heart Foundation, Danish Pharmacy Foundation of 1991, Danish Research Council, Danish Center for Evaluation and Health Technology Assessment, Denmark's Ministry of the Interior and Health, Development Fund of Copenhagen County, Villadsen Family Foundation, Eva and Henry Frænkel's Memorial Foundation, Builder LP Christensen's Foundation, Danish Animal Protection Foundation, Bristol Meyers Squibb, Merck Sharp and Dohme, AstraZeneca, The Copenhagen Trial Unit, and Bispebjerg Hospital.
Conflicts of interest NR
Notes Outcomes of interest for the IHD population were kindly provided by the authors of this study.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "The Copenhagen Trial Unit computer generated the allocation sequence and provided central secretary‐staffed telephone randomization".
Allocation concealment (selection bias) Low risk "The essential patient data were registered, and the result of the randomization as delivered to the research nurse, who informed the CCR team and the patient about the allocation".
Blinding of outcome assessment (detection bias)
All outcomes Low risk "The ... team collected secondary outcome measures blinded to intervention at baseline and without blinding at 12 months. An independent statistician analyzed the primary outcome measure blinded to intervention arm.
Incomplete outcome data (attrition bias)
All outcomes Low risk All IHD participants accounted for.
Selective reporting (reporting bias) Low risk All outcomes reported at all time points.

ACE: acute coronary event
ACS: acute coronary syndrome
AMI: acute myocardial infarction
BMI: body mass index
CABG: coronary artery bypass graft
CAD: coronary artery disease
CAGS: Coronary artery graft surgery
CCU: coronary care unit
CHD: coronary heart disease
CHF: coronary heart failure
CR: cardiac rehabilitation
CV: cardiovascular
CVD: cardiovascular disease
ECG: electrocardiogram
ET: exercise training
FU: follow‐up
GI: gastrointestinal
HR: heart rate
HRQL/HRQoL: health‐related quality of life
IHD: ischaemic heart disease
Kpm/min: kilopond meters per minutes
LVEF: left ventricular ejection fraction
METS: metabolic equivalents
MI: myocardial infarction
MOS: Medical Outcomes Study
MVPA: moderate‐to‐vigorous physical activity
NR: not reported
PCI: percutaneous coronary intervention
PTCA: percutaneous transluminal coronary angioplasty
pts: participants
PWC: physical work capacity
RCT: randomised controlled trial
RPE: rating of perceived exertion
RTW: return to work
SPPB: short physical performance battery
STEMI: ST segment elevation myocardial infarction
V02max: maximum oxygen uptake
WHO: World Health Organisation
W: watts
6MWT: six minute walk test

Characteristics of excluded studies [ordered by study ID]

Study Reason for exclusion
ACTRN12617000312347 Ineligible comparator
ACTRN12618001458224 Ineligible comparator
Agren 1989 Improper method of randomisation (based on date of birth)
Ahmadi 2020 Systematic review/meta‐analysis
Alharbi 2016 Ineligible study design
Al Namat 2017 Ineligible study design
Alsaleh 2012 Not relevant
An 2020 Systematic review/meta‐analysis
Andersson 2010 Comparator received exercise
Asbury 2012 Follow‐up only 16 weeks
Astengo 2010 Prehabilitation and outcomes of interest not measured or reported
Avila 2020 Participants received prior CR
Ballantyne 1982 No useful outcome data measured or reported
Bär 1992 Method of randomisation was inadequate; of a study population of 265 across 5 centres, only one centre randomised their participants, leaving a control group of 50 and an intervention group of 215
Baumgarten 2017 Ineligible study design
Beland 2020 Systematic review/meta‐analysis
Bettencourt 2005 Only a small subset of randomised participants responded via questionnaire. Incomplete outcome data
Bilinska 2010 Follow‐up only 6 weeks
Bilinska 2013 Follow‐up only 6 weeks
Björntorp 1972 Not a randomised study ‐ participants divided alternately after admission
Blokzijl 2018 Systematic review/meta‐analysis
Blumenthal 1997 Control group was not randomised, but selected on geographical basis
Bo 2015 Ineligible participant population
Borg 2017 Ineligible intervention
Bourke 2010 Trial terminated early due to poor recruitment
Bricca 2020 Systematic review/meta‐analysis
Broers 2020 Ineligible participant population
Bubnova 2014 Both groups recommended a home exercise training programme
Busch 2012 Comparator received exercise
Butler 2009 Participants had already received rehabilitation
Candelaria 2020 Systematic review/meta‐analysis
Carlsson 1997 Participants in both groups invited to join an exercise programme prior to randomisation
Chang 2010 Non‐RCT
Chatian 2014 Follow‐up only 3 months
Chen 2016 “Our ancillary study was designed to evaluate the probable positive effects of the integrated care team, especially inmodifiable risk‐factor control and exercise capacity.” No outcomes of interest measured or reported
Chen 2017 Systematic review/meta‐analysis
ChiCTR1800015823 Ineligible study design
ChiCTR1800016209 Ineligible comparator
ChiCTR1800016308 Ineligible participant population
ChiCTR1800020411 Ineligible study design
ChiCTR‐IOR‐14005743 Ineligible study design
ChiCTR‐IOR‐17012684 Ineligible study design
ChiCTR‐IOR‐17014149 Ineligible study design
ChiCTR‐IPR‐17011445 Ineligible comparator
Chokshi 2018 Ineligible intervention
Chow 2012 Intervention does not contain exercise
Christa 2019 Ineligible study design
Claes 2020 Prior CR
Clark 2017 Prior CR
Conboy 2020 Ineligible comparator
Cugusi 2020 Systematic review/meta‐analysis
da Costa Torres 2016 Ineligible study design
Dalçóquio 2020 Ineligible study design
Davoodvand 2009 Ineligible study design
De Bakker 2020 Ineligible comparator
Deng 2020 Ineligible study design
Devi 2014 Not relevant
DRKS00007569 Ineligible study design
Edstrom‐Pluss 2009 Comparator received exercise
Engelen 2020 Ineligible intervention
Espinosa 2004 Non‐RCT
Fontes‐Carvalho 2015 Ineligible study design
Francis 2019 Systematic review/meta‐analysis
Franssen 2020 Systematic review/meta‐analysis
Fu 2019 Systematic review/meta‐analysis
Gao 2007 Ineligible comparator
Gao 2020 Ineligible comparator
Garcia‐Bravo 2020 Ineligible comparator
Gerlach 2020 Systematic review/meta‐analysis
Ghashghaei 2012 Non‐RCT
Giallauria 2009 No outcomes of interest were measured or reported
Giallauria 2012 No outcomes of interest were measured or reported
Giallauria 2013 No outcomes of interest were measured or reported
Giannuzzi 2008 All participants (treatment and control) participated in 3 to 6 week cardiac rehabilitation programme (including supervised exercise sessions) prior to randomisation. Control group was not "usual care"
Gielen 2003 No outcomes of interest were measured or reported
Goel 2013 Ineligible study design
Gong 2015 Ineligible participant population
Grant 2018 Ineligible study design
Ha 2011 Non‐RCT
Hadadzadeh 2016 Ineligible study design
Haddadzadeh 2011 Follow‐up only 12 weeks
Hansen 2009 Non‐RCT
Hansen 2010 Non‐RCT
Hanssen 2009 Intervention does not contain exercise
Hawkes 2009 Intervention does not contain exercise
He 2018 Systematic review/meta‐analysis
He 2020b Ineligible study design
Heldal 2000 No outcomes of interest were measured or reported
Herring 2018 Prior CR
Hoejskov 2019 Ineligible study design
Hojskov 2016 Ineligible study design
Houle 2011 No outcomes of interest were measured or reported
Huerre 2010 Non‐RCT
Indraratna 2020 Systematic review/meta‐analysis
IRCT20130211012439N3 Prior CR
IRCT2014061418075N2 Not relevant
Ivers 2020 Ineligible intervention
Izawa 2006 Prior CR
Jepma 2019 Ineligible study design
Jepma 2020 Ineligible study design
Ji 2019 Systematic review/meta‐analysis
Jiang 2007 No useful outcome data were measured or reported
Jiang 2020 Ineligible intervention
Jiang 2020b Ineligible study design
JPRN‐UMIN000005177 Trial terminated
JPRN‐UMIN000010031 Both groups received cardiac rehabilitation
Kamei 2020 Systematic review/meta‐analysis
Karpova 2009 Non‐RCT
Kavanagh 1973 No outcomes of interest measured or reported
Kentala 1972 Non‐RCT
Keshavaraz 2020 Ineligible intervention
Kidholm 2016 Ineligible study design
Kim 2011 Non‐RCT
Kim 2012 Non‐RCT
Kim 2013 Non‐RCT
Kim 2014 Ineligible intervention
Kirolos 2019 Systematic review/meta‐analysis
Köhler 2020 Ineligible comparator
Krachler 1997 Not an exercise‐based CR programme
Kubilius 2012 Non‐RCT
Lavoie 2020 Ineligible intervention
Lee 2013 Non‐RCT
Li 2004 Follow‐up < 6 months
Liao 2003 Follow‐up too short (3 to 4 weeks) and no useful outcome data reported
Lie 2009 Intervention does not contain exercise
Lin 2020 Systematic review/meta‐analysis
Liu 2017 Ineligible study design
Maddison 2015 Ineligible comparator
Madssen 2014 Prior CR
Maldonado‐Martin 2018 Ineligible study design
Mameletzi 2011 No outcomes of interest measured or reported
Mandic 2013 Non‐RCT
Manresa‐Rocamora 2020 Systematic review/meta‐analysis
Mao 2021 Ineligible comparator
Mares 2018 Systematic review/meta‐analysis
Martinello 2019 Systematic review/meta‐analysis
Martinez 2011 Participants in the control group advised to perform home‐based activity
Mayer‐Berger 2014 Comparator received exercise
McCleary 2020 Ineligible intervention
McDermott 2019 Prior CR
McGregor 2020 Systematic review/meta‐analysis
Mehani 2012 Both groups received exercise
Mezey 2008 Non‐RCT
Midence 2016 Ineligible comparator
Minneboo 2017 Ineligible comparator
Moholdt 2012a Comparator received exercise
Moholdt 2012b Comparator received exercise
Molino‐Lova 2013 Participants had already received rehabilitation
Mozafari 2015 Ineligible study design
Murphy 2012 Partcipants did not have CHD
Murphy 2020 Systematic review/meta‐analysis
NCT01941355 Ineligible study design
NCT02219815 Not relevant
NCT02235753 Trial terminated
NCT02584192 Ineligible study design
NCT02778165 Ineligible comparator
NCT03415841 Ineligible intervention
NCT03704025 Ineligible comparator
NCT04271566 Ineligible intervention
NCT04294940 Prior CR
NCT04313777 Ineligible comparator
NCT04330560 Ineligible comparator
NCT04407624 Ineligible comparator
NCT04409210 Ineligible intervention
NCT04441086 Prior CR
Ngaage 2019 Ineligible comparator
Nichols 2020 Ineligible study design
Noites 2017 Prior CR
Okhomina 2020 Ineligible study design
Oliveira 2015 Ineligible study design
Olsen 2015 Ineligible study design
Ozemek 2020 Ineligible comparator
Parsa 2018 Ineligible study design
Passaglia 2020 Ineligible intervention
Pedersen 2013 Comparator received exercise
Peschel 2007 No useful outcome data measured or reported
Pfaeffli Dale 2015 Ineligible comparator
Piestrzeniewicz 2004 Both groups received CR
Pluss 2011 Comparator received exercise
Pomeshkina 2017b Ineligible study design
Poortaghi 2011 Both groups received CR prior to randomisation
Poortaghi 2013 Comparator received exercise
Powell 2018 Systematic review/meta‐analysis
Pozehl 2018 Ineligible participant population
Pratesi 2019 Prior CR
Raghuram 2014 Ineligible comparator
Rakhshan 2019 Ineligible study design
Rauch 2016 Systematic review/meta‐analysis
Regan 2020 Systematic review/meta‐analysis
Ribeiro 2012 Follow‐up only 8 weeks
Rideout 2012 Intervention does not contain exercise
Roviaro 1984 Non‐RCT
Sadeghi 2013 Follow‐up only 8 weeks
Sagar 2012 Comparator received exercise
Salzwedel 2020 Systematic review/meta‐analysis
Sangster 2015 Prior CR
Sankaran 2019 Ineligible comparator
Sato 2010 Both groups received CR
Sawatzky 2014 Follow‐up only 3 months
Schneider 2020 Ineligible intervention
Schwaab 2011 Non‐RCT
Sen 2018 Ineligible comparator
Shabani 2010 Follow‐up only 12 weeks
Shikhova 2010 Non‐RCT
Siqueira‐Catania 2013 Participants did not have CHD
Sokhteh 2020 Ineligible study design
Soleimannejad 2014 No outcomes of interest measured or reported
Son 2008 Ineligible study design
Stahle 1999 Follow‐up only 3 months
Stammers 2015 Ineligible study design
Stenlund 2005 Follow‐up only 3 months
Su 2020 Systematic review/meta‐analysis
Subedi 2020 Systematic review/meta‐analysis
Taguchi 2015 Ineligible study design
Takeyama 2000 Both groups received exercise
Taylor‐Piliae 2020 Systematic review/meta‐analysis
Thakkar 2016 Ineligible comparator
Thompson 2020 Systematic review/meta‐analysis
Tokmakidis 2003 No useful outcome data measured or reported
Treskes 2020 Ineligible intervention
Turkstra 2013 Intervention does not contain exercise
Uhlemann 2012 Comparator received exercise
Ul‐Haq 2019 Ineligible study design
Van Steenbergen 2020 Ineligible comparator
Vieira 2017 Prior CR
Walters 2010 Comparator received exercise
Wang J 2020 Ineligible intervention
Wang JW 2020 Ineligible intervention
Wang ZP 2019 Ineligible participant population
Wang ZQ 2019 Systematic review/meta‐analysis
Wienbergen 2020 Ineligible comparator
Wong 2020 Ineligible intervention
Wood 2008 Less than 50% participants had CHD
Wosornu 1996 No useful outcome data measured or reported
Xia 2018 Systematic review/meta‐analysis
Ximenes 2015 Ineligible comparator
Yamamoto 2016 Systematic review/meta‐analysis
Yang 2017 Systematic review/meta‐analysis
Yonezawa 2009 Non‐RCT
Yudi 2020 Ineligible study design
Zetta 2011 Ineligible participant population
Zhang 2019 Systematic review/meta‐analysis
Zhang 2020 Systematic review/meta‐analysis
Zhao 2018 Ineligible study design
Zheng 2008 No useful outcome data measured or reported
Zhu 2013 Intervention does not include exercise
Zhu 2014 Retraction

CHD: coronary heart disease 
CR: cardiac rehabilitation 
RCT: randomised controlled trial
NR: not reported

Characteristics of studies awaiting classification [ordered by study ID]

Aronov 2006.

Methods Study design: NR
Country: Russia
Follow‐up: 6 months
Participants Inclusion criteria: Acute coronary event (acute myocardial infarction, unstable angina, CABG)
Exclusion criteria: NR
N randomised: total: 373; intervention: 188; comparator: 185
Interventions Intervention: Standard therapy plus exercise programme ‐ moderate exercise for 1 hour, 3 times per week for 1 year
Comparator: Standard therapy
Outcomes Not clear if any outcomes of interest were measured or reported
Notes Unable to access full text 

Belardinelli 2007.

Methods Study design: RCT
Country: NR
Dates participants recruited: January 2002 to November 2004
Planned follow‐up: 5 years
Participants Inclusion criteria: NR
Exclusion criteria: NR
N randomised: total: 259
Diagnosis (% of participants): people with CAD who underwent PCI or CABG
Age (years): Intervention: 56±8 years; comparator: 58±8 years
Interventions Intervention: Group CR combining exercise training 60% peak VO2 3 times a week for 8 weeks with nutrition counselling and standard medication
Comparator: No CR
Outcomes MI, PCI, CABG, hospitalisation, cardiac death
Notes Abstract only, with incomplete reporting of study characteristics and outcome data. Full trial report not published.

Bubnova 2015.

Methods Study design: RCT
Planned follow‐up: 1 year
Participants N randomised: total: 62; intervention: 31; control: 31
Diagnosis (% of participants): PCI (100%)
Age (years): Intervention: 56±7 years; comparator: 53±8 years
Interventions Intervention: Program of moderate intensity physical training (60 min per session, 3 times per week for 6 weeks) plus education and standard therapy
Comparator: Educational program and standard therapy
Outcomes "Cardiovascular events" (not clear what these include)
Notes Conference abstract; triallists did not respond to repeated requests for further information

Chen 2020.

Methods Study design: RCT
Participants Inclusion criteria: Participants with a clinical diagnosis of AMI, aged 18 to 80 years, performed PCI, and signed a consent form.
Exclusion criteria: Current participation in any other behavioural or pharmacological study or instructor‐led exercise program, cardiogenic shock, severe heart failure (NYHA class IV or LVEF ≤ 35%), malignant arrhythmia (ventricular fibrillation, ventricular tachycardia, and frequent ventricular premature beats), or active bleeding. People with underlying conditions such as bone and joint disease or nervous system disorders that would impede full participation in the study and unavailability during the study period.
Interventions Intervention: Baduanjin sequential therapy (BST) beginning 2 days after surgery (30 min/session, twice per day, 3 days). After discharge, participants did standing Baduanjin exercises 30 min/session, five times per week for 24 weeks. Participants were provided picture‐based educational brochure, and telephone follow‐ups were provided to reinforce participants' adherence to the follow‐up assessments.
Comparator: requested to maintain original habit of lifestyle
Outcomes HRQoL
Notes The authors were contacted to clarify an unclear section within the methods describing the treatment received by the control group, but no response received.

Ghroubi 2012.

Methods Study design: RCT
Country: NR
Dates participants recruited: NR
Planned follow‐up: 2 years
Participants Inclusion criteria: people with MI who underwent coronary stenting
Exclusion criteria: NR
N randomised: total: 68; intervention: 30; comparator: 38
Diagnosis (% of participants): post‐coronary stenting after myocardial infraction
Interventions Cardiac rehabilitation programme not described
Outcomes HRQoL
Notes The authors of this conference abstract did not reply to repeated requests for an update on the status of this study.

Lubinskaya 2014.

Methods Study design: RCT
Planned follow‐up: 2 years
Participants Inclusion criteria: NR
Exclusion criteria: NR
N randomised: total: 200; intervention: 92; control: 108
Diagnosis (% of participants): CABG (100%)
Mean age: 57.7 years
Interventions Intervention: 2‐year comprehensive rehabilitation programme with cardiologist supervision (1, 3, and every 6 months), intermediate telephone/internet contact (9, 15, 21 months post‐surgery), controlled exercise training (every 6 months) and self‐controlled exercise training (daily morning exercise and walking), psychologist counselling, education programme (60 min every 6 months). 
Comparator: standard care
Outcomes Treatment costs
Notes Conference abstract; unable to locate full text despite contacting triallists

Marques‐Sule 2016.

Methods Study design: RCT
Planned follow‐up: 24 weeks
Participants Inclusion criteria: NR
Exclusion criteria: NR
N randomised: total: 90; intervention: 45; control: 45
Diagnosis (% of participants): ACS (100%)
Mean age: intervention: 69.2±4.1 years; comparator: 69.2±5.6 years
Interventions Intervention: Exercise sessions (8 cardiovascular exercises interrupted by 1 minute active breaks), 1 session per week for 2 months
Comparator: NR
Outcomes No outcomes of interest reported in either conference abstract
Notes Unable to locate full text

NCT00725088.

Methods Study design: RCT
Follow‐up: 1 year
Participants Inclusion criteria: Clinical diagnosis of ST‐elevated MI, heart function class I‐II (Killip classification), agree to take cardiopulmonary exercise testing before discharge, signature of informed consent document
Exclusion criteria: History of MI, acute MI with severe complications (pulmonary edema, severe cardiac arrhythmia or cardiogenic shock), atrial fibrillation, other severe diseases such as HIV infection, malignant tumour or chronic diseases of liver kidney or pulmonary, not capable of exercise training
Interventions Intervention: exercise training
Comparator: NR
Outcomes Cardiac mortality, MI, revascularisation, hospitalisation
Notes Triallists contacted for update on status of study, but no response received

Pater 2000.

Methods Study design: RCT
Country: Norway
Follow‐up: 3 years
Participants Inclusion criteria: 
  • Males and females aged 40 to 85 years,

  • Unequivocal hospital‐verified, definite AMI less than 3 months ago

  • People with a recent ACS (that is, established CHD with a stabilised condition after a recent unstable episode) 

  • PTCA patients (more than 4 weeks after a PTCA)

  • CABG patients (more than 4 weeks after a CABG)

  • Ambulatory patients who have signed a declaration of consent


Exclusion criteria:
  • Unstable angina pectoris

  • Scheduled angiography

  • Clinically significant heart failure

  • Severe hypertension

  • Symptoms of orthostatic hypertension or a supine systolic blood pressure of 90 mmHg or lower

  • Severe arrhythmias persisting after the acute phase of the MI

  • Psychoneurotic disorders (depression and/or anxiety)

  • Severe obstructive airway disease with permanent respiratory insufficiency

  • Uncontrolled diabetic mellitus

  • Severe orthopaedic disability

  • Serum creatinine more than double the local upper normal limit

  • Alanine amino‐transferase or aspartate amino‐transferase more than three times the local upper limit (in the context of known liver disease)

  • Presence of any condition that limits life expectancy (e.g. cancer or haematological diseases)

  • Problems expected with compliance or follow‐up

  • Participation in another trial or study during the past 30 days

  • Stroke with severe physical disability

Interventions Intervention: structured secondary prevention programme including patient education, brief counselling, and systematic physical training tailored to each individual. The exercise programme consists of 8 weeks of supervised outpatient physical training. 
Comparator: conventional care
Outcomes HRQoL
Notes Authors did not respond to repeated requests for study update.

Pomeshkina 2014.

Methods Study design: RCT
Follow‐up: 1 year
Participants Inclusion criteria: NR
Exclusion criteria: NR
N randomised: total: 64; intervention: 29; control: 35
Diagnosis (% of participants): CABG (100%)
Mean age: 54.7±4.6 years
Interventions Intervention: Common medical rehabilitation programme with long‐term (3 months) cycling training
Comparator: Common medical rehabilitation (medication, lifestyle modifications)
Outcomes Unclear if any outcomes of interest were measured or reported
Notes Triallists did not respond to requests for study updates

Rymuza 2019.

Methods Study design: RCT
Follow‐up: 12 months
Participants Inclusion criteria: participants with ACS, age > 75 years, after PCI
Exclusion criteria: NR
N randomised: total: 51; intervention: 25; control: 26
Diagnosis (% of participants): PCI (100%)
Mean age: 80 years
Interventions Intervention: training three times per week for 2 months
Comparator: received general recommendations for activity
Outcomes HRQoL
Notes Triallists did not respond to repeated requests for study updates

Sin'kova 2014.

Methods Study design: RCT
Follow‐up: NR
Participants Inclusion criteria: participants surviving MI
Exclusion criteria: NR
N randomised: total: 110; intervention: 53; control: 57
Diagnosis (% of participants): NR
Mean age: 58.3 ± 9.8 years
Interventions Intervention: Walking at a speed corresponding to 60% maximal heart rate
Comparator: NR
Outcomes Costs
Notes Unable to contact triallists for further information

Von Roeder 2011.

Methods Study design: RCT
Country: NR
Dates participants recruited: NR
Planned follow‐up: 2 years
Participants Inclusion criteria: participants with CAD and proven exercise‐induced ischaemia
Exclusion criteria: NR
N randomised: total: 103; intervention: 57; comparator: 46
Age (years): NR
Percentage male: NR
Ethnicity: NR
Interventions Intervention: regular exercise training
Comparator: PCI/stenting
Outcomes Mortality
Notes The authors of this conference abstract did not reply to repeated requests for an update on the status of this study.

Walther 2010.

Methods Study design: RCT
Country: NR
Dates participants recruited: NR
Planned follow‐up: 2 years
Participants Inclusion criteria: Male participants with indication for elective CABG
Exclusion criteria: NR
N randomised: total: 47; intervention: 23; comparator: 24
Age (mean ± SD): 64.3 ± 7 years
Percentage male: 100%
Ethnicity: NR
Interventions Intervention: four‐week pre‐operative endurance training course
Comparator: non‐active control
Outcomes HRQoL and clinical outcomes
Notes The authors of this conference abstract did not reply to repeated requests for an update on the status of this study.

ACS: acute coronary syndrome 
CABG: coronary artery bypass graft
CAD: coronary artery disease
CHD: coronary heart disease
CR: cardiac rehabilitation
HRQol: health‐related quality of life
MI: myocardial infarction
N: number
NR: not reported
PCI: percutaneous coronary intervention
PTCA: percutaneous transluminal coronary angioplasty
RCT: randomised controlled trial

Characteristics of ongoing studies [ordered by study ID]

ACTRN12616001204437.

Study name Tai Chi for stress and cardiovascular function in patients with coronary heart disease and/or hypertension: a randomised controlled trial
Methods RCT with waiting‐list control
Participants Inclusion criteria:
(1) Equal to or greater than 40 years of age, regardless of gender;
(2) With documented diagnosis of CHD (myocardial infarction, angina or revascularisation) with severity of angina class I to II according to the Canadian Cardiovascular Society functional classification, and/or with established diagnosis of hypertension according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;
(3) Ability to perform prescribed Tai Chi program;
(4) Willing to complete the 24‐week Tai Chi intervention;
(5) Not practicing Tai Chi in the past 6 months;
(6) Ability to speak and read Chinese or English fluently;
(7) Willing to sign a written informed consent.
Exclusion criteria:
(1) Pregnancy
(2) Previous or current psychological disorders not associated with depression or anxiety
(3) End‐stage congestive heart failure
(4) Permanent bed‐bound status
(5) Unstable abdominal, thoracic or cerebral aneurysm
(6) Acute myocarditis, pericarditis, pulmonary embolus or pulmonary infarction
(7) Significant limitation of physical activity for reasons other than CHD
(8) Participation in a clinical trial for an experimental drug within the last 30 days before the study
Interventions Intervention: the intervention group will be offered a standardised Tai Chi intervention over a period of 24 weeks, consisting of a 12‐week intensive Tai Chi intervention and a 12‐week sustained Tai Chi intervention.
Comparator: participants assigned to the waiting‐list control group will be instructed to maintain their routine activities and not to begin any new exercise programs during their study participation. These participants will be offered an equivalent 12‐week intensive Tai Chi intervention and 12‐week sustained Tai Chi intervention at the termination of the study, provided the Tai Chi intervention in the treatment is proved to be safe (no severe adverse events directly associated with Tai Chi).
Outcomes HRQoL, adverse events
Starting date 28 August 2015
Contact information d.chang@westernsydney.edu.au
Notes  

CTRI/2017/07/008951.

Study name Efficacy of YOGA in Indian patients with coronary artery disease
Methods RCT
Participants Inclusion criteria:
1. All adults between 30 and 70 years
2. People with acute coronary syndrome who
have undergone percutaneous coronary
intervention within 2 weeks or
3. People with stable coronary artery disease
who have undergone percutaneous coronary
intervention in the last 2 weeks
4. People who are willing and able to participate
Exclusion criteria:
1. Severe LV dysfunction
2. Unstable arrhythmia
3. Active decompensated heart failure
4. Uncontrolled hypertension ( > 180/110)
5. Contraindications to yoga
7. Contraindications to exercise testing
or training
8. NYHA IV
9. Incomplete revascularisation
Interventions Intervention: participants undergoing PCI with routine advice on discharge and enhanced usual care(physiotherapy, medications and lifestyle modifications) will be taught yoga, based on the module in the first week of each phase. On non‐class days, participants will be motivated to practice yoga sessions at home every day, and their compliance will be ensured telephonically and through a written log. The participants will be encouraged to practice until the end of the follow‐up period (3 years).
Comparator: participants will be on enhanced usual care after PCI.
Outcomes MACCE, HRQoL
Starting date 03 July 2017
Contact information drgautamsharma12@gmail.com
Notes  

CTRI/2017/10/009981.

Study name Efficacy of yoga‐based cardiac rehabilitation on clinical outcomes in post CABG patients: a randomized controlled trial.
Methods RCT
Participants Inclusion criteria:
1. People willing and able to participate
2. All adults between 35 and 65 years of age
3. People established with double or triple vessel disease planned for elective CABG
d. People with uncomplicated peri‐operative course, who are able to perform yoga
Exclusion criteria:
a. Emergency CABG
b. CABG with valve replacement surgeries
c. LVEF
d. Acute and chronic renal failure with or without dialysis
e. Regular yoga practitioners
f. Physical disabilities precluding yoga practice
g. Neuro‐psychiatric illness
h. People already exposed to yoga
Interventions Intervention: yoga plus conventional medical management which includes physiotherapy, lifestyle modifications and medications
Comparator: conventional medical management
Outcomes HRQoL, MACCE
Starting date 10/10/2017
Contact information airanbalram@gmail.com
Notes  

CTRI/2019/06/019948.

Study name Effect of cardiac rehabilitation in patients undergone myocardial infarction and percutaneous coronary intervention
Methods RCT
Participants Inclusion criteria:
1. 18 to 80 years of age
2. Diagnosed myocardial infarction who have undergone percutaneous coronary intervention not at risk due to other comorbidities.
3. Willing to give informed consent
4. Individuals with acute myocardial infarction
5. Individuals with New York Heart Association (NYHA) functional class I, II & III symptoms
Exclusion criteria:
1. Participants with medical conditions which could put them at risk during physical activity testing or training (e.g. angina), or conditions that could limit the participant’s ability to exercise (e.g. severe
orthopaedic or neurologic impairments)
2. Individuals with prior myocardial infarction
Interventions Intervention: adapted phase II and phase III of cardiac rehabilitation programme with components of physical activity, education on coronary artery disease and heart‐healthy living
Comparator: participants will not receive any supervised physical activity training. Participants will receive routine care for myocardial infarction after undergoing percutaneous coronary intervention according to current guidelines.
Outcomes HRQoL, cost effectiveness, all‐cause mortality
Starting date 02 July 2019
Contact information dr.kunjan2human@gmail.com
Notes  

NCT00756379.

Study name Century Trial, a randomized lifestyle modification study for management of stable coronary artery disease (Century)
Methods RCT (single centre)
Participants Inclusion Criteria:
  • Participants must be competent to provide written informed consent.

  • Participants must sign an Institutional Review Board (IRB) approved Informed Consent Form (ICF) and HIPAA Authorization prior to the initiation of any study procedures.

  • Men and women age ≥ 40

  • Appropriate indications for stress perfusion testing:

    • Suspected CAD:

    • Men with any chest pain syndrome and two other risk factors

    • Women > 50 years old with any chest pain syndrome and two other risk factors

    • Asymptomatic men and women > 50 years with at least three other risk factors or coronary calcium agatston score > 400.

    • Diabetic men and women and two other risk factors

  • Documented known CAD:

    • Men and women with asymptomatic or stable symptoms and known CAD by abnormal catheterisation or prior Single Photon Emission Computed Tomography (SPECT) without revascularisation after > 2 years to evaluate worsening disease; or

    • Men and women with worsening symptoms and known CAD by abnormal catheterisation or prior SPECT/ Positron emission tomography (PET) without revascularisation;

    • Men and women with chest pain syndrome and previous revascularisation

  • Asymptomatic men and women > 5 years after coronary artery bypass graft surgery (CABG) or > 2 years after PCI

  • Risk factors: diabetes, current or recent cigarette smoking (within the last 12 months), LDL >130, low HDL < 50 women, HDL < 45 men, history of metabolic syndrome, hypertension (systolic blood pressure (SPB) > 140), family history of premature (< 60 year) CAD, atherosclerotic carotid artery disease OR atherosclerotic peripheral vascular disease (APVD) as defined by ankle‐brachial index below 0.9 and/or by abnormal duplex ultrasound, CT angiography, magnetic resonance angiography (MRA) or conventional invasive angiogram or previous revascularisation procedure.

  • Framingham's high risk criteria refers to presence of diabetes mellitus with the limitation described above (c) or 10 year absolute coronary heart disease (CHD) risk of > or = 20%.

  • Chest pain is defined as 'Typical angina' if Exertional + Retrosternal + relieved with rest or sublingual nitroglycerin (NTG), 'Atypical angina' if only two of the above criteria are present and 'Non‐anginal' if one or none of the above are present.


Exclusion criteria:
  • Age < 40

  • Low pretest likelihood of CAD (= not meeting the above criteria)

  • Unstable angina high risk (dynamic ST‐Twave ECG changes and/or elevated troponin)

  • Recent MI ( < 4 weeks)

  • Recent stroke ( < 4 weeks)

  • CABG or percutaneous coronary intervention (PCI) within the last 6 months

  • Severe renal dysfunction as defined by creatinine > 2.0 mg/dL

  • Active liver disease or hepatic dysfunction, AST or ALT > x 2 the upper limit of normal (ULN)

  • Concomitant valvular heart disease

  • Left ventricular ejection fraction (LVEF) <30%

  • Severe systemic hypertension defined as systolic blood pressure (SBP) > 200 mmHg

  • Symptomatic sustained or non‐sustained ventricular tachycardia

  • Morbid obesity defined by body mass index (BMI) > 35

  • Severe disability to prevent therapeutic exercise not expected to resolve within 6 months

  • Major non‐cardiac comorbidity limiting survival or social situation/condition that, in the opinion of the investigator, will preclude the patient from participation in the study follow‐up.

  • Concurrent or prior (within last 30 days) participation in other research studies using investigational drugs or devices.

Interventions Intervention:
"P.E.T. guided comprehensive therapy program. The study intervention is comprehensive therapy program for risk factor modification. The comprehensive program of atherosclerotic risk factor modification involves treatment to target lipid levels, blood pressure and diabetes control, smoking cessation, very low fat diet and aerobic exercise program. This is in addition to standard current medical therapy as provided by primary physician. No experimental medications or procedures will be used." "During the 5 year follow‐up they will be educated and guided toward a healthy lifestyle by a dietician, an exercise physiologist/cardiovascular physician specialist."
Comparator:
"Current standard of care medical management as provided by primary physician."
Outcomes Mortality, non‐fatal MI, revascularisation, total cost
Starting date March 2009
Contact information K.Lance Gould, Professor, Internal Medicine, Cardiology, University of Texas Health Science Center, Houston
Notes  

NCT02025257.

Study name Effects of exercise in patients with coronary artery disease aged 80 years or older
Methods RCT
Participants Inclusion criteria: clinical diagnosis of acute CAD, aged 80 years or older.
Exclusion criteria: inability to understand or speak Swedish, serious physical or psychological disease interfering with participation in an exercise intervention, patients are already exercising three times or more/week
Interventions Intervention: exercise
Comparator: NR
Outcomes HRQoL
Starting date December 2013
Contact information Maria Bäck, PhD
maria.m.back@vgregion.se
http://clinicaltrials.gov/show/NCT02025257
Notes  

NCT03102346.

Study name efficAcy and Safety of Home‐baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs (ASSIST)
Methods RCT
Participants Inclusion criteria:
  1. Age range from 30 to 80.

  2. Coronary artery disease, revascularised with stent deployment.

  3. New York Heart Association (NYHA) classification Class I‐III.

  4. Good cognitive level.

  5. Ability to perform aerobic exercise.

  6. Understand and be able to use a mobile smart phone by himself or with help of family members.

  7. Signature of informed consent. The informed consent will be valid for the duration of the trial or until the subject withdraws.


Exclusion criteria:
  1. Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of acute myocardial infarction (AMI) ( > 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, atrial fibrillation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and haemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled.

  2. Hypotensive response to exercise.

  3. Acute myocardial infarction within 2 weeks.

  4. Poorly controlled hypertension baseline, hyperglycaemia, respiratory failure.

  5. Severe pulmonary hypertension.

  6. Acute phase of heart failure.

  7. Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation.

  8. Pregnant women.

  9. Subjects unable to give informed consent.

Interventions Intervention: home‐based cardiac rehabilitation
Comparator: no instructed exercise training
Outcomes MACCE, hospitalisation, HRQoL
Starting date 09 November 2017
Contact information crystalma_301@126.com
Notes  

NCT03375944.

Study name Utilisation of Telemedicine in Optimal Cardiac Rehabilitation Program in Patients After Myocardial Revascularization (RESTORE)
Methods RCT
Participants Inclusion criteria:
  • age over 18 and below 70

  • completed revascularization in participants with stable or unstable angina or after myocardial infarction without ST‐segment elevation (NSTEMI)

  • in participants with suspected myocardial scars, MRI will be recommended to confirm myocardial viability

  • eligibility to participate in a program of early cardiac rehabilitation

  • signed informed consent form

  • the ability to use telerehabilitation system


Exclusion criteria:
  • acute myocardial infarction with ST segment elevation/new onset of left bundle branch block (LBBB)

  • suboptimal (not completed) revascularisation

  • ejection fraction < 40%.

  • acute heart failure (Killip IV) at the time of admission to the hospital

  • dual antiplatelet therapy can not be maintained for 1 year after PCI

  • haemorrhagic stroke in the past

  • ischaemic stroke or transient ischaemia in previous 6 weeks

  • platelet count < 100,000 / mm3

  • chronic renal failure with creatinine clearance < 30mL / min / 1.73 m2

  • planned surgery

  • pregnancy or planned pregnancies

  • expected life expectancy less than 3 years after enrolment

Interventions Intervention:
cardiac supervision and rehabilitation ‐ optimal, continuous and regularly controlled tele‐rehabilitation, based on exercise training, intensive dietary and educational program focused on lifestyle and risk factor modification. 
Comparator:
cardiac supervision
Outcomes Mortality, cardiovascular events
Starting date March 2018
Contact information Krzysztof Milewski; kpmilewski@gmail.com
Notes  

NCT03584828.

Study name Tele‐Cardiac Rehabilitation Program
Methods RCT
Participants Inclusion criteria:
  • guideline‐based and Israeli Health Basket approved indications for cardiac rehabilitation yet participant declines to participate in centre‐based cardiac rehabilitation due to non‐medical reasons such as: distance, service availability in participants' living area, time constraints and other logistic or sociocultural barriers;

  • age ≥ 21 years;

  • compatible smartphone (android or iOS) with internet connection;

  • willing and able to comply with study protocol;

  • able and willing to follow the personalised exercise prescription, use wearable technology and smartphone app, and upload data via personal smartphone.


Exclusion criteria:
  • any unresolved cardiac condition associated with significantly increased risk during outpatient activity (clinically significant ischaemia, unresolved arrhythmia, high falling risk, etc.);

  • end‐stage/NYHA 4 or unstable heart failure (clinical) or unresolved significant arrhythmia (i.e. rapid atrial fibrillation);

  • LVEF ≤ 35% without ICD/ CRTD;

  • significant neurological or cognitive impairment or markedly unstable gait /high falling risk;

  • women of child‐bearing potential;

  • ACS within 30 days prior to screening, or having undergone cardiac surgery within 30 days prior to screening;

  • inability to perform a stress test due to physical limitations;

  • severe angina pectoris as defined by Canadian Cardiovascular Society (CCS) Angina Score > 2;

  • pulmonary disease of severity greater than mild (COPD, asthma, interstitial lung disease (ILD), connective tissue disease (CTD) with lung involvement) or chronic pulmonary thromboembolic disease (CTED));

  • severe orthopedic limitations;

  • active myocarditis, constrictive pericarditis, restrictive or hypertrophic cardiomyopathy;

  • severe aortic or mitral stenosis;

  • significant anaemia (Hb < 10 mg/dL);

  • known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results, or in the opinion of the investigator, are not suitable to participate;

  • any illness which reduces life expectancy to less than 1 year from screening.

Interventions Intervention:
"The Tele‐rehab arm will receive an exercise prescription and execution will be assessed and periodically adjusted in accordance to data received from the wearable device. Intensity and type of exercise will be moderate and will comply with exercise recommendations provided by ESC guidelines. A dedicated application will be installed on the mobile phone for patients in the research group and they will receive a smart sports watch." "Additionally, in the intervention arm, we will provide psychological support, dietary intervention and disease management services that complement the structured physical activity ‐ all by innovative smartphone applications and smart wearable devices"
Comparator:
"The usual care arm will receive general recommendations for a healthy and active lifestyle and community cardiologist and primary care physician according to local guidelines."
Outcomes hospitalisation, mortality,  HRQoL 
Starting date July 2018
Contact information Dr. Robert Klempfner Heart Rehabilitation Institute, Head, Cardiovascular Prevention and Rehabilitation Institute, Sheba Medical Center, Israel, Sheba Medical Center
Notes  

NCT03905187.

Study name Stress Management Modified Cardiac Rehabilitation in Patients After Acute Myocardial Infarction or Heart Failure
Methods RCT
Participants Inclusion criteria:
Participants aged 18 to 80 years old with a diagnosis of AMI (include ST segment elevated myocardial infarction and non‐ST segment elevated myocardial infarction) or heart failure.
Exclusion criteria:
Uncontrolled tachycardia (heart rate at rest > 120 bpm). Uncontrolled polypnoea (breath rate at rest > 30 breath per minute. Uncontrolled respiratory failure (SPO2 ≤ 90%). Uncontrolled hypertension (pre‐exercise SBP > 180 mmHg or DBP > 110 mmHg). Weight change in 72 hours > 1.8kg. Uncontrolled hyperglycaemia (random blood glucose > 18 mmol/L). Uncontrolled malignant arrhythmia with haemodynamic instability. Unoperated pseudoaneurysm. Artery dissection. Uncontrolled septic shock and septicopyaemia. Unoperated severe valvular heart disease or acute phase of heart failure caused by myocardial heart disease. Nervous system disease, motor system diseases and rheumatic diseases considered possibly worsened by exercise. Uncooperation of the participants.
Interventions Intervention 1: 
Modified CR ‐  cardiac rehabilitation including stress management, exercise and education.
Intervention 2:
Traditional CR ‐ including education and exercise.
Comparator:
Education only (control group)
Outcomes HRQoL, rehospitalisation, MACE
Starting date April 2019
Contact information crystalma@126.com
Notes  

NCT03978130.

Study name Rehabilitation at Home Using Mobile Health in Older Adults after Hospitalization for Ischemic Heart Disease (RESILIENT)
Methods Multicentre RCT
Participants Inclusion criteria:
  1. Age ≥ 65 years.

  2. Currently hospitalised for AMI, PCI, or CABG, or hospitalised for AMI, PCI or CABG within prior 2 weeks.

  3. Capable of self‐consent.

  4. Understands and is able to perform study procedures (i.e. 6‐minute walk test, use mHealth software in English or Spanish).


Exclusion criteria:
  1. Non‐ambulatory.

  2. Moderate or severe cognitive impairment.

  3. Unable/unwilling to consent.

  4. PCI‐related groin hematoma that precludes brisk walking.

  5. Incarcerated.

  6. Unable to use mHealth software in English or Spanish.

  7. Severe osteoarthritis, or joint replacement within last 3 months.

  8. Parkinson's disease or other progressive movement disorder.

  9. Regular use of walker for ambulation.

  10. Projected life expectancy < 3 months.

  11. Clinical judgment concerning other safety or non‐adherence issues.

  12. Participants admitted from long‐term care facility.

  13. Currently listed for heart transplant.

  14. Left ventricular assist device recipient.

  15. Completion of ambulatory cardiac rehabilitation program within prior 3 months.

Interventions Intervention:
mHealth‐CR: participants receive 3 components for their home activity: (1) communication with exercise therapist (in‐hospital assessment/counselling followed by regular communication post‐discharge), (2) mHealth‐CR software, and (3) wearable activity‐monitoring device. 
Comparator:
usual care
Outcomes HRQoL, hospital readmissions, mortality
Starting date January 2020
Contact information resilient@nyulangone.org
Notes  

NCT04425057.

Study name Effect of a High Intensity Interval Training in Older Adults With Coronary Artery Disease
Methods RCT
Participants Inclusion criteria:
  • diagnosed with coronary artery disease

  • discharged from hospital, less than 2 months


Exclusion criteria:
  • not able to move by themselves

Interventions Intervention: physiotherapy program during two months: interval training at a high intensity, including a warm‐up and a cool‐down. Aerobic exercises, resistance exercises, stretching.
Comparator: no physiotherapy.
Outcomes HRQoL (SF‐36)
Starting date October 2012
Contact information Elena Marques‐Sule, PhD, PT, University of Valencia
Notes  

NCT04438356.

Study name M‐Health Care for Patients After AMI on Disease Perception, Self‐Efficacy, Anxiety and Cardio‐Respiratory Fitness
Methods RCT (waiting‐list control)
Participants Inclusion criteria:
  • Taiwanese, understand Chinese

  • Participants who are over 20 years old and have AMI (including ST segment ascending and non‐ST segment ascending), diagnosed by percutaneous coronary intervention and without complications within 30±5 days, the left ventricular injection rate is greater than 40%

  • Ability and willingness to provide informed consent

  • Have a smartphone

  • Can receive and send smartphone messages


Exclusion criteria:
  • Those who can't express their wishes clearly (such as mental dysfunction)

  • Mental disorder

  • People who participate in other research projects

  • Planned coronary artery bypass surgery or other diseases that require continuous heart care

  • Abuse of alcohol or narcotics

  • Left ventricular ejection fraction (LVEF) is less than 40%

Interventions Intervention:
M‐Health app to remind participants of the walking frequency and time, and use Garmin monitoring bracelet to record daily walking steps. App content also includes knowledge about acute myocardial infarction, self‐care and anxiety.
Control:
Waiting‐list control for 3 months, then receive the same M‐Health intervention
Outcomes  
Starting date 22 July 2020
Contact information Hui‐Hsun Chiang: sheisvivian@gmail.com
Notes  

NCT04511182.

Study name Early Individualized‐Exercise Based Cardiac Rehabilitation Programs in Patients With Acute Myocardial Infarction
Methods RCT
Participants Inclusion criteria:
  1. Acute myocardial infarction (AMI) within 1 month prior to recruitment.

  2. Complete revascularisation.

  3. Men or non‐pregnant women aged from 18 to 80 years.


Exclusion criteria:
  1. Uncontrolled hypertension (systolic blood pressure/diastolic blood pressure > 160/100 mmHg), or symptomatic hypotension.

  2. Significant resting electrocardiogram abnormalities (left bundle branch block, non‐specific intraventricular conduction delay, left ventricular hypertrophy, resting ST‐segment depression), life‐threatening cardiac arrhythmias.

  3. Acute myocarditis, pericarditis or acute systemic illness.

  4. Those who are assessed by the doctor as high‐risk.

  5. Pacemaker or implantable cardioverter defibrillator.

  6. Any contraindication to exercise testing or exercise training or inability to complete a CPET.

  7. Life‐threatening diseases with limited life expectancy < 3 year.

  8. Uncontrolled unstable angina pectoris.

  9. Significant valvular disease (mitral stenosis, moderate to severe mitral insufficiency, aortic stenosis, or aortic insufficiency, severe mitral / aortic regurgitation).

  10. Severe mental or cognitive impairment.

  11. Inability to follow the procedures of the study.

Interventions Intervention: exercise intervention group. Participants will receive standard medications plus exercise based CR. Education covering topics related to AMI and exercise for AMI will be implemented and any consultations on exercise prescription and disease management will be explained by a cardiac rehabilitation team consisting of cardiologists, cardiology nurses and physiotherapists.
Comparator: participants will receive standard medications according to national guidelines, as well as education and consultations as intervention group. However, no exercise prescription is given.
Outcomes HRQoL (SF‐36), MACE
Starting date 1 February 2021
Contact information Qin Shao: shaoqindr@126.com
Notes  

NCT04858503.

Study name An Internet‐based Cardiac Rehabilitation Enhancement (i‐CARE) Intervention to Support Self‐care of Patients With Coronary Artery Disease
Methods RCT
Participants Inclusion criteria:
  • ≥ 18 years of age

  • living in the community

  • own a smartphone with internet access

  • communicable in Cantonese

  • type in Chinese or English

  • with a confirmed diagnosis of CAD


Exclusion criteria:
  • enrolled to a structured centre‐based or home‐based cardiac rehabilitation program

  • psychiatric problems

  • impaired cognitive functioning (i.e. Abbreviated Mental Test ≤ 6)

  • terminal disease with life expectancy < 1 year

Interventions Intervention:
participants in the intervention group will receive a 12‐week i‐CARE intervention, which will be designed to cover the core elements of CAD self‐care: self‐care maintenance, self‐care monitoring and self‐care management. The intervention will comprise: 1) a single individualised face‐to‐face session, and 2) an internet‐based intervention through a mobile application. Various behaviour change techniques will be used to increase the self‐efficacy of CAD patients in enacting self‐care behaviours.
Comparator:
participants will receive conventional care as arranged by hospital or community centres.
Outcomes cardiovascular events, mortality, HRQoL
Starting date May 2021
Contact information Dr. Polly Wai‐Chi Li, The University of Hong Kong pwcli@hku.hk 
Notes  

ACS: acute coronary syndrome
AMI: acute myocardial infarction
APVD: atherosclerotic peripheral vascular disease
CABG: coronary artery bypass graft
COPD: chronic obstructive pulmonary disease
CPET: cardiopulmonary exercise test
CRTD: cardiac resynchronization therapy defibrillator
CTED: chronic pulmonary thromboembolic disease
DBP: diastolic blood pressure
HDL: high‐density lipoprotein
HRQoL: health‐related quality of life
ICD: implantable cardioverter defibrillator
LDL: low‐density lipoprotein
LV: left‐ventricular
LVEF: left ventricular ejection fraction
MACCE: major adverse cardiac and cerebrovascular events
MACE: major adverse coronary event
NYHA: New York Heart Association
PCI: percutaneous coronary intervention
RCT: randomised controlled trial
SBP: systolic blood pressure

Differences between protocol and review

In addition to updating the searches, the primary outcome of hospitalisation has been split to include both all‐cause and cardiovascular hospitalisations. Due to the increased availability of HRQoL outcome data in this update, we were able to undertake a formal meta‐analysis of this outcome (based on a number of measures, including SF‐36 summary and domain scores, EQ‐5D scores, and total/overall HRQoL scores). An additional meta‐regression study level category has been added (low‐ and middle‐income versus high‐income countries), to allow us to explore if effect sizes varied by these settings.

In previous versions of this review, three additional risk of bias domains were included (groups balanced at baseline, intention‐to‐treat analysis undertaken and groups received comparable treatment (except exercise)). For this review update, we decided that these additional domains were no longer applicable and removed them.

Contributions of authors

This review update was undertaken by GD, JF and RST; namely, study selection, data extraction and risk of bias assessment.

A‐DZ provided clinical advice during the process of the update.

GD, JF and RST wrote the first draft of the review update, and all co‐authors contributed to reviewing and editing drafts of the review update.

All authors approved the final manuscript.

Sources of support

Internal sources

  • University of Glasgow, UK

    Support in form of salaries

External sources

  • NIHR, UK

    This project was supported by the NIHR via Cochrane Infrastructure funding to the Heart Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and Social Care.

Declarations of interest

GD declares no conflicts of interest.

JF declares no conflicts of interest.

NO declares work as Professor at the University of Wisconsin‐Milwaukee, USA. NO also declares being an author of a study that is eligible for inclusion in the work (funding source: European Society of Cardiology & European Association of Preventive Cardiology).

KR declares no conflicts of interest.

DRT declares being an author of a study that is eligible for inclusion in the work.

A‐DZ declares being an author of a study that is eligible for inclusion in the work.

RST declares no conflicts of interest. 

New search for studies and content updated (no change to conclusions)

References

References to studies included in this review

Andersen 1981 {published data only}

  1. Andersen GS, Christiansen P, Madsen S, Schmidt G. The value of regular, supervised physical training after acute myocardial infarction [Vaerdien af regelmaessig og overvåget fysisk traening efter akut myokardieinfarkt]. Ugeskrift for Laeger 1981;143(45):2952-5. [PubMed] [Google Scholar]

Aronov 2010 {published data only}

  1. Aronov DM, Krasnitskij VB, Bubnova MG. Efficacy of physical training and analysis of lipid-lowering therapy in patients with ischemic heart disease after acute coronary incidents. Rational Pharmacotherapy Cardiology 2010;6(1):9-19.

Aronov 2019 {published data only (unpublished sought but not used)}

  1. Aronov D, Bubnova M, Iosseliani D, Orekhov A. Clinical efficacy of a medical centre- and home-based cardiac rehabilitation program for patients with coronary heart disease after coronary bypass graft surgery. Archives of Medical Research 2019;50(3):122-32. [DOI] [PubMed] [Google Scholar]

Bäck 2008 {published data only}

  1. Bäck M, Wennerblom B, Wittboldt S, Cider A. Effects of high frequency exercise in patients before and after elective percutaneous coronary intervention. European Journal of Cardiovascular Nursing 2008;7(4):307-13. [DOI] [PubMed] [Google Scholar]

Belardinelli 2001 {published data only}

  1. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: the ETICA Trial. Journal of the American College of Cardiology 2001;37(7):1891-900. [DOI] [PubMed] [Google Scholar]

Bell 1998 {unpublished data only}

  1. Bell JM. A comparison of a multi-disciplinary home based cardiac rehabilitation programme with comprehensive conventional rehabilitation in post-myocardial infarction patients [PhD Thesis]. London (UK): University of London, 1998. [Google Scholar]

Bengtsson 1983 {published data only}

  1. Bengtsson K. Rehabilitation after myocardial infarction. Scandinavian Journal of Rehabilitation Medicine 1983;15(1):1-9. [PubMed] [Google Scholar]

Bertie 1992 {published data only}

  1. Bertie J, King A, Reed N, Marshall AJ, Ricketts C. Benefits and weaknesses of a cardiac rehabilitation programme. Journal of the Royal College of Physicians of London 1992;26(2):147-51. [PMC free article] [PubMed] [Google Scholar]

Bethell 1990 {published and unpublished data}

  1. Bethell HJ, Mullee MA. A controlled trial of community based coronary rehabilitation. British Heart Journal 1990;64(6):370-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Bettencourt 2005a {published data only}

  1. Bettencourt N, Dias C, Mateus P, Sampaio F, Santos L, Adao L, et al. Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome [Impacto da reabilitacao cardiaca na qualidade-de-vida e sintomatologia depressiva apos sindroma coronaria aguda]. Revista Portuguesa de Cardiologia 2005;24:687-96. [PubMed] [Google Scholar]

Briffa 2005 {published data only}

  1. Briffa TG, Eckermann SD, Griffiths AD, Harris PJ, Heath MR, Freedman SB, et al. Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial. Medical Journal of Australia 2005;183:450-5. [DOI] [PubMed] [Google Scholar]

Bubnova 2019 {published data only}

  1. Bubnova MG, Aronov DM. Clinical effects of a one-year cardiac rehabilitation program using physical training after myocardial infarction in patients of working age with different rehabilitation potentials. Cardiovascular Therapy and Prevention 2019;18(5):27-37. [Google Scholar]

Bubnova 2020 {published and unpublished data}

  1. Bubnova MG, Aronov DM. Physical rehabilitation after acute myocardial infarction: focus on body weight. Russian Journal of Cardiology 2020;25(5):3867. [Google Scholar]

Byrkjeland 2015 {published data only (unpublished sought but not used)}

  1. Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S. Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: a randomised clinical trial. Diabetes & Vascular Disease Research 2015;12(5):325-33. [DOI] [PubMed] [Google Scholar]
  2. Byrkjeland R, Stensaeth K, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, et al. Effects of exercise training on carotidintima‑media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques. Cardiovascular Diabetology 2016;15:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Njerve IU, Byrkjeland R, Arnesen H, Akra S, Solheim S, Seljeflot I. Effects of 12 months exercise intervention on adipose tissue expression of chemokines in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial (RCT). Journal of Thrombosis and Haemostasis : JTH 2015;13:524. [Google Scholar]
  4. Njerve IU, Byrkjeland R, Arnesen H, Solheim S, Seljeflot I. Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016;9:55-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Zaidi H, Byrkjeland R, Njerve IU, Akra S, Solheim S, Arnesen H, et al. Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial. Diabetology & Metabolic Syndrome 2019;11:109. [DOI] [PMC free article] [PubMed] [Google Scholar]

Campo 2020 {published data only}

  1. Campo G, Tonet E, Chiaranda G, Sella G, Maietti E, Bugani G, et al. Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial. Heart 2020;106:1658-64. [DOI] [PubMed] [Google Scholar]
  2. Tonet E, Maietti E, Chiaranda G, Vitali F, Serenelli M, Bugani G, et al. Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): rationale and design of a randomized clinical trial. BMC Cardiovascular Disorders 2018;18(1):98. [DOI] [PMC free article] [PubMed] [Google Scholar]

Carlsson 1998 {published data only}

  1. Carlsson R. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme. Scandinavian Cardiovascular Journal 1998;50 Suppl:1-20. [DOI] [PubMed] [Google Scholar]

Carson 1982 {published data only}

  1. Carson P, Phillips R, Lloyd M, Tucker H, Neophytou M, Buch NJ, et al. Exercise after myocardial infarction: a controlled trial. Journal of the Royal College of Physicians of London 1982;16(3):147-51. [PMC free article] [PubMed] [Google Scholar]

Chaves 2019 {published data only}

  1. Chaves GS, Ghisi GL, Britto RR, Grace SL. Maintenance of gains, morbidity, and mortality at 1 year following cardiac rehabilitation in a middle-income country: a wait-list control crossover trial. Journal of the American Heart Association 2019;8(4):e011228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chaves GS, Ghisi GL, Grace SL, Oh P, Ribeiro AL, Britto RR. Corrigendum to ‘‘Effects of comprehensive cardiacrehabilitation on functional capacity andcardiovascular risk factors in Brazilians assisted bypublic health care: protocol for a randomizedcontrolled trial’’. Brazilian Journal of Physical Therapy 2018;22(3):254. [DOI] [PMC free article] [PubMed]
  3. Chaves GS, Ghisi GL, Grace SL, Oh P, Ribeiro AL, Britto RR. Effects of comprehensive cardiac rehabilitationon functional capacity and cardiovascular risk factors in Brazilians assisted by public health care: protocol for a randomized controlled trial. Brazilian Journal of Physical Therapy 2016;20(6):592-600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chaves GS, Ghisi GL, Grace SL, Oh P, Ribeiro AL, Britto RR. Effects of comprehensive cardiac rehabilitation on functional capacity in a middle-income country: a randomised controlled trial. Heart 2019;105:406-13. [DOI] [PubMed] [Google Scholar]
  5. Ghisi GL, Chaves GS, Ribeiro AL, Oh P, Britto RR, Grace SL. Comprehensive cardiac rehabilitation effectiveness in a middle-income setting. A randomized controlled trial. Journal of Cardiopulmonary Rehabilitation 2020;40(6):399-406. [DOI] [PubMed] [Google Scholar]

DeBusk 1994 {published data only}

  1. DeBusk RF, Miller NH, Superko HR, Dennis CA, Thomas RJ, Lew HT, et al. A case management system for coronary risk factor modification following acute myocardial infarction. Annals of Internal Medicine 1994;120(9):721-9. [DOI] [PubMed] [Google Scholar]
  2. Taylor CB, Miller NH, Smith PM, DeBusk RF. The effect of a home-based, case-managed, multifactorial risk-reduction program on reducing psychological distress in patients with cardiovascular disease. Journal of Cardiopulmonary Rehabilitation 1997;17(3):157-62. [DOI] [PubMed] [Google Scholar]

Dorje 2019 {published data only}

  1. ChiCTR-INR-16009598. SMARTphone-based Home Cardiac Rehabilitation and Secondary Prevention in Chinese Coronary Heart Disease Patients (SMART-CR/SP): a randomized controlled trial. www.chictr.org.cn/hvshowproject.aspx?id=12793 (date of registration 25 October 2016).
  2. Dorje T, Zhao G, Scheer A, Tsokey L, Wang J, Chen Y, et al. SMARTphone and social media-based Cardiac Rehabilitation and Secondary Prevention (SMART-CR/SP) for patients with coronary heart disease in China: a randomised controlled trial protocol. BMJ Open 2018;8:e021908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dorje T, Zhao G, Tso K, Wang J, Chen Y, Tsokey L, et al. Correction to Lancet Digital Health 2019; published online 10 Oct 2019. Lancet Digital Health 2019. [DOI: 10.1016/S2589-7500(19)30162-1] [DOI]
  4. Dorje T, Zhao G, Tso K, Wang J, Chen Y, Tsokey L, et al. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. Lancet 2019;1(7):e363-74. [DOI] [PubMed] [Google Scholar]

Dugmore 1999 {published data only}

  1. Dugmore LD, Tipson RJ, Phillips MH, Flint EJ, Stentiford NH, Bone MF, et al. Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart 1999;81(4):359-66. [DOI] [PMC free article] [PubMed] [Google Scholar]

Engblom 1996 {published data only}

  1. Engblom E, Hamalainen H, Lind J, Mattlar CE, Ollila S, Kallio V, et al. Quality of life during rehabilitation after coronary bypass surgery. Quality of Life Research 1992;1:167-75. [DOI] [PubMed] [Google Scholar]
  2. Engblom E, Hietanen EK, Hamalainen H, Kallio V, Inberg M, Knuts L-R. Exercise habits and physical performance during comprehensive rehabilitation after coronary artery bypass surgery. European Heart Journal 1992;13:1053-9. [DOI] [PubMed] [Google Scholar]
  3. Engblom E, Korpilahti K, Hamalainen H, Puukka P, Ronnemaa T. Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors. American Journal of Cardiology 1996;78:1428-31. [DOI] [PubMed] [Google Scholar]
  4. Engblom E, Korpilahti K, Hamalainen H, Ronnemaa T, Puukka P. Quality of life and return to work 5 years after coronary artery bypass surgery. Journal of Cardiopulmonary Rehabilitation 1997;17:29-36. [DOI] [PubMed] [Google Scholar]
  5. Engblom E, Rönnemaa T, Hämäläinen H, Kallio V, Vänttinen, Knuts LR. Coronary heart disease risk factors before and after bypass surgery: results of a controlled trial on multifactorial rehabilitation. European Heart Journal 1992;13(2):232-7. [DOI] [PubMed] [Google Scholar]

Erdman 1986 {published data only}

  1. Erdman RA, Duivenvoorden HJ, Verhage F, Kazemier M, Hugenholtz PG. Predictability of beneficial effects in cardiac rehabilitation: a randomized clinical trial of psychosocial variables. Journal of Cardiopulmonary Rehabilitation 1986;6(6):206-13. [Google Scholar]

Fletcher 1994 {published data only}

  1. Fletcher BJ, Dunbar SB, Felner JM, Jensen BE, Almon L, Cotsonis G, et al. Exercise testing and training in physically disabled men with clinical evidence of coronary artery disease. American Journal of Cardiology 1994;73(2):170-4. [DOI] [PubMed] [Google Scholar]

Fridlund 1991 {published data only}

  1. Fridlund B, Högstedt B, Lidell E, Larsson PA. Recovery after myocardial infarction: effects of a caring rehabilitation programme. Scandinavian Journal of Caring Sciences 1991;5(1):23-32. [DOI] [PubMed] [Google Scholar]
  2. Fridlund B, Lidell E, Larsson PA. A caring perspective on rehabilitation after myocardial infarction: a theoretical framework and a suggestion for a rehabilitation programme. Scandinavian Journal of Caring Sciences 1989;3(3):129-35. [DOI] [PubMed] [Google Scholar]
  3. Fridlund B, Pihilgren C, Wannestig LB. A supportive - educative caring rehabilitation programme: improvements of physical health after myocardial infarction. Journal of Clinical Nursing 1992;1:141-6. [Google Scholar]
  4. Lidell E, Fridlund B. Long-term effects of a comprehensive rehabilitation programme after myocardial infarction. Scandinavian Journal of Caring Sciences 1996;10:67-74. [DOI] [PubMed] [Google Scholar]

Giallauria 2008 {published data only}

  1. Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, et al. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. European Journal of Cardiovascular Prevention and Rehabilitation 2008;15(1):113-8. [DOI] [PubMed] [Google Scholar]

Hambrecht 2004 {published data only}

  1. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004;109:1371-8. [DOI] [PubMed] [Google Scholar]
  2. Walther C, Mobius-Winkler S, Linke A, Bruegel M, Thiery J, Schuler G, et al. Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation 2008;15:107-12. [DOI] [PubMed] [Google Scholar]

Haskell 1994 {published data only}

  1. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89(3):975-90. [DOI] [PubMed] [Google Scholar]

Hassan 2016 {published data only}

  1. Hassan AM, Nahas NG. Efficacy of cardiac rehabilitation after percutaneous coronary intervention. International Journal of PharmTech Research 2016;9(4):134-41. [Google Scholar]

Hautala 2017 {published and unpublished data}

  1. Hautala AJ, Kiviniemi AM, Makikallio T, Koistinen P, Ryynanen OP, Martikainen JA, et al. Economic evaluation of exercise-based cardiac rehabilitation in patients with a recent acute coronary syndrome. Scandinavian Journal of Medicine & Science in Sports 2017;27(11):1395-403. [DOI] [PubMed] [Google Scholar]
  2. NCT01916525. Effectiveness of exercise cardiac rehabilitation (EFEX-CARE). clinicaltrials.gov/NCT01916525 (first posted 5 August 2013).

He 2020 {published data only (unpublished sought but not used)}

  1. He C, Zhu C, Zhu Y, Zou Z, Wang S, Zhai C, Hu H. Effect of exercise-based cardiac rehabilitation on clinical outcomes in patients with myocardial infarction in the absence of obstructive coronary artery disease (MINOCA). International Journal of Cardiology 2020;315:9-14. [DOI] [PubMed] [Google Scholar]

Heller 1993 {published data only}

  1. Heller RF, Knapp JC, Valenti LA, Dobson AJ. Secondary prevention after acute myocardial infarction. American Journal of Cardiology 1993;72(11):759-62. [DOI] [PubMed] [Google Scholar]

Higgins 2001 {published data only}

  1. Higgins HC, Hayes RL, McKenna KT. Rehabilitation outcomes following percutaneous coronary interventions (PCI). Patient Education & Counseling 2001;43:219-30. [DOI] [PubMed] [Google Scholar]

Hofman‐Bang 1999 {published data only}

  1. Hofman-Bang C, Lisspers J, Nordlander R, Nygren Å, Sundin Ö, Öhman A, et al. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. European Heart Journal 1999;20(20):1465-74. [DOI] [PubMed] [Google Scholar]
  2. Lisspers J, Sundin Ö, Öhman A, Hofman-Bang C, Rydén L, Nygren Å. Long-term effects of lifestyle behavior change in coronary artery disease: effects on recurrent coronary events after percutaneous coronary intervention. Health Psychology 2005;24(1):41-8. [DOI] [PubMed] [Google Scholar]
  3. Lisspers J, Sundin Ö, Hofman-Bang C, Nordlander R, Nygren Å, Rydén L, et al. Behavioral effects of a comprehensive multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: a prospective randomized, controlled study. Journal of Psychosomatic Research 1999;46(2):143-54. [DOI] [PubMed] [Google Scholar]

Holmbäck 1994 {published data only}

  1. Holmbäck AM, Säwe U, Fagher B. Training after myocardial infarction: Lack of long-term effects on physical capacity and psychological variables. Archives of Physical Medical and Rehabilitation 1994;75(5):551-4. [PubMed] [Google Scholar]

Houle 2012 {published data only}

  1. Houle J, Doyon O, Vadeboncoeur N, Turbide G, Diaz A, Poirier P. Effectiveness of a pedometer-based program using a socio-cognitive intervention on physical activity and quality of life in a setting of cardiac rehabilitation. Canadian Journal of Cardiology 2012;28:27-32. [DOI] [PubMed] [Google Scholar]

Kallio 1979 {published data only}

  1. Kallio V, Hämäläinen H, Hakkila J, Luurila OJ. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet 1979;2(8152):1091-4. [DOI] [PubMed] [Google Scholar]

Kovoor 2006 {published data only}

  1. Hall JP, Wiseman VP, King MT, Ross DL, Kovoor P, Zecchin RP, et al. Economic evaluation of a randomised trial of early return to normal activities versus cardiac rehabilitation after acute myocardial infarction. Heart, Lung and Circulation 2002;11:10-8. [DOI] [PubMed] [Google Scholar]
  2. Kovoor P, Lee AK, Carrozzi F, Wiseman V, Byth K, Zecchin R, et al. Return to full normal activities including work at two weeks after acute myocardial infarction. American Journal of Cardiology 2006;97(7):952-8. [DOI] [PubMed] [Google Scholar]

La Rovere 2002 {published data only}

  1. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 2002;106(8):945-9. [DOI] [PubMed] [Google Scholar]

Lear 2015 {published data only (unpublished sought but not used)}

  1. Lear SA, Singer J, Banner-Lukaris D, Horvat D, Park JE, Bates J, et al. Improving access to cardiac rehabilitation using the internet: a randomized trial. Studies in Health Technology and Informatics 2015;209:58-66. [PubMed] [Google Scholar]
  2. Lear SA, Singer J, Banner-Lukaris D, Horvat D, Park JE, Bates J, et al. Randomized trial of a virtual cardiac rehabilitation program delivered at a distance via the internet. Circulation. Cardiovascular Quality and Outcomes 2014;7:952-9. [DOI] [PubMed] [Google Scholar]

Leizorovicz 1991 {published data only}

  1. Leizorovicz A, Saint-Pierre A, Vasselon C, Boissel JP. Comparison of a rehabilitation programme, a counselling programme and usual care after an acute myocardial infarction: results of a long-term randomized trial. P.RE.COR. Group. European Heart Journal 1991;12(5):612-6. [DOI] [PubMed] [Google Scholar]

Lewin 1992 {published data only}

  1. Lewin B, Robertson IH, Cay EL, Irving JB, Campbell M. Effects of self-help post-myocardial infarction rehabilitation on psychological adjustment and use of health services. Lancet 1992;339(8800):1036-40. [DOI] [PubMed] [Google Scholar]

Ma 2020 {published data only (unpublished sought but not used)}

  1. Ma LY, Deng L, Yu H. The effects of a comprehensive rehabilitation and intensive education program on anxiety, depression, quality of life, and major adverse cardiac and cerebrovascular events in unprotected left main coronary artery disease patients who underwent coronary artery bypass grafting. Irish Journal of Medical Science 2020;189:477-88. [DOI] [PubMed] [Google Scholar]

Maddison 2014 {published data only}

  1. Maddison R, Pfaeffli L, Whittaker R, Stewart R, Kerr A, Jiang Y, et al. A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the HEART randomized controlled trial. European Journal of Preventive Cardiology 2014;22(6):701-9. [DOI] [PubMed] [Google Scholar]

Manchanda 2000 {published data only}

  1. Manchanda SC, Narang R, Reddy KS, Sachdeva U, Prabhakaran D, Dharmanand S, et al. Retardation of coronary atherosclerosis with yoga lifestyle intervention. Journal of the Association of Physicians of India 2000;48(7):687-94. [PubMed] [Google Scholar]

Marchionni 2003 {published data only}

  1. Marchionni N, Fattirolli F, Fumagalli S, Oldridge N, Del Lungo F, Morosi L, et al. Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial. Circulation 2003;107(17):2201-6. [DOI] [PubMed] [Google Scholar]

Maroto 2005 {published data only}

  1. Maroto MJ, Artigao Ramirez R, Morales Duran MD, Pablo Zarzosa C, Abraira V. Cardiac rehabilitation in patients with myocardial infarction: a 10-year follow-up study. Revista Espanola de Cardiologia 2005;58:1181-7. [PubMed] [Google Scholar]

Miller 1984 {published data only}

  1. DeBusk RF, Haskell WL, Miller NH, Berra K, Taylor CB, Berger WE, et al. Medically directed at-home rehabilitation soon after clinically uncomplicated acute myocardial infarction: a new model for patient care. American Journal of Cardiology 1985;55(4):251-7. [DOI] [PubMed] [Google Scholar]
  2. Miller NH, Haskell WL, Berra K, DeBusk RF. Home versus group exercise training for increasing functional capacity after myocardial infarction. Circulation 1984;70(4):645-9. [DOI] [PubMed] [Google Scholar]
  3. Taylor CB, Houston-Miller N, Ahn DK, Haskell WL, DeBusk RF. The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients. Journal of Psychosomatic Research 1986;30(5):581-7. [DOI] [PubMed] [Google Scholar]
  4. Taylor CB, Houston-Miller N, Haskell WL, DeBusk RF. Smoking cessation after acute myocardial infarction: the effects of exercise training. Addictive Behaviors 1988;13(4):331-5. [DOI] [PubMed] [Google Scholar]

Munk 2009 {published data only}

  1. Munk PS, Breland UM, Aukrust P, Ueland T, Kvaloy JT, Larsen AI. High intensity interval training reduces systemic inflammation in post-PCI patients. European Journal of Cardiovascular Prevention & Rehabilitation 2011;18:850-7. [DOI] [PubMed] [Google Scholar]
  2. Munk PS, Staal EM, Butt N, Isaksen K, Larsen AI. High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation. American Heart Journal 2009;158:734-41. [DOI] [PubMed] [Google Scholar]

Mutwalli 2012 {published data only}

  1. Mutwalli HA, Fallows SJ, Arnous AA, Zamzami MS. Randomized controlled evaluation shows the effectiveness of a home-based cardiac rehabilitation program. Saudi Medical Journal 2012;33:152-9. [PubMed] [Google Scholar]

Oerkild 2012 {published data only}

  1. Oerkild B, Frederiksen M, Hansen JF, Prescott E. Home-based cardiac rehabilitation is an attractive alternative to no cardiac rehabilitation for elderly patients with coronary heart disease: results from a randomised clinical trial. BMJ Open 2012;2:e001820. [DOI] [PMC free article] [PubMed] [Google Scholar]

Oldridge 1991 {published and unpublished data}

  1. Oldridge N, Furlong W, Feeny D, Torrance G, Guyatt G, Crowe J, et al. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. American Journal of Cardiology 1993;72:154-61. [DOI] [PubMed] [Google Scholar]
  2. Oldridge N, Guyatt G, Jones N, Crowe J, Singer J, Feeny D, et al. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. American Journal of Cardiology 1991;67(13):1084-9. [DOI] [PubMed] [Google Scholar]
  3. Oldridge N, Streiner D, Hoffmann R, Guyatt G. Profile of mood states and cardiac rehabilitation after acute myocardial infarction. Medicine and Science in Sports and Exercise 1995;27(6):900-5. [PubMed] [Google Scholar]

Ornish 1990 {published data only}

  1. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336(8708):129-33. [DOI] [PubMed] [Google Scholar]
  2. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998;280(23):2001-7. [DOI] [PubMed] [Google Scholar]
  3. Pischke CR, Scherwitz L, Weidner G, Ornish D. Long-term effects of lifestyle changes on well-being and cardiac variables among coronary heart disease patients. Health Psychology 2008;27(5):584-92. [DOI] [PubMed] [Google Scholar]

Pal 2013 {published data only}

  1. Pal A, Srivastava N, Narain VS, Agrawal GG, Rani M. Effect of yogic intervention on the autonomic nervous system in the patients with coronary artery disease: a randomized controlled trial. Eastern Mediterranean Health Journal 2013;19(5):453-8. [PubMed] [Google Scholar]

Pomeshkina 2017 {published data only (unpublished sought but not used)}

  1. Pomeshkina S, Loktionova E, Arkhipova N, Barbarash O. Home-based walking training and adherence to medical therapy in patients undergoing coronary artery bypass grafting. European Heart Journal 2015;36:634. [Google Scholar]
  2. Pomeshkina SA, Loktionova EB, Bezzubova VA, Arkhipova NV, Borovik IV, Barbarash OL. The comparative analysis of the influence of the supervised exercise training and home-based exercise training on the psychological status of the following coronary artery bypass grafting. Problems of Balneology, Physiotherapy, and Exercise Therapy 2017;94(6):10-7. [DOI] [PubMed] [Google Scholar]

Pomeshkina 2019 {published data only (unpublished sought but not used)}

  1. Pomeshkina SA, Barbarash OL, Pomeshkin EV. Exercise training and erectile dysfunction in patients after coronary artery bypass grafting. Therapeutic Archive 2019;91(9):16-20. [DOI] [PubMed] [Google Scholar]

Prabhakaran 2020 {published data only}

  1. Chandrasekaran AM, Kinra S, Ajay VS, Chattopadhyay K, Singh K, Singh K, et al. Effectiveness and cost-effectiveness of a yoga-based cardiac rehabilitation (Yoga-CaRe) program following acute myocardialinfarction: study rationale and design of a multi-center randomized controlled trial. International Journal of Cardiology 2019;280:14-8. [DOI] [PubMed] [Google Scholar]
  2. Chattopadhyay K, Chandrasekaran AM, Praveen PA, Manchanda SC, Madan K, Ajay VS, et al. Development of a yoga-based cardiac rehabilitation (Yoga-CaRe) programme for secondary prevention of myocardial infarction. Evidence-Based Complementary and Alternative Medicine 2019;2019:1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CTRI/2012/02/002408. A study on effectiveness of yoga based cardiac rehabilitation programme in India and United Kingdom. apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/02/002408 (date of registration 8 February 2012).
  4. Prabhakaran D, Chandrasekaran AM, Singh K, Mohan B, Chattopadhyay K, Chadha DS, et al. Yoga-based cardiac rehabilitation after acute myocardial infarction. Journal of the American College of Cardiology 2020;75(13):1551-61. [DOI] [PMC free article] [PubMed] [Google Scholar]

Reid 2012 {published data only}

  1. Reid DR, Morrin LI, Beaton LJ, Papadakis S, Kocourek J, McDonnell L, et al. Randomized trial of an internet-based computer-tailored expert system for physical activity in patients with heart disease. European Journal of Preventive Cardiology 2012;19(6):1357–64. [DOI] [PubMed] [Google Scholar]

Roman 1983 {published data only}

  1. Roman O, Gutierrez M, Luksic I, Chavez E, Camuzzi AL, Villalon E, et al. Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study. Cardiology 1983;70:223-31. [DOI] [PubMed] [Google Scholar]

Sandström 2005 {published data only}

  1. Sandström L, Ståhle A. Rehabilitation of elderly with coronary heart disease - Improvement in quality of life at a low cost. Advances in Physiotherapy 2005;7:60-6. [Google Scholar]

Santaularia 2017 {published data only}

  1. Santaularia N, Caminal J, Arnau A, Perramon M, Montesinos J, Abenoza Guardiola M, et al. The efficacy of a supervised exercise training programme on readmission rates in patients with myocardial ischemia: results from a randomised controlled trial. European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2017;16(3):201-12. [DOI] [PubMed] [Google Scholar]
  2. Santaularia N, Caminal J, Arnau A, Perramon M, Montesinos J, Trape J, et al. Randomized clinical trial to evaluate the effect of a supervised exercise training program on readmissions in patients with myocardial ischemia: a study protocol. BMC Cardiovascular Disorders 2013;13(1):32. [DOI] [PMC free article] [PubMed] [Google Scholar]

Schuler 1992 {published data only}

  1. Hambrecht R, Niebauer J, Marburger C, Grunze M, Kalberer B, Hauer K, et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. Journal of the American College of Cardiology 1993;22(2):468-77. [DOI] [PubMed] [Google Scholar]
  2. Niebauer J, Hambrecht R, Marburger C, Hauer K, Velich T, Hodenberg E, et al. Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. American Journal of Cardiology 1995;76(11):771-5. [DOI] [PubMed] [Google Scholar]
  3. Niebauer J, Hambrecht R, Velich T, Hauer K, Marburger C, Kalberer B, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation 1997;96(8):2534-41. [DOI] [PubMed] [Google Scholar]
  4. Niebauer J, Hambrecht R, Velich T, Marburger C, Hauer K, Kreuzer J, et al. Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program. American Journal of Cardiology 1996;78(2):163-7. [DOI] [PubMed] [Google Scholar]
  5. Nikolaus T, Schlierf G, Vogel G, Schuler G, Wagner I. Treatment of coronary heart disease with diet and exercise: problems of compliance. Annals of Nutrition and Metabolism 1991;35:1-7. [DOI] [PubMed] [Google Scholar]
  6. Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, et al. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation 1992;86(1):1-11. [DOI] [PubMed] [Google Scholar]

Seki 2003 {published data only}

  1. Seki E, Watanabe Y, Sunayama S, Iwama Y, Shimada K, Kawakami K, et al. Effects of phase III cardiac rehabilitation programs on health-related quality of life in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP). Circulation Journal 2003;67(1):73-7. [DOI] [PubMed] [Google Scholar]

Seki 2008 {published data only}

  1. Seki E, Watanabe Y, Shimada K, Sunayama S, Onishi T, Kawakami K, et al. Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease: Juntendo Cardiac Rehabilitation Program (J-CARP). Circulation Journal 2008;72(8):1230-4. [DOI] [PubMed] [Google Scholar]

Shaw 1981 {published data only}

  1. Dorn J, Naughton J, Imamura D, Trevisan M. Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction patients: the National Exercise and Heart Disease Project (NEHDP). Circulation 1999;100:1764-9. [DOI] [PubMed] [Google Scholar]
  2. Naughton J. The National Exercise and Heart Disease Project. The pre-randomization exercise program. Report number 2. Cardiology 1978;63(6):352-67. [DOI] [PubMed] [Google Scholar]
  3. Shaw LW. Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction. The National Exercise and Heart Disease Project. American Journal of Cardiology 1981;48(1):39-46. [DOI] [PubMed] [Google Scholar]
  4. Stern MJ, Cleary P. The National Exercise and Heart Disease Project: long-term psychosocial outcome. Archives of Internal Medicine 1982;142(6):1093-7. [PubMed] [Google Scholar]

Sivarajan 1982 {published data only}

  1. Ott CR, Sivarajan ES, Newton KM, Almes MJ, Bruce RA, Bergner M, et al. A controlled randomized study of early cardiac rehabilitation: the sickness impact profile as an assessment tool. Heart & Lung 1983;12(2):162-70. [PubMed] [Google Scholar]
  2. Sivarajan ES, Bruce RA, Almes MJ, Green B, Belanger L, Lindskog BD, et al. In-hospital exercise after myocardial infarction does not improve treadmill performance. New England Journal of Medicine 1981;305(7):357-62. [DOI] [PubMed] [Google Scholar]
  3. Sivarajan ES, Bruce RA, Lindskog BD, Almes MJ, Belanger L, Green B. Treadmill test responses to an early exercise program after myocardial infarction: a randomized study. Circulation 1982;65(7):1420-8. [DOI] [PubMed] [Google Scholar]
  4. Sivarajan ES, Newton KM, Almes MJ, Kempf TM, Mansfield LW, Bruce RA. Limited effects of outpatient teaching and counselling after myocardial infarction: A controlled study. Heart & Lung 1983;12(1):65-73. [PubMed] [Google Scholar]

Snoek 2020 {published data only}

  1. Snoek JA, Prescott EI, Van der Velde AE, Eijsvogels TM, Mikkelsen N, Prins LF, et al. Effectiveness of home-based mobile guided cardiac rehabilitation as alternative strategy for nonparticipation in clinic-based cardiac rehabilitation among elderly patients in Europe. A randomized clinical trial. JAMA Cardiology 2020;6(4):463–8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Specchia 1996 {published data only}

  1. Specchia G, De Servi S, Scirè A, Assandri J, Berzuini C, Angoli L, et al. Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction. Circulation 1996;94(5):978-82. [DOI] [PubMed] [Google Scholar]

Ståhle 1999 {published data only}

  1. Hage C, Mattsson E, Ståhle A. Long term effects of exercise training on physical activity level and quality of life in elderly coronary patients - a three- to six-year follow-up. Physiotherapy Research International 2003;8(1):13-22. [DOI] [PubMed] [Google Scholar]
  2. Ståhle A, Lindquist I, Mattsson E. Important factors for physical activity among elderly patients one year after an acute myocardial infarction. Scandinavian Journal of Rehabilitation Medicine 2000;32(3):111-6. [DOI] [PubMed] [Google Scholar]
  3. Ståhle A, Mattsson E, Rydén L, Unden AL, Nordlander R. Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study. European Heart Journal 1999;20(20):1475-84. [DOI] [PubMed] [Google Scholar]
  4. Ståhle A, Nordlander R, Rydén L, Mattsson E. Effects of organized aerobic group training in elderly patients discharged after an acute coronary syndrome. A randomized controlled study. Scandinavian Journal of Rehabilitation Medicine 1999;31(2):101-7. [DOI] [PubMed] [Google Scholar]
  5. Ståhle A, Tollbäck A. Effects of aerobic group training on exercise capacity, muscular endurance and recovery in elderly patients with recent coronary events: a randomized, controlled study. Advances in Physiotherapy 2001;3:29-37. [Google Scholar]

Stern 1983 {published data only}

  1. Stern MJ, Gorman PA, Kaslow L. The group counseling v exercise therapy study. A controlled intervention with subjects following myocardial infarction. Archives of Internal Medicine 1983;143(9):1719-25. [PubMed] [Google Scholar]

Sun 2016 {published data only}

  1. Sun P, Li Y, Song C, Chen D, Tao L, Shi L, Ma J, et al. Long-term effects of exercise rehabilitation on risk factors in elderly patients with stable coronary artery disease. Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2016;5:491-5. [Google Scholar]

Toobert 2000 {published data only}

  1. Toobert DJ, Glasgow RE, Nettekoven LA, Brown JE. Behavioral and psychosocial effects of intensive lifestyle management for women with coronary heart disease. Patient Education and Counseling 1998;35(3):177-88. [DOI] [PubMed] [Google Scholar]
  2. Toobert DJ, Glasgow RE, Radcliffe JL. Physiologic and related behavioral outcomes from the Women's Lifestyle Heart Trial. Annals of Behavioral Medicine 2000;22(1):1-9. [DOI] [PubMed] [Google Scholar]

Uddin 2020 {published data only}

  1. Uddin J, Joshi VL, Moniruzzaman M, Karim R, Siraj M, Rashid MA, et al. Effect of home-based cardiac rehabilitation in a lower-middle income country: results from a controlled trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2020;40(1):29-34. [DOI] [PubMed] [Google Scholar]
  2. Uddin J. Effects of cardiac rehabilitation on exercise capacity and WHO-quality of life undergoing CABG patients. A quasi-randomised controlled trial. European Journal of Heart Failure 2017;19:464. [Google Scholar]

Vecchio 1981 {published data only}

  1. Vecchio C, Cobelli F, Opasich C, Assandri J, Poggi G, Griffo R. Early functional evaluation and physical rehabilitation in patients with wide myocardial infarction [Valutazione funzionale precoce e riabilitazione fisica nei pazienti con infarto miocardico esteso]. Giornale Italiano di Cardiologia 1981;11:419-29. [PubMed] [Google Scholar]

Vermeulen 1983 {published data only}

  1. Vermeulen A, Lie KI, Durrer D. Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis. American Heart Journal 1983;105(5):798-801. [DOI] [PubMed] [Google Scholar]

VHSG 2003 {published data only}

  1. Schumacher A, Peersen K, Sommervoll L, Seljeflot I, Arnesen H, Otterstad JE. Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2006;13(3):356-62. [DOI] [PubMed] [Google Scholar]
  2. Vestfold Heartcare Study Group. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2003;10(6):429-37. [DOI] [PubMed] [Google Scholar]

Wang 2012 {published data only}

  1. Wang W, Chair SY, Thompson DR, Twinn SF. Effects of home-based rehabilitation on health-related quality of life and psychological status in Chinese patients recovering from acute myocardial infarction. Heart & Lung 2012;41:15-25. [DOI] [PubMed] [Google Scholar]

West 2012 {published data only}

  1. West RR, Jones DA, Henderson AH. Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction. Heart 2012;98:637-44. [DOI] [PubMed] [Google Scholar]

WHO 1983 {published data only}

  1. World Health Organization. Rehabilitation and comprehensive secondary prevention after acute myocardial infarction. EURO Reports and Studies 84 1983.

Wilhelmsen 1975 {published data only}

  1. Sanne H. Exercise tolerance and physical training of non-selected patients after myocardial infarction. Acta Medica Scandinavica 1973;Supplementum 551:1-124. [PubMed] [Google Scholar]
  2. Wilhelmsen L, Sanne H, Elmfeldt D, Grimby G, Tibblin G, Wedel H. A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death. Preventive Medicine 1975;4(4):491-508. [DOI] [PubMed] [Google Scholar]

Xu 2017 {published data only}

  1. Xu Y, Feng Y, Su P, Li Y, Li C, Qiao J. Impact of exercise rehabilitation on cardiac function in coronary artery disease patients after percutaneous coronary intervention. Chinese Circulation Journal 2017;32:326-30. [Google Scholar]

Yu 2003 {published data only}

  1. Yu CM, Li LS, Ho HH, Lau CP. Long-term changes in exercise capacity, quality of life, body anthropometry, and lipid profiles after a cardiac rehabilitation program in obese patients with coronary heart disease. American Journal of Cardiology 2003;91(3):321-5. [DOI] [PubMed] [Google Scholar]

Yu 2004 {published data only}

  1. Yu C, Li L, Lam M, Siu D, Miu R, Lau C. Effect of a cardiac rehabilitation program on left ventricular diastolic function and its relationship to exercise capacity in patients with coronary heart disease: experience from a randomized, controlled study. American Heart Journal 2004;147(5):e24. [DOI] [PubMed] [Google Scholar]
  2. Yu CM, Lau CP, Chau J, McGhee S, Kong SL, Cheung BM, et al. A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention. Archives of Physical Medicine and Rehabilitation 2004;85(12):1915-22. [DOI] [PubMed] [Google Scholar]

Zhang 2018 {published data only}

  1. Zhang Y, Cao H, Jiang P, Tang H. Cardiac rehabilitation in acute myocardial infarction patients after percutaneous coronary intervention: a community-based study. Medicine 2018;97(8):1-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Zwisler 2008 {published and unpublished data}

  1. Kruse M, Hochstrasser S, Zwisler AD, Kjellberg J. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial. International Journal of Technology Assessment in Health Care 2006;22(4):478-83. [DOI] [PubMed] [Google Scholar]
  2. Zwisler AD, Soja AM, Rasmussen S, Frederiksen M, Abedini S, Appel J, et al. Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial. American Heart Journal 2008;155(6):1106-13. [DOI] [PubMed] [Google Scholar]

References to studies excluded from this review

ACTRN12617000312347 {unpublished data only}

  1. ACTRN12617000312347. Does the use of personal activity trackers in patients after a heart attack result in an increase in exercise capacity. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372376 (date submitted 17 February 2017).

ACTRN12618001458224 {unpublished data only}

  1. ACTRN12618001458224. Smartphone Cardiac Rehabilitation, Assisted self-Management (SCRAM): a 21st Century Approach for Improving the Self-Management of Heart Disease. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374508 (date submitted 24 August 2018).

Agren 1989 {published data only}

  1. Agren B, Olin C, Castenfors J, Nilsson-Ehle P. Improvements of the lipoprotein profile after coronary bypass surgery: additional effects of an exercise training program. European Heart Journal 1989;10(5):451-8. [DOI] [PubMed] [Google Scholar]

Ahmadi 2020 {published data only}

  1. Ahmadi A, Roshan VD, Jalali A. Coronary vasomotion and exercise induced adaptations in coronary artery disease patients: A systematic review and meta analysis. Journal of Research in Medical Sciences 2020;25:76. [DOI] [PMC free article] [PubMed] [Google Scholar]

Alharbi 2016 {published data only}

  1. Alharbi M, Gallagher R, Kirkness A, Sibbritt D, Tofler G. Long-term outcomes from Healthy Eating and Exercise Lifestyle Program for overweight people with heart disease and diabetes. European Journal of Cardiovascular Nursing: Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2016;15(1):91-9. [DOI] [PubMed] [Google Scholar]

Al Namat 2017 {published data only}

  1. Al Namat R, Aursulesei V, Felea MG, Costache II, Petris A, Mitu O, et al. Heart-type Fatty Acid-Binding Protein (H-FABP) in patients with coronary artery bypass graft surgery undergoing cardiac rehabilitation program. Revista de Chimie 2017;68(7):1485-89. [Google Scholar]

Alsaleh 2012 {published data only}

  1. Alsaleh E, Blake H, Windle R. Behavioural intervention to increase physical activity among patients with coronary heart disease: protocol for a randomised controlled trial. International Journal of Nursing Studies 2012;49:1489-93. [DOI] [PubMed] [Google Scholar]

An 2020 {published data only}

  1. An S, Song R. Effects of health coaching on behavioral modification among adults with cardiovascular risk factors: systematic review and meta-analysis. Patient Education and Counseling 2020;103(10):2029-38. [DOI] [PubMed] [Google Scholar]

Andersson 2010 {published data only}

  1. Andersson A, Sundel KL, Unden AL, Schenck-Gustafsson K, Eriksson I. A five-year rehabilitation programme for younger women after a coronary event reduces the need for hospital care. Scandinavian Journal of Public Health 2010;38:566-73. [DOI] [PubMed] [Google Scholar]

Asbury 2012 {published data only}

  1. Asbury EA, Webb CM, Probert H, Wright C, Barbir M, Fox K, et al. Cardiac rehabilitation to improve physical functioning in refractory angina: a pilot study. Cardiology 2012;122:170-7. [DOI] [PubMed] [Google Scholar]

Astengo 2010 {published data only}

  1. Astengo M, Dahl A, Karlsson T, Mattsson-Hulten L, Wiklund O, Wennerblom B. Physical training after percutaneous coronary intervention in patients with stable angina: effects on working capacity, metabolism, and markers of inflammation. European Journal of Cardiovascular Prevention & Rehabilitation 2010;17:349-54. [DOI] [PubMed] [Google Scholar]

Avila 2020 {published data only}

  1. Avila A, Claes J, Buys R, Azzawi M, Vanhees L, Cornelissen V. Home-based exercise with telemonitoring guidance in patients with coronary artery disease: does it improve long-term physical fitness? European Journal of Preventive Cardiology 2020;27(4):367-77. [DOI] [PubMed] [Google Scholar]

Ballantyne 1982 {published data only}

  1. Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. The effect of moderate physical exercise on the plasma lipoprotein subfractions of male survivors of myocardial infarction. Circulation 1982;65(5):913-8. [DOI] [PubMed] [Google Scholar]

Bär 1992 {published data only}

  1. Bär FW, Hoppener P, Diederiks J, Vonken H, Bekkers J, Hoofd W, et al. Cardiac rehabilitation contributes to the restoration of leisure and social activities. Journal of Cardiopulmonary Rehabilitation 1992;12(2):117-25. [Google Scholar]

Baumgarten 2017 {published data only}

  1. Baumgarten H, Steinmetz C, Borst C, Walther T, Walther C. Preoperative exercise training before elective coronary artery bypass graft surgery: a prospective randomized evaluation on feasibility and effects on operative outcomes. Thoracic and Cardiovascular Surgeon 2017;65:S1-S110. [Google Scholar]

Beland 2020 {published data only}

  1. Beland M, Lavoie KL, Briand S, White UK, Gemme C, Bacon SL. Aerobic exercise alleviates depressive symptoms in patients with a major non-communicable chronic disease: a systematic review and meta-analysis. British Journal of Sports Medicine 2020;54(5):272. [DOI] [PubMed] [Google Scholar]

Bettencourt 2005 {published data only}

  1. Bettencourt N, Dias C, Mateus P, Sampaio F, Santos L, Adao L, et al. Impact of cardiac rehabilitation on quality of life and depression after acute coronary syndrome [Impacto da reabilitacao cardiaca na qualidade-de-vida e sintomatologia depressiva apos sindroma coronaria aguda]. Revista Portuguesa de Cardiologia 2005;24(5):687-96. [PubMed] [Google Scholar]

Bilinska 2010 {published data only}

  1. Bilinska M, Kosydar-Piechna M, Gasiorowska A, Mikulski T, Piotrowski W, Nazar K, et al. Influence of dynamic training on hemodynamic, neurohormonal responses to static exercise and on inflammatory markers in patients after coronary artery bypass grafting. Circulation Journal 2010;74:2598-604. [DOI] [PubMed] [Google Scholar]

Bilinska 2013 {published data only}

  1. Bilinska M, Kosydar-Piechna M, Mikulski T, Piotrowicz E, Gasiorowska A, Piotrowski W, et al. Influence of aerobic training on neurohormonal and hemodynamic responses to head-up tilt test and on autonomic nervous activity at rest and after exercise in patients after bypass surgery. Cardiology Journal 2013;20:17-24. [DOI] [PubMed] [Google Scholar]

Björntorp 1972 {published data only}

  1. Björntorp, Berchtold P, Grimby G, Lindholm B, Sanne H, Tibblin G, et al. Effects of physical training on glucose tolerance, plasma insulin and lipids and on body composition in men after myocardial infarction. Acta Medica Scandinavica 1972;192(1-6):439-43. [DOI] [PubMed] [Google Scholar]

Blokzijl 2018 {published data only}

  1. Blokzijl F, Dieperink W, Keus F, Reneman MF, Mariani MA, Van der Horst IC. Cardiac rehabilitation for patients having cardiac surgery: a systematic review. Journal of Cardiovascular Surgery 2018;59(6):817-29. [DOI] [PubMed] [Google Scholar]

Blumenthal 1997 {published data only}

  1. Blumenthal JA, Wei J, Babyak MA, Krantz DS, Frid DJ, Coleman RE, et al. Stress management and exercise training in cardiac patients with myocardial ischemia: effects on prognosis and evaluation of mechanisms. Archives of Internal Medicine 1997;157(19):2213-23. [PubMed] [Google Scholar]

Bo 2015 {published data only}

  1. Bo E, Bergland A, Stranden E, Jorgensen JJ, Sandbaek G, Grotta OJ, et al. Effects of 12 weeks of supervised exercise after endovascular treatment: a randomized clinical trial. Physiotherapy Research International : The Journal for Researchers and Clinicians in Physical Therapy 2015;20(3):147-57. [DOI] [PubMed] [Google Scholar]

Borg 2017 {published data only}

  1. Borg S, Oberg B, Nilsson L, Sodelund A, Back M. The role of a behavioural medicine intervention in physiotherapy for the effects of rehabilitation outcomes in exercise-based cardiac rehabilitation (ECRA) - the study protocol of a randomised, controlled trial. BMC Cardiovascular Disorders 2017;17(1):134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Bourke 2010 {published data only}

  1. Bourke L, Tew GA, Milo M, Crossman DC, Saxton JM, Chico TJ. Study protocol: a randomised controlled trial investigating the effect of exercise training on peripheral blood gene expression in patients with stable angina. BMC Public Health 2010;10:620. [DOI] [PMC free article] [PubMed] [Google Scholar]

Bricca 2020 {published data only}

  1. Bricca A, Harris LK, Saracutu M, Smith SM, Juhl CB, Skou ST. The benefits and harms of therapeutic exercise on physical and psychosocial outcomes in people with multimorbidity: protocol for a systematic review. Journal of Comorbidity 2020;10:1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Broers 2020 {published data only}

  1. Broers ER, Widdershoven J, Denollet J, Lodder P, Kop WJ, Wetzels M, et al. Personalized eHealth program for life-style change: results from the "Do Cardiac Health Advanced New Generated Ecosystem (Do CHANGE 2)" randomized controlled trial. Psychosomatic Medicine 2020;82(4):409-19. [DOI] [PubMed] [Google Scholar]

Bubnova 2014 {published data only}

  1. Bubnova MG, Aronov DM, Krasnitskii VB, Ioseliani DG, Novikova NK, Rodzinskaia EM. A home exercise training program after acute coronary syndrome and/or endovascular coronary intervention: efficiency and a patient motivation problem. Terapevticheskii Arkhiv 2014;86:23-32. [PubMed] [Google Scholar]

Busch 2012 {published data only}

  1. Busch JC, Lillou D, Wittig G, Bartsch P, Willemsen D, Oldridge N, et al. Resistance and balance training improves functional capacity in very old participants attending cardiac rehabilitation after coronary bypass surgery. Journal of the American Geriatrics Society 2012;60:2270-6. Erratum in: Journal of the American Geriatrics Society 2013;61(3)479. [DOI] [PubMed] [Google Scholar]

Butler 2009 {published data only}

  1. Butler L, Furber S, Phongsavan P, Mark A, Bauman A. Effects of a pedometer-based intervention on physical activity levels after cardiac rehabilitation: a randomized controlled trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2009;29:105-14. [DOI] [PubMed] [Google Scholar]

Candelaria 2020 {published data only}

  1. Candelaria D, Randall S, Ladak L, Gallagher R. Health-related quality of life and exercise‑based cardiac rehabilitation in contemporary acute coronary syndrome patients: a systematic review and meta-analysis. Quality of Life Research 2020;29:579-92. [DOI] [PubMed] [Google Scholar]

Carlsson 1997 {published data only}

  1. Carlsson R, Lindberg G, Westin L, Israelsson B. Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction. Heart 1997;77(3):256-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Chang 2010 {published data only}

  1. Chang R, Koo M, Kan C, Yu Z, Chu I, Hsu C, et al. Effects of Tai Chi rehabilitation on heart rate responses in patients with coronary artery disease. American Journal of Chinese Medicine 2010;38:461-72. [DOI] [PubMed] [Google Scholar]

Chatian 2014 {published data only}

  1. Chatian M, Tarchalski JL, Lisowski J, Poziomska-Piatkowska E. The influence of the outpatient cardiologic rehabilitation on the physical fitness at patients after a STEMI [Wpływ rehabilitacji ambulatoryjnej kardiologicznej na sprawności fizycznej na pacjentów po STEMI]. Polski Merkuriusz Lekarski 2014;36:88-91. [PubMed] [Google Scholar]

Chen 2016 {published data only}

  1. Chen J, Lin T, Voon W, Lai W, Huang M, Sheu S, et al. Beneficial effects of home-based cardiac rehabilitation on metabolic profiles in coronary heart-disease patients. Kaohsiung Journal of Medical Sciences 2016;32(5):267-75. [DOI] [PubMed] [Google Scholar]

Chen 2017 {published data only}

  1. Chen Y, Tsai J, Liou Y, Chan P. Effectiveness of endurance exercise training in patients with coronary artery disease: A meta-analysis of randomised controlled trials. European Journal of Cardiovascular Nursing 2017;16(5):397-408. [DOI] [PubMed] [Google Scholar]

ChiCTR1800015823 {unpublished data only}

  1. ChiCTR1800015823. Effects of cardiac rehabilitation physical and breathing exercise on stage III rehabilitation in patients with stable coronary artery disease: a randomized controlled trial study. www.chictr.org.cn/hvshowproject.aspx?id=13015 (date registered 23 April 2018).

ChiCTR1800016209 {unpublished data only}

  1. ChiCTR1800016209. Effectiveness of different type of Baduanjin excercise on I and II phase cardiac rehabilitation for acute myocardial infarction: a randomized controlled trail (BECHAMI). www.chictr.org.cn/hvshowproject.aspx?id=19855 (date registered 5 June 2018).

ChiCTR1800016308 {unpublished data only}

  1. ChiCTR1800016308. Study on the effect of physical assessment and training on the prevention and rehabilitation of chronic diseases in middle and old age. www.chictr.org.cn/showproj.aspx?proj=27729 (date of registration 24 May 2018).

ChiCTR1800020411 {unpublished data only}

  1. ChiCTR1800020411. The effectiveness of eHealth cardiac rehabilitation on health outcomes of Chinese patients with coronary artery disease. www.chictr.org.cn/showprojen.aspx?proj=33906 (date of registration 28 December 2018).

ChiCTR‐IOR‐14005743 {unpublished data only}

  1. ChiCTR-IOR-14005743. The efficacy of Qigong Baduanjin Exercise on patients with coronary heart disease after PCI. www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR-IOR-14005743 (date of registration 26 December 2014).

ChiCTR‐IOR‐17012684 {unpublished data only}

  1. ChiCTR-IOR-17012684. Exercise prescription of Taijiquan in rehabilitation of elderly patients with coronary heart disease. www.chictr.org.cn/showprojen.aspx?proj=21653 (date of registration 15 September 2017).

ChiCTR‐IOR‐17014149 {unpublished data only}

  1. ChiCTR-IOR-17014149. The effect of Baduanjin exercise on cardiac rehabilitation in patients with stable coronary artery disease: a randomized controlled trial. www.chictr.org.cn/com/25/showproj.aspx?proj=24131 (date of registration 26 December 2017).

ChiCTR‐IPR‐17011445 {unpublished data only}

  1. ChiCTR-IPR-17011445. The effects of I stage cardiac rehabilitation on cardiopulmonary function in patients undergoing open heart surgery: a randomized controlled study. www.chictr.org.cn/showproj.aspx?proj=19355 (date of registration 20 May 2017).

Chokshi 2018 {published data only}

  1. Chokshi N, Adusumalli S, Small D, Morris A, Feingold J, Ha Y, et al. Effect of loss-framed financial incentives and personalized goal-setting on physical activity among ischemic heart disease patients using wearable devices: the active reward randomized clinical trial. Journal of General Internal Medicine 2018;33:176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chokshi NP, Adusumalli S, Small DS, Morris A, Feingold J, Ha YP, et al. Loss-framed financial incentives and personalized goal-setting to increase physical activity among ischemic heart disease patients using wearable devices: the ACTIVE REWARD randomized trial. Journal of the American Heart Association 2018;7(12):e009173. [DOI] [PMC free article] [PubMed] [Google Scholar]

Chow 2012 {published data only}

  1. Chow CK, Redfern J, Thiagalingam A, Jan S, Whittaker R, Hackett M, et al. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open 2012;2:e000606. [DOI] [PMC free article] [PubMed] [Google Scholar]

Christa 2019 {published data only}

  1. Christa E, Srivastava P, Chandran DS, Jaryal AK, Yadav RK, Roy A, et al. Effect of yoga-based cardiac rehabilitation on heart rate variability: randomized controlled trial in patients post-MI. International Journal of Yoga Therapy 2019;29(1):43-50. [DOI] [PubMed] [Google Scholar]
  2. Christa SE, Jaryal AK, Yadav RK, Roy A, Chandran DS, Deepak KK. Effects of yoga based cardiac rehabilitation on vascular and endothelial function in patients post myocardial infarction - a randomized controlled trial. FASEB Journal 2018;32:S1. [Google Scholar]

Claes 2020 {published data only}

  1. Claes J, Cornelissen V, McDermott C, Moyna N, Pattyn N, Cornelis N, et al. Feasibility, acceptability, and clinical effectiveness of a technology-enabled cardiac rehabilitation platform (Physical Activity Toward Health-I): randomized controlled trial. Journal of Medical Internet Research 2020;22(2):19. [DOI] [PMC free article] [PubMed] [Google Scholar]

Clark 2017 {published data only}

  1. Clark IN, Baker FA, Peiris CL, Shoebridge G, Taylor NF. Participant-selected music and physical activity in older adults following cardiac rehabilitation: a randomized controlled trial. Clinical Rehabilitation 2017;31(3):329-39. [DOI] [PubMed] [Google Scholar]

Conboy 2020 {published data only}

  1. Conboy L, Krol J, Tomas J, Yeh GY, Wayne P, Salmoirago-Blotcher E. Tai Chi for heart attack survivors: qualitative insights. BMJ Supportive & Palliative Care 2020;10(4):6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Cugusi 2020 {published data only}

  1. Cugusi L, Prosperini L, Mura G. Exergaming for quality of life in persons living with chronic diseases: a systematic review and meta-analysis. PM & R : the Journal of Injury, Function, and Rehabilitation 2020 Sept 10 [Epub ahead of print]. [DOI: 10.1002/pmrj.12444] [DOI] [PubMed]

da Costa Torres 2016 {published data only}

  1. da Costa Torres D, Da Silva PR, Lima Reis HJ, Paisani DM, Chiavegato LD. Effectiveness of an early mobilization program on functional capacity after coronary artery bypass surgery: randomized controlled trial. European Respiratory Journal 2016;48(S60):PA4419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. da Costa Torres D, dos Santos PM, Reis HJ, Paisani DM, Chiavegato LD. Effectiveness of an early mobilization program on functional capacity after coronary artery bypass surgery: a randomized controlled trial protocol. SAGE Open Medicine 2016;4:1-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Dalçóquio 2020 {published data only}

  1. Dalçóquio T, Mendonça Furtado RH, Arantes FB, dos Santos MA, Alves LS, et al. Effect of exercise training on platelet aggregation and on P2Y12 inhibitor resistance after myocardial infarction: a randomized clinical trial. Journal of the American College of Cardiology 2020;75:1618. [Google Scholar]

Davoodvand 2009 {published data only}

  1. Davoodvand S, Elahi N, Haghighizadeh M. Effectiveness of short-term cardiac rehabilitation on clinical manifestations in post-MI patients. Hayat 2009;15(3):66-74. [Google Scholar]

De Bakker 2020 {published data only}

  1. De Bakker M, Den Uijl I, Ter Hoeve N, Van Domburg RT, Geleijnse ML, Van dem Berg-Emons RJ, et al. Association between exercise capacity and health-related quality of life during and after cardiac rehabilitation in acute coronary syndrome patients: a substudy of the OPTICARE randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2020;101(4):650-7. [DOI] [PubMed] [Google Scholar]

Deng 2020 {published data only}

  1. Deng BY, Shou XL, Ren AH, Liu XW, Wang QN, Wang BZ, et al. Effect of aerobic training on exercise capacity and quality of life in patients older than 75 years with acute coronary syndrome undergoing percutaneous coronary intervention. Physiotherapy Theory and Practice 2020 Sept 29 [Epub ahead of print]. [DOI: 10.1080/09593985.2020.1825580] [DOI] [PubMed]

Devi 2014 {published data only}

  1. Devi R, Powell J, Singh S. A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial. Journal of Medical Internet Research 2014;16(9):e186. [DOI] [PMC free article] [PubMed] [Google Scholar]

DRKS00007569 {unpublished data only}

  1. DRKS00007569. Evaluation of a multimodal motivation and training program for cardiac rehab aftercare (Vision 2 - Healthy Heart). www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00007569 (date of registration 8 May 2015).

Edstrom‐Pluss 2009 {published data only}

  1. Edstrom-Pluss C, Billing E, Held C, Henriksson P, Kiessling A, Karlsson MR, et al. Long-term beneficial effects of an expanded cardiac rehabilitation after an acute myocardial infarction or coronary artery by-pass grafting: a five year follow-up of a randomized controlled study. European Heart Journal 2009;30:75-6. [Google Scholar]

Engelen 2020 {published data only}

  1. Engelen MM, Van Dulmen S, Puijk-Hekman S, Vermeulen H, Nijhuis-van der Sanden MW, Bredie SJ, et al. Evaluation of a web-based self-management program for patients with cardiovascular disease: explorative randomized controlled trial. Journal of Medical Internet Research 2020;22(7):14. [DOI] [PMC free article] [PubMed] [Google Scholar]

Espinosa 2004 {published data only}

  1. Espinosa Caliani S, Bravo Navas JC, Gomez-Doblas JJ, Collantes Rivera R, Gonzalez Jimenez B, Martinez Lao M, et al. Postmyocardial infarction cardiac rehabilitation in low risk patients. Results with a coordinated program of cardiological and primary care. Revista Espanola de Cardiologia 2004;57:53-9. [PubMed] [Google Scholar]

Fontes‐Carvalho 2015 {published data only}

  1. Fontes-Carvalho R, Sampaio F, Teixeira M, Gama V, Leite-Moreira AF. The role of a structured exercise training program on cardiac structure and function after acute myocardial infarction: study protocol for a randomized controlled trial. Trials 2015;16:90. [DOI] [PMC free article] [PubMed] [Google Scholar]

Francis 2019 {published data only}

  1. Francis T, Kabboul N, Rac V, Mitsakakis N, Pechlivanoglou P, Bielecki J, et al. The effect of cardiac rehabilitation on health-related quality of life in patients with coronary artery disease: a meta-analysis. Canadian Journal of Cardiology 2019;35(3):352-64. [DOI] [PubMed] [Google Scholar]

Franssen 2020 {published data only}

  1. Franssen WM, Franssen GH, Spaas J, Solmi F, Eijnde BO. Can consumer wearable activity tracker-based interventions improve physical activity and cardiometabolic health in patients with chronic diseases? A systematic review and meta-analysis of randomised controlled trials. International Journal of Behavioral Nutrition and Physical Activity 2020;17(1):20. [DOI] [PMC free article] [PubMed] [Google Scholar]

Fu 2019 {published data only}

  1. Fu C, Wang H, Wei Q, He C, Zhang C. Effects of rehabilitation exercise on coronary artery after percutaneous coronary intervention in patients with coronary heart disease: a systematic review and meta-analysis. Disability & Rehabilitation 2019;41(24):2881-7. [DOI] [PubMed] [Google Scholar]

Gao 2007 {published data only}

  1. Gao WG, Hu DY, Ma WL, Tang CZ, Li J, Hasimu B, et al. Effect of health management on the rehabilitation of patients undergoing coronary artery bypass graft. Journal of Clinical Rehabilitative Tissue Engineering Research 2007;11(25):4874-8. [Google Scholar]

Gao 2020 {published data only}

  1. Gao L, Maddison R, Rawstorn J, Ball K, Oldenburg B, Chow C, et al. Economic evaluation protocol for a multicentre randomised controlled trial to compare Smartphone Cardiac Rehabilitation, Assisted self-Management (SCRAM) versus usual care cardiac rehabilitation among people with coronary heart disease. BMJ Open 2020;10(8):8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Garcia‐Bravo 2020 {published data only}

  1. Garcia-Bravo S, Cano-de-la-Cuerda R, Dominguez-Paniagua J, Campuzano-Ruiz R, Barrenada-Copete E, Lopez-Navas MJ, et al. Effects of virtual reality on cardiac rehabilitation programs for ischemic heart disease: a randomized pilot clinical trial. International Journal of Environmental Research and Public Health 2020;17(22):17. [DOI] [PMC free article] [PubMed] [Google Scholar]

Gerlach 2020 {published data only}

  1. Gerlach S, Mermier C, Kravitz L, Degnan J, Dalleck L, Zuhl M. Comparison of treadmill and cycle ergometer exercise during cardiac rehabilitation: a meta-analysis. Archives of Physical Medicine and Rehabilitation 2020;101(4):690-9. [DOI] [PubMed] [Google Scholar]

Ghashghaei 2012 {published data only}

  1. Ghashghaei FE, Sadeghi M, Marandi SM, Ghashghaei SE. Exercise-based cardiac rehabilitation improves hemodynamic responses after coronary artery bypass graft surgery. Arya Atherosclerosis 2012;7:151-6. [PMC free article] [PubMed] [Google Scholar]

Giallauria 2009 {published data only}

  1. Giallauria F, Galizia G, Lucci R, D'Agostino M, Vitelli A, Maresca L, et al. Favourable effects of exercise-based cardiac rehabilitation after acute myocardial infarction on left atrial remodeling. International Journal of Cardiology 2009;136:300-6. [DOI] [PubMed] [Google Scholar]

Giallauria 2012 {published data only}

  1. Giallauria F, Acampa W, Ricci F, Vitelli A, Maresca L, Mancini M, et al. Effects of exercise training started within 2 weeks after acute myocardial infarction on myocardial perfusion and left ventricular function: a gated SPECT imaging study. European Journal of Preventive Cardiology 2012;19:1410-9. [DOI] [PubMed] [Google Scholar]

Giallauria 2013 {published data only}

  1. Giallauria F, Acampa W, Ricci F, Vitelli A, Torella G, Lucci R, et al. Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function. European Journal of Nuclear Medicine & Molecular Imaging 2013;40:315-24. [DOI] [PubMed] [Google Scholar]

Giannuzzi 2008 {published data only}

  1. Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Archives of Internal Medicine 2008;168(20):2194-204. [DOI] [PubMed] [Google Scholar]

Gielen 2003 {published data only}

  1. Gielen S, Erbs S, Linke A, Mobius-Winkler S, Schuler G, Hambrecht R. Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion. American Heart Journal 2003;145(1):e3. [DOI] [PubMed] [Google Scholar]

Goel 2013 {published data only}

  1. Goel K, Pack QR, Lahr B, Greason KL, Lopez-Jimenez F, Squires RW, et al. Cardiac rehabilitation is associated with reduced long-term mortality in patients undergoing combined heart valve and CABG surgery. European Journal of Preventive Cardiology 2013;22(2):159-68. [DOI] [PubMed] [Google Scholar]

Gong 2015 {published data only}

  1. Gong J, Chen X, Li S. Efficacy of a community-based physical activity program KM2H2 for stroke and heart attack prevention among senior hypertensive patients: a cluster randomized controlled phase-II trial. PLoS One 2015;10(10):e0139442. [DOI] [PMC free article] [PubMed] [Google Scholar]

Grant 2018 {published data only}

  1. Grant E, Hochman J, Summapund J, Zhong H, Guo Y, Estrin D, et al. Engagement and outcomes among older adults with mobile health (mHealth) cardiac rehabilitation: pilot study. Journal of the American Geriatrics Society 2018;66:S284. [Google Scholar]

Ha 2011 {published data only}

  1. Ha Yi-Kyung, Jung Yoen-Yi. Development and application of an early exercise program for open heart surgery patients. Journal of Korean Critical Care Nursing 2011;4:1p. [Google Scholar]

Hadadzadeh 2016 {published data only}

  1. Hadadzadeh MH, Maiya AG, Shad B, Mirbolouk F, Padma KR, Devasia T, et al. Effects of early exercise-based cardiac rehabilitation on functional capacity in post-event CAD patients: a randomized controlled trial. Cardiopulmonary Physical Therapy Journal 2016;27:23. [Google Scholar]

Haddadzadeh 2011 {published data only}

  1. Haddadzadeh MH, Maiya AG, Padmakumar R, Shad B, Mirbolouk F. Effect of exercise-based cardiac rehabilitation on ejection fraction in coronary artery disease patients: a randomized controlled trial. Heart Views 2011;12:51-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hansen 2009 {published data only}

  1. Hansen D, Dendale P, Leenders M, Berger J, Raskin A, Vaes J, et al. Reduction of cardiovascular event rate: different effects of cardiac rehabilitation in CABG and PCI patients. Acta Cardiologica 2009;64:639-44. [DOI] [PubMed] [Google Scholar]

Hansen 2010 {published data only}

  1. Hansen D, Dendale P, Raskin A, Schoonis A, Berger J, Vlassak I, et al. Long-term effect of rehabilitation in coronary artery disease patients: randomized clinical trial of the impact of exercise volume. Clinical Rehabilitation 2010;24:319-27. [DOI] [PubMed] [Google Scholar]

Hanssen 2009 {published data only}

  1. Hanssen TA, Nordrehaug JE, Eide GE, Hanestad BR. Does a telephone follow-up intervention for patients discharged with acute myocardial infarction have long-term effects on health-related quality of life? A randomised controlled trial. Journal of Clinical Nursing 2009;18:1334-45. [DOI] [PubMed] [Google Scholar]

Hawkes 2009 {published data only}

  1. Hawkes AL, Atherton J, Taylor CB, Scuffham P, Eadie K, Miller NH, et al. Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients. BMC Cardiovascular Disorders 2009;9(1):16. [DOI] [PMC free article] [PubMed]

He 2018 {published data only}

  1. He C, Gan X, Cui N. Effects of cardiac rehabilitation training on rehabilitation of patients with coronary heart disease: a meta-analysis. Chinese Nursing Research 2018;32(15):2369-79. [Google Scholar]

He 2020b {published data only}

  1. He W, Huang Y, Zhang Y, She W, Fang L, Wang Z. Cardiac rehabilitation therapy for coronary slow flow phenomenon [Kardiale Rehabilitationsbehandlung bei koronarem Slow-flow-Phanomen]. Herz 2020;45(5):468-74. [DOI] [PubMed] [Google Scholar]

Heldal 2000 {published data only}

  1. Heldal M, Sire S, Dale J. Randomised training after myocardial infarction: short and long-term effects of exercise training after myocardial infarction in patients on beta-blocker treatment. A randomized, controlled study. Scandinavian Cardiovascular Journal 2000;34(1):59-64. [DOI] [PubMed] [Google Scholar]

Herring 2018 {published data only}

  1. Herring LY, Dallosso H, Chatterjee S, Bodicoat D, Schreder S, Khunti K, et al. Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trial. Trials 2018;19(1):537. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hoejskov 2019 {published data only}

  1. Hoejskov I, Moons P, Hansen NV, La Cour S, Gluud C, Winkel P, et al. Early rehabilitation after coronary artery bypass grafting - Results from the SheppHeartCABG trial. European Journal of Preventive Cardiology 2017;24:S98. [Google Scholar]
  2. Hoejskov IE, Moons P, Egerod I, Olsen PS, Thygesen LC, Hansen NV, et al. Early physical and psycho-educational rehabilitation in patients with coronary artery bypass grafting: a randomized controlled trial. Journal of Rehabilitation Medicine 2019;51(2):136-43. [DOI] [PubMed] [Google Scholar]
  3. Hojskov IE, Moons P, Hansen NV, La Cour S, Olsen PS, Gluud C, et al. SheppHeartCABG trial—comprehensive early rehabilitation after coronary artery bypass grafting: a protocol for a randomised clinical trial. BMJ Open 2017;7(1):e013038. [DOI] [PMC free article] [PubMed] [Google Scholar]

Hojskov 2016 {published data only}

  1. Hojskov IE, Moons P, Hansen NV, Greve H, Olsen DB, La Cour S, et al. Early physical training and psycho-educational intervention for patients undergoing coronary artery bypass grafting. The SheppHeart randomized 2 × 2 factorial clinical pilot trial. European Journal of Cardiovascular Nursing 2016;15(6):425-37. [DOI] [PubMed] [Google Scholar]

Houle 2011 {published data only}

  1. Houle J, Doyon O, Vadeboncoeur N, Turbide G, Diaz A, Poirier P. Innovative program to increase physical activity following an acute coronary syndrome: randomized controlled trial. Patient Education & Counseling 2011;85:e237-44. [DOI] [PubMed] [Google Scholar]

Huerre 2010 {published data only}

  1. Huerre C, Guiot A, Marechaux S, Auffray JL, Bauchart JJ, Montaigne D, et al. Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome. Archives of Cardiovascular Diseases 2010;103:19-25. [DOI] [PubMed] [Google Scholar]

Indraratna 2020 {published data only}

  1. Indraratna P, Tardo D, Yu J, Delbaere K, Brodie M, Lovell N, et al. Mobile phone technologies in the management of ischemic heart disease, heart failure, and hypertension: systematic review and meta-analysis. JMIR mHealth and uHealth 2020;8(7):17. [DOI] [PMC free article] [PubMed] [Google Scholar]

IRCT20130211012439N3 {unpublished data only}

  1. IRCT20130211012439N3. Comparative evaluation of discharge planning and cardiac rehabilitation on the health outcomes of patients undergoing coronary artery bypass graft surgery. en.irct.ir/trial/36344 (registration date 16 January 2019).

IRCT2014061418075N2 {unpublished data only}

  1. IRCT2014061418075N2. The effect of a cardiac rehabilitation program on quality of life in acute coronary syndrome ‎patients. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2014061418075N2 (date of registration 15 July 2014).

Ivers 2020 {published data only}

  1. Ivers NM, Schwalm J, Bouck Z, McCready T, Taljaard M, Grace SL, et al. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial. BMJ (Clinical Research Ed.) 2020;369:m1731. [DOI] [PMC free article] [PubMed] [Google Scholar]

Izawa 2006 {published data only}

  1. Izawa KP, Watanabe S, Oka K, Kobayashi T, Osada N, Omiya K. The effects of unsupervised exercise training on physical activity and physiological factors after supervised cardiac rehabilitation. Journal of the Japanese Physical Therapy Association 2006;9:1-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Jepma 2019 {published data only}

  1. Jepma P, Jorstad HT, Snaterse M, Ter Riet G, Kragten HJ, Lachman S, et al. Successful lifestyle modification in older patients with coronary artery disease: results from the RESPONSE-2 Trial. European Geriatric Medicine 2019;10:S157. [Google Scholar]

Jepma 2020 {published data only}

  1. Jepma P, Jorstad HT, Snaterse M, ter Riet G, Kragten H, Lachman S, et al. Lifestyle modification in older versus younger patients with coronary artery disease. Heart 2020;106(14):1066-72. [DOI] [PMC free article] [PubMed] [Google Scholar]

Ji 2019 {published data only}

  1. Ji HG, Fang L, Yuan L, Zhang Q. Effects of exercise-based cardiac rehabilitation in patients with acute coronary syndrome: a meta-analysis. Medical Science Monitor 2019;25:5015-27. [DOI] [PMC free article] [PubMed] [Google Scholar]

Jiang 2007 {published data only}

  1. Jiang X, Sit JW, Wong TK. A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China. Journal of Clinical Nursing 2007;16(10):1886-97. [DOI] [PubMed] [Google Scholar]

Jiang 2020 {published data only}

  1. Jiang W, Zhang Y, Yan F, Liu H, Gao R. Effectiveness of a nurse-led multidisciplinary self-management program for patients with coronary heart disease in communities: a randomized controlled trial. Patient Education & Counseling 2020;103(4):854-63. [DOI] [PubMed] [Google Scholar]

Jiang 2020b {published data only}

  1. Jiang J, Chi Q, Wang Y, Jin X, Yu S. Five-animal frolics exercise improves anxiety and depression outcomes in patients with coronary heart disease: a single-blind randomized controlled trial. Evidence-based Complementary & Alternative Medicine 2020;6937158:[DOI:10.1155/2020/6937158]. [DOI] [PMC free article] [PubMed] [Google Scholar]

JPRN‐UMIN000005177 {unpublished data only}

  1. JPRN-UMIN000005177. Japanese prospective multicenter study on outpatient cardiac rehabilitation after the percutaneous coronary intervention. apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000005177  (date of registration 3 March 2011).

JPRN‐UMIN000010031 {unpublished data only}

  1. JPRN-UMIN000010031. Impact of comprehensive cardiac rehabilitation program on stabilization of coronary plaque after acute coronary syndrome. apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN-UMIN000010031 (date of registration 25 February 2013).

Kamei 2020 {published data only}

  1. Kamei T, Kanamori T, Yamamoto Y, Edirippulige S. The use of wearable devices in chronic disease management to enhance adherence and improve telehealth outcomes: a systematic review and meta-analysis. Journal of Telemedicine and Telecare 2020 Aug 20 [Epub ahead of print]. [DOI: 10.1177/1357633X20937573] [DOI] [PubMed]

Karpova 2009 {published data only}

  1. Karpova ES, Kotel'nikova EV, Lipchanskaia TP, Poliakova NV, Liamina NP. Rehabilitative and prophylactic measures including physical training for the correction of risk factors in patients presenting with ischemic heart disease following percutaneous coronary interventions. Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury 2009;6:6-9. [PubMed] [Google Scholar]

Kavanagh 1973 {published data only}

  1. Kavanagh T, Shephard RJ, Doney H, Pandit V. Exercise versus hypnotherapy in coronary rehabilitation. Canadian Family Physician 1973;19:62-6. [PMC free article] [PubMed] [Google Scholar]

Kentala 1972 {published data only}

  1. Kentala E. Physical fitness and feasibility of physical rehabilitation after myocardial infarction in men of working age. Annals of Clinical Research 1972;4(Suppl 9):1-84. [PubMed] [Google Scholar]

Keshavaraz 2020 {published data only}

  1. Keshavaraz N, Naderifar M, Firouzkohi M, Abdollahimohammad A, Akbarizadeh MR. Effect of telenursing on the self-efficacy of patients with myocardial infarction: a quasi-experimental study. Signa Vitae 2020;16(2):92-6. [Google Scholar]

Kidholm 2016 {published data only}

  1. Kidholm K, Rasmussen MK, Andreasen JJ, Hansen J, Nielsen G, Spindler H, et al. Cost-utility analysis of a cardiac telerehabilitation program: the teledialog project. Telemedicine and e-Health 2016;22(7):553-63. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kim 2011 {published data only}

  1. Kim C, Kim DY, Moon CJ. Prognostic influences of cardiac rehabilitation in Korean acute myocardial infarction patients. Annals of Rehabilitation Medicine 2011;35:375-80. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kim 2012 {published data only}

  1. Kim C, Choi HE, Kim BO, Lim MH. Impact of exercise-based cardiac rehabilitation on in-stent restenosis with different generations of drug eluting stent. Annals of Rehabilitation Medicine 2012;36:254-61. [DOI] [PMC free article] [PubMed] [Google Scholar]

Kim 2013 {published data only}

  1. Kim HJ, Oh JK, Kim C, Jee H, Shin KA, Kim YJ. Effects of six-week cardiac rehabilitation and exercise on adiponectin in patients with acute coronary syndrome. Kardiologia Polska 2013;71:924-30. [DOI] [PubMed] [Google Scholar]

Kim 2014 {published data only}

  1. Kim S, Lee S, Kim G, Kang S, Ahn J. Effects of a comprehensive cardiac rehabilitation program in patients with coronary heart disease in Korea. Nursing & Health Sciences 2014;16(4):476-82. [DOI] [PubMed] [Google Scholar]

Kirolos 2019 {published data only}

  1. Kirolos I, Yakoub D, Pendola F, Picado O, Kirolos A, Levine YC, et al. Cardiac physiology in post myocardial infarction patients: the effect of cardiac rehabilitation programs-a systematic review and update meta-analysis. Annals of Translational Medicine 2019;7(17):10. [DOI] [PMC free article] [PubMed] [Google Scholar]

Köhler 2020 {published data only}

  1. Köhler AK, Jaarsma T, Tingström P, Nilsson S. The effect of problem-based learning after coronary heart disease - a randomised study in primary health care (COR-PRIM). BMC Cardiovascular Disorders 2020;20:1-11. [DOI] [PMC free article] [PubMed] [Google Scholar]

Krachler 1997 {published data only}

  1. Krachler M, Lindschinger M, Eber B, Watzinger N, Wallner S. Trace elements in coronary heart disease. Biological Trace Element Research 1997;60(3):175-85. [DOI] [PubMed] [Google Scholar]

Kubilius 2012 {published data only}

  1. Kubilius R, Jasiukeviciene L, Grizas V, Kubiliene L, Jakubseviciene E, Vasiliauskas D. The impact of complex cardiac rehabilitation on manifestation of risk factors in patients with coronary heart disease. Medicina (Kaunas, Lithuania) 2012;48:166-73. [PubMed] [Google Scholar]

Lavoie 2020 {published data only}

  1. Lavoie A, Dubé V. Home-based motivational interviewing nursing intervention to reduce sedentary behaviour among elderly persons following coronary artery bypass surgery: a pilot study. Canadian Journal of Cardiovascular Nursing 2020;30(2):4-12. [Google Scholar]

Lee 2013 {published data only}

  1. Lee HY, Kim JH, Kim BO, Byun YS, Cho S, Goh CW, et al. Regular exercise training reduces coronary restenosis after percutaneous coronary intervention in patients with acute myocardial infarction. International Journal of Cardiology 2013;167:2617-22. [DOI] [PubMed] [Google Scholar]

Li 2004 {published data only}

  1. Li H, Guo L, Sun JZ, Feng JZ, Wang P, Wu GL, et al. Effect of exercise therapy on the quality of life in patients after successful percutaneous transluminal coronary angioplasty. Chinese Journal of Clinical Rehabilitation 2004;8(9):1601-3. [Google Scholar]

Liao 2003 {published data only}

  1. Liao X, Ma H, Dong Y. Effects of early rehabilitation programme on heart rate variability and quality of life in patients with uncomplicated acute myocardial infarction. Journal of Rehabilitation Medicine 2003;18(3):153-5. [Google Scholar]

Lie 2009 {published data only}

  1. Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH. Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program. Quality of Life Research 2009;18(2):201-7. [DOI] [PubMed]

Lin 2020 {published data only}

  1. Lin MY, Weng WS, Apriliyasari RW, Truong PV, Tsai PS. Effects of patient activation intervention on chronic diseases: a meta-analysis. Journal of Nursing Research 2020;28(5):16. [DOI] [PubMed] [Google Scholar]

Liu 2017 {published data only}

  1. Liu SX, Chen YY, Xie KL, Zhang WL. Effects of aerobic exercise combined with resistance training on the cardiorespiratory fitness and exercise capacity of patients with stable coronary artery disease. Zhonghua Xin Xue Guan Bing Za Zhi 2017;45(12):1067-71. [DOI] [PubMed] [Google Scholar]

Maddison 2015 {published data only}

  1. Maddison R, Pfaeffli L, Whittaker R, Stewart R, Kerr A, Jiang Y, et al. A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the HEART randomized controlled trial. European Journal of Preventive Cardiology 2015;22(6):701-9. [DOI] [PubMed] [Google Scholar]

Madssen 2014 {published data only}

  1. Madssen E, Arbo I, Granoien I, Walderhaug L, Moholdt T. Peak oxygen uptake after cardiac rehabilitation: a randomized controlled trial of a 12-month maintenance program versus usual care. PLoS One 2014;9(9):e107924. [DOI] [PMC free article] [PubMed] [Google Scholar]

Maldonado‐Martin 2018 {published data only}

  1. Maldonado-Martin S, Jayo-Montoya JA, Matajira-Chia T, Villar-Zabala B, Goiriena JJ, Aispuru GR. Effects of combined high-intensity aerobic interval training program and Mediterranean diet recommendations after myocardial infarction (INTERFARCT Project): study protocol for a randomized controlled trial. Trials 2018;19(1):156. [DOI] [PMC free article] [PubMed] [Google Scholar]

Mameletzi 2011 {published data only}

  1. Mameletzi D, Kouidi E, Koutlianos N, Deligiannis A. Effects of long-term exercise training on cardiac baroreflex sensitivity in patients with coronary artery disease: a randomized controlled trial. Clinical Rehabilitation 2011;25:217-27. [DOI] [PubMed] [Google Scholar]

Mandic 2013 {published data only}

  1. Mandic S, Hodge C, Stevens E, Walker R, Nye ER, Body D, et al. Effects of community-based cardiac rehabilitation on body composition and physical function in individuals with stable coronary artery disease: 1.6-year follow-up. Biomed Research International 2013;2013:7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Manresa‐Rocamora 2020 {published data only}

  1. Manresa-Rocamora A, Ribeiro F, Sarabia JM, Ibias J, Oliveira NL, Vera-Garcia FJ, et al. Exercise-based cardiac rehabilitation and parasympathetic function in patients with coronary artery disease: a systematic review and meta-analysis. Clinical Autonomic Research 2020;31(2):187-203. [DOI] [PubMed] [Google Scholar]

Mao 2021 {published data only}

  1. Mao S, Zhang XX, Chen MG, Wang CY, Chen QB, Guo LH, et al. Beneficial effects of baduanjin exercise on left ventricular remodelling in patients after acute myocardial infarction: an exploratory clinical trial and proteomic analysis. Cardiovascular Drugs and Therapy 2021;35:21-32. [DOI] [PubMed] [Google Scholar]

Mares 2018 {published data only}

  1. Mares MA, McNally S, Fernandez RS. Effectiveness of nurse-led cardiac rehabilitation programs following coronary artery bypass graft surgery: a systematic review. JBI Database of Systematic Reviews and Implementation Reports 2018;16(12):2304-29. [DOI] [PubMed] [Google Scholar]

Martinello 2019 {published data only}

  1. Martinello N, Saunders S, Reid R. The effectiveness of interventions to maintain exercise and physical activity in post-cardiac rehabilitation populations: a systematic review and meta-analysis of randomized controlled trials. Journal of Cardiopulmonary Rehabilitation and Prevention 2019;39(3):161-7. [DOI] [PubMed] [Google Scholar]

Martinez 2011 {published data only}

  1. Martinez DG, Nicolau JC, Lage RL, Toschi-Dias E, Matos LD, Alves MJ, et al. Effects of long-term exercise training on autonomic control in myocardial infarction patients. Hypertension 2011;58:1049-56. [DOI] [PubMed] [Google Scholar]

Mayer‐Berger 2014 {published data only}

  1. Mayer-Berger W, Simic D, Mahmoodzad J, Burtscher R, Kohlmeyer M, Schwitalla B, et al. Efficacy of a long-term secondary prevention programme following inpatient cardiovascular rehabilitation on risk and health-related quality of life in a low-education cohort: a randomized controlled study. European Journal of Preventive Cardiology 2014;21:145-52. [DOI] [PubMed] [Google Scholar]

McCleary 2020 {published data only}

  1. McCleary N, Ivers NM, Schwalm JD, Witterman HO, Taljaard M, Desveaux L, et al. Interventions supporting cardiac rehabilitation completion: process evaluation investigating theory-based mechanisms of action. Health Psychology 2020;39(12):1048-61. [DOI] [PubMed] [Google Scholar]

McDermott 2019 {published data only}

  1. McDermott C, McCormack CM, McDermott L, O'Shea O, Kelly SM, McCarren A, et al. Comparison of selected health indices in Irish and Belgian participants commencing a home-based, technology enabled cardiac rehabilitation program. European Journal of Preventive Cardiology 2019;26:S40-S41. [Google Scholar]

McGregor 2020 {published data only}

  1. McGregor G, Powell R, Kimani P, Underwood M. Does contemporary exercise-based cardiac rehabilitation improve quality of life for people with coronary artery disease? A systematic review and meta-analysis. BMJ Open 2020;10(6):19. [DOI] [PMC free article] [PubMed] [Google Scholar]

Mehani 2012 {published data only}

  1. Mehani SH. Autonomic adaptation and functional capacity outcomes after hospital-based cardiac rehabilitation post coronary artery bypass graft. Indian Journal of Physiotherapy and Occupational Therapy 2012;6(3):263.

Mezey 2008 {published data only}

  1. Mezey B, Kullmann L, Smith K, Sarolta B, Sandori K, Belicza E, et al. Outpatient cardiac rehabilitation: initial experience in the first Hungarian multicenter study. Orvosi Hetilap 2008;149(8):353-9. [DOI] [PubMed] [Google Scholar]

Midence 2016 {published data only}

  1. Midence L, Arthur HM, Oh P, Stewart DE, Grace SL. Women's health behaviours and psychosocial well-being by cardiac rehabilitation program model: a randomized controlled trial. Canadian Journal of Cardiology 2016;32(8):956-62. [DOI] [PubMed] [Google Scholar]
  2. Midence L, Oh P, Grace SL. Women's health care use following cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 2015;35(5):374. [Google Scholar]
  3. Midence L, Oh P, Grace SL. Women's risk factor control by cardiac rehabilitation program model: a randomized controlled trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2015;35(5):374-5. [Google Scholar]

Minneboo 2017 {published data only}

  1. Minneboo M, Lachman S, Snaterse M, Jorstad HT, Ter Riet G, Boekholdt S, et al. Community-based lifestyle intervention in patients with coronary artery disease: the RESPONSE-2 trial. Journal of the American College of Cardiology 2017;70(3):318-27. [DOI] [PubMed] [Google Scholar]

Moholdt 2012a {published data only}

  1. Moholdt T, Aamot IL, Granoien I, Gjerde L, Myklebust G, Walderhaug L, et al. Aerobic interval training increases peak oxygen uptake more than usual care exercise training in myocardial infarction patients: a randomized controlled study. Clinical Rehabilitation 2012;26:33-44. [DOI] [PubMed] [Google Scholar]

Moholdt 2012b {published data only}

  1. Moholdt T, Bekken Vold M, Grimsmo J, Slordahl SA, Wisloff U. Home-based aerobic interval training improves peak oxygen uptake equal to residential cardiac rehabilitation: a randomized, controlled trial. PLoS One 2012;7:e41199. [DOI] [PMC free article] [PubMed] [Google Scholar]

Molino‐Lova 2013 {published data only}

  1. Molino-Lova R, Pasquini G, Vannetti F, Paperini A, Forconi T, Polcaro P, et al. Effects of a structured physical activity intervention on measures of physical performance in frail elderly patients after cardiac rehabilitation: a pilot study with 1-year follow-up. Internal and Emergency Medicine 2013;8:581-9. [DOI] [PubMed] [Google Scholar]

Mozafari 2015 {published data only}

  1. Mozafari A, Moini L, Mohebi S, Hejazi SF, Marvi M, Doram VO, et al. Quality of life and assessment of efficacy of rehabiliation on improvement of quality of life and its supbtypes after PCI in Qom. Arak Medical University Journal 2015;18(5):88-96. [Google Scholar]

Murphy 2012 {published data only}

  1. Murphy SM, Edwards RT, Williams N, Raisanen L, Moore G, Linck P, et al. An evaluation of the effectiveness and cost effectiveness of the National Exercise Referral Scheme in Wales, UK: a randomised controlled trial of a public health policy initiative. Journal of Epidemiology & Community Health 2012;66:745-53. Erratum in: Journal of Epidemiology & Community Health 2012;66(11)1082. [DOI] [PMC free article] [PubMed] [Google Scholar]

Murphy 2020 {published data only}

  1. Meehan G, Koshy A, Kunniardy P, Murphy A, Farouque O, Yudi M. A systematic review and meta-analysis of randomized controlled trials assessing smartphone based cardiac rehabilitation in patients with coronary heart diseae. Journal of the American College of Cardiology 2020;75:2004. [Google Scholar]
  2. Murphy AC, Meehan G, Koshy AN, Kunniardy P, Farouque O, Yudi MB. Efficacy of smartphone-based secondary preventive strategies in coronary artery disease. Clinical Medicine Insights: Cardiology 2020;14:1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

NCT01941355 {unpublished data only}

  1. NCT01941355. Trial of rehabilitation in phase 1 after coronary artery bypass grafting (SheppHeart). clinicaltrials.gov/NCT01941355 (first posted 13 September 2013).

NCT02219815 {unpublished data only}

  1. NCT02219815. Pre-operative rehabilitation for reduction of hospitalization after coronary bypass and valvular surgery. clinicaltrials.gov/NCT02219815 (first posted 19 August 2014).

NCT02235753 {unpublished data only}

  1. NCT02235753. High-intensity exercise after acute cardiac event (HITCARE). clinicaltrials.gov/NCT02235753  (first posted 10 September 2014).

NCT02584192 {unpublished data only}

  1. NCT02584192. Efficacy of early home-based cardiac rehabilitation program for patients after acute myocardial infarction. clinicaltrials.gov/ct2/show/NCT02584192 (first posted 22 October 2015).

NCT02778165 {unpublished data only}

  1. NCT02778165. My Cardiac Recovery (MyCaRe): a pilot RCT. clinicaltrials.gov/ct2/show/NCT02778165 (first posted 19 May 2016).

NCT03415841 {unpublished data only}

  1. NCT03415841. Kardia - a smartphone-based care model for outpatient cardiac rehabilitation. clinicaltrials.gov/ct2/show/NCT03415841 (first posted 30 January 2018).

NCT03704025 {unpublished data only}

  1. NCT03704025. Home-based exercise training in cardiac patients. clinicaltrials.gov/ct2/show/NCT03704025 (first posted 12 October 2018).

NCT04271566 {unpublished data only}

  1. NCT04271566. Drug utilisation and lifestyle intervention study in patients attending cardiac outpatient clinic. clinicaltrials.gov/show/NCT04271566 (first posted 17 February 2020).

NCT04294940 {unpublished data only}

  1. NCT04294940. Impact of a digital solution (CardiCare™) on cardiorespiratory fitness improvement in patients discharged from a phase 2 cardiac rehabilitation following an acute coronary syndrome. clinicaltrials.gov/show/NCT04294940 (first posted 4 March 2020).

NCT04313777 {unpublished data only}

  1. NCT04313777. Virtual reality therapy in cardiology. clinicaltrials.gov/show/NCT04313777 (first posted 18 March 2020).

NCT04330560 {unpublished data only}

  1. NCT04330560. Electronic Activity Tracking System (EATs). clinicaltrials.gov/show/NCT04330560 (first posted 1 April 2020).

NCT04407624 {unpublished data only}

  1. NCT04407624. Effects of intermittent exercise training programs in patients with myocardial infarction. clinicaltrials.gov/show/NCT04407624 (first posted 29 May 2020).

NCT04409210 {unpublished data only}

  1. NCT04409210. Cardio-cerebrovascular co-prevention and co-management based on Internet+. clinicaltrials.gov/show/NCT04409210 (first posted 1 June 2020).

NCT04441086 {unpublished data only}

  1. NCT04441086. Emotion regulation intervention to sustain physical activity in rural-dwelling women and men after myocardial infarction. clinicaltrials.gov/show/NCT04441086 (first posted 22 June 2020).

Ngaage 2019 {published data only}

  1. Ngaage D, Mitchell N, Dean A, Hirst C, Akowuah E, Doherty P, et al. Feasibility study of early outpatient review and early cardiac rehabilitation after cardiac surgery: mixed-methods research design - a study protocol. BMJ Open 2019;9(12):8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Nichols 2020 {published data only}

  1. Nichols S, Taylor C, Goodman T, Page R, Kallvikbacka-Bennett A, Nation F, et al. Routine exercise-based cardiac rehabilitation does not increase aerobic fitness: a CARE CR study. International Journal of Cardiology 2020;305:25-34. [DOI] [PubMed] [Google Scholar]

Noites 2017 {published data only}

  1. Noites A, Freitas CP, Pinto J, Melo C, Vieira A, Albuquerque A, et al. Effects of a phase IV home-based cardiac rehabilitation program on cardiorespiratory fitness and physical activity. Heart, Lung & Circulation 2017;26(5):455-62. [DOI] [PubMed] [Google Scholar]

Okhomina 2020 {published data only}

  1. Okhomina VI, Seals SR, Anugu P, Adu-Boateng G, Sims M, Marshall GD. Adherence and retention of African Americans in a randomized controlled trial with a yoga-based intervention: the effects of health promoting programs on cardiovascular disease risk study. Ethnicity & Health 2020;25(6):812-24. [DOI] [PubMed] [Google Scholar]

Oliveira 2015 {published data only}

  1. Oliveira NL, Ribeiro F, Alves AJ, Silva G, Silva N, Guimaraes JT, et al. Exercise-based cardiac rehabilitation improves arterial stiffness on myocardial infarction patients: a randomized controlled trial. Medicine & Science in Sports & Exercise 2014;45:324-5. [Google Scholar]
  2. Oliveira NL, Ribeiro F, Silva G, Alves AJ, Silva N, Guimaraes JT, et al. Effect of exercise-based cardiac rehabilitation on arterial stiffness and inflammatory and endothelial dysfunction biomarkers: a randomized controlled trial of myocardial infarction patients. Atherosclerosis 2015;239(1):150-7. [DOI] [PubMed] [Google Scholar]

Olsen 2015 {published data only}

  1. Olsen RH, Pedersen LR, Jurs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. International Journal of Cardiology 2015;185:229-35. [DOI] [PubMed] [Google Scholar]
  2. Olsen RH, Pedersen LR, Snoer M, Haugaard SB, Prescott E. The effect of a 12-week interval training or weight loss program on coronary flow reserve in overweight patients with coronary artery disease: primary outcome of the randomised controlled CUT-IT trial. Circulation 2016;134:S46. [Google Scholar]
  3. Olsen RH, Pedersen LR, Snoer M, Jurs A, Haugaard SB, Prescott E. The effect of a 12-week interval training or weight loss program on coronary flow reserve in overweight patients with coronary artery disease: primary outcome of the randomised controlled CUT-IT trial. European Journal of Preventive Cardiology 2014;21:S46. [Google Scholar]
  4. Pedersen LR, Olsen RH, Anholm C, Astrup A, Eugen-Olsen J, Fenger M, et al. Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial. Cardiovascular Diebetology 2019;18(1):127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pedersen LR, Olsen RH, Anholm C, Walzern RL, Fenger M, Eugen-Olsen J, et al. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: a randomized trial. Atherosclerosis 2016;246:221-8. [DOI] [PubMed] [Google Scholar]
  6. Pedersen LR, Olsen RH, Haugaard SB, Prescott E. Weight loss or exercise to improve insulin sensitivity in overweight CAD patients? One year follow-up in the randomised CUT-IT trial. European Heart Journal 2016;37:925-6. [Google Scholar]
  7. Pedersen LR, Olsen RH, Jurs A, Astrup A, Chabanova E, Simonsen L, et al. A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: the CUT-IT trial. European Journal of Preventive Cardiology 2015;22(8):1009-17. [DOI] [PubMed] [Google Scholar]

Ozemek 2020 {published data only}

  1. Ozemek C, Strath SJ, Riggin K, Harber MP, Imboden MT, Kaminsky LA. Pedometer feedback interventions increase daily physical activity in phase III cardiac rehabilitation participants. Journal of Cardiopulmonary Rehabilitation and Prevention 2020;40(3):183-8. [DOI] [PubMed] [Google Scholar]

Parsa 2018 {published data only}

  1. Parsa A, Sadeghi M, Roghani F, Golshani J, Khani A, Yazdekhasti S. Effects of changes in myocardial dysfunction on quality of life in patients undergoing coronary angioplasty after cardiac rehabilitation. Iranian Heart Journal 2018;19(1):52-60. [Google Scholar]

Passaglia 2020 {published data only}

  1. Passaglia L, Nascimento BR, Brant LC, Ribeiro AL. Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): a randomized trial. Journal of the American College of Cardiology 2020;75(11):2003. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pedersen 2013 {published data only}

  1. Pedersen LR, Olsen RH, Frederiksen M, Astrup A, Chabanova E, Hasbak P, et al. Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol. BMC Cardiovascular Disorders 2013;13:106. [DOI] [PMC free article] [PubMed] [Google Scholar]

Peschel 2007 {published data only}

  1. Peschel T, Sixt S, Beitz F, Sonnabend M, Muth G, Thiele H, et al. High, but not moderate frequency and duration of exercise training induces downregulation of the expression of inflammatory and atherogenic adhesion molecules. European Journal of Cardiovascular Prevention and Rehabilitation 2007;14(3):476-82. [DOI] [PubMed] [Google Scholar]

Pfaeffli Dale 2015 {published data only}

  1. Pfaeffli Dale L, Whittaker R, Dixon R, Stewart R, Jiang Y, Yannan C, et al. Acceptability of a mobile health exercise-based cardiac rehabilitation intervention: a randomized trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2015;35(5):312-9. [DOI] [PubMed] [Google Scholar]
  2. Pfaeffli Dale L, Whittaker R, Jiang Y, Rolleston A, Stewart R, Maddison R. Effects of an mHealth cardiac rehabilitation intervention on lifestyle change: results from the Text4Heart randomised controlled trial. Heart, Lung and Circulation 2015;24:S77. [Google Scholar]

Piestrzeniewicz 2004 {published data only}

  1. Piestrzeniewicz K, Navarro-Kuczborska N, Bolinska H, Jegier A, Maciejewski M. The impact of comprehensive cardiac rehabilitation in young patients after acute myocardial infarction treated with primary coronary intervention on the clinical outcome and leading again a "normal" life [Korzystne efekty kompleksowej rehabilitacji kardiologicznej u osob do 55 roku zycia, po zawale miesnia sercowego, leczonych za pomoca pierwotnej angioplastyki]. Polskie Archiwum Medycyny Wewnetrznej 2004;111(3):309-17. [PubMed] [Google Scholar]

Pluss 2011 {published data only}

  1. Pluss CE, Billing E, Held C, Henriksson P, Kiessling A, Karlsson MR, et al. Long-term effects of an expanded cardiac rehabilitation programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study. Clinical Rehabilitation 2011;25:79-87. [DOI] [PubMed] [Google Scholar]

Pomeshkina 2017b {published data only}

  1. Pomeshkina SA, Loktionova EB, Arkhipova NV, Barbarash OL. Efficacy of home-based exercise training and adherence to therapy in patients after coronary artery bypass grafting. Kardiologiia 2017;1:23-9. [PubMed] [Google Scholar]

Poortaghi 2011 {published data only}

  1. Poortaghi S, Atri SB, Safayian A, Baghernia A. General health improves with home-based cardiac rehabilitation program. Saudi Medical Journal 2011;32:407-11. [PubMed] [Google Scholar]

Poortaghi 2013 {published data only}

  1. Poortaghi S, Baghernia A, Golzari SE, Safayian A, Atri SB. The effect of home-based cardiac rehabilitation program on self efficacy of patients referred to cardiac rehabilitation center. BMC Research Notes 2013;6:287. [DOI] [PMC free article] [PubMed] [Google Scholar]

Powell 2018 {published data only}

  1. Powell R, McGregor G, Ennis S, Kimani PK, Underwood M. Is exercise-based cardiac rehabilitation effective? A systematic review and meta-analysis to re-examine the evidence. BMJ Open 2018;8(3):14. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pozehl 2018 {published data only}

  1. Pozehl BJ, McGuire R, Duncan K, Kupzyk K, Norman J, Artinian NT, et al. Effects of the HEART camp trial on adherence to exercise in patients with heart failure. Journal of Cardiac Failure 2018;24(10):654-60. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pratesi 2019 {published data only}

  1. Pratesi A, Baldasseroni S, Barucci R, Pallante R, Foschini A, Venturini S, et al. Effects of cardiac rehabilitation in maintaining physical performance of patients aged >75 years over the long-term period, after an acute coronary syndrome or heart surgery. European Geriatric Medicine 2016;7:S20. [Google Scholar]
  2. Pratesi A, Baldasseroni S, Burgisser C, Orso F, Barucci R, Silverii M, et al. Long-term functional outcomes after cardiac rehabilitation in older patients. Data from the Cardiac Rehabilitation in Advanced aGE: EXercise TRaining and Active follow-up (CR-AGE EXTRA) randomised study. European Journal of Preventive Cardiology 2019;26(14):1470-8. [DOI] [PubMed] [Google Scholar]

Raghuram 2014 {published data only}

  1. Raghuram N, Parachuri VR, Swarnagowri MV, Babu S, Chaku R, Kulkarni R, et al. Yoga based cardiac rehabilitation after coronary artery bypass surgery: one-year results on LVEF, lipid profile and psychological states--a randomized controlled study. Indian Heart Journal 2014;66(5):490-502. [DOI] [PMC free article] [PubMed] [Google Scholar]

Rakhshan 2019 {published data only}

  1. Rakhshan M, Toufigh A, Dehghani A, Yakatalab S. Effect of cardiac rehabilitation on sexual satisfaction among patients after coronary artery bypass graft surgery. Journal of Cardiopulmonary Rehabilitation and Prevention 2019;39(6):E26-E30. [DOI] [PubMed] [Google Scholar]

Rauch 2016 {published data only}

  1. Rauch B, Davos CH, Doherty P, Saure D, Metzendorf M, Salzwedel A, et al. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies - the Cardiac Rehabilitation Outcome Study (CROS). European Journal of Preventive Cardiology 2016;23(18):1914-39. [DOI] [PMC free article] [PubMed] [Google Scholar]

Regan 2020 {published data only}

  1. Regan R, Sampath KK, Devan H, Arumugam A. Effectiveness of physiotherapy interventions on disease-specific and generic outcomes for individuals with cardiovascular diseases in India – a systematic review and meta-analysis. Physical Therapy Reviews 2020;25(3):159-74. [Google Scholar]

Ribeiro 2012 {published data only}

  1. Ribeiro F, Alves AJ, Teixeira M, Miranda F, Azevedo C, Duarte JA, et al. Exercise training enhances autonomic function after acute myocardial infarction: a randomized controlled study. Revista Portuguesa de Cardiologia 2012;31:135-41. [DOI] [PubMed] [Google Scholar]

Rideout 2012 {published data only}

  1. Rideout A, Lindsay G, Godwin J. Patient mortality in the 12 years following enrolment into a pre-surgical cardiac rehabilitation programme. Clinical Rehabilitation 2012;26:642-7. [DOI] [PubMed] [Google Scholar]

Roviaro 1984 {published data only}

  1. Roviaro S, Holmes DS, Holmsten RD. Influence of a cardiac rehabilitation program on the cardiovascular, psychological, and social functioning of cardiac patients. Journal of Behavioral Medicine 1984;7(1):61-81. [DOI] [PubMed] [Google Scholar]

Sadeghi 2013 {published data only}

  1. Sadeghi M, Garakyaraghi M, Khosravi M, Taghavi M, Sarrafzadegan N, Roohafza H. The impacts of cardiac rehabilitation program on echocardiographic parameters in coronary artery disease patients with left ventricular dysfunction. Cardiology Research and Practice 2013;2013. [DOI] [PMC free article] [PubMed]

Sagar 2012 {published data only}

  1. Sagar N, Bangi NA, Moiz JA. Effect of supervised versus home based phase II cardiac rehabilitation program on exercise capacity and quality of life in post CABG patients. Indian Journal of Physiotherapy and Occupational Therapy - An International Journal 2012;6:59-64.

Salzwedel 2020 {published data only}

  1. Salzwedel A, Jensen K, Rauch B, Doherty P, Metzendorf MI, Hackbusch M, et al. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: update of the Cardiac Rehabilitation Outcome Study (CROS-II). European Journal of Preventive Cardiology 2020;27(16):1756-74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Sangster 2015 {published data only}

  1. Sangster J, Furber S, Allman-Farinelli M, Phongsavan P, Redfern J, Haas M, et al. Effectiveness of a pedometer-based telephone coaching program on weight and physical activity for people referred to a cardiac rehabilitation program. A randomized controlled trial. Journal of Cardiopulmonary Rehabilitation and Prevention 2015;35(2):124-9. [DOI] [PubMed] [Google Scholar]

Sankaran 2019 {published data only}

  1. Sankaran S, Dendale P, Coninx K. Evaluating the impact of the HeartHab app on motivation, physical activity, quality of life, and risk factors of coronary artery disease patients: multidisciplinary crossover study. JMIR mHealth and uHealth 2019;7(4):e10874. [DOI] [PMC free article] [PubMed] [Google Scholar]

Sato 2010 {published data only}

  1. Sato S, Makita S, Uchida R, Ishihara S, Masuda M. Effect of Tai Chi training on baroreflex sensitivity and heart rate variability in patients with coronary heart disease. International Heart Journal 2010;51:238-41. [DOI] [PubMed] [Google Scholar]

Sawatzky 2014 {published data only}

  1. Sawatzky JA, Kehler DS, Ready AE, Lerner N, Boreskie S, Lamont D, et al. Prehabilitation program for elective coronary artery bypass graft surgery patients: a pilot randomized controlled study. Clinical Rehabilitation 2014;28:648-57. [DOI] [PubMed]

Schneider 2020 {published data only}

  1. Schneider LH, Hadjistavropoulos HD, Dear BF, Titov N. Efficacy of internet-delivered cognitive behavioural therapy following an acute coronary event: a randomized controlled trial. Internet Interventions 2020;21:12. [DOI] [PMC free article] [PubMed] [Google Scholar]

Schwaab 2011 {published data only}

  1. Schwaab B, Waldmann A, Katalinic A, Sheikhzadeh A, Raspe H. Inpatient cardiac rehabilitation versus medical care - a prospective multicentre controlled 12 months follow-up in patients with coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation 2011;18:581-6. [DOI] [PubMed] [Google Scholar]

Sen 2018 {published data only}

  1. Sen N, Tanwar S, Jain A. Better cardiovascular outcomes of combined specific indian yoga and aerobic exercise in obese coronary patients with type 2 diabetes. Journal of the American College of Cardiology 2018;71(11):2115. [Google Scholar]

Shabani 2010 {published data only}

  1. Shabani R, Gaeini AA, Nikoo MR, Nikbackt H, Sadegifar M. Effect of cardiac rehabilitation program on exercise capacity in women undergoing coronary artery bypass graft in Hamadan-Iran. International Journal of Preventive Medicine 2010;1:247-51. [PMC free article] [PubMed] [Google Scholar]

Shikhova 2010 {published data only}

  1. Shikhova EV, Guliaeva SF, Tsarev Iu K, Chervotkina LA. Clinical and cost effectiveness of rehabilitation programs including physical exercises for patients with ischemic heart disease under conditions of resort and outpatient clinics. Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury 2010;6:9-12. [PubMed] [Google Scholar]

Siqueira‐Catania 2013 {published data only}

  1. Siqueira-Catania A, Cezaretto A, Barros CR, Salvador EP, Dos Santos TC, Ferreira SR. Cardiometabolic risk reduction through lifestyle intervention programs in the Brazilian public health system. Diabetology & Metabolic Syndrome 2013;5:21. [DOI] [PMC free article] [PubMed] [Google Scholar]

Sokhteh 2020 {published data only}

  1. Sokhteh AS, Mofrad ZP, Rafizadeh O, Yaghoubinia F. The effect of cardiac rehabilitation program on functional capacity and waist to hip ratio in patients with coronary artery disease: a clinical trial. Japan Journal of Nursing Science 2020 Oct 27 [Epub ahead of print]. [DOI: 10.1111/jjns.12386] [DOI] [PubMed]

Soleimannejad 2014 {published data only}

  1. Soleimannejad K, Nouzari Y, Ahsani A, Nejatian M, Sayehmiri K. Evaluation of the effect of cardiac rehabilitation on left ventricular diastolic and systolic function and cardiac chamber size in patients undergoing percutaneous coronary intervention. Journal of Tehran University Heart Center 2014;9:54-8. [PMC free article] [PubMed] [Google Scholar]

Son 2008 {published data only}

  1. Son YJ. The development and effects of an integrated symptom management program for prevention of recurrent cardiac events after percutaneous coronary intervention. Journal of Korean Academy of Nursing 2008;38(2):217-28. [DOI] [PubMed] [Google Scholar]

Stahle 1999 {published data only}

  1. Stahle A, Nordlander R, Ryden L, Mattsson E. Effects of organized aerobic group training in elderly patients discharged after an acute coronary syndrome. A randomized controlled study. Scandinavian Journal of Rehabilitation Medicine 1999;31:101-7. [DOI] [PubMed] [Google Scholar]

Stammers 2015 {published data only}

  1. Stammers AN, Kehler DS, Afilalo J, Avery LJ, Bagshaw SM, Grocott HP, et al. Protocol for the PREHAB study - Pre-operative Rehabilitation for reduction of Hospitalization After coronary Bypass and valvular surgery: a randomised controlled trial. BMJ Open 2015;5(3):e007250. [DOI] [PMC free article] [PubMed] [Google Scholar]

Stenlund 2005 {published data only}

  1. Stenlund T, Lindström B, Granlund M, Burell G. Cardiac rehabilitation for the elderly: Qi Gong and group discussions. European Journal of Cardiovascular Prevention and Rehabilitation 2005;12(1):5-11. [PubMed] [Google Scholar]

Su 2020 {published data only}

  1. Su JJ, Yu DS, Paguio JT. Effect of eHealth cardiac rehabilitation on health outcomes of coronary heart disease patients: a systematic review and meta-analysis. Journal of Advanced Nursing 2020;76(3):754-72. [DOI] [PubMed] [Google Scholar]

Subedi 2020 {published data only}

  1. Subedi N, Rawstorn JC, Gao L, Koorts H, Maddison R. Implementation of telerehabilitation interventions for the self-management of cardiovascular disease: systematic review. JMIR mHealth and uHealth 2020;8(11):17. [DOI] [PMC free article] [PubMed] [Google Scholar]

Taguchi 2015 {published data only}

  1. Taguchi T, Adachi H, Hoshizaki H, Oshima S, Kurabayashi M. Effect of physical training on ventilatory patterns during exercise in patients with heart disease. Journal of Cardiology 2015;65:343-8. [DOI] [PubMed] [Google Scholar]

Takeyama 2000 {published data only}

  1. Takeyama J, Itoh H, Kato M, Koike A, Aoki K, Fu LT, et al. Effects of physical training on the recovery of the autonomic nervous activity during exercise after coronary artery bypass grafting: effects of physical training after CABG. Japanese Circulation Journal 2000;64(11):809-13. [DOI] [PubMed] [Google Scholar]

Taylor‐Piliae 2020 {published data only}

  1. Taylor-Piliae RE, Finley BA. Tai Chi exercise for psychological well-being among adults with cardiovascular disease: a systematic review and meta-analysis. European Journal of Cardiovascular Nursing 2020;19(7):580-91. [DOI] [PubMed] [Google Scholar]

Thakkar 2016 {published data only}

  1. Thakkar J, Redfern J, Thiagalingam A, Chow CK. Patterns, predictors and effects of texting intervention on physical activity in CHD - insights from the TEXT ME randomized clinical trial. European Journal of Preventive Cardiology 2016;23(17):1894-902. [DOI] [PubMed] [Google Scholar]

Thompson 2020 {published data only}

  1. Thompson G, Davison GW, Crawford J, Hughes CM. Exercise and inflammation in coronary artery disease: a systematic review and meta-analysis of randomised trials. Journal of Sport Sciences 2020;38(7):814-26. [DOI] [PubMed] [Google Scholar]

Tokmakidis 2003 {published data only}

  1. Tokmakidis SP, Volaklis KA. Training and detaining effects of a combined-strength and aerobic exercise program on blood lipids in patients with coronary artery disease. Journal of Cardiopulmonary Rehabilitation 2003;23(3):193-200. [DOI] [PubMed] [Google Scholar]
  2. Volaklis KA, Douda HT, Kokkinos PF, Tokmakidis SP. Physiological alterations to detraining following prolonged combined strength and aerobic training in cardiac patients. European Journal of Cardiovascular Prevention and Rehabilitation 2006;13(3):375-80. [DOI] [PubMed] [Google Scholar]

Treskes 2020 {published data only}

  1. Treskes RW, Van Winden LA, Van Keulen N, Van der Vekde ET, Beeres SL, Atsma DE, et al. Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial. JAMA Network Open 2020;3(4):e202165. [DOI] [PMC free article] [PubMed] [Google Scholar]

Turkstra 2013 {published data only}

  1. Turkstra E, Hawkes AL, Oldenburg B, Scuffham PA. Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart). BMC Cardiovascular Disorders 2013;13(1):33. [DOI] [PMC free article] [PubMed] [Google Scholar]

Uhlemann 2012 {published data only}

  1. Uhlemann M, Adams V, Lenk K, Linke A, Erbs S, Adam J, et al. Impact of different exercise training modalities on the coronary collateral circulation and plaque composition in patients with significant coronary artery disease (EXCITE trial): study protocol for a randomized controlled trial. Trials 2012;13:167. [DOI] [PMC free article] [PubMed] [Google Scholar]

Ul‐Haq 2019 {published data only}

  1. Ul-Haq Z, Khan D, Hisam A, Yousafzai YM, Hafeez S, Zulfiqar F, et al. Effectiveness of cardiac rehabilitation on health-related quality of life in patients with myocardial infarction in Pakistan. Journal of the College of Physicians and Surgeons--Pakistan 2019;29(9):803-9. [DOI] [PubMed] [Google Scholar]

Van Steenbergen 2020 {published data only}

  1. Van Steenbergen GJ, Van Veghel D, Ter Woorst J, Van Lieshout D, Dekker L. IMPROV-ED trial: eHealth programme for faster recovery and reduced healthcare utilisation after CABG. Netherlands Heart Journal 2020;29(2):80-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Vieira 2017 {published data only}

  1. Vieira A, Melo C, Machado J, Gabriel J. Virtual reality exercise on a home-based phase III cardiac rehabilitation program, effect on executive function, quality of life and depression, anxiety and stress: a randomized controlled trial. Disability and Rehabilitation. Assistive Technology 2018;13(2):112-23. [DOI] [PubMed] [Google Scholar]
  2. Vieira AS, Cristina Damas Argel de Melo M, Andreia Raquel Santos Noites SP, Machado JP, Joaquim Gabriel MM. The effect of virtual reality on a home-based cardiac rehabilitation program on body composition, lipid profile and eating patterns: a randomized controlled trial. European Journal of Integrative Medicine 2017;9:69-78. [Google Scholar]

Walters 2010 {published data only}

  1. Walters DL, Sarela A, Fairfull A, Neighbour K, Cowen C, Stephens B, et al. A mobile phone-based care model for outpatient cardiac rehabilitation: the care assessment platform (CAP). BMC Cardiovascular Disorders 2010;10:8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Wang J 2020 {published data only}

  1. Wang J. Clinical efficacy of early cardiac rehabilitation nursing for patients with acute myocardial infarction after interventional therapy. International Journal of Clinical and Experimental Medicine 2020;13(10):7986-92. [Google Scholar]

Wang JW 2020 {published data only}

  1. Wang JW, Zeng ZC, Dong R, Sheng JJ, Lai YQ, Yu JB, et al. Efficacy of a WeChat based intervention to adherence to secondary prevention in patients undergoing coronary artery bypass graft in China: a randomized controlled trial. Journal of Telemedicine & Telecare 2020;0(0):1-9. [DOI] [PubMed] [Google Scholar]

Wang ZP 2019 {published data only}

  1. Wang ZP, Ji LL, Xiang AX, Wang YC, Jiang DJ, Zhang N, et al. Effect of cardiac rehabilitation on cardiopulmonary function in patients with diabetes mellitus complicated with acute myocardial infarction and heart failure. Investigacion Clinica 2019;60(3):506-14. [Google Scholar]

Wang ZQ 2019 {published data only}

  1. Wang ZQ, Peng X, Li K, Wu CJ. Effects of combined aerobic and resistance training in patients with heart failure: a meta-analysis of randomized, controlled trials. Nursing & Health Sciences 2019;21(2):148-56. [DOI] [PubMed] [Google Scholar]

Wienbergen 2020 {published data only}

  1. Weinbergen H, Fach A, Erdmann J, Katalinic A, Eisemann N, Krawitz P, et al. New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial. Clinical Research in Cardiology 2020;110(2):153-61. [DOI] [PubMed] [Google Scholar]

Wong 2020 {published data only}

  1. Wong EM, Chair SY, Leung DY, Sit JW, Chan AW, Leung KC. The effect of an e-health web-based support programme on psychological outcomes and health related quality of life among Chinese patients with coronary heart disease: a parallel-group randomised controlled trial. Lancet 2018;388:86. [Google Scholar]
  2. Wong EM, Chair SY, Leung DYP, Sit JW. Randomized controlled trial on amount of physical exercise of a home-based e-health educational intervention for middle-aged adults with coronary heart disease. Journal of the Hong Kong College of Cardiology 2016;24:A21. [Google Scholar]
  3. Wong EM, Leung DYP, Chair S, Sit JW. Effects of a web‐based educational support intervention on total exercise and cardiovascular risk markers in adults with coronary heart disease. Worldviews on Evidence-Based Nursing 2020;17(4):283-92. [DOI] [PubMed] [Google Scholar]

Wood 2008 {published data only}

  1. Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012. [DOI] [PubMed]

Wosornu 1996 {published data only}

  1. Wosornu D, Bedford D, Ballantyne D. A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgery. European Heart Journal 1996;17(6):854-63. [DOI] [PubMed] [Google Scholar]

Xia 2018 {published data only}

  1. Xia T, Huang F, Peng Y, Huang B, Pu X, Yang Y, et al. Efficacy of different types of exercise-based cardiac rehabilitation on coronary heart disease: a network meta-analysis. Journal of General Internal Medicine 2018;33(12):2201-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Ximenes 2015 {published data only}

  1. Ximenes NN, Borges DL, Lima RO, Barbosa e Silva MG, Silva LN, Costa MA, et al. Effects of resistance exercise applied early after coronary artery bypass grafting: a randomized controlled trial. Brazilian Journal of Cardiovascular Surgery 2015;30(6):620-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Yamamoto 2016 {published data only}

  1. Yamamoto S, Hotta K, Ota E, Mori R, Matsunaga A. Effects of resistance training on muscle strength, exercise capacity, and mobility in middle-aged and elderly patients with coronary artery disease: a meta-analysis. Journal of Cardiology 2016;68(2):125-34. [DOI] [PubMed] [Google Scholar]

Yang 2017 {published data only}

  1. Yang X, Li Y, Ren X, Xiong X, Wu L, Li J, et al. Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Scientific Reports 2017;7:44789. [DOI] [PMC free article] [PubMed] [Google Scholar]

Yonezawa 2009 {published data only}

  1. Yonezawa R, Masuda T, Matsunaga A, Takahashi Y, Saitoh M, Ishii A, et al. Effects of phase II cardiac rehabilitation on job stress and health-related quality of life after return to work in middle-aged patients with acute myocardial infarction. International Heart Journal 2009;50(3):279-90. [DOI] [PubMed]

Yudi 2020 {published data only}

  1. Yudi M, Farouque O, Jelinek M. Can a smartphone-based secondary prevention program facilitate early mobilisation in patients with acute coronary syndromes? Heart Lung and Circulation 2015;24:S450. [Google Scholar]
  2. Yudi MB, Clark DJ, Tsang D, Jelinek M, Kalten K, Joshi S, et al. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial. Coronary Artery Disease 2020;16(1):170. [DOI] [PubMed] [Google Scholar]
  3. Yudi MB, Clark DJ, Tsang D, Jelinek M, Kalten K, Joshi S, et al. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol. BMC Cardiovascular Disorders 2016;16:170. [DOI] [PMC free article] [PubMed] [Google Scholar]

Zetta 2011 {published data only}

  1. Zetta S, Smith K, Jones M, Allcoat P, Sullivan F. Evaluating the angina plan in patients admitted to hospital with angina: a randomized controlled trial. Cardiovascular Therapeutics 2011;29(2):112-24. [DOI] [PubMed] [Google Scholar]

Zhang 2019 {published data only}

  1. Zhang H, Chang R. Effects of exercise after percutaneous coronary intervention on cardiac function and cardiovascular adverse events in patients with coronary heart disease: systematic review and meta-analysis. Journal of Sports Science & Medicine 2019;18(2):213-22. [PMC free article] [PubMed] [Google Scholar]

Zhang 2020 {published data only}

  1. Zhang YP, Hu RX, Han M, Lai BY, Liang SB, Chen BJ, et al. Evidence base of clinical studies on Qi Gong: a bibliometric analysis. Complementary Therapies in Medicine 2020;50:8. [DOI] [PubMed] [Google Scholar]

Zhao 2018 {published data only}

  1. Zhao F, Lin Y, Zhai L, Gao C, Zhang J, Ye Q, et al. Effects of cardiac rehabilitation qigong exercise in patients with stable coronary artery disease undergoing phase III rehabilitation: a randomized controlled trial (with video). Journal of Traditional Chinese Medical Sciences 2018;5(4):420-30. [Google Scholar]

Zheng 2008 {published data only}

  1. Zheng H, Luo M, Shen Y, Ma Y, Kang W. Effects of 6 months exercise training on ventricular remodelling and autonomic tone in patients with acute myocardial infarction and percutaneous coronary intervention. Journal of Rehabilitation Medicine 2008;40(9):776-9. [DOI] [PubMed] [Google Scholar]

Zhu 2013 {published data only}

  1. Zhu LX, Ho SC, Sit JW. The effect of a TTM-based exercise stage-matched intervention on angina in patients with coronary heart disease: a randomized controlled trial. International Journal of Cardiology 2013;1:S6. [DOI] [PubMed] [Google Scholar]

Zhu 2014 {published data only}

  1. Zhu L, Ho S, Sit JW, He H. Effect of a transtheoretical model-based stage-matched exercise intervention on exercise behavior and angina in patients with coronary heart disease: a randomized controlled trial: retraction. Journal of Cardiovascular Nursing 2014;29(5):471. Retraction of doi:10.1097/JCN.0000000000000162. [DOI] [PubMed]

References to studies awaiting assessment

Aronov 2006 {published data only}

  1. Aronov DM, Krasnitski VB, Bubnova MG, Posdniakov IuM, Ioseliani DV, Shchegol'kov AN, et al. Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia). Terapevticheskii Arkhiv 2006;78(9):33-8. [PubMed] [Google Scholar]

Belardinelli 2007 {published data only}

  1. Belardinelli R, Lacalaprice F, Piccoli G, Iacobone G, Piva R. Long-term benefits of cardiac rehabilitation in patients with incomplete revascularization: 5-year follow-up. Circulation 2007;116(16):3543. [Google Scholar]

Bubnova 2015 {published data only}

  1. Bubnova M, Aronov D, Krasnitsky V, Novikova N. Effectiveness of physical rehabilitation in hypertensive patients after acute myocardial infarction treated with primary coronary intervention. Journal of Hypertension 2015;33:e136. [Google Scholar]

Chen 2020 {published data only}

  1. Chen M, Liang X, Kong L, Wang J, Wang F, Hu X, et al. Effect of Baduanjin Sequential Therapy on the quality of life and cardiac function in patients with AMI after PCI: a randomized controlled trial. Evidence-based Complementary & Alternative Medicine 2020;8171549:[DOI:org/10.1155/2020/8171549]. [DOI] [PMC free article] [PubMed] [Google Scholar]

Ghroubi 2012 {published data only}

  1. Ghroubi S, Elleuch W, Abid L, Kammoun S, Elleuch MH. The effects of cardiovascular rehabilitation after coronary stenting [Apport de la readaptation cardiovasculaire dans les suites d'une angioplastie transluminale]. Annals of Physical and Rehabilitation Medicine 2012;55:e307+e309. [Google Scholar]

Lubinskaya 2014 {published data only}

  1. Lubinskaya E, Nikolaeva O. Cost-effectiveness of 2-year comprehensive cardiac rehabilitation program after coronary bypass surgery. European Journal of Preventive Cardiology 2014;21:S74. [Google Scholar]

Marques‐Sule 2016 {published data only}

  1. Marques-Sule E, Sempere-Rubio N, Villaplana-Torres LA, Espi-Lopez GV, Mesa Rico R, Timonet Andreu E, et al. Cardiac rehabilitation in order to manage arterial pressure in elders after acute coronary syndrome. European Journal of Cardiovascular Nursing 2016;15:S103-4. [Google Scholar]
  2. Marques-Sule E, Sempere-Rubio N, Villaplana-Torres LA, Espi-Lopez GV, Mesa Rico R, Timonet Andreu E, et al. Effectiveness of an exercise-based physiotherapy programme on exercise capacity after an acute coronary syndrome. European Journal of Cardiovascular Nursing 2016;15:S51-2. [Google Scholar]

NCT00725088 {unpublished data only}

  1. NCT00725088. Study of rehabilitation therapy on patients after acute myocardial infarction. clinicaltrial.gov/NCT00725088 (first posted 30 July 2008).

Pater 2000 {published data only}

  1. Pater C, Jacobsen C, Rollag A, Sandvik L, Erikssen J, Kogstad E. Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study). Current Controlled Trials in Cardiovascular Medicine 2000;1(3):177-83. [DOI] [PMC free article] [PubMed] [Google Scholar]

Pomeshkina 2014 {published data only}

  1. Pomeshkina SS, Loktionova EB, Arkhipova NV, Barbarash OL. Physical exercise and compliance with nonpharmacologic treatment of patients with coronary artery disease undergoing coronary artery bypass grafting. European Journal of Preventive Cardiology 2014;21:S107. [Google Scholar]

Rymuza 2019 {published data only}

  1. Rymuza H, Dabrowski R, Krauze N, Kowalik I, Smolis-Bak E, Ciszewski A, et al. Exercise training after acute coronary syndromes in the octogenarians has beneficial effect on the course of the disease and the exercise tolerance: single-center, prospective 12-months evaluation. European Heart Journal 2019;40(Suppl 1):2814. [Google Scholar]

Sin'kova 2014 {published data only}

  1. Sin'kova MN, Isakov LK, Pepeliaeva TV, Tarasov NI, Tepliakov AT, Mikharliamov FI. The economic analysis of the total cost of rehabilitation of the patients suffering from coronary heart disease. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury 2014;6:22-5. [PubMed] [Google Scholar]

Von Roeder 2011 {unpublished data only}

  1. Von Roeder MD, Adams V, Walther C, Erbs S, Linke A, Hambrecht R, et al. Exercise training vs. PCI/stenting in stable coronary artery disease: long term effects on antiatherosclerotic mediators. European Heart Journal 2011;32:226-7. [Google Scholar]

Walther 2010 {unpublished data only}

  1. Walther C, Fiess A. Preoperative exercise training is associated with less peri- and postoperative adverse events but similar long term outcome in patients with stable coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation 2010;17:S59. [Google Scholar]

References to ongoing studies

ACTRN12616001204437 {unpublished data only}

  1. ACTRN12616001204437. Tai Chi for stress and cardiovascular function. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=369625 (date registered 31 August 2016).

CTRI/2017/07/008951 {unpublished data only}

  1. CTRI/2017/07/008951. Efficacy of YOGA in Indian patients with coronary artery disease. www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=16214&EncHid=&modid=&compid=%27,%2716214det%27 (registered on 3 July 2017).

CTRI/2017/10/009981 {unpublished data only}

  1. CTRI/2017/10/009981. Efficacy of yoga based cardiac rehabilitation on clinical outcomes in post CABG patients: a randomized controlled trial. www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=16258&EncHid=&modid=&compid=%27,%2716258det%27 (registered on 3 October 2017).

CTRI/2019/06/019948 {unpublished data only}

  1. CTRI/2019/06/019948. Effect of cardiac rehabilitation in patients undergone myocardial infarction and percutaneouscoronary intervention. www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=32819&EncHid=&modid=&compid=%27,%2732819det%27 (registered on 28 June 2019).

NCT00756379 {published data only}

  1. NCT00756379. Century trial, a randomized lifestyle modification study for management of stable coronary artery disease (Century). clinicaltrials.gov/ct2/show/NCT00756379 (first posted 22 September 2008).

NCT02025257 {unpublished data only}

  1. NCT02025257. Effects of exercise in patients with coronary artery disease aged 80 years or older. clinicaltrials.gov/NCT02025257 (first posted 1 January 2014).

NCT03102346 {unpublished data only}

  1. NCT03102346. efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs (ASSIST). clinicaltrials.gov/ct2/show/NCT03102346 (first posted 5 April 2017).

NCT03375944 {published data only}

  1. NCT03375944. Utilisation of telemedicine in optimal cardiac rehabilitation program in patients after myocardial revascularization (RESTORE). clinicaltrials.gov/ct2/show/NCT03375944 (first posted 18 December 2017).

NCT03584828 {published data only}

  1. NCT03584828. Tele-cardiac rehabilitation program. clinicaltrials.gov/ct2/show/NCT03584828 (first posted 12 July 2018).

NCT03905187 {published data only}

  1. NCT03905187. Stress management modified cardiac rehabilitation in patients after acute myocardial infarction or heart failure. https://clinicaltrials.gov/ct2/show/NCT03905187 (first posted 5 April 2019).

NCT03978130 {published data only}

  1. NCT03978130. Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (RESILIENT). clinicaltrials.gov/ct2/show/NCT03978130 (first posted 6 June 2019).

NCT04425057 {unpublished data only}

  1. NCT04425057. Effect of a high intensity interval training in elderly with ischemic heart disease. clinicaltrials.gov/ct2/show/NCT04425057 (first posted 11 June 2020).

NCT04438356 {unpublished data only}

  1. NCT04438356. M-Health care for patients after AMI on disease perception, self-efficacy, anxiety and cardio-respiratory fitness. clinicaltrials.gov/ct2/show/NCT04438356 (first posted 18 June 2020).

NCT04511182 {unpublished data only}

  1. NCT04511182. Early individualized-exercise based cardiac rehabilitation programs in patients with acute myocardial infarction. clinicaltrials.gov/ct2/show/NCT04511182 (first posted 13 August 2020).

NCT04858503 {published data only}

  1. NCT04858503. An internet-based cardiac rehabilitation enhancement (i-CARE) Intervention to support self-care of patients with coronary artery disease. clinicaltrials.gov/ct2/show/NCT04858503 (first posted 26 April 2021).

Additional references

Anderson 2017

  1. Anderson L, Nguyen TT, Dall CH, Burgess L, Bridges C, Taylor RS. Exercise-based cardiac rehabilitation in heart transplant recipients. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No: CD012264. [DOI: 10.1002/14651858.CD012264.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]

Aronov 2002

  1. Aronov DM, Zaitsev VP. Assessment of quality of life of patients with cardiovascular diseases. Kardiologiia 2002;42:92-5. [PubMed] [Google Scholar]

BACPR 2017

  1. British Association for Cardiovascular Prevention and Rehabilitation. The BACPR Standards and Core Components for Cardiovascular Disease Prevention and Rehabilitation 2017 (3rd Edition). Available at www.bacpr.com/resources/BACPR_Standards_and_Core_Components_2017.pdf (accessed 12 January 2021).

Balshem 2011

  1. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64:401–6. [DOI] [PubMed] [Google Scholar]

BHF 2020

  1. British Heart Foundation (BHF). Heart Statistics. www.bhf.org.uk/what-we-do/our-research/heart-statistics (accessed prior to 20 September 2021).

Briggs 2017

  1. Briggs A, LLoyd A, Pickard SS. Minimal clinically important difference in Eq-5D: we can calculate it, but does that mean we should? . www.ispor.org/docs/default-source/presentations/1066.pdf?sfvrsn=25feffd6_1 (accessed June 2021).

Campbell 2020

  1. Campbell M, McKenzie JE, Sowden A, Katikreddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020;368:I6890. [DOI: 10.1136/bmj.l6890] [DOI] [PMC free article] [PubMed] [Google Scholar]

Clausen 1976

  1. Clausen JP, Trap-Jensen J. Heart rate and arterial blood pressure during exercise in patients with angina pectoris: effects of exercise training and of nitroglycerin. Circulation 1976;53:436–42. [DOI] [PubMed] [Google Scholar]

Dalal 2015

  1. Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ 2015;351:h5000. [DOI: 10.1136/bmj.h5000] [DOI] [PMC free article] [PubMed] [Google Scholar]

Deeks 2011

  1. Deeks JJ, Higgins JP, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.

Egger 1997

  1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34. [DOI] [PMC free article] [PubMed] [Google Scholar]

GRADEpro GDT [Computer program]

  1. McMaster University (developed by Evidence Prime) GRADEpro GTD. Hamilton (ON): McMaster University (developed by Evidence Prime), accessed prior to 12 October 2021. Available at gradepro.org.

Hambrecht 2000

  1. Hambrecht R, Wolff A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. New England Journal of Medicine 2000;342:454–60. [DOI] [PubMed] [Google Scholar]

Heran 2008a

  1. Heran BS, Wong MM, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No: CD003823. [DOI: 10.1002/14651858.CD003823.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]

Heran 2008b

  1. Heran BS, Wong MMY, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No: CD003822. [DOI: 10.1002/14651858.CD003822.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]

Higgins 2011

  1. Higgins JP, Altman DG, Stene JA. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.

Huang 2021

  1. Huang R, Palmer SC, Cao Y, Zhang H, Sun Y, Su W, et al. Cardiac rehabilitation programs for chronic heart disease: a bayesian network meta-analysis. Canadian Journal of Cardiology 2021;37(1):162-71. [DOI] [PubMed] [Google Scholar]

Knuuti 2020

  1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal 2020;41:407-77. [DOI] [PubMed] [Google Scholar]

Kotseva 2018

  1. Kotseva K, Wood D, De Bacquer D, EUROASPIRE Investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. European Journal of Preventive Cardiology 2018;25(12):1242-51. [DOI] [PubMed] [Google Scholar]

Lefebvre 2019

  1. Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.cochrane-handbook.org.

Liberati 2009

  1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6:e1000100. [DOI] [PMC free article] [PubMed] [Google Scholar]

Long 2019

  1. Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ, Coats AJ, et al. Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No: CD003331. [DOI: 10.1002/14651858.CD003331.pub5] [DOI] [PMC free article] [PubMed] [Google Scholar]

Mensah 2017

  1. Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in cardiovascular mortality: possible causes and implications. Circulation Research 2017;120(2):366-80. [DOI] [PMC free article] [PubMed] [Google Scholar]

Nielsen 2019

  1. Nielsen KM, Zwisler AD, Taylor RS, Svendsen JH, Lindschou J, Anderson L, et al. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No: CD011828. [DOI: 10.1002/14651858.CD011828.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]

Pavy 2006

  1. Pavy B, Iliou MC, Meurin P, Tabet JY, Corone S. Safety of exercise training for cardiac patients: results of the French registry of complications during cardiac rehabilitation. Archives of Internal Medicine 2006;166:2329-34. [DOI] [PubMed] [Google Scholar]

Pelliccia 2020

  1. Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al, ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. European Heart Journal 2020 Aug 29 [Epub ahead of print]. [DOI: 10.1093/eurheartj/ehaa60] [DOI]

Peters 2017

  1. Peters AE, Keeley EC. Trends and predictors of participation in cardiac rehabilitation following acute myocardial infarction: data from the behavioral risk factor surveillance system. Journal of the American Heart Association 2017;7:e007664. [DOI] [PMC free article] [PubMed] [Google Scholar]

Piepoli 2010

  1. Piepoli MF, Corrà U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al, Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. European Journal of Cardiovascular Prevention & Rehabilitation 2010;17:1-17. [DOI] [PubMed] [Google Scholar]

Prabhakaran 2018

  1. Prabhakaran D, Anand S, Watkins D, Gaziano T, Wi Y, Mbanya JC, et al. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, third edition. Lancet 2018;391(10126):1224-36. [DOI] [PMC free article] [PubMed] [Google Scholar]

Review Manager 2014 [Computer program]

  1. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Risom 2017

  1. Risom SS, Zwisler AD, Johansen PP, Sibilitz KL, Lindschou J, Gluud C, et al. Exercise-based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No: CD011197. [DOI: 10.1002/14651858.CD011197.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]

Ruano‐Ravina 2016

  1. Ruano-Ravina A, Pena-Gil C, Abu-Assi E, Raposeiras S, Van 't Hof A, Meindersma E, et al. Participation and adherence to cardiac rehabilitation programs. A systematic review. International Journal of Cardiology 2016;223:436-43. [DOI] [PubMed] [Google Scholar]

Santiago de Araújo Pio 2019

  1. Santiago de Araújo Pio C, Chaves GS, Davies P, Taylor RS, Grace SL. Interventions to promote patient utilisation of cardiac rehabilitation. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No: CD007131. [DOI: 10.1002/14651858.CD007131.pub4] [DOI] [PMC free article] [PubMed] [Google Scholar]

Schünemann 2021

  1. Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, Guyatt GH. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.

Smith 2011

  1. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. Journal of the American College of Cardiology 2011;58(23):2432-46. [DOI] [PubMed] [Google Scholar]

StataCorp 2020 [Computer program]

  1. Stata Statistical Software: Release 16.1.. College Station, TX, USA: StataCorp, 2020. Available at www.stata.com.

Taylor 2006

  1. Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factors improvements? European Journal of Cardiopulmonary Rehabilitation 2006;136:369-74. [DOI] [PubMed] [Google Scholar]

Van Camp 1986

  1. Van Camp SP, Peterson RA. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA 1986;256:1160-3. [DOI] [PubMed] [Google Scholar]

WHO 2018

  1. World Health Organization. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. www.who.int/healthinfo/global_burden_disease/estimates/en/ (accessed prior to 12 October 2021).

Wyrwich 2004

  1. Wyrwich KW, Spertus JA, Koenke K, Tierney WM, Babu AN, Wolinsky FD. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. American Heart Journal 2004;147:615-22. [DOI] [PubMed] [Google Scholar]

References to other published versions of this review

Anderson 2016

  1. Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No: CD001800. [DOI: 10.1002/14651858.CD001800.pub3] [DOI] [PMC free article] [PubMed] [Google Scholar]

Heran 2011

  1. Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No: CD001800. [DOI: 10.1002/14651858.CD001800.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]

Jolliffe 2001

  1. Jolliffe J, Rees K, Taylor RR, Thompson DR, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No: CD001800. [DOI: 10.1002/14651858.CD001800] [DOI] [PubMed] [Google Scholar]

Sibilitz 2016

  1. Sibilitz KL, Berg SK, Tang LH, Risom SS, Gluud C, Lindschou J, et al. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No: CD010876. [DOI: 10.1002/14651858.CD010876.pub2] [DOI] [PubMed] [Google Scholar]

Taylor 2004

  1. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. American Journal of Medicine 2004;116(110):682-92. [DOI] [PubMed] [Google Scholar]

Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of Wiley

RESOURCES